dihydroxyphenylalanine has been researched along with fluorodopa f 18 in 767 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 22 (2.87) | 18.7374 |
| 1990's | 191 (24.90) | 18.2507 |
| 2000's | 224 (29.20) | 29.6817 |
| 2010's | 279 (36.38) | 24.3611 |
| 2020's | 51 (6.65) | 2.80 |
| Authors | Studies |
|---|---|
| Aigner, TG; Cohen, RM; Doudet, DJ; McLellan, CA | 1 |
| Barrio, JR; Bida, G; Bishop, A; Namavari, M; Satyamurthy, N | 1 |
| Fukumura, T; Goto, I; Ichiya, Y; Kato, M; Kuwabara, Y; Masuda, K; Otsuka, M; Sasaki, M; Shima, F | 1 |
| Calne, DB; Fahn, S; Heiman, GA; Nygaard, TG; Snow, BJ; Takahashi, H | 1 |
| Brooks, DJ; Frackowiak, RS; Lees, AJ; Sawle, GV; Wroe, SJ | 1 |
| Chan, GL; Holden, JE; Morrison, KS; Ruth, TJ | 1 |
| Cedarbaum, JM; Diksic, M; Evans, A; Gjedde, A; Guttman, M; Léger, G; Reches, A; Woodward, W | 1 |
| Bjurling, P; Hartvig, P; Hörnfelt, K; Långström, B; Lindner, KJ; Tedroff, J | 1 |
| Guillaume, M; Luxen, A; Melega, WP; Pike, VW; Solin, O; Wagner, R | 1 |
| Aigner, TG; Cohen, RM; Doudet, DJ; McLellan, CA; Wyatt, RJ | 1 |
| Argentini, M; Cogoli-Greuter, M; Mäder, T; Weinreich, R; Wiese, C; Winterhalter, KH | 1 |
| Barrio, JR; Grafton, SC; Hawk, TC; Hoffman, JM; Huang, SC; Luxen, A; Mahoney, DK; Mazziotta, JC; Melega, WP; Phelps, ME | 1 |
| Brooks, DJ; Findley, LJ; Ibanez, V; Marsden, CD; Playford, ED; Sawle, GV; Thompson, PD | 1 |
| Aigner, TG; Brücke, T; Cohen, RM; Doudet, DJ; McLellan, CA | 1 |
| Diksic, M; Dyve, S; Evans, A; Gjedde, A; Guttman, M; Kuwabara, H; Léger, G; Reith, J | 1 |
| Cogoli-Greuter, M; Weinreich, R; Wiese, C; Winterhalter, KH | 2 |
| Adam, MJ; Chan, GL; Hewitt, KA; Pate, BD; Ruth, TJ; Schofield, P | 1 |
| Bergman, J; Haaparanta, M; Laihinen, A; Rinne, JO; Rinne, UK; Ruotsalainen, U; Solin, O | 1 |
| Hatazawa, J; Ido, T; Ishiwata, K; Itoh, M; Matsumoto, M; Mejia, AA; Nakamura, T; Seo, S; Watabe, H; Watanuki, S | 1 |
| Bhatt, M; Calne, DB; Li, D; Martin, WR; Snow, BJ | 1 |
| Bhatt, MH; Calne, DB; Martin, WR; Peppard, R; Snow, BJ | 1 |
| Dunn, BB; Kiesewetter, DA | 1 |
| Adams, HR; Channing, MA; Dunn, BB; Goldstein, DS; Kiesewetter, DO; Kirk, KL | 1 |
| Brooks, DJ | 4 |
| Calne, DB; Hewitt, KA; Morrison, KS; Pate, BD; Ruth, TJ; Snow, BJ | 1 |
| Barrio, JR; Hoffman, JM; Melega, WP; Phelps, ME; Schneider, JS | 1 |
| Adams, HR; Aigner, TG; Cohen, RM; Doudet, DJ; Finn, RT; McLellan, CA; Miyake, H; Wyatt, R | 1 |
| Barrio, JR; Chen, B; Grafton, S; Hoffman, JM; Huang, SC; Mazziotta, JC; Melega, WP; Phelps, ME; Satyamurthy, N; Yu, DC | 1 |
| Kung, HF | 1 |
| Barrio, JR; Grafton, ST; Huang, SC; Melega, WP; Phelps, ME; Satyamurthy, N | 1 |
| Barrio, JR; Grafton, S; Hoffman, JM; Huang, SC; Mazziotta, JC; Melega, WP; Phelps, ME; Satyamurthy, N; Yu, DC | 1 |
| Fowler, JS; Wolf, AP | 1 |
| Brown, K; Chirakal, R; Firnau, G; Garnett, ES; Nahmias, C | 1 |
| Fletcher, JG; Kirk, KL; Phillips, RS; Von Tersch, RL | 1 |
| Barrio, JR; Luxen, A; Melega, WP; Nissenson, CH; Perlmutter, MM; Phelps, ME | 1 |
| Cantineau, R; Christiaens, L; Guillaume, M; Lemaire, C | 1 |
| Diksic, M; Dyve, S; Gjedde, A; Guttman, M; Kuwabara, H; Reith, J | 1 |
| Barrio, JR; Hoffman, JM; Luxen, A; Melega, WP; Nissenson, CH; Phelps, ME | 1 |
| Cedarbaum, J; Dhawan, V; Eidelberg, D; Fahn, S; Ginos, JZ; Greene, P; Moeller, JR; Rottenberg, DA; Sidtis, JJ; Strother, SC | 1 |
| Brooks, DJ; Frackowiak, RS; Jones, T; Leenders, KL; Marsden, CD; Perani, D; Sager, H; Salmon, EP; Tyrrell, P | 1 |
| DeJesus, OT; Nickles, R; Sunderland, JJ | 1 |
| Calne, DB; Johnston, RG; Martin, WR; McFarland, PA; McLean, DR; McPhee, MS; Petruk, KC; Schindel, DR; Wilson, AF; Witt, NJ | 1 |
| Barrio, JR; Hoffman, JM; Huang, SC; Mazziotta, JC; Melega, WP; Phelps, ME; Satyamurthy, N; Schneider, JS; Yu, DC | 1 |
| Barrio, JR; Bida, GT; Cook, JS; Luxen, A; Perlmutter, M; Phelps, ME; Satyamurthy, N; Van Moffaert, G | 1 |
| Kensett, MJ; Pike, VW; Silvester, DJ; Turton, DR; Waters, SL | 1 |
| Martin, WR; Myers, JA; Rosenberg, NL | 1 |
| Adams, HR; Chen, JJ; Chiueh, CC; Cohen, RM; Finn, RD; Francis, BE; Huang, SJ; Kirk, KL | 1 |
| Calne, DB; Martin, WR; Palmer, MR; Patlak, CS | 1 |
| Adam, MJ; Calne, DB; Chu, NS; Clark, C; Huang, CC; Li, D; Okada, J; Peppard, RF; Ruth, TJ; Wolters, EC | 1 |
| Adams, HR; Aigner, TG; Cohen, RM; Doudet, DJ; Finn, RT; McLellan, CA; Miyake, H; Wan, RQ | 1 |
| Hayden, MR; Martin, WR | 1 |
| Chirakal, R; Firnau, G; Garnett, ES; Nahmias, C; Schrobilgen, G; Sood, S | 1 |
| Chirakal, R; Firnau, G; Garnett, ES | 2 |
| Abeysekera, B; Adam, MJ; Grierson, JR; Pate, BD; Ruth, TJ | 1 |
| Chaly, T; Diksic, M | 1 |
| Boyes, BE; Cumming, P; Martin, WR; McGeer, EG | 1 |
| Chirakal, R; Firnau, G; Garnett, ES; Nahmias, C; Sood, S | 2 |
| Burns, RS; Chirakal, R; Chiueh, CC; Firnau, G; Garnett, ES; Kopin, IJ; Nahmias, C | 1 |
| Adam, MJ; Ammann, W; Bergstrom, M; Harrop, R; Laihinen, A; Martin, WR; Rogers, JG; Ruth, TJ; Sayre, CI; Stoessl, AJ | 1 |
| Adam, M; Boyes, BE; Cumming, P; Martin, WR; McGeer, EG; Ruth, TJ | 1 |
| Chirakal, R; Firnau, G; Garnett, ES; Lang, AE; Nahmias, C | 1 |
| Adam, MJ; Cumming, P; Grierson, J; Häusser, M; Martin, WR; McGeer, EG; Ruth, TJ | 1 |
| Frackowiak, RS; Leenders, KL; Lees, AJ | 1 |
| Firnau, G; Garnett, ES; Harvey, J | 1 |
| Diksic, M; Farrokhzad, S | 1 |
| Bergman, J; Haaparanta, M; Hietala, J; Kirvelä, O; Kuoppamäki, M; Räkköläinen, V; Ruotsalainen, U; Solin, O; Syvälahti, E; Vuorio, K | 1 |
| Antonini, A; Günther, I; Leenders, KL; Maguire, PR; Missimer, J; Psylla, M; Vontobel, P | 1 |
| Brooks, DJ; Morrish, PK; Sawle, GV | 2 |
| Defer, G; Fénelon, G; Fontaine, A; Frouin, V; Gény, C; Hantraye, P; Mangin, JF; Remy, P; Ricolfi, F; Samson, Y | 1 |
| Ase, A; Cumming, P; Diksic, M; Gjedde, A; Harrison, J; Jolly, D; Kuwabara, H; Laliberté, C | 1 |
| Brooks, DJ; Burn, DJ; Mark, MH; Menza, MA | 1 |
| Najafi, A | 1 |
| Haycock, JW; Hornykiewicz, O; Kish, SJ; Zhong, XH | 1 |
| Fujiwara, T; Hatazawa, J; Ido, T; Ishiwata, K; Itoh, M; Iwata, R; Meguro, K; Sasaki, H; Takahashi, T | 1 |
| Nickles, RJ; Oakes, TR; Roberts, AD | 1 |
| Channing, MA; Eckelman, WC; Kawai, K; Kiesewetter, DO | 1 |
| Chan, GL; Dobko, T; Doudet, DJ; Hewitt, KA; Pate, BD; Ruth, TJ; Schofield, P | 1 |
| Brooks, DJ; Burn, DJ; Marsden, CD; Mathias, CJ; Quinn, NP; Rinne, JO | 1 |
| Cumming, P; Diksic, M; Evans, AC; Gjedde, A; Guttman, M; Kuwabara, H; Léger, GC; Yasuhara, Y | 1 |
| Cordes, M; Poewe, W | 1 |
| Gordin, A; Kaakkola, S; Männistö, PT | 1 |
| Cumming, P; Gjedde, A; Kuwabara, H | 1 |
| Martin, WR; Perlmutter, JS | 1 |
| Chaly, T; Dhawan, V; Eidelberg, D; Fahn, S; Giladi, N; Ishikawa, T; Przedborski, S; Spetsieris, P; Takikawa, S | 1 |
| Calne, DB; Cooper, S; Cordes, M; Pate, BD; Ruth, TJ; Schulzer, M; Snow, BJ | 1 |
| Calne, DB; Lee, CS; Mak, E; Schulzer, M; Snow, BJ; Vingerhoets, FJ | 1 |
| Calne, DB; Langston, JW; Schulzer, M; Snow, BJ; Tetrud, JW; Vingerhoets, FJ | 1 |
| Comar, D; Damhaut, P; Lemaire, C; Plenevaux, A | 1 |
| Fink, G; Heiss, WD; Herholz, K; Jacobs, A; Mielke, R; Pietrzyk, U; Slansky, I; Würker, M | 1 |
| Chirakal, R; Firnau, G; Garnett, ES; Nahmias, C; Wahl, L | 1 |
| Brooks, DJ; Burn, DJ; Lammertsma, AA; Luthra, S; Morrish, PK; Osman, S; Sawle, GV; Snow, BJ | 1 |
| Defer, GL; Degos, JD; Malapert, D; Remy, P; Ricolfi, F; Samson, Y | 1 |
| Martin, WR; Snow, BJ; Vingerhoets, FJ | 1 |
| Dethy, S; Goldman, S; Luxen, A; Monclus, M; Pauwels, T | 1 |
| Bhatt, MH; Calne, DB; Eisen, A; Peppard, R; Snow, BJ; Takahashi, H | 1 |
| Ido, T; Kogure, K; Nagasawa, H | 1 |
| Björklund, A; Brooks, D; Brundin, P; Frackowiak, R; Lindvall, O; Marsden, CD; Odin, P; Rothwell, JC; Sawle, G; Widner, H | 1 |
| Chaly, T; Dahl, R; Dhawan, V; Eidelberg, D; Mandel, F; Robeson, W; Spetsieris, P; Takikawa, S; Zanzi, I | 1 |
| Calne, DB; Chan, GL; Hammerstad, JP; Hewitt, KA; Pate, BD; Ruth, TJ | 1 |
| Calne, DB; Nygaard, TG; Snow, BJ; Takahashi, H | 2 |
| Adams, R; Bankiewicz, K; Comi, G; Di Chiro, G; Kopin, IJ; Miletich, RS; Plunkett, R | 1 |
| Calne, DB; Cooper, S; Holden, JE; Morrison, S; Ruth, TJ; Schulzer, M; Snow, BJ; Vingerhoets, FJ | 1 |
| Cumming, P; Gjedde, A; Kuwabara, H; Léger, GC | 1 |
| Beer, HF; Haeberli, M; Hasler, P; Reddy, GN; Schubiger, AP | 1 |
| Cedarbaum, JM; Evans, A; Gjedde, A; Guttman, M; Kuwabara, H; Léger, G; Reches, A | 1 |
| Bhatia, K; Brooks, DJ; Burn, DJ; Marsden, CD; Sawle, GV; Turjanski, N | 1 |
| Chaly, T; Dahl, R; Dhawan, V; Eidelberg, D; Fahn, S; Margouleff, D; Moeller, JR; Patlak, CS; Robeson, W; Takikawa, S | 1 |
| Calne, DB; Kimura, H; McGeer, EG; Snow, BJ; Takahashi, H; Tooyama, I; Yamada, T | 1 |
| Calne, DB; Hewitt, KA; Kawamata, T; McGeer, EG; Pate, BD; Ruth, TJ; Snow, BJ; Yamada, T | 1 |
| Cumming, P; Evans, AC; Gjedde, A; Guttman, M; Kuwabara, H; Léger, GC; Yasuhara, Y | 1 |
| Calne, DB; Cordes, M; Morrison, S; Ruth, TJ; Snow, BJ; Sossi, V | 1 |
| Bhatt, MH; Calne, DB; Nakamura, K; Nomoto, M; Okada, A; Osame, M; Snow, BJ | 1 |
| Sawle, GV | 1 |
| Brooks, DJ; Burn, DJ | 1 |
| Barrio, JR; Grafton, ST; Huang, SC; Mazziotta, JC; Melega, WP; Phelps, ME; Yu, DC | 1 |
| Fujiwara, T; Hatazawa, J; Ido, T; Itoh, M; Iwata, R; Kogure, K; Nagasawa, H; Saito, H; Seo, S; Watanuki, S | 1 |
| Fukumura, T; Goto, I; Hosokawa, S; Ichiya, Y; Kato, M; Kuwabara, Y; Masuda, K; Otsuka, M; Sasaki, M | 1 |
| Fukui, M; Miyagi, Y; Morioka, T; Otsuka, M | 1 |
| Antonini, A; Beer, HF; Günther, I; Nickles, RJ; Psylla, M; Reddy, GN; Reist, HW; Schubiger, PA; Vontobel, P; Zollinger, A | 1 |
| Aquilonius, SM; Hartvig, PG; Långström, B; Tedroff, J | 1 |
| Snow, BJ | 1 |
| Cesaro, P; Defer, GL; Degos, JD; Fenelon, G; Gaston, A; Geny, C; Jeny, R; Keravel, Y; Monfort, JC; Nguyen, JP; Peschanski, M; Remy, P; Ricolfi, F; Samson, Y; Villafane, G | 1 |
| Cohen, RM; Doudet, DJ; Ernst, M; Hankerson, JG; Hardy, K; Jons, PH; Matochik, JA; Pascualvaca, D; Zametkin, AJ | 1 |
| Belakhlef, A; Chaly, T; Dhawan, V; Eidelberg, D; Ishikawa, T; Mandel, F; Margouleff, C; Patlak, C; Robeson, W | 1 |
| Chaly, T; Dahl, JR; Dhawan, V; Eidelberg, D; Ishikawa, T; Mandel, F; Margouleff, C; Robeson, W; Spetsieris, P | 1 |
| Fukumura, T; Ichiya, Y; Kuwabara, Y; Masuda, K; Otsuka, M; Sasaki, M; Yoshida, T | 1 |
| Holden, JE; Ruth, TJ; Schulzer, M; Snow, BJ; Vingerhoets, FJ | 1 |
| Nahmias, C; Wahl, L | 2 |
| Ishii, S; Ishiwata, K; Nozaki, T; Senda, M; Shinoda, M | 1 |
| Belakhlef, A; Chaly, T; Dahl, R; Dhawan, V; Eidelberg, D; Ishikawa, T; Mandel, F; Margouleff, C; Robeson, W | 1 |
| Fukumura, T; Hosokawa, S; Ichiya, Y; Kato, M; Kuwabara, Y; Masuda, K; Otsuka, M; Sasaki, M; Yoshida, T | 1 |
| Huang, SC; Lin, KP; Melega, WP; Phelps, ME; Quintana, J; Raleigh, MJ; Stout, DB; Yu, DC | 1 |
| Antonini, A; Boecker, H; Conrad, B; Grafin von Einsiedel, H; Kruggel, F; Kuwert, T; Leenders, K; Weindl, A | 1 |
| Barrio, JR; Bida, G; Bishop, A; Satyamurthy, N | 1 |
| Akiguchi, I; Fukuyama, H; Hanakawa, T; Kato, M; Kimura, J; Shibasaki, H | 1 |
| Babchyck, B; Chaly, T; Dhawan, V; Eidelberg, D; Ishikawa, T; Kazumata, K; Mandel, F; Margouleff, C; Neumeyer, J; Zanzi, I | 1 |
| Belakhlef, A; Chaly, T; Dhawan, V; Eidelberg, D; Ishikawa, T; Kazumata, K; Margouleff, C; Margouleff, D; Robeson, W; Takikawa, S | 1 |
| Barrio, JR; Cherry, SR; Huang, SC; Jacobson, A; Melega, WP; Namavari, M; Phelps, ME; Quintana, J; Satyamurthy, N; Yu, DC | 1 |
| Heiss, WD; Herholz, K; Lanfermann, H; Pietrzyk, U; Thiel, A; Wagner, R; Wienhard, K | 1 |
| Barrio, JR; Huang, SC; Lin, KP; Melega, W; Phelps, ME; Yu, DC | 1 |
| Fujiwara, T; Ido, T; Itoh, M; Itoyama, Y; Iwata, R; Kimura, I; Nagasawa, H; Saito, H; Tanji, H | 1 |
| Hatano, K; Ishiwata, K; Yanagisawa, T | 1 |
| Itoh, M; Itoyama, Y; Nagasawa, H; Tanji, H | 2 |
| Huang, SC; Melega, WP; Phelps, ME; Raleigh, MJ; Stout, DB | 1 |
| DeJesus, OT; Endres, CJ; Holden, JE; Nickles, RJ; Shelton, SE | 2 |
| Fallon, J; Keator, D; Lee, A; Maguire, G; Najafi, A; Riley, G; Tang, C; Wu, JC | 1 |
| Calne, DB; Chu, NS; Huang, CC; Lee, C; Lu, CS; Shinotoh, H; Snow, BJ; Takahashi, H | 1 |
| Calne, DB; de la Fuente-Fernández, R; Kishore, A | 1 |
| Loc'h, C; Mazière, B; Wang, RF | 1 |
| Brooks, DJ; Lees, AJ; Turjanski, N | 2 |
| Björklund, A; Brooks, DJ; Brown, R; Brundin, P; Gustavii, B; Hagell, P; Jahanshahi, M; Lindvall, O; Marsden, CD; Morrish, P; Odin, P; Quinn, NP; Rehncrona, S; Rothwell, JC; Sawle, G; Wenning, GK; Widner, H | 1 |
| Ballinger, JR; Ichise, M | 1 |
| Cumming, P; Gjedde, A; Reith, J | 2 |
| Bergmans, P; Booij, J; Stoof, JC; Tissingh, G; Van Royen, EA; Winogrodzka, A; Wolters, EC | 1 |
| Barrio, JR; Huang, SC; Phelps, ME | 1 |
| Fujiwara, T; Ishii, K; Itoh, M; Iwata, R; Orihara, H | 1 |
| Fujiwara, T; Itoh, M; Meguro, K; Yamadori, A; Yamaguchi, S | 1 |
| Calne, DB; Hashimoto, S; MacLeod, P; Rouleau, GA; Schulzer, M; Shinotoh, H; Silveira, I; Snow, BJ; Thiessen, B | 1 |
| Cumming, P; Deep, P; Gjedde, A | 1 |
| Antonini, A; Günther, I; Leenders, KL; Psylla, M; Reist, HW; Vontobel, P; Zollinger, A | 1 |
| Bergman, JR; Haaparanta, MT; Oikonen, VJ; Rinne, JO; Rinne, UK; Ruotsalainen, UH; Ruottinen, HM; Solin, OH | 1 |
| Buckley, KR; Chan, GL; Doudet, D; Endres, CJ; Holden, JE; Morrison, KS; Pate, BD; Ruth, TJ; Snow, BJ; Sossi, V; Vingerhoets, FJ | 1 |
| Bell, K; Bunney, BG; Bunney, WE; Fallon, J; Keator, D; Klein, E; Najafi, A; Tang, C; Widmark, C; Wu, JC | 1 |
| Barrio, JR; Huang, SC; Melega, WP; Phelps, ME; Raleigh, MJ; Stout, DB | 1 |
| Antonini, A; Günther, I; Leenders, KL; Maguire, RP; Missimer, J; Psylla, M; Vontobel, P | 1 |
| Fujii, R; Horii, H; Ido, T; Imahori, Y; Kanatsuna, T; Kimura, M; Kumakura, Y; Nakamura, T; Toyama, K; Ueda, S; Wakita, K; Yagyu, T; Yuasa, M | 1 |
| Bailey, DL; Brooks, DJ; Morrish, PK; Rakshi, JS; Sawle, GV | 1 |
| Bergman, J; Haaparanta-Solin, M; Hakko, H; Hämäläinen, T; Hietala, J; Kuoppamäki, M; Laakso, A; Räsänen, P; Ryynänen, OP; Solin, O; Syvälahti, E; Tiihonen, J; Vilkman, H | 1 |
| Bergman, JR; Haaparanta, MT; Laihinen, AO; Oikonen, VJ; Rinne, JO; Rinne, UK; Ruotsalainen, UH; Ruottinen, HM; Solin, OH | 1 |
| Aigner, TA; Chan, GL; Doudet, DJ; Holden, JE; McGeer, EG; Ruth, TJ; Wyatt, RJ | 1 |
| Cohen, RM; Ernst, M; Jons, PH; Matochik, JA; Zametkin, AJ | 1 |
| Cabaret, M; Caparros-Lefebvre, D; Godefroy, O; Petit, H; Rémy, P; Samson, Y; Steinling, M | 1 |
| Bendriem, B; Fontaine, A; Frouin, V; Remy, P; Ribeiro, MJ; Trébossen, R | 1 |
| Poewe, WH; Wenning, GK | 1 |
| Nahmias, C; Wahl, LM | 1 |
| Barlogie, B; Dhodapkar, M; Eidelberg, D; Harik, SI; Rudnicki, SA | 1 |
| Bauer, R; Bergmann, R; Brust, P; Füchtner, F; Johannsen, B; Steinbach, J; Vorwieger, G; Walter, B; Zwiener, U | 2 |
| Brown, WD; DeJesus, OT; Holden, JE; Nickles, RJ; Oakes, TR; Roberts, AD; Taylor, MD | 1 |
| Barrio, JR; Huang, SC; Satyamurthy, N; Stout, DB; Yee, RE | 1 |
| Antonini, A; Chokroverty, S; Dhawan, V; Eidelberg, D; Hening, WA; Trenkwalder, C; Walters, AS | 1 |
| Bergman, J; Eronen, E; Haaparanta, M; Hietala, J; Kuoppamäki, M; Räkköläinen, V; Ruotsalainen, U; Salokangas, RK; Solin, O; Syvälahti, E; Vilkman, H; Vuorio, K | 1 |
| Hardie, RJ | 1 |
| Chan, GL; DeJesus, OT; Doudet, DJ; English, C; Holden, JE; Jivan, S; McGeer, EG; Ruth, TJ | 1 |
| Beanlands, R; Chirakal, R; Coates, G; Fallen, EL; Kamath, M; Nahmias, C; Thomson, M; Wahl, L; Woodcock, G | 1 |
| Brooks, DJ; Burn, DJ; Ceravolo, R; Maraganore, D; Piccini, P | 1 |
| Ashburner, J; Bailey, DL; Brooks, DJ; Friston, KJ; Ito, K; Morrish, PK; Rakshi, JS; Uema, T | 1 |
| Hatano, K; Ishiwata, K; Ito, K; Kaneko, S; Omura, H; Senda, M | 1 |
| Hoegerle, S; Kraft, A; Moser, E; Nitzsche, EU; Schneider, B | 1 |
| Brooks, DJ; Piccini, P | 1 |
| Cumming, P; Danielsen, EH; Gee, AD; Gjedde, A; Hansen, SB; Hermansen, F; Smith, DF; Venkatachalam, TK | 1 |
| Carson, RE; Cohen, RM; Doudet, DJ; Wyatt, RJ | 1 |
| Agid, Y; Dormont, D; Dupel, C; Jedynak, P; Lehéricy, S; Marsault, C; Remy, P; Samson, Y; Serdaru, M; Veber, H; Vidailhet, M | 1 |
| Cohen, RM; Ernst, M; Jons, PH; Matochik, JA; Pascualvaca, D; Zametkin, AJ | 1 |
| Ashburner, J; Bailey, DL; Brooks, DJ; Dagher, A; Friston, KJ; Ito, K; Jenkins, IH; Morrish, PK; Rakshi, JS; Uema, T | 1 |
| Brown, WD; DeJesus, OT; Holden, JE; Houser, WD; Malischke, L; Nickles, RJ; Pyzalski, RW; Roberts, AD; Shelton, SE; Uno, H | 1 |
| Chen, A; Cumming, P; Dagher, A; Deep, P; Gjedde, A; Kapczinski, F; Reutens, D; Wong, DF; Yokoi, F | 1 |
| Brown, WD; DeJesus, OT; Holden, JE; Malischke, LM; Nickles, RJ; Oakes, TR; Roberts, AD; Schueller, MJ; Taylor, MD | 1 |
| Cumming, P; Dagher, A; Deep, P; Gjedde, A; Sadikot, A | 1 |
| Fasth, KJ; Hartvig, P; Långström, B; Tedroff, J; Torstenson, R | 1 |
| Abe, Y; Ito, K; Kachi, T; Kato, T; Sobue, G; Yanagisawa, N | 1 |
| Aigner, TG; Doudet, D; Fernández-Ruiz, J | 1 |
| Degueldre, C; Franck, G; Garraux, G; Laureys, S; Lemaire, C; Peigneux, P; Salmon, E | 1 |
| Bergman, J; Haaparanta, M; Hublin, C; Partinen, M; Rinne, JO; Ruottinen, HM; Solin, O | 1 |
| Barrio, JR; DeLanney, LE; Farahani, KF; Huang, SC; Irwin, I; Langston, JW; Phelps, ME; Satyamurthy, N; Shoghi-Jadid, K; Stout, DB; Togaski, DM; Yee, RE | 1 |
| Imahori, Y; Kawano, H; Misawa, A; Sawada, T; Takeuchi, Y | 1 |
| Alanen, A; Bergman, J; Haaparanta, M; Hietala, J; Ilonen, T; Salokangas, RK; Solin, O; Syvälahti, E; Taiminen, T; Vilkman, H | 1 |
| Morrish, PK | 1 |
| Bergman, J; Haaparanta, M; Nurmi, E; Portin, R; Rinne, JO; Ruottinen, H; Solin, O | 1 |
| Acorn, T; Dagher, A; Darvesh, S; Desrosiers, J; Gaudet, P; Hebb, A; Hong, M; King, D; Law, A; Mendez, I; Robertson, H; Weerasinghe, S | 1 |
| Calne, DB; de la Fuente-Fernández, R; Kishore, A; Mak, EK; Pal, PK; Ruth, TJ; Schulzer, M; Snow, BJ; Stoessl, AJ; Vingerhoets, FJ | 1 |
| Abe, Y; Arahata, Y; Hatano, K; Ishigaki, T; Ito, K; Kachi, T; Kato, T; Kawasumi, Y; Nagano, AS; Nakamura, A; Yamada, T | 1 |
| Cumming, P; Deep, P; Evans, AC; Gjedde, AH; Kuwabara, H; Rousset, OG | 1 |
| Barrio, JR; Farahani, KF; Huang, SC; Phelps, ME; Satyamurthy, N; Shoghi-Jadid, K; Stout, DB; Yee, RE; Yeh, EL | 1 |
| DeJesus, OT; Haaparanta, M; Nickles, RJ; Solin, O | 1 |
| Bergman, J; Haaparanta, M; Koskenvuo, M; Laihinen, A; Marttila, R; Rinne, JO; Rinne, UK; Ruottinen, H; Solin, O | 1 |
| Aebischer, P; Bloch, J; Brown, WD; Carvey, P; Chen, EY; Chu, Y; Déglon, N; Emborg, ME; Hantraye, P; Holden, JE; Kordower, JH; Leventhal, L; Ling, Z; Ma, SY; McBride, J; Palfi, S; Pyzalski, R; Roitberg, BZ; Taylor, MD; Trono, D | 1 |
| Chang, CW; Chen, JB; Chtsai, CS; Lin, HM; Liu, RS; Wang, HE | 1 |
| Bryant, T; Cohen, RM; Doudet, D; Elkashef, AM; Li, SH; Wyatt, RJ | 1 |
| Arai, H; Higuchi, M; Hu, XS; Ido, T; Itoh, M; Matsui, T; Okamura, N; Sasaki, H; Shinkawa, M; Tashiro, M | 1 |
| Azari, NP; Keel, A; Knorr, U; Leenders, KL; Ludin, HP; Maguire, RP; Nienhusmeier, M; Seitz, RJ; Weder, B | 1 |
| Bamborschke, S; Ghaemi, M; Heiss, WD; Rudolf, J; Schmülling, S | 1 |
| McGee-Minnich, L; Mink, JW; Moerlein, SM; Perlmutter, JS; Racette, BA; Videen, TO | 1 |
| Artiges, E; Bragulat, V; Dollé, F; Hinnen, F; Jouvent, R; Martinot, J; Martinot, M | 1 |
| Bergman, J; Eronen, E; Eskola, O; Niinivirta, M; Oikonen, V; Rinne, UK; Ruottinen, HM; Solin, O; Sonninen, P | 1 |
| Altehoefer, C; Brink, I; Ghanem, N; Hoegerle, S; Moser, E; Nitzsche, E | 1 |
| Bergman, J; Forssell, H; Jääskeläinen, SK; Kaasinen, V; Rinne, JO; Sonninen, P; Tenovuo, O | 1 |
| Burger, C; Dimitrakopoulou-Strauss, A; Strauss, LG | 1 |
| Graham, MM | 1 |
| Breeze, RE; Culver, S; Dillon, S; DuMouchel, W; Eidelberg, D; Fahn, S; Freed, CR; Greene, PE; Kao, R; Trojanowski, JQ; Tsai, WY; Winfield, H | 1 |
| Bauer, R; Bergmann, R; Brust, P; Füchtner, F; Vorwieger, G; Walter, B | 1 |
| Bergman, J; Eskola, O; Nurmi, E; Rinne, OJ; Ruottinen, HM; Solin, O | 1 |
| Doudet, DJ; Holden, JE; Sossi, V | 1 |
| Andersen, F; Bender, D; Cumming, P; Danielsen, EH; Falborg, L; Gillings, N; Gjedde, A; Marthi, K; Munk, O; Møller, A; Smith, D; Steffensen, E; Sørensen, JC; Vafaee, M | 1 |
| Ghaemi, M; Heiss, WD; Herholz, K; Hilker, R; Rudolf, J | 1 |
| Brooks, DJ; Chaudhuri, KR; Hajnal, JV; Herlihy, AH; Hu, MT; White, SJ | 1 |
| Bergman, J; Brück, A; Eskola, O; Kaasinen, V; Nurmi, E; Rinne, JO; Solin, O | 1 |
| Cumming, P; Doudet, D; Munk, OL | 1 |
| Cumming, P; Danielsen, EH; Gjedde, A; Hermansen, F; Smith, D | 1 |
| Bottlaender, M; Condé, F; Coulon, C; Dollé, F; Frouin, V; Fuseau, C; Grégoire, MC; Hantraye, P; Hinnen, F; Poyot, T | 1 |
| Beckmann, H; Ellitok, E; Gerhard, A; Lauer, M; Reske, SN; Schirrmeister, H; Stöber, G | 1 |
| Bergman, J; Haaparanta, M; Nurmi, E; Rinne, JO; Ruottinen, HM; Solin, O; Sonninen, P | 1 |
| Breeze, R; Chaly, T; Dhawan, V; Eidelberg, D; Fahn, S; Freed, C; Fukuda, M; Greene, P; Ma, Y; Nakamura, T | 1 |
| Bergman, J; Brück, A; Haaparanta, M; Laihinen, A; Lindell, A; Portin, R; Rinne, JO; Solin, O | 1 |
| Jankovic, J; Kapadia, AS | 1 |
| Andersen, F; Bender, D; Cumming, P; Danielsen, EH; Gee, AD; Gjedde, A; Hansen, SB; Hermansen, F; Smith, DF; Østergaard, L | 1 |
| Hisanaga, K; Iwasaki, Y; Jin, K; Mochizuki, H; Sato, N; Suzuki, H; Tanji, H | 1 |
| Barrio, JR; Cheng, DW; Huang, SC; Namavari, M; Satyamurthy, N; Yee, RE | 1 |
| Stoessl, AJ | 1 |
| Barrio, JR; Delanney, LE; Delfani, K; Farahani, KF; Huang, SC; Irwin, I; Janson, AM; Langston, JW; Milonas, C; Phelps, ME; Satyamurthy, N; Shoghi-Jadid, K; Stout, DB; Togasaki, DM; Yee, RE | 1 |
| Bailey, DL; Brooks, DJ; Bryson, H; Ceravolo, R; Jorga, KM; Piccini, P | 1 |
| Broussolle, E; Guillouet, S; Thobois, S | 1 |
| Altehoefer, C; Brink, I; Ghanem, N; Hoegerle, S; Manz, T; Moser, E; Neumann, HP; Nitzsche, E; Reincke, M | 1 |
| de La Fuente-Fernández, R; Doudet, DJ; Holden, JE; McKenzie, J; Ruth, TJ; Sossi, V; Stoessl, AJ | 1 |
| Berman, KF; Carson, RE; Esposito, G; Kohn, PD; Meyer-Lindenberg, A; Miletich, RS; Quarantelli, M; Weinberger, DR | 1 |
| Acorn, T; Dagher, A; Darvesh, S; Desrosiers, J; Gaudet, P; Hong, M; King, D; McAlister, V; Mendez, I; Robertson, H; Weerasinghe, S | 1 |
| Hedrich, K; Heiss, WD; Herholz, K; Hilker, R; Klein, C; Ozelius, LJ; Pramstaller, PP; Vieregge, P | 1 |
| Bauer, R; Bergmann, R; Brust, P; Elhalag, E; Fritz, A; Füchtner, F; Hinz, R; Johannsen, B; Steinbach, J; Vorwieger, G; Walter, B; Zwiener, U | 1 |
| DeJesus, OT; Holden, JE; Nickles, RJ; Roberts, AD; Shelton, SE | 1 |
| Imperial, M; Lam, RW; Liddle, PF; Ngan, E; Ruth, TJ; Scarrow, G; Shiah, IS; Sossi, V; Stoessl, J; Yatham, LN | 1 |
| Angelberger, P; Füchtner, F; Hammerschmidt, F; Kvaternik, H; Simovc, BP; Steinbach, J | 1 |
| Deuschl, G; Ghaemi, M; Heiss, WD; Hilker, R; Raethjen, J; Rudolf, J; Sobesky, J | 1 |
| Breakefield, XO; Calne, DB; Hedrich, K; Klein, C; Leung, J; Lieberman, A; Nausieda, PA; Pal, PK; Samii, A; Stoessl, AJ | 1 |
| Bergman, J; Haaparanta, M; Hietala, J; Laakso, A; Salokangas, RK; Solin, O; Syvälahti, E; Vilkman, H | 1 |
| Carrasquillo, JA; Chen, CC; Eisenhofer, G; Goldstein, DS; Pacak, K; Whatley, M | 1 |
| Breeze, R; Dhawan, V; Eidelberg, D; Fahn, S; Feigin, A; Freed, C; Fukuda, M; Greene, P; Ma, Y; Shi, Q | 1 |
| Jennings, D; Marek, K; Seibyl, J | 1 |
| Bailey, DL; Brooks, DJ; Ito, K; Morrish, PK; Pavese, N; Rakshi, JS; Uema, T | 1 |
| Chen, CY; Chou, YH; Huang, WS; Liu, JC; Liu, RS; Ma, KH | 1 |
| Adler, LA; Chua, HC | 1 |
| Tang, GH; Tang, XL; Wang, YX; Yin, DZ; Zhang, L | 1 |
| Andersen, F; Cumming, P; Dall, AM; Danielsen, EH; Gjedde, AH; Møller, A; Sørensen, JC; Zimmer, J | 1 |
| Altehoefer, C; Brink, I; Ghanem, N; Hoegerle, S; Moser, E; Neumann, HP; Schipper, J | 1 |
| de la Fuente-Fernandez, R; Holden, JE; Ruth, TJ; Sossi, V; Stoessl, AJ | 1 |
| Dendi, R; Goldstein, DS; Holmes, C; Li, ST; Sharabi, Y | 1 |
| Agid, Y; Brice, A; Broussolle, E; Chapoy, E; Costes, N; Dürr, A; Guillouet, S; Lohmann, E; Pollak, P; Rascol, O; Remy, P; Ribeiro, MJ; Thobois, S | 1 |
| Seibyl, JP | 1 |
| Cheng, CY; Chiang, YH; Chou, YH; Huang, WS; Lin, JC; Liu, RS | 1 |
| Piccini, P | 1 |
| Aide, N; Balogova, S; Colombet, C; De Beco, V; Grahek, D; Jacob, T; Kerrou, K; Montravers, F; Talbot, JN; Younsi, N | 1 |
| Brin, MF; Freeman, TB; Godbold, J; Goetz, CG; Kordower, JH; Nauert, GM; Olanow, CW; Perl, DP; Shannon, KM; Sossi, V; Stoessl, AJ | 1 |
| Ghaemi, M; Heiss, WD; Hilker, R; Razai, N; Rudolf, J; Szelies, B; Weisenbach, S | 1 |
| Mink, JW; Perlmutter, JS | 1 |
| Pirker, W | 1 |
| Behr, T; Bornschein, B; Dodel, RC; Höffken, H; Klockgether, T; Möller, JC; Oertel, WH; Siebert, U | 1 |
| Andringa, G; Cools, AR; Eshuis, S; Ibrahim, M; Leenders, KL; Maguire, RP; Perentes, E; Roth, D | 1 |
| Asenbaum, S; Becherer, A; Czech, T; Henk, C; Karanikas, G; Kletter, K; Marosi, C; Szabó, M; Wadsak, W; Wunderbaldinger, P; Zettinig, G | 1 |
| Aalto, S; Eskola, O; Forssell, H; Hagelberg, N; Jääskeläinen, SK; Någren, K; Rinne, JO; Scheinin, H; Taiminen, T | 1 |
| Brooks, DJ; Frey, KA; Marek, KL; Oakes, D; Paty, D; Prentice, R; Shults, CW; Stoessl, AJ | 1 |
| Bergman, J; Eskola, O; Forsback, S; Grönroos, T; Haapalinna, A; Haaparanta, M; Marjamäki, P; Niemi, R; Rinne, J; Solin, O | 1 |
| Heiss, WD; Hilker, R | 1 |
| Connemann, BJ; Juengling, FD; Kassubek, J; Reske, SN; Schönfeldt-Lecuona, C; Spitzer, M | 1 |
| Grasby, P; Lawrence, AD; McGowan, S; Quested, D; Sales, T | 1 |
| DeJesus, OT; Doudet, DJ; Endres, CJ; Holden, JE; Nickles, JR; Uno, H | 1 |
| Brunelle, F; de Lonlay, P; Fékété, CN; Jaubert, F; Rahier, J; Saudubray, JM | 1 |
| Antonini, A; Leenders, KL; Linazasoro, G; Maguire, RP | 1 |
| Eisenhofer, G; Eldadah, BA; Goldstein, DS; Holmes, C; Kopin, IJ; Pacak, K | 1 |
| Brooks, DJ; Eunson, L; Graham, E; Khan, NL; Lees, AJ; Pavese, N; Piccini, PP; Quinn, NP; Scherfler, C; Wood, NW | 1 |
| Al-Rashid, I; Angeles Mena, M; Castilla, C; Cools, A; Eshuis, S; Fontan, A; Garcia de Yebenes, J; Gonzalo, I; Hernández, I; Leenders, K; López, I; Maguire, P; Perez Higueras, A; Pruim, J; Rabano, A; Rojo, A; Sanchez Albisua, J; Sanchez Pernaute, R | 1 |
| Aebischer, P; Bloch, J; Condé, F; Dauguet, J; Déglon, N; Dollé, F; Hantraye, P; Hinnen, F; Kishima, H; Palfi, S; Poyot, T; Pralong, W | 1 |
| Abe, Y; Arahata, Y; Dagher, A; Hatano, K; Ito, K; Iwai, K; Kachi, T; Kato, T; Kawasumi, Y; Nagano-Saito, A; Nakamura, A; Washimi, Y; Yamada, T | 1 |
| Bauer, R; Brust, P; Füchtner, F; Hinz, R; Müller, M; Steinbach, J; Walter, B | 1 |
| Ametamey, SM; Belokon, YN; Fedorova, OS; Krasikova, RN; Kuznetsova, OF; Mosevich, IK; Nader, M; Schubiger, PA; Shatik, SV; Vyskocil, S; Zaitsev, VV | 1 |
| Bailey, DL; Brooks, DJ; Pavese, N; Remy, P; Whone, AL | 1 |
| Angelberger, P; Becherer, A; Dudczak, R; Karanikas, G; Kletter, K; Kurtaran, A; Raderer, M; Szabó, M; Wunderbaldinger, P | 1 |
| Biraben, A; Depaulis, A; Douaud, G; Remy, P; Ribeiro, MJ; Semah, F | 1 |
| Cumming, P; Danielsen, EH; Gjedde, A; Kumakura, Y; Reilhac, A | 1 |
| Bauer, R; Brust, P; Fritz, H; Füchtner, F; Hinz, R; Kuwabara, H; Müller, M; Walter, B; Zwiener, U | 1 |
| Bauer, R; Brust, P; Füchtner, F; Ganapathy, V; Herzau, M; Kuwabara, H; Opfermann, T; Stark, H; Steinbach, J; Vorwieger, G; Walter, B | 1 |
| de la Fuente-Fernández, R; Holden, JE; Ruth, TJ; Schulzer, M; Sossi, V; Stoessl, J | 1 |
| Allen, RC; Cornfeldt, ML; Doudet, DJ; Honey, CR; Schweikert, AW | 1 |
| Balan, KK | 1 |
| Ahlskog, JE; Albin, RL; Brooks, DJ; Carbon, M; Dhawan, V; Eidelberg, D; Fahn, S; Feigin, A; Guttman, M; Gwinn-Hardy, K; Holloway, R; Innis, R; Katz, RG; Kieburtz, K; Kish, SJ; Lange, N; Langston, JW; Marek, K; McFarland, H; Morin, L; Moy, C; Murphy, D; Oertel, WH; Oliver, G; Palesch, Y; Powers, W; Ravina, B; Seibyl, J; Sethi, KD; Sheehy, P; Shults, CW; Stoessl, AJ | 1 |
| Evanoff, B; Good, L; Jennings, D; Perlmutter, JS; Racette, BA; Tabbal, SD | 1 |
| Chang, CW; Chen, JC; Chou, KL; Chou, YT; Lin, MT; Liu, RS | 1 |
| Fischman, AJ | 2 |
| Aalto, S; Bergman, J; Brück, A; Nurmi, E; Rinne, JO | 1 |
| Bartenstein, P; Cumming, P; Gjedde, A; Gründer, G; Kumakura, Y; Vernaleken, I | 1 |
| Auburger, G; Berman, KF; Evans, EW; Hernandez, DG; Jain, S; Johnson, J; Lopez, GJ; McInerney-Leo, A; Meyer-Lindenberg, A; Nussbaum, RL; Paisán-Ruíz, C; Schäffer, AA; Singleton, AB | 1 |
| Biraben, A; Bouilleret, V; Chassoux, F; Ribeiro, MJ; Semah, F; Syrota, A; Taussig, D | 1 |
| Coburger, S; Ghaemi, M; Heiss, WD; Herholz, K; Hilker, R; Jacobs, AH; Rudolf, J; Schweitzer, K; Weisenbach, S | 1 |
| Boddaert, N; Bourgeois, S; Brunelle, F; De Lonlay, P; Delzescaux, T; Dollé, F; Jaubert, F; Nihoul-Fékété, C; Ribeiro, MJ; Syrota, A | 1 |
| Hsieh, HJ; Lin, SH; Liu, HM | 1 |
| Ahsan, RL; Ampuero, I; Brooks, DJ; Cantarero, S; de Yébenes, JG; Fanjul, S; Fontan, A; Gómez Garre, P; Hernandez, J; Hirano, M; Hoenicka, J; Jones, A; Nyggard, T; Pavese, N; Perez-Tur, J; Piccini, P; Rojo, A; Ros, R; Tai, YF; Vazquez, A; Vidal, L | 1 |
| Bley, TA; Brink, I; Hoegerle, S; Klisch, J | 1 |
| Broussolle, E; Remy, P; Thobois, S | 1 |
| Chang, CP; Chu, YK; Hsieh, HJ; Lin, SH; Wang, SJ | 1 |
| Brouwers, AH; De Hooge, MN; De Vries, EG; Jager, PL; Kema, IP; Koopmans, KP; Van der Horst-Schrivers, AN; Wolffenbuttel, BH | 1 |
| Abe, H; Hashiguchi, H; Ishida, Y; Kawai, K; Magata, Y; Mukai, T; Saji, H; Takeda, R; Yoshimoto, M | 1 |
| Christensen, S; Cumming, P; Danielsen, EH; Gjedde, A; Kumakura, Y | 1 |
| Barker, RA; Brooks, DJ; Cheesman, AL; Lewis, SJ; Owen, AM; Robbins, TW | 1 |
| Avila, J; de Yébenes, JG; Hoenicka, J; Honnorat, J; Kopp, N; Pérez, M; Ros, R; Sánchez, MP; Streichenberger, N; Thobois, S | 1 |
| Borghammer, P; Cumming, P; Kumakura, Y | 1 |
| Declerck, JM; Leong, FJ; McLaughlin, RA; Pan, XB; Silverman, DH; Wright, TG | 1 |
| Lilien, DL; Patterson, J; Tainter, K; Zweig, RM | 1 |
| Hundemer, HP; Kaasinen, V; Leenders, KL; Maguire, RP | 1 |
| Boddaert, N; Brunelle, F; de Lonlay, P; Mention, K; Nihoul-Fékété, C; Ribeiro, M; Touati, G; Valayanopoulos, V | 1 |
| Burghaus, L; Heiss, WD; Herholz, K; Hilker, R; Jacobs, AH; Kalbe, E; Klein, JC; Thomas, AV; Weisenbach, S | 1 |
| Fogelman, I; Heinisch, M; Langsteger, W | 1 |
| Brink, I; Neumann, HP; Schaefer, O; Walz, M | 1 |
| Bartenstein, P; Buchholz, HG; Cumming, P; Gründer, G; Kumakura, Y; Müller, MJ; Siessmeier, T; Stoeter, P; Vernaleken, I | 1 |
| Adams, J; de la Fuente-Fernández, R; Schulzer, M; Sossi, V; Stoessl, J | 1 |
| Antenor, JA; Good, L; McGee-Minnich, L; Moerlein, SM; Perlmutter, JS; Racette, BA; Videen, TO | 1 |
| Aalto, S; Bergman, J; Brück, A; Nurmi, E; Rinne, JO; Vahlberg, T | 1 |
| Balan, K; Seshadri, N; Wat, J | 1 |
| Balash, Y; Bartels, AL; de Jong, BM; Giladi, N; Leenders, KL; Maguire, RP; Pruim, J; Schaafsma, JD; Veenma, L; Youdim, MB | 1 |
| Deleu, D; Hanssens, Y | 1 |
| Ebadi, M; Govitrapong, P; Klongpanichapak, S; Sharma, SK | 1 |
| Chen, W; Cloughesy, T; Czernin, J; Delaloye, S; Kamdar, N; Pope, W; Satyamurthy, N; Schiepers, C; Silverman, DH | 1 |
| Gorman, JM | 1 |
| Montandon, ML; Ruest, T; Schoenahl, F; Zaidi, H | 1 |
| Ametamey, SM; Blagoev, M; Hengerer, B; Hintermann, S; Honer, M; Schubiger, PA; Waldmeier, P | 1 |
| Bartenstein, P; Braus, DF; Buchholz, HG; Cumming, P; Heinz, A; Kienast, T; Larsen, JL; Mann, K; Rösch, F; Schreckenberger, M; Siessmeier, T; Smolka, MN; Wrase, J | 1 |
| Ahsan, RL; Brooks, DJ; de Yébenes, JG; Pavese, N; Piccini, P; Tai, YF | 1 |
| Abe, H; Hashiguchi, H; Ishida, Y; Kawai, K; Magata, Y; Mukai, T; Saji, H; Takeda, R | 1 |
| Fanti, S; Nanni, C; Rubello, D | 2 |
| de Vries, EG; Elsinga, PH; Jager, PL; Kema, IP; Koopmans, KP; Neels, OC; Sluiter, WJ; van der Horst-Schrivers, AN | 1 |
| Aide, N; de Beco, V; Grahek, D; Grangé, JD; Gutman, F; Kerrou, K; Lotz, JP; Montravers, F; Ruszniewski, P; Talbot, JN | 1 |
| Gault, N; Grahek, D; Gutman, F; Kerrou, K; Montravers, F; Schlienger, M; Talbot, JN; Touboul, E | 1 |
| Balard, M; de Beco, V; Grahek, D; Gutman, F; Kerrou, K; Montravers, F; Nataf, V; Talbot, JN | 1 |
| Brink, I; Hoegerle, S; Lange-Nolde, A; Moser, E; Reincke, M; Slawik, M; Zajic, T | 1 |
| Bartenstein, P; Buchholz, HG; Cumming, P; Gründer, G; Kumakura, Y; Siessmeier, T; Stoeter, P; Vernaleken, I | 1 |
| Dhawan, V; Eckert, T; Eidelberg, D; Feigin, A; Frucht, S; Lewis, DE | 1 |
| Sperling, MA | 1 |
| Adzick, NS; Alavi, A; Freifelder, R; Ganguly, A; Hardy, OT; Hernandez-Pampaloni, M; Ruchelli, E; Saffer, JR; Stanley, CA; Suchi, M; Zhuang, H | 1 |
| Beuthien-Baumann, B; Bredow, J; Kotzerke, J; Strumpf, A; Zessin, J | 1 |
| Al-Nahhas, A; Ambrosini, V; Campana, D; Castellucci, P; Fanti, S; Farsad, M; Franchi, R; Montini, G; Nanni, C; Rubello, D; Tomassetti, P | 1 |
| Koerts, J; Koning, M; Leenders, KL; Portman, AT; van Beilen, M | 1 |
| Hardy, OT; Litman, RS | 1 |
| Crews, C; Goldstein, DS; Hallett, M; Hardy, J; Holmes, C; Imrich, R; Lopez, G; Peckham, E; Singleton, A | 1 |
| Bartenstein, P; Buchholz, HG; Cumming, P; Gründer, G; Heinz, A; Kienast, T; Kumakura, Y; Siessmeier, T; Vernaleken, I | 1 |
| Bellanné-Chantelot, C; Boddaert, N; Bourgeois, S; Brunelle, F; De Lonlay, P; Delzescaux, T; Jaubert, F; Nihoul-Fékété, C; Ribeiro, MJ; Valayannopoulos, V | 1 |
| Binkofski, F; Büchel, C; Gaser, C; Hagenah, J; Hedrich, K; Hilker, R; Klein, C; Pramstaller, PP; Reetz, K; Siebner, HR; Thiel, A; van Eimeren, T | 1 |
| Ell, PJ; Groves, AM; Haim, SB; Win, T | 1 |
| Chen, W; Cloughesy, T; Dahlbom, M; Huang, SC; Schiepers, C | 1 |
| Adams, KT; Carrasquillo, JA; Chen, CC; Eisenhofer, G; Hadi, M; Ling, A; Martiniova, L; Pacak, K; Timmers, HJ; Whatley, M | 1 |
| Balan, KK; Brown, MJ; Chatterjee, K; Gurnell, M; Mackenzie, IS; Simpson, H | 1 |
| Adzick, NS; Alavi, A; Becker, S; Divgi, C; Ernst, LM; Freifelder, R; Hardy, OT; Hernandez-Pampaloni, M; MacMullen, C; Saffer, JR; Scheuermann, JS; Stanley, CA; Zhuang, H | 1 |
| Vallabhajosula, S | 1 |
| Chen, W; Seibyl, JP; Silverman, DH | 1 |
| Bellanné-Chantelot, C; Boddaert, N; Brunelle, F; Delzescaux, T; Jaubert, F; Lonlay, P; Nihoul-Fékété, C; Ribeiro, MJ; Valayannopoulos, V; Verkarre, V | 1 |
| Brousseau, M; Cahouet, A; Dubois, S; Girault, S; Illouz, F; Lacoeuille, F; Morel, O; Picquet, J; Rodien, P; Rohmer, V | 1 |
| Barthlen, W; Blankenstein, O; Eberhard, T; Fuechtner, F; Höhne, C; Koch, M; Lorenz-Depiereux, B; Mau, H; Mohnike, K; Mohnike, W | 1 |
| Biraben, A; Bouilleret, V; Chassoux, F; Mantzaridez, M; Ribeiro, MJ; Semah, F; Trebossen, R | 1 |
| Kato, T | 1 |
| Brown, L; Dickson, D; Farrer, M; Skipper, L; Solida, A; Vingerhoets, FJ; Wider, C; Wszolek, ZK | 1 |
| Brouwers, AH; Chirakal, R; Gulenchyn, KY; Jager, PL; Koopmans, KP; Marriott, CJ | 1 |
| Al-Nahhas, A; Ambrosini, V; Fanti, S; Nanni, C; Rubello, D | 1 |
| Barlier, A; Colavolpe, C; De Micco, C; Henry, JF; Morange, I; Mundler, O; Niccoli-Sire, P; Palazzo, FF; Sebag, F; Taïeb, D; Tessonnier, L | 1 |
| Ambrosini, V; Campana, D; Castellucci, P; Fanti, S; Franchi, R; Montini, G; Nanni, C; Rizzello, A; Rubello, D; Tomassetti, P | 1 |
| Bara-Jimenez, W; Brown, AK; Cropley, VL; Fujita, M; Hallett, M; Herscovitch, P; Innis, RB; Nathan, PJ; Pike, VW; Sangare, J; Zhang, XY | 1 |
| Chen, W; Cloughesy, T; Czernin, J; Freitas, B; Ledezma, CJ; Pope, W; Sai, V | 1 |
| Arbizu, J; Dominguez-Prado, I; Garrastachu, P; Richter, JA; Rodriguez-Fraile, M; Rotellar, F; Sangro, B | 1 |
| de Vries, EG; Koornstra, JJ; Porte, RJ | 1 |
| Blankenstein, O; Höhne, C; Kork, F; Mohnike, W | 1 |
| Berman, KF; Dreher, JC; Kohn, P; Meyer-Lindenberg, A | 1 |
| Bose, SK; Cunliffe, R; Grasby, PM; Howes, OD; Mehta, MA; Stokes, PR; Turkheimer, FE | 1 |
| Allen, P; Broome, M; Fusar-Poli, P; Grasby, P; Howes, O; McGuire, P; Valli, I | 1 |
| Bartenstein, P; Buchholz, HG; Cumming, P; Dolan, RJ; Gründer, G; Hariri, AR; Heinz, A; Kienast, T; Kumakura, Y; Schlagenhauf, F; Smolka, MN; Sterzer, P; Wrase, J | 1 |
| Ishii, K; Ishiwata, K; Isse, K; Nakamura, M; Oda, K; Saito, T; Shimizu, T | 1 |
| Goldstein, DS | 1 |
| Dierckx, RA; Eshuis, SA; Jager, PL; Jonkman, S; Leenders, KL; Maguire, RP | 1 |
| Asselin, MC; Bramon-Bosch, E; Broome, M; Grasby, PM; Howes, OD; Johns, L; McGuire, PK; Montgomery, AJ; Murray, RM; Tabraham, P; Valli, I; Valmaggia, L | 1 |
| Auernhammer, CJ; Bartenstein, P; Göke, B; Haug, A; Pöpperl, G; Schmidt, G; Tiling, R; Wängler, B | 1 |
| Beheshti, M; Broinger, G; Dralle, H; Kohlfürst, S; Langsteger, W; Nader, M; Pirich, C; Pöcher, S; Vali, R; Waldenberger, P | 1 |
| Brouwers, AH; Fiebrich, HB; van Bergeijk, L; van den Berg, G | 1 |
| Agopian, VG; Auerbach, MS; Benz, MR; Czernin, JG; Dumont, RA; Imani, F; Lai, CK; Walter, MA; Yeh, MW | 1 |
| Tenenbaum, F | 1 |
| Arbizu, J; Blesa, J; Collantes, M; Juri, C; Luquin, MR; Martí-Climent, JM; Obeso, JA; Peñuelas, I; Prieto, E; Quincoces, G; Richter, JA; Riverol, M; Rodriguez-Oroz, MC; Zubieta, JL | 1 |
| Brück, A; Eskola, O; Helenius, H; Jokinen, P; Rauhala, E; Rinne, JO | 1 |
| Brouwers, AH; de Vries, EG; Fiebrich, HB; Koopmans, KP | 1 |
| Brouwers, AH; de Jong, JR; de Vries, EG; Dierckx, RA; Elsinga, PH; Fiebrich, HB; Jager, PL; Kema, IP; Kerstens, MN; Links, TP; Pijl, ME; Sluiter, WJ; van der Wal, JE | 1 |
| Dollé, F; Ducongé, F; Gombert, K; Kuhnast, B; Le Helleix, S; Pestourie, C; Tavitian, B; Thézé, B | 1 |
| Goldstein, DS; Holmes, C; Kopin, IJ; Sewell, L | 1 |
| Ambrosini, V; Fanti, S; Marzola, MC; Rubello, D | 1 |
| Aigrain, Y; Brunelle, F; Capito, C; Crétolle, C; De Lonlay, P; Jaubert, F; Khen-Dunlop, N; Nihoul-Fékété, C; Ribeiro, MJ | 1 |
| Coenen, HH; Ermert, J; Wagner, FM | 1 |
| Cumming, P; Kumakura, Y | 1 |
| Bhatia, KP; Brooks, DJ; Cohen, L; Khan, NL; Lees, AJ; Pavese, N; Piccini, P; Quinn, NP; Scherfler, C; Wood, NW | 1 |
| Kiesewetter, DO; Kvetnansky, R; Lai, EW; Martiniova, L; Merino, MJ; Pacak, K; Seidel, J; Thomasson, D | 1 |
| Buck, AK; Dralle, H; Glatting, G; Karges, W; Luster, M; Mottaghy, FM; Neumaier, B; Pauls, S; Reske, SN; Solbach, C; Verburg, FA; Zeich, K | 2 |
| Cavet, M; Dousset, B; Faraggi, M; Hignette, C; Modis, C; Richard, B; Tenenbaum, F | 1 |
| Adams, KT; Carrasquillo, JA; Chen, CC; Eisenhofer, G; Havekes, B; Ling, A; Martiniova, L; Pacak, K; Timmers, HJ; Whatley, M | 1 |
| Marek, K; Poewe, W; Scherfler, C; Tolosa, E | 1 |
| D'Souza, M; Garg, G; Jaimini, A; Khurana, A; Mishra, A; Mondal, A; Sharma, R; Tripathi, M; Varshney, R | 1 |
| Kauhanen, S; Minn, H; Nuutila, P; Seppänen, M | 1 |
| Conte-Devolx, B; De Micco, C; Ghander, C; Henry, JF; Mundler, O; Palazzo, FF; Reynaud, R; Sebag, F; Taïeb, D; Tessonnier, L | 1 |
| Bartenstein, P; Buchholz, HG; Cumming, P; Danielsen, EH; Gjedde, A; Gründer, G; Heinz, A; Kumakura, Y; Vernaleken, I | 1 |
| Breeze, R; Chaly, T; Dhawan, V; Eidelberg, D; Fahn, S; Freed, C; Greene, P; Ma, Y; Tang, C | 1 |
| Dudczak, R; Traub-Weidinger, T | 1 |
| Carrasquillo, JA; Chen, CC; Chowdhury, I; Gharib, AM; Gundabolu, B; Nieman, LK; Sinaii, N; Whatley, M; Zemskova, MS | 1 |
| Al-Nahhas, A; Ambrosini, V; Fanti, S; Ferdeghini, M; Gross, MD; Marzola, MC; Massaro, A; Pelizzo, MR; Rubello, D; Toniato, A | 1 |
| Alexopoulos, DK; Chen, CC; Jacobs, S; King, KS; Mattox, DE; Pacak, K; Reynolds, JC; Whatley, MA | 1 |
| D'Souza, M; Datta, A; Garg, G; Grover, RK; Jaimini, A; Kumar, N; Mishra, AK; Mondal, A; Panwar, P; Sharma, R; Singh, D; Tripathi, M; Varshney, R | 1 |
| Chu, Y; Kordower, JH | 1 |
| Gabriel, M; Henninger, B; Kendler, D; Knoflach, M; Kroiss, A; Putzer, D; Virgolini, IJ; Vonguggenberg, E; Warwitz, B | 1 |
| Baudrexel, S; Diederich, NJ; Eggers, C; Heiss, WD; Hilker, R; Hohmann, C; Kalbe, E; Klein, JC; Vollmar, S; Weisenbach, S | 1 |
| Bauerfeind, P; Clavien, PA; Hany, T; Muller, MK; Schiesser, M; Veit-Haibach, P; Weber, M | 1 |
| Cahouet, A; Giraud, P; Girault, S; Lacoeuille, F; Morel, O | 1 |
| Chew, SL | 1 |
| Airas, L; Marttila, RJ; Paavilainen, T; Rinne, JO; Rissanen, E; Virta, J | 1 |
| Anlauf, M; Bartenstein, P; Fottner, C; Helisch, A; Klöppel, G; Kreft, A; Lackner, KJ; Musholt, TJ; Rossmann, H; Schadmand-Fischer, S; Schreckenberger, M; Weber, MM | 1 |
| Chabrier, G; Detour, J; Goichot, B; Greget, M; Imperiale, A; Keomany, J; Pessaux, P; Rust, E | 1 |
| Allen, P; Asselin, MC; Broome, M; Fusar-Poli, P; Grasby, PM; Howes, OD; McGuire, PK; Valli, I | 1 |
| Bressman, S; Brüggemann, N; Condefer, K; Dhawan, V; Hagenah, J; Klein, C; Kornreich, R; Ozelius, L; Palmese, C; Pastores, G; Roe, A; Sathe, S; Saunders-Pullman, R; Stanley, K; Tagliati, M | 1 |
| Behnke, S; Berg, D; Schröder, U | 1 |
| Clavien, PA; Hany, TF; Hesselmann, R; Schaefer, NG; Schiesser, M; Soyka, J; Strobel, K; Veit-Haibach, P | 1 |
| Forsback, S; Gouverneur, V; Kirjavainen, A; Luthra, SK; Robins, EG; Sandford, G; Solin, O; Teare, H | 1 |
| Remy, P | 1 |
| Schwarz, J | 1 |
| Hussain, K; Ismail, D | 1 |
| Bourgeat, P; Coulthard, A; Crozier, S; Daglish, M; Dowson, N; Fay, M; MacFarlane, D; Rose, S; Salvado, O; Smith, J; Thomas, P; Winter, C | 1 |
| Baller, EB; Berman, KF; Bronstein, JA; Eisenberg, DP; Kohn, PD; Masdeu, JC | 1 |
| Bakay, RA; Deogaonkar, M; Lieu, CA; Subramanian, T | 1 |
| Brignell, CM; Brooks, DJ; Cohen, L; Curran, HV; Hoshi, R; Piccini, P; Tai, YF | 1 |
| Arbizu, J; Guillén, J; Luquin, MR; Manrique, M; Marcilla, I; Ordoñez, C | 1 |
| Endres, CJ; Hayashi, T; Iida, H; Kumakura, Y; Matsubara, K; Minato, K; Watabe, H | 1 |
| Allegri, V; Castellucci, P; di Dalmazi, G; Fanti, S; Grassi, I; Montini, GC; Nanni, C; Pagotto, U; Pasquali, R; Vicennati, V | 1 |
| Ashworth, M; Blankenstein, O; De Coppi, P; Eaton, S; Hussain, K; Ismail, D; Mohnike, W; Nah, SA; Pierro, A; Ron, O; Smith, VV; Totonelli, G; Zani, A | 1 |
| Beer, AJ; Buck, AK; Eckel, F; Herrmann, K | 1 |
| Chao, HY; Hsu, WL; Kao, CH; Lan, WC; Lin, MC; Xie, HL | 1 |
| Allen, P; Bose, S; Egerton, A; Howes, O; McGuire, P; Murray, R; Stahl, D; Turkheimer, F; Valli, I; Valmaggia, L | 1 |
| Agarwal, A; Kumar, A; Mathur, NB; Sharma, M | 1 |
| Brooks, DJ; Lewis, SJ; Pavese, N; Rivero-Bosch, M; Whone, AL | 1 |
| Bendlin, BB; Brown, WD; Chung, MK; DeJesus, O; Gallagher, CL; Holden, JE; Johnson, SC; McLaren, DG; Nickles, RJ; Oakes, TR; Pyzalski, R; Xu, G | 1 |
| Martin, WR | 1 |
| Birke, AM; Criswell, SR; Flores, HP; Moerlein, SM; Perlmutter, JS; Racette, BA; Videen, TO | 1 |
| Calcagni, ML; Castaldi, P; Corsello, SM; Fanti, S; Galli, G; Giordano, A; Perotti, G; Rufini, V; Treglia, G | 1 |
| Benlloc, L; Cuello, D; Fragoso, M; Salazar, G | 1 |
| Doi, R; Fukuyama, S; Kasai, T; Masue, M; Nishibori, H; Okamoto, S; Tokumi, T; Uemoto, S; Yorifuji, T; Yoshizawa, A | 1 |
| Beuthien-Baumann, B; Herting, B; Kotzerke, J; Langner, J; Löhle, M; Oehme, L; Perick, M; Reichmann, H; Storch, A; van den Hoff, J; Wolz, M | 1 |
| Adam, MJ; Levine, DS; Metzger, DL; Nadel, HR; Oviedo, A; Skarsgard, E | 1 |
| Bjorklund, A; Brooks, DJ; Lindvall, O; Oertel, WH; Piccini, P; Pogarell, O; Politis, M; Quinn, NP; Wu, K | 1 |
| Bendlin, BB; Buyan-Dent, L; Christian, BT; Dejesus, OT; Gallagher, CL; Harding, SJ; Holden, JE; Johnson, SC; Mueller, B; Nickles, RJ; Stone, CK | 1 |
| Brouwers, AH; de Jong, JR; de Vries, EG; Dierckx, RA; Fiebrich, HB; Kema, IP; Koopmans, KP; Links, TP; Sluiter, W; Walenkamp, AM | 1 |
| Cascini, G; Cuccurullo, V; Mansi, L; Rossi, A; Rotondo, A; Tamburrini, O | 1 |
| Goldstein, DS; Holmes, C; Park, MY; Sewell, L; Sharabi, Y | 1 |
| Chang, IC; Hsieh, HJ; Kao, CH; Liu, SH; Lue, KH | 1 |
| Doi, H; Fujimaru, R; Hosokawa, Y; Kawakita, R; Masue, M; Matsumoto, T; Nishibori, H; Yorifuji, T | 1 |
| Altrinetti, V; Bianchi, P; Cabria, M; Cistaro, A; Conte, M; Fanti, S; Foppiani, L; Garaventa, A; Lopci, E; Nanni, C; Pession, A; Piccardo, A; Puntoni, M; Sorrentino, S; Villavecchia, G | 1 |
| Chen, X; Cleary, S; Dawson, LF; Eisenhofer, G; Kiesewetter, DO; Kvetnansky, R; Lai, EW; Martiniova, L; Pacak, K; Phillips, JK; Powers, JF; Seidel, J; Thomasson, D | 1 |
| Brooks, DJ; Chaudhuri, KR; Metta, V; Pavese, N; Ramlackhansingh, A; Simpson, BS | 1 |
| Ahonen, A; Arola, J; Ebeling, T; Heiskanen, I; Kajander, S; Kauhanen, S; Korsoff, P; Lisinen, I; Minn, H; Nuutila, P; Sane, T; Schalin-Jäntti, C; Schildt, J; Seppänen, M; Väisänen, M; Välimäki, MJ; Virtanen, S | 1 |
| Al-Nahhas, A; Bellan, E; Chondrogiannis, S; Ferretti, A; Grassetto, G; Marzola, MC; Massaro, A; Mazza, A; Rampin, L; Rubello, D | 1 |
| Chirakal, R; Gulenchyn, KY; Jager, PL; Major, P; Reid, R; Yakemchuk, VN | 1 |
| Ambrosini, V; Castaldi, P; Cremonini, N; de Waure, C; Fanti, S; Filice, A; Giordano, A; Perotti, G; Rufini, V; Santimaria, M; Treglia, G; Versari, A; Villani, MF | 1 |
| Boedeker, CC; Brink, I; Hentschel, M; Neumann, HP; Rottenburger, C | 1 |
| Gesuwan, K; Herscovitch, P; Kebebew, E; Kitano, M; Linehan, WM; Millo, C; Nilubol, N; Weisbrod, AB | 1 |
| Brooks, DJ; Eggert, K; Gerhard, A; Lewis, SJ; Mathias, CJ; Oertel, W; Pavese, N; Rivero-Bosch, M | 1 |
| Allen, P; Broome, M; Egerton, A; Fusar-Poli, P; Hirao, K; Howes, OD; Kambeitz, J; Luigjes, J; McGuire, P; Valli, I | 1 |
| Cloughesy, T; Czernin, J; Fueger, B; Lai, A; Nghiemphu, P; Phelps, ME; Satyamurthy, N; Wagle, N; Walter, F; Walter, MA | 1 |
| Ametamey, SM; Franck, D; Keller, C; Krämer, SD; Kuznetsova, OF; Mu, L; Müller, A; Müller, C; Ross, TL; Schibli, R; Schweinsberg, C | 1 |
| Castaldi, P; Cocciolillo, F; de Waure, C; Di Nardo, F; Giordano, A; Gualano, MR; Rufini, V; Treglia, G | 1 |
| Altrinetti, V; Chiti, A; Cistaro, A; Fanti, S; Garaventa, A; Lopci, E; Nanni, C; Pession, A; Piccardo, A; Villavecchia, G | 1 |
| Calabria, F; Chiaravalloti, A; Di Pietro, B; Grasso, C; Schillaci, O | 1 |
| Birke, AM; Crippin, JS; Criswell, SR; Flores, HP; Moerlein, SM; Perlmutter, JS; Racette, BA; Videen, TO | 1 |
| Bours, V; Caberg, JH; Dive, D; Garraux, G; Jamar, M; Moonen, G; Vanbellinghen, JF | 1 |
| Berman, KF; Carver, FW; Coppola, R; Holroyd, T; Ianni, A; Jabbi, M; Kippenhan, JS; Kohn, P; Masdeu, JC; Nash, T; Robinson, SE; Rubinstein, D | 1 |
| Apers, JA; de Heide, LJ; Glaudemans, AW; Oomen, PH; Totté, ER; van Beek, AP | 1 |
| Grahek, D; Kerrou, K; Montravers, F; Nataf, V; Pascal, O; Soussan, M; Talbot, JN | 1 |
| Byrne, BJ; Chien, YH; Hwu, WL; Lee, NC; Muramatsu, S; Snyder, RO; Tai, CH; Tseng, SH; Tzen, KY; Wu, RM | 1 |
| Chowdhury, FU; Gross, MD; Marzola, MC; Rubello, D; Scarsbrook, AF; Waterfield, RT; Wong, KK | 1 |
| Forsback, S; Johansson, J; Joutsa, J; Kaasinen, V; Martikainen, K; Niemelä, S; Rinne, JO | 1 |
| Alavi, A; Blomberg, BA; Moghbel, MC; Saboury, B; Stanley, CA | 1 |
| Boulanger, C; Imperiale, A; Ollier, JC; Roedlich, MN; Rust, E; Schneegans, O | 1 |
| Gallowitsch, HJ; Malle, P; Sorschag, M | 1 |
| Cocciolillo, F; de Waure, C; Di Nardo, F; Giordano, A; Poscia, A; Rufini, V; Treglia, G | 1 |
| Benz, MR; Campbell, D; Dumont, RA; Mix, M; Neumann, HP; Rischke, HC; Rössler, J; Seufert, J; Weber, WA; Wiech, T; Wild, D | 1 |
| Goichot, B; Hubele, F; Imperiale, A; Rust, E; Taieb, D; Taquet, MC; Veillon, F | 1 |
| Giordano, A; Mirk, P; Rufini, V; Treglia, G | 1 |
| Calabria, F; Schillaci, O | 1 |
| Ahonen, A; Schalin-Jäntti, C; Seppänen, M | 1 |
| Ambrosini, V; Castaldi, P; Cremonini, N; Fanti, S; Filice, A; Giordano, A; Perotti, G; Rufini, V; Treglia, G; Versari, A; Villani, MF | 1 |
| Dinelle, K; Farrer, MJ; Holden, JE; Kornelsen, R; Mah, C; McCormick, S; Sossi, V; Stoessl, AJ; Walker, MD | 1 |
| Capuron, L; Crowe, RJ; Drake, DF; Goodman, MM; Miller, AH; Pagnoni, G; Spivey, JR; Votaw, JR; Woolwine, BJ | 1 |
| Demjaha, A; Howes, OD; Kapur, S; McGuire, PK; Murray, RM | 1 |
| Chiti, A; D'Ambrosio, D; Fanti, S; Lopci, E; Marengo, M; Nanni, C; Pession, A | 1 |
| Eskola, O; Jokinen, P; Joutsa, J; Kaasinen, V; Rinne, JO | 1 |
| Brouwers, AH; de Groot, JW; Hofstra, RM; Koopmans, KP; Links, TP; Muller Kobold, AC; Plukker, JT; van der Horst-Schrivers, AN; Verbeek, HH | 1 |
| Brinkmann, DH; Giannini, C; Kitange, GJ; Laack, NN; Lowe, VJ; Pafundi, DH; Parney, IF; Peterson, TE; Pokorny, JL; Ramiscal, JA; Sarkaria, JN; Youland, RS | 1 |
| De Sanctis, V; Di Stefano, D; Enrici, RM; Esposito, V; Falco, T; Lanzetta, G; Minniti, G; Scaringi, C | 1 |
| Chang, HH; Hsu, WM; Huang, SF; Jou, ST; Lee, H; Lee, YL; Liao, YF; Lin, DT; Lin, KH; Liu, YL; Lu, MY; Luo, TY; Shen, LH; Tzen, KY; Wu, PY; Yang, YL | 1 |
| Barlier, A; Blanchet, EM; Chen, CC; Deveze, A; Fakhry, N; Gabriel, S; Morange, I; Pacak, K; Sebag, F; Taïeb, D | 1 |
| Chaddock, CA; Howes, OD; Joyce, EM; McGuire, P; Roiser, JP | 1 |
| Allen, P; Bhattacharyya, S; Bloomfield, MA; Chaddock, CA; Egerton, A; Howes, OD; McGuire, PK; Winton-Brown, TT | 1 |
| Buvat, I; Capelle, L; Dulou, R; Dutertre, G; Foehrenbach, H; Gontier, E; Guillevin, R; Lahutte, M; Nioche, C; Soret, M | 1 |
| Avatapalle, B; Banerjee, I; Clayton, PE; Cosgrove, KE; Dunne, MJ; Padidela, R; Stevens, A | 1 |
| Hao, R; Yang, J; Zhu, X | 1 |
| Bartsch, O; Fottner, C; Helisch, A; Lackner, KJ; Mann, WJ; Miederer, M; Musholt, TJ; Papaspyrou, K; Rossmann, H; Schreckenberger, M; Weber, MM | 1 |
| Balogova, S; Huchet, V; Kerrou, K; Michaud, L; Montravers, F; Nataf, V; Talbot, JN | 1 |
| D'Souza, MM; Jaimini, A; Mehta, S; Mishra, AK; Mondal, A; Pandey, S; Panwar, P; Saw, S; Sharma, R; Singh, D; Solanki, Y; Tripathi, M | 1 |
| Brinkmann, DH; Giannini, C; Grams, MP; Hoover, JM; Hu, LS; Kemp, BJ; Laack, NN; Lowe, VJ; Morris, JM; Pafundi, DH; Parney, IF; Sarkaria, JN; Youland, RS | 1 |
| Howes, OD; Kim, E; Kwon, JS; McGinnity, CJ; Shidahara, M; Tsoumpas, C; Turkheimer, FE | 1 |
| Cardillo, G; Di Franco, D; Enang, GN; Giordano, A; Rufini, V; Stefanelli, A; Treglia, G | 1 |
| Bal, C; Bandopadhyaya, GP; Gupta, DK; Karunanithi, S; Khangembam, BC; Kumar, A; Kumar, R; Malhotra, A; Sharma, P | 1 |
| Bergman, J; Brück, A; Johansson, J; Jokinen, P; Karrasch, M; Rinne, JO | 1 |
| Behnke, S; Berg, D; Buchholz, HG; Fassbender, K; Schreckenberger, M; Schroeder, U | 1 |
| Bomanji, J; Dickson, J; Endozo, R; Erlandsson, K; Hussain, K; Meintjes, M; Menezes, L; Townsend, C | 1 |
| Bal, C; Bandopadhyaya, GP; Gupta, DK; Karunanithi, S; Kumar, A; Malhotra, A; Sharma, P; Singla, S | 1 |
| Cabria, M; Cistaro, A; Conte, M; Garaventa, A; Lopci, E; Piccardo, A; Villavecchia, G | 1 |
| Chen, HW; Fang, CK; Hwang, JJ; Liu, RS; Wang, WH | 1 |
| Bal, C; Bandopadhyaya, GP; Goenka, A; Gupta, DK; Karunanithi, S; Khangembam, BC; Kumar, A; Kumar, R; Malhotra, A; Sharma, P | 1 |
| Franci, X; Lemaire, CF; Libert, LC; Luxen, AJ; Maruoka, K; Ooi, T; Plenevaux, AR | 1 |
| Addeo, P; Averous, G; Bachellier, P; Imperiale, A; Namer, IJ | 1 |
| Balogova, S; Kaliska, L; Kunikowska, J; Montravers, F; Slavikova, K; Talbot, JN; Treglia, G; Vereb, M | 1 |
| Bloomfield, MA; Curran, HV; Egerton, A; Howes, OD; Kapur, S; Morgan, CJ | 1 |
| Chondrogiannis, S; Colletti, PM; Ferretti, A; Grassetto, G; Maffione, AM; Marzola, MC; Opocher, G; Rampin, L; Rubello, D; Schiavi, F | 1 |
| Blanchet, EM; Chen, CC; Herscovitch, P; Martucci, V; Millo, C; Pacak, K | 1 |
| Demjaha, A; Egerton, A; Howes, OD; Kapur, S; McGuire, PK; Murray, RM; Stone, JM | 1 |
| Decristoforo, C; Fraedrich, G; Frech, A; Gasser, RW; Kroiss, A; Prommegger, R; Putzer, D; Shulkin, BL; Sprinzl, GM; Uprimny, C; Url, C; Virgolini, IJ; Widmann, G | 1 |
| Giovanella, L; Treglia, G | 1 |
| Arbizu, J; Collantes, M; DiCaudo, C; Luquin, MR; Marcilla, I; Ordóñez, C; Peñuelas, I; Riverol, M | 1 |
| Egerton, A; Howes, OD; Ibrahim, K; Leung, G; McGuire, PK; Turkheimer, F; Williams, M | 1 |
| Al-Nahhas, A; Chondrogiannis, S; Marzola, MC; Mazza, A; Opocher, G; Rubello, D; Venkatanarayana, TD | 1 |
| Blanchet, EM; Bluemke, DA; Maass-Moreno, R; Martucci, V; Millo, C; Pacak, K | 1 |
| Cumming, P; Dautzenberg, K; Gründer, G; Henkel, K; Kumakura, Y; Mottaghy, FM; Prinz, S; Rademacher, L; Rex, S; Schlüter, T; Schmaljohann, J; Vernaleken, I; Winz, O | 1 |
| Benard, F; Chan, EK; Cheung, A; Hsu, F; Kosztyla, R; Ma, R; Moiseenko, V; Nichol, A; Wilson, D; Zhang, S | 1 |
| Alavi, A; Eriksson, O; Liu, C; Mintz, A; Naji, A; Yu, M | 1 |
| Allen-Auerbach, M; Chen, W; Czernin, J; DeSalles, AA; Lizarraga, KJ; Phelps, ME; Yong, WH | 1 |
| Bal, C; Ballal, S; Gupta, DK; Karunanithi, S; Khangembam, BC; Kumar, A; Kumar, R; Sharma, P | 1 |
| Conte, M; Foppiani, L; Lopci, E; Morana, G; Piccardo, A | 1 |
| Bacca, A; Bernini, G; Carrara, D; Chiacchio, S; Congregati, C; Duce, V; Mariani, G; Materazzi, G; Simi, P; Taddei, S; Volterrani, D; Zampa, V | 1 |
| Afshar-Oromieh, A; Combs, SE; Debus, J; Giesel, FL; Haberkorn, U; Kratochwil, C; Leotta, K; Rieken, S | 1 |
| Benz, MR; Buck, AK; Chen, W; Cloughesy, T; Czernin, J; Herrmann, K; Lai, A; Phelps, ME; Pomykala, KL | 1 |
| Bachellier, P; Detour, J; Duclos, B; Gabriel, S; Goichot, B; Imperiale, A; Kurtz, JE; Namer, IJ; Rust, E; Taïeb, D | 1 |
| Schillaci, O | 1 |
| Dudczak, R; Hacker, M; Javor, D; Karanikas, G; Khameneh, A; Magnaldi, S; Mayerhoefer, ME; Mitterhauser, M; Schuetz, M | 1 |
| Cistaro, A; Conte, M; Fanti, S; Foppiani, L; Garaventa, A; Lopci, E; Morana, G; Naseri, M; Piccardo, A; Puntoni, M; Sorrentino, S; Villavecchia, G | 1 |
| Figarella-Branger, D; Guedj, E; Kaphan, E; Metellus, P; Sala, Q; Taieb, D | 1 |
| Cloughesy, TF; Dahlbom, M; Huang, SC; Phelps, ME; Schiepers, C; Wardak, M | 1 |
| Cabria, M; Cama, A; Garrè, ML; Milanaccio, C; Morana, G; Nozza, P; Piccardo, A; Puntoni, M; Rossi, A; Zefiro, D | 1 |
| Chen, W; Cloughesy, TF; Czernin, J; Elashoff, D; Ellingson, BM; Geist, C; Grogan, T; Phelps, ME; Pope, WB; Schwarzenberg, J; Silverman, DH | 1 |
| Bendlin, BB; Buyan-Dent, L; Christian, BT; DeJesus, OT; Gallagher, CL; Harding, SJ; Holden, JE; Li, CT; Nickles, RJ; Oh, J; Okonkwo, O; Palotti, M; Stone, CK | 1 |
| Bloomfield, MA; Demjaha, A; Egerton, A; Howes, OD; Maximen, L; Mouchlianitis, E; Pepper, F; Selvaraj, S; Tomasi, G; Turkheimer, F; Veronese, M | 1 |
| Arya, V; Blankenstein, O; Eberhard, T; Hauptmann, K; Hussain, K; Iakoubov, R; Kühnen, P; Lauffer, LM; Matthae, R; Mohnike, W; Raile, K; Rothe, K; Singer, M; Wächter, S | 1 |
| Eggers, C; Kracht, L; Pedrosa, DJ; Schwartz, F; Timmermann, L | 1 |
| Chen, W; De Salles, AA; Lizarraga, KJ | 1 |
| Bell, C; Dowson, N; Fay, M; Gal, Y; Jeffree, RL; Pagnozzi, A; Poole, CM; Puttick, S; Rose, S; Thomas, P | 1 |
| Xie, T; Zaidi, H | 1 |
| Forsback, S; Kauhanen, S; Kemppainen, J; Minn, H; Seppänen, M | 1 |
| Santhanam, P; Taïeb, D | 1 |
| Chang, SJ; Chuang, KS; Lin, HH; Shih, CT; Wu, J | 1 |
| Bluemel, C; Buck, AK; Czernin, J; Ernestus, RI; Herrmann, K; Homola, GA; Kessler, AF; Lapa, C; Linsenmann, T; Löhr, M; Monoranu, CM; Samnick, S | 1 |
| Goedicke, A; Kops, ER; Mottaghy, FM; Rong, Y; Vernaleken, I; Winz, OH | 1 |
| Bozzao, A; Cicone, F; Maurizi Enrici, R; Minniti, G; Papa, A; Romano, A; Scaringi, C; Scopinaro, F; Tavanti, F | 1 |
| Benisvy, D; Darcourt, J; Dufour, M; Fontana, X; Koulibaly, PM; Ouvrier, MJ; Sapin, N; Schiazza, A | 1 |
| Bachellier, P; Castinetti, F; Guillet, B; Imperiale, A; Kessler, L; Moreau, F; Mundler, O; Namer, IJ; Sebag, F; Taïeb, D; Vix, M | 1 |
| Anner, P; Dudczak, R; Haug, A; Karanikas, G; Mayerhoefer, M; Sesti, A; Wadsak, W; Weber, M | 1 |
| de Vries, EG; Dierckx, RA; Glaudemans, AW; Noordzij, W; Slart, RH; Tio, RA; van Beek, AP; van der Horst-Schrivers, AN; van Ginkel, B; Walenkamp, AM | 1 |
| Carney, JA; Chen, CC; Papadakis, GZ; Patronas, NJ; Stratakis, CA | 1 |
| Chen, W; Cloughesy, TF; Czernin, J; Ellingson, BM; Harris, RJ; Karavaeva, E; Lai, A; Leu, K; Liau, LM; Nghiemphu, PL; Pope, WB; Shabihkhani, M; Yong, WH | 1 |
| Brouwers, AH; Dierckx, RA; DiMagno, SG; Elsinga, PH; Kema, IP; Kuik, WJ; Neumann, KD; Zijlma, R | 1 |
| Bachellier, P; Bahougne, T; Goichot, B; Imperiale, A; Namer, IJ; Taïeb, D | 1 |
| Bergman, J; Johansson, J; Joutsa, J; Kaasinen, V; Niemelä, S; Voon, V | 1 |
| Carapella, C; Chiaravalloti, A; Di Pietro, B; Di Russo, C; Fiorentini, A; Floris, R; Pace, A; Palumbo, B; Schillaci, O; Villani, V | 1 |
| Ambrosini, V; Castellucci, P; Fanti, S; Morigi, JJ; Nanni, C | 1 |
| Bachellier, P; Gangi, A; Garnon, J; Imperiale, A; Namer, IJ | 1 |
| Acevedo-Báñez, I; García-Gómez, FJ; Mangas-Cruz, MA; Muñiz-Grijalvo, O; Tirado-Hospital, JL | 1 |
| Glaudemans, AW; Slart, RH; Stormezand, GN | 1 |
| Bozzao, A; Cicone, F; Filss, CP; Galldiks, N; Langen, KJ; Minniti, G; Papa, A; Rossi-Espagnet, C; Scaringi, C; Scopinaro, F; Shah, NJ | 1 |
| Abbruzzese, G; Arnaldi, D; Bossert, I; Brugnolo, A; Campus, C; Castaldi, A; De Carli, F; Girtler, N; Marinelli, L; Morbelli, S; Nobili, F; Piccardo, A; Picco, A | 1 |
| Chiu, CH; Huang, YY; Liu, CC; Liu, YL; Shiue, CY; Tang, KH; Tsai, CL; Tzen, KY; Wen, HP | 1 |
| Giovanella, L; Ruberto, T; Treglia, G | 1 |
| Edwards, R; Wirth, T | 1 |
| Garrè, ML; Morana, G; Nobili, F; Piccardo, A; Rossi, A | 1 |
| Acevedo-Báñez, I; Álvarez-Pérez, RM; Borrego-Dorado, I; Cuenca-Cuenca, JI; García-Gómez, FJ; García-Jiménez, R; García-Morillo, JS; Martínez-Castillo, R; Pachón-Garrudo, VM; Rivas-Infante, E; Tirado-Hospital, JL | 1 |
| Franci, X; Genon, JL; Giacomelli, F; Kuci, S; Lemaire, C; Libert, L; Luxen, A | 1 |
| Debry, C; Dietemann, S; Imperiale, A; Namer, IJ; Onea, A | 1 |
| Kumar, A; Kumar, R; Shamim, SA | 1 |
| Bell, C; Dowson, N; Fay, M; Gal, Y; Puttick, S; Rose, S; Smith, J; Thomas, P | 1 |
| Cheng, J; Li, C; Li, X; Liu, H; Liu, L; Niu, H; Sheng, H; Wang, F; Wen, Z; Zhang, W | 1 |
| Blonski, M; Janvier, L; Karcher, G; Morel, O; Olivier, P; Taillandier, L; Verger, A; Vignaud, JM | 1 |
| Guérin, C; Lowery, A; Paladino, NC; Sebag, F; Taïeb, D | 1 |
| Abdullah, AE; Archier, A; Guerin, C; Heimburger, C; Henry, JF; Imperiale, A; Morange, I; Mundler, O; Palazzo, FF; Schneegans, O; Sebag, F; Taïeb, D | 1 |
| Bernard Ir, C; Hustinx, R; Salmon, E | 1 |
| de Labriolle-Vaylet, C; Jehanno, N; Michon, J; Montravers, F; Wartski, M | 1 |
| Harada, N; Kakiuchi, T; Kanazawa, M; Muramatsu, S; Ohba, H; Tsukada, H | 1 |
| Adams, KT; Buchmann, I; Chen, CC; Fojo, AT; Herscovitch, P; Janssen, I; Kebebew, E; Millo, CM; Nambuba, J; Pacak, K; Patronas, NJ; Sadowski, SM; Taieb, D | 1 |
| Archier, A; Barlier, A; Beschmout, E; Castinetti, F; Fakhry, N; Gabriel, S; Garrigue, P; Guerin, C; Guillet, B; Loundou, A; Montava, M; Morange, I; Pacak, K; Sebag, F; Taïeb, D; Varoquaux, A | 1 |
| Knie, B; Moskopp, D; Plotkin, M; Prasad, V; Zschieschang, P | 1 |
| Coburn, M; Cumming, P; Dietrich, CA; Gründer, G; Henkel, K; Hilgers, RD; Kumakura, Y; Mohammadkhani Shali, S; Mottaghy, FM; Prinz, S; Rademacher, L; Schabram, I; Schmaljohann, J; Stoppe, C; Vernaleken, I; Winz, O | 1 |
| de Jong, BM; Leenders, KL; Pikstra, ARA; van der Hoorn, A | 1 |
| Garrè, ML; Lopci, E; Massollo, M; Morana, G; Naseri, M; Piccardo, A; Puntoni, M; Rossi, A; Severino, M; Tortora, D | 1 |
| Chang, HH; Hsu, WM; Huang, SF; Jeng, YM; Jou, ST; Lee, H; Lee, YL; Liao, YF; Lin, DT; Lin, KH; Liu, YL; Lu, CC; Lu, MY; Miser, JS; Tzen, KY; Yang, YL | 1 |
| Imperiale, A; Pacak, K; Taïeb, D | 1 |
| Bachellier, P; Caudrelier, J; Cazzato, RL; Gangi, A; Garnon, J; Imperiale, A; Koch, G; Namer, IJ; Ramamurthy, N; Rao, P; Tsoumakidou, G | 1 |
| Calabria, EN; Calabria, FF; Chiaravalloti, A; Grillea, G; Schillaci, O | 1 |
| Carideo, L; Cicone, F; Clerico, A; Langen, KJ; Minniti, G; Paiano, M; Scaringi, C; Scopinaro, F | 1 |
| Averous, G; Charlin, E; Heimburger, C; Imperiale, A; Kurtz, JE; Lang, H | 1 |
| Bhidayasiri, R; Boonla, C; Chotipanich, C; Dissayabutra, T; Joutsa, J; Kaewwilai, L; Muensri, S; Rinne, J; Tosukhowong, P | 1 |
| Dudczak, R; El-Rabadi, K; Hacker, M; Karanikas, G; Mayerhofer, M; Mitterhauser, M; Nakuz, T; Scherer, T; Weber, M | 1 |
| Bozzao, A; Cicone, F; Mancuso, V; Minniti, G; Napolitano, A; Romano, A; Rossi Espagnet, MC; Scaringi, C | 1 |
| Boisson, F; Brasse, D; Detour, J; Imperiale, A; Kessler, L; Kreutter, G; Lavaux, T; Marchand, P; Namer, IJ; Pierre, A | 1 |
| Bloomfield, MA; Curran, HV; Freeman, TP; Howes, OD; Morgan, CJ; Mouchlianitis, E; Roiser, JP | 1 |
| Giovanella, L; July, M; Santhanam, P; Treglia, G | 1 |
| Goichot, B; Heimburger, C; Helali, M; Imperiale, A; Rohr, S | 1 |
| Hijioka, M; Inden, M; Inubushi, T; Kitamura, Y; Morikawa, S; Oda, K; Taniguchi, T; Tooyama, I; Yanagisawa, D | 1 |
| Ebbehoj, A; Gormsen, LC; Poulsen, PL; Søndergaard, E | 1 |
| Beck, K; Howes, OD; Kim, E; Kwon, JS; Lee, JS; Lee, YS; Park, JW; Seo, S; Veronese, M | 1 |
| Ito, T; Jensen, RT | 1 |
| Alakurtti, K; Alho, H; Arponen, E; Forsback, S; Hirvonen, J; Johansson, J; Joutsa, J; Kaasinen, V; Lahti, T; Majuri, J; Parkkola, R; Voon, V | 1 |
| Foßhag, E; Franck, D; Kunkel, F; Pretze, M; Wängler, B; Wängler, C | 1 |
| Boellaard, R; de Heide, LJ; de Vries, EG; Glaudemans, AW; Noordzij, W; Slart, RH; van Beek, AP; van der Horst-Schrivers, AN; van Ginkel, B | 1 |
| Chang, HH; Hsu, WM; Jou, ST; Ko, CL; Ko, KY; Liu, CJ; Liu, YL; Lu, MY; Tzen, KY; Yang, YL; Yen, RF | 1 |
| Bund, C; Chenard, MP; Heimburger, C; Imperiale, A; Kremer, S; Lefebvre, F; Lhermitte, B; Namer, IJ; Proust, F | 1 |
| Arbizu, J; Galldiks, N; Langen, KJ; Law, I; Pope, WB | 1 |
| Capriati, V; Dimiccoli, V; Mandracchia, D; Maqoud, F; Mele, A; Scilimati, A; Tolomeo, A; Trapani, A; Trapani, G; Tricarico, D; Vitale, P | 1 |
| Dierckx, RA; Koole, M; Leenders, KL; Lopes Alves, I; Marques da Silva, AM; Meles, SK; Willemsen, AT | 1 |
| Bloomfield, M; Howes, OD; Jauhar, S; Kapur, S; Natesan, S; Rogdaki, M; Turkheimer, F; Veronese, M | 1 |
| Bialecki, E; Chinot, O; Colin, C; Figarella-Branger, D; Guedj, E; Metellus, P; Sala, Q; Taieb, D; Verger, A | 1 |
| Bahri, MA; Becker, G; Garraux, G; Hustadt, F; Lemaire, C; Luxen, A; Michel, A; Plenevaux, A | 1 |
| Cuccurullo, V; Di Stasio, GD; Mansi, L; Prisco, MR | 1 |
| Aasly, J; Adam, M; Agarwal, PA; Dinelle, K; Ding, YS; Farrer, M; Guttman, M; Hasegawa, K; Mak, E; McKenzie, J; Neilson, N; Schulzer, M; Shahinfard, E; Sossi, V; Stoessl, AJ; Strongosky, A; Uitti, RJ; Vafai, N; Wile, DJ; Wszolek, ZK; Zabetian, CP; Zhang, J | 1 |
| Apud, JA; Berman, KF; Eisenberg, DP; Gregory, MD; Hegarty, CE; Ianni, AM; Kohn, PD; Rubinstein, DY; Yankowitz, L | 1 |
| Ambrosini, V; Balogova, S; Beheshti, M; Bozkurt, MF; Chiti, A; Decristoforo, C; Delgado-Bolton, R; Fanti, S; Giammarile, F; Kjaer, A; Kunikowska, J; Oyen, WJG; Rubello, D; Sundin, A; Virgolini, I | 1 |
| Despot, M; Golubić, AT; Huić, D; Kusačić Kuna, S; Mutvar, A; Pasini Nemir, E; Samardžić, T; Žuvić, M | 1 |
| Cuny, T; Ginet, M; Marie, PY; Schmitt, E; Verger, A | 1 |
| Borghammer, P; Brooks, DJ; Gaig, C; Garrido, A; Iranzo, A; Møller, A; Otto, M; Pavese, N; Santamaria, J; Serradell, M; Stokholm, MG; Svendsen, KB; Tolosa, E; Vilas, D; Østergaard, K | 1 |
| Checkoway, H; Criswell, SR; Flores, HP; Huang, J; Moerlein, SM; Nielsen, SS; Perlmutter, JS; Racette, BA; Seixas, N; Sheppard, L; Warden, M | 1 |
| Borson-Chazot, F; Bournaud, C; Combemale, P; Giammarile, F; Giraudet, AL; Houzard, C; Kryza, D; Lifante, JC; Mognetti, T; Moreau, A | 1 |
| He, Q; Shi, X; Wang, X; Zhang, B; Zhang, X | 1 |
| Goldstein, DS; Holmes, C; Lopez, GJ; Sharabi, Y; Wu, T | 1 |
| Brusgaard, K; Christesen, HT; Christiansen, CD; Detlefsen, S; Ekström, K; Globa, E; Hovendal, C; Melikyan, M; Nielsen, AL; Petersen, H; Rasmussen, AH; Rasmussen, L | 1 |
| Blazak, J; Condon, L | 1 |
| Carideo, L; Cicone, F; Mamede, M; Minniti, G; Russo, I; Scaringi, C; Scopinaro, F | 1 |
| Berger, E; El-Rabadi, K; Hacker, M; Haug, A; Karanikas, G; Nakuz, TS; Wadsak, W | 1 |
| Brinkmann, DH; Giannini, C; Hunt, CH; Kemp, BJ; Laack, NN; Lowe, VJ; Morris, JM; Pafundi, DH; Parney, IF; Youland, RS | 1 |
| Bottoni, G; Mancardi, MM; Morana, G; Piccardo, A; Verrico, A | 1 |
| Adams, KT; Castinetti, F; Chen, CC; Essamet, W; Guerin, C; Jha, A; Ling, A; Pacak, K; Pang, Y; Quezado, MM; Roche, P; Romanet, P; Sebag, F; Taïeb, D | 1 |
| Gao, L; Liang, F; Tao, L; Weng, J; Xu, W; Yu, J; Zhang, J; Zheng, J | 1 |
| Egerton, A; Hathway, P; Howes, OD; Jauhar, S; Kapur, S; McGuire, P; Nour, MM; Rogdaki, M; Stone, J; Turkheimer, FE; Veronese, M | 1 |
| Göllner, A; Hacker, M; Hartenbach, M; Hartenbach, S; Karanikas, G; Mayerhoefer, M; Mazal, P; Rasul, S; Rebhan, K | 1 |
| Chang, CW; Chen, TW; Chen, YR; Chung, YH; Farn, SS; Huang, YC; Tien, SW; Yeh, CN; Yu, CS | 1 |
| Berends, AMA; Bolt, JW; Brouwers, AH; de Krijger, RR; Kats-Ugurlu, G; Kerstens, MN; Korpershoek, E; Links, TP; Noordzij, W; van der Horst-Schrivers, ANA; van Etten, B; Walenkamp, AME | 1 |
| Bloomfield, MAP; Bonoldi, I; Dahoun, T; Froudist-Walsh, S; Hennah, W; Howes, OD; Jauhar, S; Korth, C; Nosarti, C; Pardiñas, AF; Prata, D; Veronese, M; Walters, J | 1 |
| Brunaud, L; Chevalier, E; Cuny, T; Gasman, S; Houy, S; Klein, M; Moog, S; Ory, S; Rame, M; Weryha, G | 1 |
| Addeo, P; Averous, G; Bachellier, P; Goichot, B; Imperiale, A; Leroy Freschini, B | 1 |
| Addeo, P; Bund, C; Goichot, B; Heimburger, C; Imperiale, A | 1 |
| Bertaux, M; Chevalier, E; Guedj, E; Marie, PY; Micard, E; Poussier, S; Toch, SR; Van Der Gucht, A; Verger, A | 1 |
| Chantalat, E; Deslandres, M; Gornes, H; Perallon, R; Rimailho, J; Vaysse, C | 1 |
| Borgan, F; Egerton, A; Howes, OD; Jauhar, S; McCutcheon, R; McGuire, P; Nour, M; Pepper, F; Rogdaki, M; Stone, J; Turkheimer, F; Veronese, M | 1 |
| Bodner, G; Brammen, L; Karanikas, G; Koperek, O; Niederle, B; Niederle, MB; Riss, P; Scheuba, C; Selberherr, A | 1 |
| Adams, RA; Dahoun, T; Expert, P; Howes, OD; Jauhar, S; McCutcheon, RA; Mehta, MA; Nour, MM; Pepper, F; Turkheimer, F; Veronese, M | 1 |
| Djaldetti, R; Greenbaum, L; Lorberboym, M; Poewe, W; Rigbi, A; Roditi, Y; Scherfler, C; Steinmetz, A | 1 |
| Arcella, A; Carideo, L; Cicone, F; Giangaspero, F; Minniti, G; Scaringi, C; Scopinaro, F | 1 |
| Bellu, L; Bertin, D; Caccese, M; Cuppari, L; Evangelista, L; Lombardi, G; Reccia, P; Zagonel, V | 1 |
| Carideo, L; Cicone, F; Minniti, G; Scopinaro, F | 1 |
| Cuccurullo, V; Di Stasio, GD; Mansi, L | 1 |
| Ben Abdelghani, M; Blondet, C; El Ghannudi, S; Germain, P; Imperiale, A; Romain, B | 1 |
| Arcolin, M; Bertoldo, A; Dipasquale, O; Expert, P; Fisher, PM; Howes, O; Khan, W; Moro, L; Rizzo, G; Svarer, C; Turkheimer, FE; Veronese, M | 1 |
| Barclay, CL; Barua, NU; Blinder, S; Boca, M; Boiko, C; Broadfoot, J; Cronin, D; Dharia, S; Fibiger, HC; Gill, SS; Harrison, R; Howell, M; Irving, C; Johnson, D; Johnson, GA; Kinch, S; Lawrence, AD; Lewis, O; Longpre, L; Luz, M; Marshall, C; Mohr, E; Mooney, L; Pritchard, G; Schroers, C; Skinner, P; Sossi, V; Stoessl, AJ; Whone, AL; Woolley, M | 1 |
| Allegri, V; Ambrosini, V; Calabrò, D; Fanti, S | 1 |
| Ansquer, C; Bera, G; Bergeret, S; Chanson, P; Charbit, J; Lussey-Lepoutre, C | 1 |
| Calabria, F; Chiaravalloti, A; Cimini, A; Di Giorgio, E; Esposito, V; Schillaci, O; Ursini, F; Zinzi, M | 1 |
| Basher, RK; Behera, A; Bhattacharya, A; Kang, M; Mittal, BR; Nada, R; Shukla, J; Sood, A; Walia, R | 1 |
| Ansquer, C; Drui, D; Kraeber-Bodéré, F; Lugat, A; Mirallié, E | 1 |
| Hoberück, S; Kotzerke, J; Martino, F; Michler, E; Platzek, I | 1 |
| Decazes, P; Hapdey, S; Humbert, O; Marie-Cardine, A; Vera, P | 1 |
| Bloomfield, MAP; Bonoldi, I; D'Ambrosio, E; Dahoun, T; Froudist-Walsh, S; Howes, OD; Jauhar, S; Pardiñas, AF; Rogdaki, M; Veronese, M; Walters, JTR | 1 |
| Chabrier, G; Imperiale, A; Rotania, M | 1 |
| Bund, C; Cebula, H; Chibbaro, S; Lefebvre, F; Lhermitte, B; Namer, IJ; Pin, Y; Proust, F; Todeschi, J | 1 |
| Bonoldi, I; D'Ambrosio, E; Howes, OD; Jauhar, S; Kempton, MJ; Kim, E; Kim, S; Kotoula, V; Kwon, JS; Pepper, F; Rogdaki, M; Turkheimer, F; Veronese, M | 1 |
| Bacher Svendsen, K; Borghammer, P; Brooks, DJ; Fedorova, TD; Gaig, C; Garrido, A; Gersel Stokholm, M; Hiraoka, K; Iranzo, A; Møller, A; Okamura, N; Otto, M; Pavese, N; Santamaria, J; Serradell, M; Tolosa, E; Vilas, D; Østergaard, K | 1 |
| Beuthien-Baumann, B; Kotzerke, J; Löhle, M; Oehme, L; Reichmann, H; Storch, A; van den Hoff, J; Wolz, M | 1 |
| Amthauer, H; Apostolova, I; Betts, MJ; Buchert, R; de Boer, L; Düzel, E; Guitart-Masip, M; Metzger, C; Perosa, V; Ziegler, G | 1 |
| Capotosti, A; Indovina, L; Lanni, V; Lorusso, M; Rufini, V; Taralli, S | 1 |
| Chaves, LT; De Jong, BM; Dierckx, RAJO; Doorduin, J; Kremer, BPH; Leenders, KL; Stormezand, GN; Vállez García, D | 1 |
| Barlier, A; Brue, T; Castinetti, F; Cuny, T; D'Anella, P; Jullien, M; Reichert, T; Taieb, D | 1 |
| Berman, KF; Eisenberg, DP; Gregory, MD; Groden, C; Grogans, SE; Ianni, AM; Kim, J; Lopez, G; Masdeu, JC; Sidransky, E | 1 |
| Bertaux, M; Bielle, F; Choquet, S; Garcilazo, Y; Kas, A; Mokhtari, K; Ollivier, M; Rozenblum, L | 1 |
| Drzezga, A; Eggers, C; Greuel, A; Hammes, J; Maier, F; Ruppert, MC; Schwartz, F; Stürmer, S; Tahmasian, M; Timmermann, L; Tittgemeyer, M; van Eimeren, T | 1 |
| Barachini, O; Bernt, R; Hergan, K; Mirzaei, S; Pirich, C; Zandieh, S | 1 |
| Bozzao, A; Carideo, L; Cicone, F; Minniti, G; Scaringi, C; Scopinaro, F; Villani, V | 1 |
| Arabi, H; Bortolin, K; Garibotto, V; Ginovart, N; Zaidi, H | 1 |
| Andersen, KB; Borghammer, P; Brooks, DJ; Fedorova, TD; Hansen, AK; Kinnerup, M; Knudsen, K; Nahimi, A; Pavese, N; Sommerauer, M; Van Den Berge, N; Vang, K | 1 |
| De Leon, DD; Saade-Lemus, S; States, LJ | 1 |
| Brinkmann, DH; Herman, MG; Hunt, CH; Kemp, BJ; Laack, NN; Lowe, V; Pafundi, DH; Qian, J | 1 |
| Glubrecht, D; Krys, D; Mattingly, S; Wuest, F; Wuest, M | 1 |
| Aouidad, I; Jublanc, C; Montravers, F; Talbot, JN; Zhang-Yin, J | 1 |
| Albert, NL; Castello, A; Galldiks, N; Girard, A; Guedj, E; Lopci, E; Verger, A; Zaragori, T | 1 |
| Eggers, C; Eidelberg, D; Fink, GR; Holtbernd, F; Ma, Y; Oh, A; Spetsieris, P; Tang, CC; Timmermann, L | 1 |
| Brun, G; Guedj, E; Kaphan, E; Molines, E; Salgues, B | 1 |
| Krasikova, RN | 1 |
| Aarts, E; Cools, R; Hofmans, L; Määttä, JI; van den Bosch, R; Verkes, RJ | 1 |
| Cloughesy, TF; Ellingson, BM; Hagiwara, A; Lai, A; Liau, LM; Nghiemphu, PL; Oughourlian, TC; Raymond, C; Salamon, N; Tatekawa, H; Wang, C; Yao, J | 1 |
| Even-Sapir, E; Freedman, N; Giladi, N; Kestenbaum, M; Kuten, J; Lerman, H; Linevitz, A; Shiner, T | 1 |
| Garg, PK; Garg, S; Lokitz, SJ; Nazih, R; Nedrelow, JK; Putegnat, B; Reynolds, C; Sanchez, I; Thornton, PS; Truong, L; Uffman, J | 1 |
| Mittal, BR; Modi, M; Shree, R; Shukla, J; Sood, A; Vatsa, R | 1 |
| de Mestier, L; Deleval, N; Dieudonné, A; Hentic, O; Lebtahi, R; Pesque, L; Ruszniewski, P; Viry, F | 1 |
| Ansquer, C; Carlier, T; Faivre-Chauvet, A; Fleury, V; Frampas, E; Guyetant, S; Kraeber-Bodéré, F; Le Bras, M; Leux, C; Maucherat, B; Rauscher, A; Régenet, N; Scotet-Cérato, E; Senellart, H; Touchefeu, Y | 1 |
| Brouwers, AH; de Groot, DJA; Noordzij, W; Veenstra, EB; Walenkamp, AME | 1 |
| Bal, CS; Deepak, KK; Goyal, H; Goyal, V; Gupta, P; Kumar, R; Patel, C; Sharma, A; Tripathi, M | 1 |
| Capelle, L; Itti, E; Kauv, P; Louarn, N; Mokhtari, K | 1 |
| Anderson, SK; Brinkmann, D; Brown, P; Hunt, C; Kabat, B; Kaufmann, T; Kemp, B; Kizilbash, S; Laack, NN; Lowe, V; Pafundi, D; Ruff, M; Sarkaria, J; Seaberg, M; Uhm, J; Vogen, D; Wan Chan Tseung, HS; Yan, E; Zakhary, M; Zhang, Y | 1 |
| Ashok, AH; Bonoldi, I; Ciampoli, M; Daly, E; Devroye, C; Gudbrandsen, M; Howes, OD; Jauhar, S; McCutcheon, RA; Owen, MJ; Papaleo, F; Rogdaki, M; Turkheimer, F; van Amelsvoort, T; Van Den Bree, M; Veronese, M | 1 |
| Bagni, O; Filippi, L; Spinelli, GP | 1 |
| Cicone, F; Langen, KJ; Minniti, G | 1 |
| Bairov, VG; Mitrofanova, LB; Nikitina, IL; Perminova, AA; Ryzhkova, DV; Sukhotskaya, AA | 1 |
| Cottereau, AS; Dousset, B; Garcia, C; Libe, R; Tenenbaum, F | 1 |
| Chen, YC; Li, D; Li, R; Shang, S; Tian, Y; Yin, X; Zhang, Y; Zhao, H; Zheng, L | 1 |
| Berman, KF; Eisenberg, DP; Gregory, MD; Lopez, G; Sidransky, E | 1 |
| Chen, YC; Huang, T; Jiang, T; Tian, YY; Wang, F; Wang, SY; Zhang, YD; Zhou, LL | 1 |
| Brixi, H; Cadiot, G; Deguelte, S; Jallerat, P; Morland, D; Papathanassiou, D | 1 |
| Allott, K; Alvarez-Jimenez, M; Aquino, K; Chen, Z; Chopra, S; Cropley, V; Finlay, A; Fornito, A; Francey, S; Graham, J; Harrigan, S; McGorry, P; Nelson, B; O'Donoghue, B; Pantelis, C; Pozaruk, A; Razi, A; Sabaroedin, K; Saluja, B; Sharma, S; Tran, N; Williams, R; Wood, SJ; Yuen, HP | 1 |
| Breen, WG; Brinkmann, DH; Brown, PD; Giri, S; Hunt, CH; Jacobson, SB; Jones, JE; Kizilbash, SH; Laack, NN; Mahajan, A; Pafundi, DH; Routman, DM; Ruff, MW; Uhm, JH; Youland, RS | 1 |
| Albillo, D; Blesa, J; Del Álamo, M; Duque, A; Fernández-Rodríguez, B; Foffani, G; Gasca-Salas, C; Guida, P; Hernández-Fernández, F; Martínez-Fernández, R; Mata-Marín, D; Matarazzo, M; Montero, JI; Obeso, I; Obeso, JA; Pineda-Pardo, JA; Plaza de Las Heras, I; Rachmilevitch, I; Rodríguez-Rojas, R; Toltsis, G; Trompeta, C | 1 |
| Cadiot, G; Deguelte, S; Jallet, L; Morland, D; Papathanassiou, D | 1 |
| Chen, J; Chen, L; Chu, J; Jiang, L; Luo, G; Shi, X; Wang, J; Wu, L; Yang, Y; Yi, C; Zhang, X | 1 |
| Brixi, H; Cadiot, G; Deguelte, S; Lelièvre, M; Morland, D; Perrier, M; Triumbari, EKA | 1 |
| Chen, P; Cools, R; den Ouden, H; Geurts, DEM; Hofmans, L; Määttä, JI; Papadopetraki, D; van den Bosch, R | 1 |
| Mohammadi Ghalebin, M; Sadremomtaz, A | 1 |
80 review(s) available for dihydroxyphenylalanine and fluorodopa f 18
| Article | Year |
|---|---|
Production of 6-[18F]fluoro-L-dopa and its metabolism in vivo--a critical review.
Topics: Animals; Dihydroxyphenylalanine; Fluorine Radioisotopes; Humans; Tomography, Emission-Computed | 1992 |
Overview of radiopharmaceuticals for diagnosis of central nervous disorders.
Topics: Brain Diseases; Dihydroxyphenylalanine; Glucose; Humans; Perfusion; Receptors, Dopamine; Technetium; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 1991 |
The heritage of radiotracers for positron emission tomography.
Topics: Carbon Radioisotopes; Deoxyglucose; Dihydroxyphenylalanine; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Metaraminol; Tomography, Emission-Computed | 1990 |
New 18F tracers for the investigation of brain functions.
Topics: Brain; Dihydroxyphenylalanine; Fluorine Radioisotopes; Humans; Hydrocarbons, Fluorinated; Spiperone; Tomography, Emission-Computed | 1990 |
Cerebral glucose and dopa metabolism in movement disorders.
Topics: Animals; Brain; Deoxy Sugars; Deoxyglucose; Dihydroxyphenylalanine; Humans; Huntington Disease; Parkinson Disease; Tomography, Emission-Computed | 1987 |
General properties and clinical possibilities of new selective inhibitors of catechol O-methyltransferase.
Topics: Animals; Behavior, Animal; Benzophenones; Catechol O-Methyltransferase Inhibitors; Catecholamines; Catechols; Dihydroxyphenylalanine; Humans; Levodopa; Microdialysis; Nitriles; Nitrophenols; Pentanones; Tolcapone; Tomography, Emission-Computed | 1994 |
Functional positron emission tomographic studies of striatal dopaminergic activity. Changes induced by drugs and nigrostriatal degeneration.
Topics: Animals; Antiparkinson Agents; Dihydroxyphenylalanine; Dopamine; Humans; Levodopa; Neostriatum; Nerve Degeneration; Substantia Nigra; Tomography, Emission-Computed | 1996 |
Fluorodopa PET scanning in Parkinson's disease.
Topics: Animals; Dihydroxyphenylalanine; Dopamine; Humans; Parkinson Disease; Substantia Nigra; Tomography, Emission-Computed | 1996 |
[PET study of dopamine metabolism and dopamine D2 receptor in juvenile parkinsonism].
Topics: Age of Onset; Brain; Dihydroxyphenylalanine; Dopamine; Fluorine Radioisotopes; Glucose; Humans; Parkinson Disease; Receptors, Dopamine D2; Tomography, Emission-Computed | 1997 |
[PET study using 6-[18F]-fluorodopa in Parkinson's disease].
Topics: Animals; Brain; Dihydroxyphenylalanine; Dopamine; Fluorine Radioisotopes; Humans; Parkinson Disease; Tomography, Emission-Computed | 1997 |
Contributions of positron emission tomography to elucidating the pathogenesis of idiopathic parkinsonism and dopa responsive dystonia.
Topics: Brain; Diagnosis, Differential; Dihydroxyphenylalanine; Dystonia; Fluorine Radioisotopes; Humans; Neurons; Parkinson Disease; Tomography, Emission-Computed | 1997 |
Advances in imaging Parkinson's disease.
Topics: Brain Mapping; Dihydroxyphenylalanine; Humans; Parkinson Disease; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 1997 |
Biological imaging and the molecular basis of dopaminergic diseases.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Aromatic-L-Amino-Acid Decarboxylases; Brain; Cell Count; Dihydroxyphenylalanine; Dopamine; Haplorhini; Humans; Kinetics; Parkinson Disease; Putamen; Rodentia; Substantia Nigra; Tomography, Emission-Computed | 1997 |
[Three-dimensional positron emission tomography imaging system and its application for medical use].
Topics: Carbon Radioisotopes; Dihydroxyphenylalanine; Fluorine Radioisotopes; Humans; Image Processing, Computer-Assisted; Radiopharmaceuticals; Tomography, Emission-Computed | 1997 |
The natural history of Parkinson's disease.
Topics: Cell Count; Dihydroxyphenylalanine; Disabled Persons; Disease Progression; Fluorine Radioisotopes; Humans; Parkinson Disease; Risk Factors; Substantia Nigra | 1998 |
Etiology of Parkinson's disease: contributions from 18F-DOPA positron emission tomography.
Topics: Dihydroxyphenylalanine; Discriminant Analysis; Environment; Follow-Up Studies; Humans; Parkinson Disease; Pedigree; Tomography, Emission-Computed; Twin Studies as Topic | 1999 |
PET studies and motor complications in Parkinson's disease.
Topics: Antiparkinson Agents; Brain; Corpus Striatum; Dihydroxyphenylalanine; Dyskinesia, Drug-Induced; Fluorine Radioisotopes; Humans; Levodopa; Neural Pathways; Opioid Peptides; Parkinson Disease; Pulse Therapy, Drug; Putamen; Receptors, Opioid; Tomography, Emission-Computed | 2000 |
Assessing the integrity of the dopamine system in Parkinson's disease: how best to do it?
Topics: Brain; Corpus Striatum; Dihydroxyphenylalanine; Dopamine; Fluorine Radioisotopes; Humans; Neural Pathways; Parkinson Disease; Severity of Illness Index; Substantia Nigra; Tetrabenazine; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 2001 |
Contributions of PET and SPECT to the understanding of the pathophysiology of Parkinson's disease.
Topics: Aging; Animals; Antiparkinson Agents; Basal Ganglia; Brain Tissue Transplantation; Cell Transplantation; Cerebrovascular Circulation; Diagnosis, Differential; Dihydroxyphenylalanine; Dopamine Agonists; Electric Stimulation Therapy; Fetal Tissue Transplantation; Forecasting; Genetic Predisposition to Disease; Humans; Iatrogenic Disease; Imagination; Ligands; Mesencephalon; Motor Activity; Nerve Degeneration; Neurodegenerative Diseases; Neurons; Neuroprotective Agents; Neurotransmitter Agents; Parkinson Disease; Parkinson Disease, Secondary; Parkinsonian Disorders; Radiopharmaceuticals; Rats; Receptors, Dopamine; Risk; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon; Tremor | 2001 |
Diagnostic localization of pheochromocytoma: the coming of age of positron emission tomography.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Dihydroxyphenylalanine; Fluorine Radioisotopes; Humans; Indium Radioisotopes; Pheochromocytoma; Radiopharmaceuticals; Somatostatin; Tomography, Emission-Computed | 2002 |
Do dopamine agonists or levodopa modify Parkinson's disease progression?
Topics: Animals; Antiparkinson Agents; Benzothiazoles; Carrier Proteins; Dihydroxyphenylalanine; Disease Progression; Dopamine Agonists; Dopamine Plasma Membrane Transport Proteins; Humans; Indoles; Iodine Radioisotopes; Levodopa; Membrane Glycoproteins; Membrane Transport Proteins; Neostriatum; Nerve Tissue Proteins; Parkinson Disease; Pramipexole; Radiopharmaceuticals; Thiazoles; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon; Treatment Outcome; Tropanes | 2002 |
Management of ADHD in adults.
Topics: Adolescent; Adult; Age Factors; Amphetamines; Antidepressive Agents; Antihypertensive Agents; Attention Deficit Disorder with Hyperactivity; Brain; Central Nervous System Stimulants; Child; Cholinergic Agents; Clinical Trials as Topic; Dihydroxyphenylalanine; Humans; Methylphenidate; Pemoline; Tomography, Emission-Computed; Treatment Outcome | 2002 |
Imaging studies in movement disorders.
Topics: Brain; Cocaine; Dihydroxyphenylalanine; Dopamine; Humans; Movement Disorders; Parkinson Disease; Predictive Value of Tests; Radiopharmaceuticals; Severity of Illness Index; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 2003 |
Dyskinesias after transplantation in Parkinson's disease.
Topics: Animals; Brain Tissue Transplantation; Dihydroxyphenylalanine; Dyskinesias; Fetal Tissue Transplantation; Humans; Mesencephalon; Parkinson Disease; Putamen | 2002 |
Dysfunction of dopaminergic pathways in dystonia.
Topics: Animals; Basal Ganglia; Brain Mapping; Dihydroxyphenylalanine; Dopamine; Dystonia; Humans; In Vitro Techniques; Motor Activity; Nerve Net; Neural Inhibition; Neural Pathways; Receptors, Dopamine; Tomography, Emission-Computed | 2004 |
Assessment of neuroimaging techniques as biomarkers of the progression of Parkinson's disease.
Topics: Animals; Basal Ganglia; Biomarkers; Cocaine; Diagnostic Imaging; Dihydroxyphenylalanine; Disease Progression; Dopamine Plasma Membrane Transport Proteins; Humans; Levodopa; Membrane Glycoproteins; Membrane Transport Proteins; Nerve Tissue Proteins; Neuropeptides; Parkinson Disease; Radiopharmaceuticals; Technology Assessment, Biomedical; Tetrabenazine; Tomography, Emission-Computed, Single-Photon; Vesicular Biogenic Amine Transport Proteins; Vesicular Monoamine Transport Proteins | 2003 |
The sensitivity of 18-fluorodopa positron emission tomography and magnetic resonance imaging in Parkinson's disease.
Topics: Brain; Diagnosis, Differential; Dihydroxyphenylalanine; Disease Progression; Humans; Magnetic Resonance Imaging; Parkinson Disease; Sensitivity and Specificity; Tomography, Emission-Computed | 2004 |
The role of radiotracer imaging in Parkinson disease.
Topics: Biomarkers; Biotransformation; Blood-Brain Barrier; Carbon Radioisotopes; Clinical Trials as Topic; Cocaine; Corpus Striatum; Dihydroxyphenylalanine; Dopamine; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Forecasting; Humans; Iodine Radioisotopes; Neurons; Parkinson Disease; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Receptors, Dopamine; Substantia Nigra; Tetrabenazine; Tomography, Emission-Computed, Single-Photon | 2005 |
Role of [18F]-dopa-PET imaging in assessing movement disorders.
Topics: Dihydroxyphenylalanine; Dopamine Agonists; Fluorine Radioisotopes; Humans; Parkinson Disease; Positron-Emission Tomography | 2005 |
Imaging of pheochromocytoma and paraganglioma.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Dihydroxyphenylalanine; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Paraganglioma; Pheochromocytoma; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2005 |
[Advantages and limitations in the assessment of neuroprotective treatment of Parkinson's disease by functional imaging].
Topics: Antiparkinson Agents; Cocaine; Dihydroxyphenylalanine; Fluorine Radioisotopes; Humans; Parkinson Disease; Radiopharmaceuticals; Tomography, Emission-Computed, Single-Photon | 2005 |
[Radiological innovations in the screening and diagnosis of the inborn errors of metabolism].
Topics: Aldose-Ketose Isomerases; Amidinotransferases; Brain Chemistry; Congenital Hyperinsulinism; Creatine; Dihydroxyphenylalanine; Dopa Decarboxylase; Genetic Testing; Guanidinoacetate N-Methyltransferase; Humans; Infant; Infant, Newborn; Magnetic Resonance Spectroscopy; Metabolism, Inborn Errors; Nerve Tissue Proteins; Pancreas; Pentose Phosphate Pathway; Pentoses; Plasma Membrane Neurotransmitter Transport Proteins; Positron-Emission Tomography; Radiography; Radiopharmaceuticals | 2005 |
The role of fluorodeoxyglucose, 18F-dihydroxyphenylalanine, 18F-choline, and 18F-fluoride in bone imaging with emphasis on prostate and breast.
Topics: Bone Neoplasms; Breast Neoplasms; Choline; Dihydroxyphenylalanine; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Practice Guidelines as Topic; Practice Patterns, Physicians'; Prostatic Neoplasms; Radionuclide Imaging; Radiopharmaceuticals | 2006 |
[PET and malignant cerebral tumors].
Topics: Brain Neoplasms; Choline; Dideoxynucleosides; Dihydroxyphenylalanine; Fluorodeoxyglucose F18; Glioma; Humans; Methionine; Positron-Emission Tomography; Radiopharmaceuticals | 2006 |
Congenital hyperinsulinism - a review of the disorder and a discussion of the anesthesia management.
Topics: Anesthesia; Dihydroxyphenylalanine; Hepatic Veins; Humans; Hyperinsulinism; Infant; Infant, Newborn; Insulin; Pancreas; Pancreatectomy; Radionuclide Imaging; Radiopharmaceuticals | 2007 |
Non-[18F]FDG PET in clinical oncology.
Topics: Antibodies; Choline; Dideoxynucleosides; Dihydroxyphenylalanine; Fluorodeoxyglucose F18; Medical Oncology; Neoplasms; Oxygen; Positron-Emission Tomography; Radiopharmaceuticals; Receptors, Estrogen; Receptors, Somatostatin | 2007 |
(18)F-labeled positron emission tomographic radiopharmaceuticals in oncology: an overview of radiochemistry and mechanisms of tumor localization.
Topics: Amino Acids; Animals; Bone and Bones; Cell Hypoxia; Choline; Dideoxynucleosides; Dihydroxyphenylalanine; Estradiol; Fluorine Radioisotopes; Fluoroacetates; Fluorodeoxyglucose F18; Glucose; Humans; Membrane Lipids; Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2007 |
3,4-dihydroxy-6-[18f]-fluoro-L-phenylalanine positron emission tomography in patients with central motor disorders and in evaluation of brain and other tumors.
Topics: Adrenal Gland Neoplasms; Amino Acids; Brain Neoplasms; Caudate Nucleus; Dihydroxyphenylalanine; Fluorine Radioisotopes; Glioma; Humans; Movement Disorders; Neuroendocrine Tumors; Parkinsonian Disorders; Positron-Emission Tomography; Putamen; Radiopharmaceuticals | 2007 |
6-L-18F-fluorodihydroxyphenylalanine PET in neuroendocrine tumors: basic aspects and emerging clinical applications.
Topics: Adenoma, Islet Cell; Dihydroxyphenylalanine; Humans; Hyperinsulinism; Neuroendocrine Tumors; Pancreatic Neoplasms; Pheochromocytoma; Positron-Emission Tomography; Thyroid Neoplasms | 2008 |
PET imaging of brain tumors.
Topics: Biopsy; Brain; Brain Neoplasms; Cell Proliferation; Diagnostic Imaging; Dihydroxyphenylalanine; Fluorodeoxyglucose F18; Humans; Lipids; Medical Oncology; Methionine; Positron-Emission Tomography; Radiopharmaceuticals; Tyrosine | 2008 |
[Adrenal incidentaloma and nuclear medicine examination].
Topics: 19-Iodocholesterol; 3-Iodobenzylguanidine; Adenoma; Adrenal Cortex Neoplasms; Adrenal Gland Neoplasms; Adult; Dihydroxyphenylalanine; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Incidental Findings; Pheochromocytoma; Positron-Emission Tomography; Radiopharmaceuticals | 2009 |
PET studies of cerebral levodopa metabolism: a review of clinical findings and modeling approaches.
Topics: Animals; Brain; Computer Simulation; Dihydroxyphenylalanine; Dopa Decarboxylase; Dopamine; Humans; Levodopa; Parkinson Disease; Pharmacokinetics; Positron-Emission Tomography | 2009 |
PET and PET/CT in endocrine tumours.
Topics: Carbon Radioisotopes; Dihydroxyphenylalanine; Endocrine Gland Neoplasms; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Image Interpretation, Computer-Assisted; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2010 |
Lewy body pathology in fetal grafts.
Topics: alpha-Synuclein; Animals; Corpus Striatum; Dihydroxyphenylalanine; Dopamine Plasma Membrane Transport Proteins; Female; Fetal Tissue Transplantation; Fetus; Fluorine Radioisotopes; Graft Survival; Humans; Isotope Labeling; Lewy Bodies; Melanins; Pregnancy; Substantia Nigra | 2010 |
Transcranial sonography in the premotor diagnosis of Parkinson's disease.
Topics: Dihydroxyphenylalanine; Humans; Motor Neurons; Parkinson Disease; Positron-Emission Tomography; Predictive Value of Tests; Ultrasonography, Doppler, Transcranial | 2010 |
[Functional imaging: role for the diagnosis and therapeutic evaluation of Parkinson's disease].
Topics: Antiparkinson Agents; Brain Chemistry; Diagnosis, Differential; Dihydroxyphenylalanine; Dopamine Agents; Glucose; Humans; Nortropanes; Parkinson Disease; Radiopharmaceuticals; Tomography, Emission-Computed, Single-Photon | 2010 |
[Nuclear medicine imaging in patients with Parkinson's syndrome: an update].
Topics: Animals; Brain; Dihydroxyphenylalanine; Disease Progression; Dopamine; Energy Metabolism; Fluorodeoxyglucose F18; Genetic Predisposition to Disease; Humans; Nerve Degeneration; Neurons; Parkinson Disease; Parkinsonian Disorders; Positron-Emission Tomography; Receptors, Dopamine; Regional Blood Flow; Sensitivity and Specificity; Tomography, Emission-Computed, Single-Photon | 2010 |
Role of 18F-DOPA PET/CT imaging in congenital hyperinsulinism.
Topics: Congenital Hyperinsulinism; Dihydroxyphenylalanine; Humans; Infant, Newborn; Models, Biological; Positron-Emission Tomography; Tomography, Emission-Computed | 2010 |
Pathophysiological premises to radiotracers for bone metastases.
Topics: Bone and Bones; Bone Neoplasms; Choline; Dihydroxyphenylalanine; Diphosphonates; Humans; Iodine Radioisotopes; Organometallic Compounds; Organophosphorus Compounds; Radiography; Radionuclide Imaging; Radiopharmaceuticals; Technetium Compounds; Technetium Tc 99m Sestamibi | 2011 |
Diagnostic performance of 18F-dihydroxyphenylalanine positron emission tomography in patients with paraganglioma: a meta-analysis.
Topics: Dihydroxyphenylalanine; Humans; Multimodal Imaging; Paraganglioma; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2012 |
Molecular imaging of brain tumors with 18F-DOPA PET and PET/CT.
Topics: Brain Neoplasms; Dihydroxyphenylalanine; Fluorine Radioisotopes; Humans; Magnetic Resonance Imaging; Multimodal Imaging; Neoplasm Metastasis; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Sensitivity and Specificity; Tomography, X-Ray Computed | 2012 |
Contemporary nuclear medicine imaging of neuroendocrine tumours.
Topics: Chromaffin System; Dihydroxyphenylalanine; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Neuroendocrine Tumors; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, Emission-Computed, Single-Photon | 2012 |
The value of radiologic interventions and (18)F-DOPA PET in diagnosing and localizing focal congenital hyperinsulinism: systematic review and meta-analysis.
Topics: Congenital Hyperinsulinism; Dihydroxyphenylalanine; Fluorine Radioisotopes; Humans; Pancreas; Positron-Emission Tomography; Radiopharmaceuticals | 2013 |
Nuclear medicine in NET.
Topics: Biomarkers, Tumor; Cell Proliferation; Dihydroxyphenylalanine; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Multimodal Imaging; Neoplasm Staging; Neuroendocrine Tumors; Positron-Emission Tomography; Prognosis; Radionuclide Imaging; Receptors, Peptide; Receptors, Somatostatin; Tomography, X-Ray Computed | 2012 |
Detection rate of recurrent medullary thyroid carcinoma using fluorine-18 dihydroxyphenylalanine positron emission tomography: a meta-analysis.
Topics: Carcinoma, Neuroendocrine; Dihydroxyphenylalanine; Humans; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prevalence; Radiopharmaceuticals; Reproducibility of Results; Risk Factors; Sensitivity and Specificity; Thyroid Neoplasms | 2012 |
Diagnostic performance of fluorine-18-dihydroxyphenylalanine positron emission tomography in diagnosing and localizing the focal form of congenital hyperinsulinism: a meta-analysis.
Topics: Congenital Hyperinsulinism; Dihydroxyphenylalanine; Evidence-Based Medicine; Humans; Positron-Emission Tomography; Prevalence; Radiopharmaceuticals; Reproducibility of Results; Risk Factors; Sensitivity and Specificity | 2012 |
Comparison of different positron emission tomography tracers in patients with recurrent medullary thyroid carcinoma: our experience and a review of the literature.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Neuroendocrine; Dihydroxyphenylalanine; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Thyroid Neoplasms; Tomography, X-Ray Computed | 2013 |
Integrating genetic and imaging investigations into the clinical management of congenital hyperinsulinism.
Topics: ATP-Binding Cassette Transporters; Calcium; Child; Child, Preschool; Congenital Hyperinsulinism; Decision Trees; Dihydroxyphenylalanine; Humans; Infant, Newborn; Insulin; Insulin Secretion; Insulin-Secreting Cells; KATP Channels; Multimodal Imaging; Pancreas; Positron-Emission Tomography; Potassium Channels, Inwardly Rectifying; Receptors, Drug; Sulfonylurea Receptors; Tomography, X-Ray Computed | 2013 |
Diagnostic role of 18F-dihydroxyphenylalanine positron emission tomography in patients with congenital hyperinsulinism: a meta-analysis.
Topics: Congenital Hyperinsulinism; Dihydroxyphenylalanine; Humans; Positron-Emission Tomography; Quality Control | 2013 |
18F-fluorodihydroxyphenylalanine vs other radiopharmaceuticals for imaging neuroendocrine tumours according to their type.
Topics: 3-Iodobenzylguanidine; Bronchial Neoplasms; Carcinoma, Merkel Cell; Dihydroxyphenylalanine; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Lung Neoplasms; Multimodal Imaging; Neoplasm Metastasis; Neuroendocrine Tumors; Octreotide; Radionuclide Imaging; Radiopharmaceuticals; Receptors, Somatostatin; Recurrence; Sensitivity and Specificity; Thyroid Neoplasms; Tomography, Emission-Computed, Single-Photon | 2013 |
What is currently the best radiopharmaceutical for the hybrid PET/CT detection of recurrent medullary thyroid carcinoma?
Topics: Amines; Blood Glucose; Bone and Bones; Carcinoma, Neuroendocrine; Dihydroxyphenylalanine; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiation Dosage; Radiopharmaceuticals; Receptors, Somatostatin; Thyroid Neoplasms; Tomography, X-Ray Computed | 2013 |
Normal biodistribution pattern and physiologic variants of 18F-DOPA PET imaging.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Child; Dihydroxyphenylalanine; Female; Humans; Image Interpretation, Computer-Assisted; Male; Middle Aged; Positron-Emission Tomography; Tissue Distribution; Tomography, X-Ray Computed; Young Adult | 2013 |
18F-fluorodihydroxyphenylalanine in the diagnosis of neuroendocrine tumors.
Topics: Adrenal Gland Neoplasms; Carcinoma, Neuroendocrine; Dihydroxyphenylalanine; Humans; Intestinal Neoplasms; Neuroendocrine Tumors; Pancreatic Neoplasms; Paraganglioma; Pheochromocytoma; Positron-Emission Tomography; Radiopharmaceuticals; Stomach Neoplasms; Thyroid Neoplasms | 2014 |
Role of (18) F-FDOPA PET/CT imaging in endocrinology.
Topics: Adrenal Gland Neoplasms; Carbidopa; Carcinoid Tumor; Carcinoma, Neuroendocrine; Dihydroxyphenylalanine; Dopamine Agents; Fluorodeoxyglucose F18; Humans; Multimodal Imaging; Neuroendocrine Tumors; Paraganglioma; Pheochromocytoma; Positron-Emission Tomography; Radiopharmaceuticals; Thyroid Neoplasms; Tomography, X-Ray Computed | 2014 |
18F-FDOPA PET for the diagnosis of parkinsonian syndromes.
Topics: Brain; Dihydroxyphenylalanine; Disease Progression; Humans; Image Processing, Computer-Assisted; Parkinsonian Disorders; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Time Factors | 2014 |
Current status of PET imaging of neuroendocrine tumours ([18F]FDOPA, [68Ga]tracers, [11C]/[18F]-HTP).
Topics: 5-Hydroxytryptophan; Carbon Radioisotopes; Dihydroxyphenylalanine; Gallium Radioisotopes; Humans; Image Enhancement; Molecular Imaging; Neuroendocrine Tumors; Positron-Emission Tomography; Radiopharmaceuticals | 2015 |
[(18)F]6-fluoro-3,4-dihydroxy-L-phenylalanine--recent modern syntheses for an elusive radiotracer.
Topics: Dihydroxyphenylalanine; Radiopharmaceuticals | 2015 |
PET/Computed Tomography in Neuroendocrine Tumor: Value to Patient Management and Survival Outcomes.
Topics: Adrenal Gland Neoplasms; Dihydroxyphenylalanine; Fluorodeoxyglucose F18; Gallium Radioisotopes; Gastrointestinal Neoplasms; Humans; Multimodal Imaging; Neuroendocrine Tumors; Pancreatic Neoplasms; Paraganglioma; Pheochromocytoma; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Radiotherapy; Thyroid Neoplasms; Tomography, X-Ray Computed | 2015 |
Increasing feasibility and utility of (18)F-FDOPA PET for the management of glioma.
Topics: Dihydroxyphenylalanine; Feasibility Studies; Glioma; Humans; Neoplasm Grading; Positron-Emission Tomography; Radiotherapy Planning, Computer-Assisted | 2015 |
Pitfalls and Limitations of PET/CT in Brain Imaging.
Topics: Amyloid; Artifacts; Brain; Dihydroxyphenylalanine; Fluorodeoxyglucose F18; Functional Neuroimaging; Humans; Movement; Multimodal Imaging; Patient Positioning; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2015 |
Role of positron emission tomography imaging in Multiple Endocrine Neoplasia syndromes.
Topics: 5-Hydroxytryptophan; Biomarkers, Tumor; Dihydroxyphenylalanine; Ephedrine; Fluorodeoxyglucose F18; Genetic Predisposition to Disease; Humans; Methionine; Multiple Endocrine Neoplasia; Mutation; Phenotype; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Receptors, Somatostatin | 2018 |
Molecular imaging in neuroendocrine tumors: recent advances, controversies, unresolved issues, and roles in management.
Topics: Dihydroxyphenylalanine; Female; Gallium Radioisotopes; Glucagon-Like Peptide 1; Humans; Molecular Imaging; Neuroendocrine Tumors; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Receptors, Somatostatin; Sensitivity and Specificity; Tomography, X-Ray Computed | 2017 |
The use of amino acid PET and conventional MRI for monitoring of brain tumor therapy.
Topics: Amino Acids; Brain Neoplasms; Dihydroxyphenylalanine; Humans; Methionine; Positron-Emission Tomography; Radiopharmaceuticals; Tyrosine | 2017 |
Nuclear Medicine in Patients with NET: Radiolabeled Somatostatin Analogues and their Brothers.
Topics: Dihydroxyphenylalanine; Fluorodeoxyglucose F18; Humans; Neuroendocrine Tumors; Nuclear Medicine; Octreotide; Organometallic Compounds; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Somatostatin | 2017 |
Accuracy of
Topics: Brain Neoplasms; Diagnosis, Differential; Dihydroxyphenylalanine; Humans; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Prospective Studies; Radiation Injuries; Retrospective Studies; Tyrosine | 2018 |
Comparison Between 18F-Dopa and 18F-Fet PET/CT in Patients with Suspicious Recurrent High Grade Glioma: A Literature Review and Our Experience.
Topics: Brain Neoplasms; Dihydroxyphenylalanine; Glioma; Humans; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Tyrosine | 2019 |
Physiopathological Premises to Nuclear Medicine Imaging of Pancreatic Neuroendocrine Tumours.
Topics: Animals; Dihydroxyphenylalanine; Dimerization; Edetic Acid; Fluorodeoxyglucose F18; Glucagon-Like Peptide-1 Receptor; Humans; Indium Radioisotopes; Insulinoma; Ligands; Mice; Neuroendocrine Tumors; Nuclear Medicine; Octreotide; Pancreatic Neoplasms; Pentetic Acid; Positron-Emission Tomography; Radionuclide Imaging; Radiopharmaceuticals; Receptors, Somatostatin | 2019 |
Novel PET tracers: added value for endocrine disorders.
Topics: Dihydroxyphenylalanine; Endocrine System Diseases; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Neuroendocrine Tumors; Positron-Emission Tomography; Radiopharmaceuticals | 2019 |
18-F-L 3,4-Dihydroxyphenylalanine PET/Computed Tomography in the Management of Congenital Hyperinsulinism.
Topics: Congenital Hyperinsulinism; Dihydroxyphenylalanine; Humans; Infant; Positron Emission Tomography Computed Tomography | 2020 |
Nucleophilic Synthesis of 6-l-[
Topics: Catalysis; Chemistry Techniques, Synthetic; Copper; Dihydroxyphenylalanine; Halogenation | 2020 |
49 trial(s) available for dihydroxyphenylalanine and fluorodopa f 18
| Article | Year |
|---|---|
The effect of entacapone (OR-611) on brain [18F]-6-L-fluorodopa metabolism: implications for levodopa therapy of Parkinson's disease.
Topics: Aged; Brain; Carbidopa; Catechol O-Methyltransferase Inhibitors; Catechols; Corpus Striatum; Dihydroxyphenylalanine; Drug Synergism; Female; Fluorine Radioisotopes; Humans; Levodopa; Male; Middle Aged; Nitriles; Occipital Lobe; Parkinson Disease; Tomography, Emission-Computed | 1994 |
The rate of progression of Parkinson's disease. A longitudinal [18F]DOPA PET study.
Topics: Aged; Aging; Caudate Nucleus; Dihydroxyphenylalanine; Disease Progression; Humans; Longitudinal Studies; Middle Aged; Neostriatum; Parkinson Disease; Putamen; Tomography, Emission-Computed | 1996 |
Decreasing striatal 6-FDOPA uptake with increasing duration of cocaine withdrawal.
Topics: Adult; Brain Chemistry; Cocaine; Dihydroxyphenylalanine; Female; Fluorine Radioisotopes; Humans; Male; Narcotics; Neostriatum; Substance Withdrawal Syndrome; Tomography, Emission-Computed | 1997 |
Striatal [18F]fluorodopa utilization after COMT inhibition with entacapone studied with PET in advanced Parkinson's disease.
Topics: Aged; Aged, 80 and over; Analysis of Variance; Catechol O-Methyltransferase Inhibitors; Catechols; Corpus Striatum; Dihydroxyphenylalanine; Enzyme Inhibitors; Female; Humans; Male; Middle Aged; Nitriles; Parkinson Disease; Tomography, Emission-Computed | 1995 |
Validation of the three-dimensional acquisition mode in positron emission tomography for the quantitation of [18F]fluoro-DOPA uptake in the human striata.
Topics: Adult; Brain Mapping; Corpus Striatum; Dihydroxyphenylalanine; Humans; Linear Models; Male; Occipital Lobe; Reference Values; Reproducibility of Results; Tomography, Emission-Computed | 1998 |
Stimulation of dopa decarboxylase activity in striatum of healthy human brain secondary to NMDA receptor antagonism with a low dose of amantadine.
Topics: Adult; Amantadine; Antiparkinson Agents; Dihydroxyphenylalanine; Dopa Decarboxylase; Dopamine Agents; Enzyme Activation; Female; Fluorine Radioisotopes; Frontal Lobe; Humans; Kinetics; Linear Models; Male; Neostriatum; Receptors, N-Methyl-D-Aspartate; Time Factors; Tomography, Emission-Computed | 1999 |
Cognitive impairment and the brain dopaminergic system in Parkinson disease: [18F]fluorodopa positron emission tomographic study.
Topics: Aged; Caudate Nucleus; Cognition Disorders; Dihydroxyphenylalanine; Dopamine; Female; Frontal Lobe; Humans; Male; Middle Aged; Neuropsychological Tests; Parkinson Disease; Predictive Value of Tests; Putamen; Reaction Time; Regression Analysis; Task Performance and Analysis; Tomography, Emission-Computed; Verbal Behavior | 2000 |
18F-DOPA positron emission tomography for tumour detection in patients with medullary thyroid carcinoma and elevated calcitonin levels.
Topics: Aged; Calcitonin; Carcinoma, Medullary; Dihydroxyphenylalanine; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Radiopharmaceuticals; Receptors, Somatostatin; Thyroid Neoplasms; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2001 |
Transplantation of embryonic dopamine neurons for severe Parkinson's disease.
Topics: Adult; Age Factors; Aged; Brain; Brain Tissue Transplantation; Control Groups; Culture Techniques; Dihydroxyphenylalanine; Dopamine; Double-Blind Method; Female; Fetal Tissue Transplantation; Fluorine Radioisotopes; Humans; Male; Mesencephalon; Middle Aged; Neurons; Parkinson Disease; Severity of Illness Index; Tomography, Emission-Computed | 2001 |
Blinded positron emission tomography study of dopamine cell implantation for Parkinson's disease.
Topics: Adult; Age Factors; Aged; Dihydroxyphenylalanine; Double-Blind Method; Humans; Middle Aged; Parkinson Disease; Putamen; Substantia Nigra; Tomography, Emission-Computed | 2001 |
18F-dopa PET evidence that tolcapone acts as a central COMT inhibitor in Parkinson's disease.
Topics: Aged; Benzophenones; Catechol O-Methyltransferase; Catechol O-Methyltransferase Inhibitors; Caudate Nucleus; Cross-Over Studies; Dihydroxyphenylalanine; Dopamine; Enzyme Inhibitors; Humans; Middle Aged; Neostriatum; Neurons; Nitrophenols; Parkinson Disease; Putamen; Tolcapone; Tomography, Emission-Computed | 2002 |
Dyskinesia after fetal cell transplantation for parkinsonism: a PET study.
Topics: Adult; Brain; Caudate Nucleus; Cohort Studies; Dihydroxyphenylalanine; Double-Blind Method; Dyskinesias; Fetal Tissue Transplantation; Fluorine Radioisotopes; Humans; Middle Aged; Parkinsonian Disorders; Putamen; Tomography, Emission-Computed | 2002 |
A comparison of the progression of early Parkinson's disease in patients started on ropinirole or L-dopa: an 18F-dopa PET study.
Topics: Aged; Antiparkinson Agents; Dihydroxyphenylalanine; Disease Progression; Fluorine Radioisotopes; Follow-Up Studies; Humans; Indoles; Levodopa; Middle Aged; Parkinson Disease; Tomography, Emission-Computed | 2002 |
18F-DOPA positron emission tomography for the detection of glomus tumours.
Topics: Adult; Aged; Carotid Body Tumor; Dihydroxyphenylalanine; Female; Glomus Tumor; Humans; Male; Middle Aged; Paraganglioma; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Single-Blind Method; Tomography, Emission-Computed | 2003 |
Crossover study of (99m)Tc-TRODAT-1 SPECT and (18)F-FDOPA PET in Parkinson's disease patients.
Topics: Aged; Corpus Striatum; Cross-Over Studies; Dihydroxyphenylalanine; Female; Humans; Male; Middle Aged; Organotechnetium Compounds; Parkinson Disease; Putamen; Radiopharmaceuticals; Reference Values; Reproducibility of Results; Sensitivity and Specificity; Tissue Distribution; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon; Tropanes | 2003 |
Positron emission tomography with [(18)F]FDOPA and [(18)F]FDG in the imaging of small cell lung carcinoma: preliminary results.
Topics: Adult; Aged; Carcinoma, Small Cell; Dihydroxyphenylalanine; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, Emission-Computed | 2003 |
A double-blind controlled trial of bilateral fetal nigral transplantation in Parkinson's disease.
Topics: Adult; Aged; Brain Tissue Transplantation; Cell Survival; Dihydroxyphenylalanine; Dopamine; Double-Blind Method; Dyskinesias; Female; Fetal Tissue Transplantation; Functional Laterality; Humans; Male; Middle Aged; Neurons; Parkinson Disease; Substantia Nigra; Tomography, Emission-Computed; Treatment Outcome | 2003 |
[18F]fluorodopa uptake in the upper brainstem measured with positron emission tomography correlates with decreased REM sleep duration in early Parkinson's disease.
Topics: Adult; Aged; Aged, 80 and over; Brain Stem; Dihydroxyphenylalanine; Female; Humans; Male; Middle Aged; Neurotransmitter Agents; Parkinson Disease; Polysomnography; Sleep Wake Disorders; Sleep, REM; Tomography, Emission-Computed | 2003 |
Brain tumour imaging with PET: a comparison between [18F]fluorodopa and [11C]methionine.
Topics: Adult; Aged; Brain Neoplasms; Dihydroxyphenylalanine; Female; Humans; Male; Methionine; Middle Aged; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, Emission-Computed | 2003 |
A technique for standardized central analysis of 6-(18)F-fluoro-L-DOPA PET data from a multicenter study.
Topics: Algorithms; Antiparkinson Agents; Canada; Dihydroxyphenylalanine; Dopamine Agents; France; Germany; Humans; Image Interpretation, Computer-Assisted; Indoles; Levodopa; Parkinson Disease; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, Emission-Computed; Treatment Outcome; United Kingdom | 2004 |
Imaging of advanced neuroendocrine tumors with (18)F-FDOPA PET.
Topics: Adult; Aged; Aged, 80 and over; Dihydroxyphenylalanine; Female; Humans; Indium Radioisotopes; Male; Middle Aged; Neuroendocrine Tumors; Octreotide; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2004 |
Levodopa effect on [18F]fluorodopa influx to brain: normal volunteers and patients with Parkinson's disease.
Topics: Adrenergic beta-Agonists; Aged; Aged, 80 and over; Blood-Brain Barrier; Body Fluid Compartments; Brain; Cerebellum; Dihydroxyphenylalanine; Dopamine; Dopamine Agents; Drug Synergism; Female; Humans; Levodopa; Magnetic Resonance Imaging; Male; Metabolic Clearance Rate; Middle Aged; Parkinson Disease; Presynaptic Terminals; Putamen; Reference Values; Tomography, Emission-Computed | 2004 |
Cortical 6-[18F]fluoro-L-dopa uptake and frontal cognitive functions in early Parkinson's disease.
Topics: Aging; Cerebral Cortex; Cognition Disorders; Dihydroxyphenylalanine; Female; Humans; Male; Middle Aged; Parkinson Disease; Radionuclide Imaging; Radiopharmaceuticals; Severity of Illness Index; Statistics as Topic; Tissue Distribution | 2005 |
Involvement of the basal ganglia in refractory epilepsy: an 18F-fluoro-L-DOPA PET study using 2 methods of analysis.
Topics: Adult; Algorithms; Anticonvulsants; Basal Ganglia; Brain Mapping; Dihydroxyphenylalanine; Drug Resistance; Epilepsy; Female; Humans; Image Interpretation, Computer-Assisted; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2005 |
Characterization of hyperinsulinism in infancy assessed with PET and 18F-fluoro-L-DOPA.
Topics: Congenital Hyperinsulinism; Dihydroxyphenylalanine; Female; Humans; Infant; Infant, Newborn; Male; Organ Specificity; Pancreas; Positron-Emission Tomography; Radiopharmaceuticals; Severity of Illness Index; Tissue Distribution; Whole-Body Counting | 2005 |
Dopamine storage capacity in caudate and putamen of patients with early Parkinson's disease: correlation with asymmetry of motor symptoms.
Topics: Aged; Brain; Caudate Nucleus; Dihydroxyphenylalanine; Dopamine; Fluorine Radioisotopes; Functional Laterality; Humans; Middle Aged; Parkinson Disease; Positron-Emission Tomography; Putamen; Reference Values; Sensitivity and Specificity; Time Factors | 2006 |
Improving influx constant and ratio estimation in FDOPA brain PET analysis for Parkinson's disease.
Topics: Brain; Brain Mapping; Dihydroxyphenylalanine; Female; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Male; Middle Aged; Parkinson Disease; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; ROC Curve; Sensitivity and Specificity; Tissue Distribution | 2005 |
Dementia in Parkinson disease: functional imaging of cholinergic and dopaminergic pathways.
Topics: Acetates; Acetylcholine; Acetylcholinesterase; Aged; Atrophy; Binding, Competitive; Brain; Brain Mapping; Dihydroxyphenylalanine; Dopamine; Female; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neural Pathways; Neuropsychological Tests; Parkinson Disease; Piperidines; Positron-Emission Tomography; Synaptic Transmission | 2005 |
18F-FDOPA PET imaging of brain tumors: comparison study with 18F-FDG PET and evaluation of diagnostic accuracy.
Topics: Adult; Aged; Brain Neoplasms; California; Dihydroxyphenylalanine; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2006 |
Role of 18F-dopa PET/CT imaging in the management of patients with 111In-pentetreotide negative GEP tumours.
Topics: Adult; Aged; Aged, 80 and over; Biopsy, Needle; Digestive System Neoplasms; Dihydroxyphenylalanine; Female; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Metastasis; Neuroendocrine Tumors; Positron-Emission Tomography; Radionuclide Imaging; Radiopharmaceuticals; Sensitivity and Specificity; Somatostatin; Tomography, X-Ray Computed; Ultrasonography | 2007 |
The effects of carbidopa on uptake of 6-18F-Fluoro-L-DOPA in PET of pheochromocytoma and extraadrenal abdominal paraganglioma.
Topics: Abdominal Neoplasms; Adrenal Gland Neoplasms; Carbidopa; Dihydroxyphenylalanine; Female; Humans; Image Enhancement; Male; Metabolic Clearance Rate; Middle Aged; Paraganglioma, Extra-Adrenal; Pheochromocytoma; Positron-Emission Tomography; Radiopharmaceuticals | 2007 |
Basal ganglia involvement in temporal lobe epilepsy: a functional and morphologic study.
Topics: Adolescent; Adult; Basal Ganglia; Basal Ganglia Diseases; Dihydroxyphenylalanine; Dopamine; Down-Regulation; Energy Metabolism; Epilepsy, Temporal Lobe; Female; Fluorodeoxyglucose F18; Glucose; Humans; Male; Middle Aged; Neostriatum; Neural Pathways; Positron-Emission Tomography; Predictive Value of Tests; Sensitivity and Specificity; Substantia Nigra | 2008 |
Dopamine cell implantation in Parkinson's disease: long-term clinical and (18)F-FDOPA PET outcomes.
Topics: Adult; Age Factors; Aged; Brain; Cell Transplantation; Dihydroxyphenylalanine; Dopamine; Double-Blind Method; Female; Follow-Up Studies; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Movement; Neostriatum; Parkinson Disease; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Sex Factors; Treatment Outcome | 2010 |
Comparison of dopamine turnover, dopamine influx constant and activity ratio of striatum and occipital brain with ¹⁸F-dopa brain PET in normal controls and patients with Parkinson's disease.
Topics: Case-Control Studies; Dihydroxyphenylalanine; Dopamine; Early Diagnosis; Female; Humans; Male; Middle Aged; Neostriatum; Occipital Lobe; Parkinson Disease; Positron-Emission Tomography; Reproducibility of Results; ROC Curve | 2011 |
Complementary roles of 18F-DOPA PET/CT and 18F-FDG PET/CT in medullary thyroid cancer.
Topics: Adult; Aged; Calcitonin; Carcinoembryonic Antigen; Carcinoma, Neuroendocrine; Cell Proliferation; Dihydroxyphenylalanine; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Ki-67 Antigen; Kinetics; Male; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Positron-Emission Tomography; Prospective Studies; Recurrence; Thyroid Neoplasms; Tomography, X-Ray Computed | 2011 |
18F-DOPA PET/CT in neuroblastoma: comparison of conventional imaging with CT/MR.
Topics: Child; Dihydroxyphenylalanine; Female; Humans; Magnetic Resonance Imaging; Male; Multimodal Imaging; Neuroblastoma; Neuroendocrine Tumors; Positron-Emission Tomography; Sensitivity and Specificity; Tomography, X-Ray Computed | 2012 |
Gene therapy for aromatic L-amino acid decarboxylase deficiency.
Topics: Amino Acid Metabolism, Inborn Errors; Antibodies; Aromatic-L-Amino-Acid Decarboxylases; Child; Child, Preschool; Demography; Dependovirus; Dihydroxyphenylalanine; Female; Gene Transfer Techniques; Genetic Therapy; Genetic Vectors; Humans; Male; Motor Activity; Neurotransmitter Agents; Positron-Emission Tomography; Taiwan | 2012 |
Feasibility of carbidopa premedication in pediatric patients: a pilot study.
Topics: Carbidopa; Child; Child, Preschool; Dihydroxyphenylalanine; Drug Interactions; Female; Fluorine Radioisotopes; Humans; Male; Neuroblastoma; Pilot Projects; Premedication; Radionuclide Imaging; Radiopharmaceuticals | 2012 |
18F-FDOPA PET/CT for detection of recurrence in patients with glioma: prospective comparison with 18F-FDG PET/CT.
Topics: Adolescent; Adult; Brain Neoplasms; Child; Dihydroxyphenylalanine; Female; Fluorodeoxyglucose F18; Glioma; Humans; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prospective Studies; Recurrence; Reference Standards; Sensitivity and Specificity; Tomography, X-Ray Computed; Young Adult | 2013 |
Prospective comparison of (99m)Tc-GH SPECT/CT and (18)F-FDOPA PET/CT for detection of recurrent glioma: a pilot study.
Topics: Brain Neoplasms; Dihydroxyphenylalanine; Female; Glioma; Humans; Male; Multimodal Imaging; Organotechnetium Compounds; Pilot Projects; Positron-Emission Tomography; Prospective Studies; Recurrence; Sugar Acids; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed | 2014 |
Integrated whole-body PET/MRI with 18F-FDG, 18F-FDOPA, and 18F-FDA in paragangliomas in comparison with PET/CT: NIH first clinical experience with a single-injection, dual-modality imaging protocol.
Topics: Adult; Dihydroxyphenylalanine; Dopamine; Female; Fluorodeoxyglucose F18; Humans; Injections; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; National Institutes of Health (U.S.); Paraganglioma; Positron-Emission Tomography; Tomography, X-Ray Computed; United States; Whole Body Imaging | 2014 |
Factors affecting ¹⁸F FDOPA standardized uptake value in patients with primary brain tumors after treatment.
Topics: Adult; Aged; Aged, 80 and over; Biological Transport; Brain Neoplasms; Dihydroxyphenylalanine; Female; Humans; Male; Middle Aged; Neoplasm Grading; Positron-Emission Tomography; Tomography, X-Ray Computed; Young Adult | 2015 |
Prospective comparison of (68)Ga-DOTATATE and (18)F-FDOPA PET/CT in patients with various pheochromocytomas and paragangliomas with emphasis on sporadic cases.
Topics: Adrenal Gland Neoplasms; Adult; Aged; Aged, 80 and over; Dihydroxyphenylalanine; False Positive Reactions; Female; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Organometallic Compounds; Paraganglioma; Pheochromocytoma; Positron Emission Tomography Computed Tomography; Prospective Studies; Young Adult | 2016 |
Biochemical and clinical effects of Whey protein supplementation in Parkinson's disease: A pilot study.
Topics: Amino Acids; Antiparkinson Agents; Brain; Dietary Supplements; Dihydroxyphenylalanine; Double-Blind Method; Female; Follow-Up Studies; Glutathione; Homocysteine; Humans; Male; Middle Aged; Parkinson Disease; Pilot Projects; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Severity of Illness Index; Soybean Proteins; Treatment Outcome; Whey Proteins | 2016 |
Prospective trial evaluating the sensitivity and specificity of 3,4-dihydroxy-6-[18F]-fluoro-L-phenylalanine (18F-DOPA) PET and MRI in patients with recurrent gliomas.
Topics: Adolescent; Adult; Brain; Brain Neoplasms; Contrast Media; Dihydroxyphenylalanine; Female; Glioma; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Grading; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Salvage Therapy; Sensitivity and Specificity; Young Adult | 2018 |
The cognitive effects of a promised bonus do not depend on dopamine synthesis capacity.
Topics: Adult; Cognition; Corpus Striatum; Cues; Dihydroxyphenylalanine; Dopamine; Female; Humans; Male; Middle Aged; Motivation; Positron-Emission Tomography; Reward; Stroop Test; Young Adult | 2020 |
Initial Results of a Phase 2 Trial of
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Immunological; Bevacizumab; Brain Neoplasms; Chemotherapy, Adjuvant; Cognition; Confidence Intervals; Dihydroxyphenylalanine; Dose Fractionation, Radiation; Female; Glioblastoma; Humans; Kaplan-Meier Estimate; Male; Methylation; Middle Aged; O(6)-Methylguanine-DNA Methyltransferase; Positron-Emission Tomography; Progression-Free Survival; Prospective Studies; Quality of Life; Radiopharmaceuticals; Radiotherapy, Image-Guided; Temozolomide; Young Adult | 2021 |
Initial results of a phase II trial of
Topics: Adult; Brain Neoplasms; Dihydroxyphenylalanine; Glioma; Humans; Magnetic Resonance Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Re-Irradiation | 2022 |
Striatal Blood-Brain Barrier Opening in Parkinson's Disease Dementia: A Pilot Exploratory Study.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Blood-Brain Barrier; Corpus Striatum; Dementia; Dihydroxyphenylalanine; Humans; Parkinson Disease; Prospective Studies | 2022 |
638 other study(ies) available for dihydroxyphenylalanine and fluorodopa f 18
| Article | Year |
|---|---|
Positron emission tomography with 18F-dopa: interpretation and biological correlates in nonhuman primates.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Carbidopa; Cerebral Cortex; Corpus Striatum; Dihydroxyphenylalanine; Dopamine; Homovanillic Acid; Hydroxyindoleacetic Acid; Macaca mulatta; Methoxyhydroxyphenylglycol; Parkinson Disease, Secondary; Receptors, Dopamine; Tomography, Emission-Computed | 1992 |
Regioselective radiofluorodestannylation with [18F]F2 and [18F]CH3COOF: a high yield synthesis of 6-[18F]Fluoro-L-dopa.
Topics: Dihydroxyphenylalanine; Fluorine Radioisotopes | 1992 |
Increased striatal 18F-dopa uptake and normal glucose metabolism in idiopathic dystonia syndrome.
Topics: Adult; Caudate Nucleus; Deoxyglucose; Dihydroxyphenylalanine; Dopamine; Dystonia; Dystonia Musculorum Deformans; Female; Fluorodeoxyglucose F18; Glucose; Humans; Male; Middle Aged; Putamen; Tomography, Emission-Computed; Torticollis | 1992 |
Long-term treatment response and fluorodopa positron emission tomographic scanning of parkinsonism in a family with dopa-responsive dystonia.
Topics: Adult; Aged; Brain; Child; Child, Preschool; Dihydroxyphenylalanine; Dystonia; Family; Female; Fluorine Radioisotopes; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Pedigree; Tomography, Emission-Computed | 1992 |
The identification of presymptomatic parkinsonism: clinical and [18F]dopa positron emission tomography studies in an Irish kindred.
Topics: Adult; Caudate Nucleus; Dihydroxyphenylalanine; Family; Female; Fluorine Radioisotopes; Humans; Ireland; Male; Middle Aged; Parkinson Disease; Pedigree; Putamen; Tomography, Emission-Computed | 1992 |
Plasma L-[18F]6-fluorodopa input function: a simplified method.
Topics: Dihydroxyphenylalanine; Fluorine Radioisotopes; Humans; Regression Analysis; Time Factors; Tomography, Emission-Computed | 1992 |
3-O-methyldopa administration does not alter fluorodopa transport into the brain.
Topics: Amino Acid Transport Systems; Amino Acids; Animals; Binding, Competitive; Biological Transport; Blood-Brain Barrier; Brain; Carrier Proteins; Dihydroxyphenylalanine; Macaca fascicularis; Male; Tomography, Emission-Computed; Tyrosine | 1992 |
Regional brain kinetics of 6-fluoro-(beta-11C)-L-dopa and (beta-11C)-L-dopa following COMT inhibition. A study in vivo using positron emission tomography.
Topics: Animals; Benzophenones; Brain; Carbon Radioisotopes; Catechol O-Methyltransferase; Catechol O-Methyltransferase Inhibitors; Corpus Striatum; Dihydroxyphenylalanine; Female; Half-Life; Macaca mulatta; Methyldopa; Nitrophenols; Tolcapone; Tomography, Emission-Computed | 1992 |
Delayed L-phenylalanine infusion allows for simultaneous kinetic analysis and improved evaluation of specific-to-nonspecific fluorine-18-dopa uptake in brain.
Topics: Animals; Brain; Carbidopa; Cerebral Cortex; Corpus Striatum; Dihydroxyphenylalanine; Macaca mulatta; MPTP Poisoning; Phenylalanine; Time Factors; Tomography, Emission-Computed | 1992 |
Metabolism of 5-fluoro-dopa and 6-fluoro-dopa enantiomers in aggregating cell cultures of fetal rat brain.
Topics: Animals; Aromatic Amino Acid Decarboxylase Inhibitors; Brain; Cells, Cultured; Dihydroxyphenylalanine; Female; Fetus; Levodopa; Rats; Rats, Inbred Strains; Stereoisomerism; Time Factors | 1992 |
The effects of carbidopa administration on 6-[18F]fluoro-L-dopa kinetics in positron emission tomography.
Topics: Adult; Animals; Carbidopa; Dihydroxyphenylalanine; Female; Fluorine Radioisotopes; Humans; Injections, Intravenous; Macaca nemestrina; Male; Tomography, Emission-Computed | 1992 |
Isolated tremor and disruption of the nigrostriatal dopaminergic system: an 18F-dopa PET study.
Topics: Adult; Aged; Corpus Striatum; Dihydroxyphenylalanine; Dopamine; Fluorine Radioisotopes; Humans; Levodopa; Middle Aged; Parkinson Disease; Posture; Reference Values; Substantia Nigra; Tomography, Emission-Computed; Tremor | 1992 |
New rapid analysis method demonstrates differences in 6-[18F] fluoro-L-dopa plasma input curves with and without carbidopa and in hemi-MPTP lesioned monkeys.
Topics: Animals; Carbidopa; Dihydroxyphenylalanine; Dopamine; Fluorine Radioisotopes; Functional Laterality; Kinetics; Macaca mulatta; MPTP Poisoning; Reference Values; Synapses; Time Factors | 1991 |
Dopa decarboxylase activity of the living human brain.
Topics: Brain; Dihydroxyphenylalanine; Dopa Decarboxylase; Fluorine Radioisotopes; Humans; Kinetics; Magnetic Resonance Imaging; Mathematics; Organ Specificity; Reference Values; Tomography, Emission-Computed | 1991 |
Comparative metabolism of fluorinated 3,4-dihydroxyphenylalanine isomers in aggregating brain cell cultures.
Topics: Animals; Brain; Cell Aggregation; Cells, Cultured; Decarboxylation; Dihydroxyphenylalanine; Levodopa; Methylation; Stereoisomerism | 1992 |
Routine determination of [18F]-L-6-fluorodopa and its metabolites in blood plasma is essential for accurate positron emission tomography studies.
Topics: Adsorption; Age Factors; Aluminum Oxide; Carbidopa; Chromatography, High Pressure Liquid; Dihydroxyphenylalanine; Humans; Tomography, Emission-Computed; Tyrosine | 1992 |
[18F]-6-fluorodopa PET scanning in Parkinson's disease after selective COMT inhibition with nitecapone (OR-462).
Topics: Adult; Aged; Catechol O-Methyltransferase Inhibitors; Catechols; Cerebellum; Chromatography, High Pressure Liquid; Corpus Striatum; Dihydroxyphenylalanine; Female; Fluorine Radioisotopes; Humans; Male; Middle Aged; Parkinson Disease; Pentanones; Tomography, Emission-Computed | 1992 |
Absorbed dose estimates in positron emission tomography studies based on the administration of 18F-labeled radiopharmaceuticals.
Topics: Adult; Animals; Deoxyglucose; Dihydroxyphenylalanine; Dogs; Floxuridine; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Injections, Intravenous; Mice; Middle Aged; Radiation Dosage; Tissue Distribution; Tomography, Emission-Computed, Single-Photon | 1991 |
The nigrostriatal dopaminergic pathway in Wilson's disease studied with positron emission tomography.
Topics: Adult; Corpus Striatum; Dihydroxyphenylalanine; Dopamine; Female; Hepatolenticular Degeneration; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Receptors, Dopamine; Substantia Nigra; Tomography, Emission-Computed | 1991 |
Positron emission tomography in progressive supranuclear palsy.
Topics: Aged; Dihydroxyphenylalanine; Dopamine; Humans; Male; Middle Aged; Substantia Nigra; Supranuclear Palsy, Progressive; Tomography, Emission-Computed | 1991 |
Stability of 6-[18F]fluorodopa preparations.
Topics: Dihydroxyphenylalanine; Drug Stability; Quality Assurance, Health Care | 1991 |
A single column, rapid quality control procedure for 6-[18F]fluoro-L-dopa and 6-[18F]fluorodopamine PET imaging agents.
Topics: Chromatography, High Pressure Liquid; Dihydroxyphenylalanine; Dopamine; Fluorine Radioisotopes; Humans; Quality Control; Tomography, Emission-Computed | 1991 |
Detection of preclinical Parkinson's disease with PET.
Topics: Adult; Caudate Nucleus; Corpus Striatum; Dihydroxyphenylalanine; Diseases in Twins; Dopamine; Female; Fluorine Radioisotopes; Humans; Male; Middle Aged; Parkinson Disease; Parkinson Disease, Secondary; Putamen; Reference Values; Tomography, Emission-Computed; Tremor | 1991 |
The reproducibility of striatal uptake data obtained with positron emission tomography and fluorine-18-L-6-fluorodopa tracer in non-human primates.
Topics: Animals; Corpus Striatum; Dihydroxyphenylalanine; Fluorine Radioisotopes; Macaca fascicularis; Macaca mulatta; Male; Reproducibility of Results; Tomography, Emission-Computed | 1991 |
6-[18F]fluoro-L-dopa metabolism in MPTP-treated monkeys: assessment of tracer methodologies for positron emission tomography.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; Animals; Brain Chemistry; Chromatography, High Pressure Liquid; Dihydroxyphenylalanine; Dopamine; Female; Homovanillic Acid; Macaca nemestrina; Male; Tomography, Emission-Computed | 1991 |
Postinjection L-phenylalanine increases basal ganglia contrast in PET scans of 6-18F-DOPA.
Topics: Animals; Basal Ganglia; Carbidopa; Dihydroxyphenylalanine; Female; Fluorine Radioisotopes; Macaca mulatta; Male; Phenylalanine; Time Factors; Tomography, Emission-Computed | 1991 |
Modelling approach for separating blood time-activity curves in positron emission tomographic studies.
Topics: Dihydroxyphenylalanine; Fluorine Radioisotopes; Humans; Oxygen Radioisotopes; Time Factors; Tomography, Emission-Computed | 1991 |
L-6-[18F]fluoro-dopa metabolism in monkeys and humans: biochemical parameters for the formulation of tracer kinetic models with positron emission tomography.
Topics: Adult; Animals; Blood Chemical Analysis; Brain; Carbidopa; Dihydroxyphenylalanine; Fluorine Radioisotopes; Humans; Macaca nemestrina; Male; Tissue Distribution; Tomography, Emission-Computed | 1991 |
Kinetics and modeling of L-6-[18F]fluoro-dopa in human positron emission tomographic studies.
Topics: Adult; Brain; Dihydroxyphenylalanine; Fluorine Radioisotopes; Humans; Models, Biological; Time Factors; Tomography, Emission-Computed | 1991 |
Oxygenation of fluorinated tyrosines by mushroom tyrosinase releases fluoride ion.
Topics: Basidiomycota; Catechol Oxidase; Chromatography, High Pressure Liquid; Dihydroxyphenylalanine; Fluorides; Kinetics; Molecular Structure; Monophenol Monooxygenase; Oxidation-Reduction; Tyrosine | 1990 |
Comparative in vivo metabolism of 6-[18F]fluoro-L-dopa and [3H]L-dopa in rats.
Topics: Animals; Brain; Carbidopa; Chromatography, High Pressure Liquid; Dihydroxyphenylalanine; Fluorine Radioisotopes; Injections, Intravenous; Kinetics; Levodopa; Male; Rats; Rats, Inbred Strains; Tritium | 1990 |
No-carrier-added regioselective preparation of 6-[18F]fluoro-L-dopa.
Topics: Benzaldehydes; Chromatography, High Pressure Liquid; Dihydroxyphenylalanine; Dimethyl Sulfoxide; Fluorine Radioisotopes; Hydrolysis | 1990 |
Blood-brain transfer and metabolism of 6-[18F]fluoro-L-dopa in rat.
Topics: Animals; Blood-Brain Barrier; Brain; Decarboxylation; Dihydroxyphenylalanine; Dopa Decarboxylase; Fluorine Radioisotopes; Linear Models; Models, Neurological; Rats; Rats, Inbred Strains | 1990 |
The effects of carbidopa on the metabolism of 6-[18F]fluoro-L-dopa in rats, monkeys and humans.
Topics: Adult; Animals; Carbidopa; Cerebellum; Dihydroxyphenylalanine; Fluorine Radioisotopes; Humans; Macaca fascicularis; Male; Rats; Rats, Inbred Strains | 1990 |
The metabolic anatomy of Parkinson's disease: complementary [18F]fluorodeoxyglucose and [18F]fluorodopa positron emission tomographic studies.
Topics: Adult; Brain; Deoxy Sugars; Deoxyglucose; Dihydroxyphenylalanine; Energy Metabolism; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Parkinson Disease; Tomography, Emission-Computed | 1990 |
The nigrostriatal dopaminergic system assessed in vivo by positron emission tomography in healthy volunteer subjects and patients with Parkinson's disease.
Topics: Aged; Carbon Radioisotopes; Caudate Nucleus; Dihydroxyphenylalanine; Dopamine; Fluorine Radioisotopes; Humans; Middle Aged; Nomifensine; Parkinson Disease; Putamen; Tomography, Emission-Computed | 1990 |
Synthesis of 18F-6-FD.
Topics: Dihydroxyphenylalanine; Drug Stability; Fluorine Radioisotopes; Quality Control | 1990 |
Treatment of refractory Parkinson's disease with adrenal medullary autografts utilizing two-stage surgery.
Topics: Adrenal Medulla; Blood-Brain Barrier; Caudate Nucleus; Dihydroxyphenylalanine; Follow-Up Studies; Humans; Middle Aged; Parkinson Disease; Tomography, Emission-Computed; Transplantation, Autologous; Transplantation, Heterotopic | 1990 |
6-[18F]fluoro-L-dopa probes dopamine turnover rates in central dopaminergic structures.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Brain; Brain Chemistry; Dihydroxyphenylalanine; Dopamine; Fluorescent Dyes; Fluorine Radioisotopes; Macaca nemestrina; Male; Parkinson Disease; Parkinson Disease, Secondary; Putamen; Tomography, Emission-Computed | 1990 |
Remote, semiautomated production of 6-[18F]fluoro-L-dopa for human studies with PET.
Topics: Dihydroxyphenylalanine; Fluorine Radioisotopes; Humans; Isotope Labeling; Tomography, Emission-Computed | 1990 |
Labelled agents for PET studies of the dopaminergic system--some quality assurance methods, experience and issues.
Topics: Carbon Radioisotopes; Dihydroxyphenylalanine; Fluorine Radioisotopes; Nomifensine; Quality Assurance, Health Care; Raclopride; Receptors, Dopamine; Salicylamides; Tomography, Emission-Computed | 1990 |
Cyanide-induced parkinsonism: clinical, MRI, and 6-fluorodopa PET studies.
Topics: Cyanides; Dihydroxyphenylalanine; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Parkinson Disease, Secondary; Potassium Cyanide; Suicide, Attempted; Tomography, Emission-Computed | 1989 |
Quality control procedure for 6-[18F]fluoro-L-DOPA: a presynaptic PET imaging ligand for brain dopamine neurons.
Topics: Brain; Chromatography, High Pressure Liquid; Dihydroxyphenylalanine; Dopamine; Drug Stability; Electrochemistry; Humans; Pyrogens; Quality Control; Tomography, Emission-Computed | 1989 |
Nigrostriatal function in humans studied with positron emission tomography.
Topics: Adult; Aged; Aged, 80 and over; Aging; Corpus Striatum; Dihydroxyphenylalanine; Female; Humans; Male; Middle Aged; Substantia Nigra; Tomography, Emission-Computed | 1989 |
Positron emission tomography in manganese intoxication.
Topics: Adult; Brain; Chronic Disease; Dihydroxyphenylalanine; Humans; Magnetic Resonance Imaging; Manganese Poisoning; Parkinson Disease, Secondary; Tomography, Emission-Computed | 1989 |
6-18F-L-dopa imaging of the dopamine neostriatal system in normal and clinically normal MPTP-treated rhesus monkeys.
Topics: Animals; Cerebral Cortex; Corpus Striatum; Dihydroxyphenylalanine; Dopamine; Female; Macaca; Macaca mulatta; Male; MPTP Poisoning; Tomography, Emission-Computed | 1989 |
[18F]fluoro-L-dopa for the in vivo study of intracerebral dopamine.
Topics: Animals; Brain; Dihydroxyphenylalanine; Dopamine; Humans; Methylation; Radiochemistry; Radioisotopes; Safety; Tomography, Emission-Computed | 1986 |
High yield synthesis of 6-[18F]fluoro-L-dopa.
Topics: Arsenic; Arsenicals; Boranes; Chromatography, High Pressure Liquid; Dihydroxyphenylalanine; Fluorides; Fluorine; Isomerism; Isotope Labeling; Levodopa; Radioisotopes; Silanes; Silicon Compounds; Solvents | 1986 |
Routine synthesis of L-[18F]6-fluorodopa with fluorine-18 acetyl hypofluorite.
Topics: Acetates; Dihydroxyphenylalanine; Esters; Fluorine; Indicators and Reagents; Methods; Radioisotopes | 1986 |
High yield synthesis of 6-[18F]fluoro-L-dopa by regioselective fluorination of protected L-dopa with [18F]acetylhypofluorite.
Topics: Acetates; Chromatography, High Pressure Liquid; Dihydroxyphenylalanine; Esters; Fluorine; Isotope Labeling; Radioisotopes | 1986 |
Determination of plasma [18F]-6-fluorodopa during positron emission tomography: elimination and metabolism in carbidopa treated subjects.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Age Factors; Carbidopa; Chromatography, High Pressure Liquid; Dihydroxyphenylalanine; Dystonia; Humans; Kinetics; Metabolic Clearance Rate; Parkinson Disease; Pyridines; Tomography, Emission-Computed | 1986 |
Cerebral metabolism of 6-[18F]fluoro-L-3,4-dihydroxyphenylalanine in the primate.
Topics: Animals; Brain; Corpus Striatum; Dihydroxyphenylalanine; Dopamine; Female; Frontal Lobe; Kinetics; Levodopa; Macaca mulatta; Male; Occipital Lobe | 1987 |
Determination and visualization of damage to striatal dopaminergic terminals in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism by [18F]-labeled 6-fluoro-L-dopa and positron emission tomography.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Corpus Striatum; Dihydroxyphenylalanine; Macaca mulatta; Parkinson Disease, Secondary; Pyridines; Receptors, Dopamine; Tomography, Emission-Computed | 1987 |
Positron emission tomography in Parkinson's disease: glucose and DOPA metabolism.
Topics: Adult; Aged; Blood Glucose; Brain; Caudate Nucleus; Cerebellum; Deoxyglucose; Dihydroxyphenylalanine; Fluorodeoxyglucose F18; Humans; Levodopa; Middle Aged; Parkinson Disease; Putamen; Tomography, Emission-Computed | 1987 |
Altered metabolism of [18F]-6-fluorodopa in the hooded rat following inhibition of catechol-O-methyltransferase with U-0521.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Catechol O-Methyltransferase Inhibitors; Corpus Striatum; Dihydroxyphenylalanine; Dopamine; Kinetics; Propiophenones; Rats; Time Factors; Tissue Distribution; Tomography, Emission-Computed | 1987 |
A rostrocaudal gradient for aromatic acid decarboxylase in the human striatum.
Topics: Adolescent; Adult; Aging; Aromatic-L-Amino-Acid Decarboxylases; Child; Corpus Striatum; Dihydroxyphenylalanine; Dystonia; Female; Humans; Male; Parkinson Disease; Putamen; Tomography, Emission-Computed | 1987 |
Kinetics of in vitro decarboxylation and the in vivo metabolism of 2-18F- and 6-18F-fluorodopa in the hooded rat.
Topics: Animals; Carbidopa; Corpus Striatum; Decarboxylation; Dihydroxyphenylalanine; Fluorine Radioisotopes; In Vitro Techniques; Kinetics; Male; Rats; Rats, Inbred Strains; Structure-Activity Relationship; Tissue Distribution | 1988 |
Metabolites of 6-[18F]fluoro-L-dopa in human blood.
Topics: Adult; Dihydroxyphenylalanine; Dopamine; Fluorine Radioisotopes; Homovanillic Acid; Humans; Middle Aged | 1988 |
Steele-Richardson-Olszewski syndrome. Brain energy metabolism, blood flow and fluorodopa uptake measured by positron emission tomography.
Topics: Adult; Brain; Cerebrovascular Circulation; Dihydroxyphenylalanine; Energy Metabolism; Fluorine Radioisotopes; Humans; Middle Aged; Oxygen Consumption; Supranuclear Palsy, Progressive; Tomography, Emission-Computed | 1988 |
Estimation of the radiation dose in man due to 6-[18F]fluoro-L-dopa.
Topics: Adult; Animals; Dihydroxyphenylalanine; Dogs; Female; Fluorine; Humans; Male; Mathematics; Middle Aged; Radiation Dosage; Radioisotopes; Tissue Distribution | 1985 |
New synthesis of fluorine-18-labeled 6-fluoro-L-dopa by cleaving the carbon-silicon bond with fluorine.
Topics: Chemical Phenomena; Chemistry; Dihydroxyphenylalanine; Fluorine; Radioisotopes | 1985 |
Aromatic radiofluorination with [18F]fluorine gas: 6-[18F]fluoro-L-dopa.
Topics: Chromatography, High Pressure Liquid; Dihydroxyphenylalanine; Fluorine; Isotope Labeling; Levodopa; Magnetic Resonance Spectroscopy; Radioisotopes | 1984 |
Presynaptic dopamine function in striatum of neuroleptic-naive schizophrenic patients.
Topics: Adult; Caudate Nucleus; Dihydroxyphenylalanine; Dopamine; Female; Fluorine Radioisotopes; Humans; Male; Neostriatum; Putamen; Receptors, Dopamine; Schizophrenia; Tomography, Emission-Computed | 1995 |
Complementary positron emission tomographic studies of the striatal dopaminergic system in Parkinson's disease.
Topics: Adult; Aged; Carbon Radioisotopes; Caudate Nucleus; Corpus Striatum; Deoxyglucose; Dihydroxyphenylalanine; Dopa Decarboxylase; Dopamine; Dopamine Antagonists; Energy Metabolism; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glucose; Humans; Male; Middle Aged; Parkinson Disease; Putamen; Raclopride; Receptors, Dopamine D2; Salicylamides; Tomography, Emission-Computed | 1995 |
Clinical and [18F] dopa PET findings in early Parkinson's disease.
Topics: Antiparkinson Agents; Case-Control Studies; Dihydroxyphenylalanine; Discriminant Analysis; Female; Fluorine Radioisotopes; Humans; Male; Middle Aged; Parkinson Disease; Predictive Value of Tests; Putamen; Selegiline; Severity of Illness Index; Time Factors; Tomography, Emission-Computed | 1995 |
Clinical correlates of [18F]fluorodopa uptake in five grafted parkinsonian patients.
Topics: Brain; Dihydroxyphenylalanine; Fetal Tissue Transplantation; Fluorine Radioisotopes; Graft Survival; Humans; Magnetic Resonance Imaging; Middle Aged; Parkinson Disease; Tomography, Emission-Computed | 1995 |
Metabolism and blood-brain clearance of L-3,4-dihydroxy-[3H]phenylalanine ([3H]DOPA) and 6-[18F]fluoro-L-DOPA in the rat.
Topics: Animals; Blood-Brain Barrier; Carbidopa; Dihydroxyphenylalanine; Fluorine Radioisotopes; Male; Methylation; Rats; Rats, Wistar; Tritium | 1995 |
Personality correlates of [18F]dopa striatal uptake: results of positron-emission tomography in Parkinson's disease.
Topics: Aged; Arousal; Brain; Brain Mapping; Caudate Nucleus; Corpus Striatum; Dihydroxyphenylalanine; Dominance, Cerebral; Dopamine; Female; Fluorine Radioisotopes; Humans; Male; Middle Aged; Parkinson Disease; Personality; Tomography, Emission-Computed | 1995 |
Measures and pitfalls for successful preparation of "no carrier added" asymmetric 6-[18F]fluor-L-dopa from 18F-fluoride ion.
Topics: Chromatography, High Pressure Liquid; Dihydroxyphenylalanine; Fluorine Radioisotopes | 1995 |
Striatal 3,4-dihydroxyphenylalanine decarboxylase in aging: disparity between postmortem and positron emission tomography studies?
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aging; Corpus Striatum; Dihydroxyphenylalanine; Dopa Decarboxylase; Dopamine; Female; Humans; Male; Middle Aged; Tomography, Emission-Computed | 1995 |
Assessment of dopamine metabolism in brain of patients with dementia by means of 18F-fluorodopa and PET.
Topics: Aged; Alzheimer Disease; Analysis of Variance; Brain; Corpus Striatum; Dementia; Dementia, Vascular; Dihydroxyphenylalanine; Dopamine; Fluorine Radioisotopes; Frontal Lobe; Humans; Middle Aged; Models, Theoretical; Occipital Lobe; Reference Values; Temporal Lobe; Tomography, Emission-Computed | 1994 |
Development of an improved target for [18F]F2 production.
Topics: Aluminum; Cyclotrons; Dihydroxyphenylalanine; Fluorine Radioisotopes; Methods; Nickel | 1995 |
Synthesis of polymer-bound 6-thiolatomercury and 6-mercuric sulfonate DOPA precursors and their halodemercuration reactivity.
Topics: Dihydroxyphenylalanine; Mercury Compounds; Polymers; Prodrugs; Sulfates | 1995 |
Routes of administration and effect of carbidopa pretreatment on 6-[18F]fluoro-L-dopa/PET scans in non-human primates.
Topics: Administration, Oral; Animals; Carbidopa; Cerebral Cortex; Corpus Striatum; Dihydroxyphenylalanine; Injections, Intraperitoneal; Injections, Intravenous; Intubation, Gastrointestinal; Macaca fascicularis; Premedication; Time Factors; Tomography, Emission-Computed | 1995 |
Positron emission tomography studies on the dopaminergic system and striatal opioid binding in the olivopontocerebellar atrophy variant of multiple system atrophy.
Topics: Autonomic Nervous System Diseases; Carbon Radioisotopes; Corpus Striatum; Dihydroxyphenylalanine; Diprenorphine; Dopamine; Female; Fluorine Radioisotopes; Humans; Male; Middle Aged; Olivopontocerebellar Atrophies; Receptors, Opioid; Tomography, Emission-Computed | 1995 |
Regional striatal DOPA transport and decarboxylase activity in Parkinson's disease.
Topics: Biological Transport; Blood-Brain Barrier; Caudate Nucleus; Corpus Striatum; Dihydroxyphenylalanine; Dopa Decarboxylase; Fluorine Radioisotopes; Humans; Middle Aged; Parkinson Disease; Putamen; Tomography, Emission-Computed | 1995 |
[Presynaptic nigrostriatal function in Parkinson disease and Parkinson-plus syndromes. Comparative studies using positron emission tomography with L-6-(18F)fluorodopa].
Topics: Adult; Aged; Aged, 80 and over; Corpus Striatum; Dihydroxyphenylalanine; Dominance, Cerebral; Dopamine; Female; Fluorine Radioisotopes; Humans; Kinetics; Male; Middle Aged; Neural Pathways; Neurologic Examination; Parkinson Disease; Parkinson Disease, Secondary; Receptors, Dopamine; Substantia Nigra; Synaptic Transmission; Tomography, Emission-Computed | 1994 |
A kinetic analysis of 6-[18F]fluoro-L-dihydroxyphenylalanine metabolism in the rat.
Topics: Animals; Corpus Striatum; Dihydroxyphenylalanine; Male; Mathematics; Rats; Tomography, Emission-Computed | 1994 |
Assessment of fetal tissue transplantation in Parkinson's disease: does PET play a role?
Topics: Animals; Brain Tissue Transplantation; Dihydroxyphenylalanine; Disease-Free Survival; Fetal Tissue Transplantation; Fluorine Radioisotopes; Humans; Neostriatum; Parkinson Disease; Tomography, Emission-Computed; Treatment Outcome | 1994 |
Metabolic topography of the hemiparkinsonism-hemiatrophy syndrome.
Topics: Adult; Atrophy; Brain; Deoxyglucose; Dihydroxyphenylalanine; Female; Fluorodeoxyglucose F18; Glucose; Humans; Male; Middle Aged; Parkinson Disease; Syndrome; Tomography, Emission-Computed | 1994 |
Age-dependent decline of nigrostriatal dopaminergic function: a positron emission tomographic study of grandparents and their grandchildren.
Topics: Adult; Aged; Aging; Corpus Striatum; Dihydroxyphenylalanine; Dopamine; Family; Female; Humans; Male; Substantia Nigra; Tomography, Emission-Computed | 1994 |
Longitudinal fluorodopa positron emission tomographic studies of the evolution of idiopathic parkinsonism.
Topics: Adult; Aged; Dihydroxyphenylalanine; Disease Progression; Female; Humans; Male; Middle Aged; Parkinson Disease; Substantia Nigra; Tomography, Emission-Computed | 1994 |
Positron emission tomographic evidence for progression of human MPTP-induced dopaminergic lesions.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Adult; Aged; Aged, 80 and over; Corpus Striatum; Dihydroxyphenylalanine; Disease Progression; Dopamine; Female; Humans; Male; Middle Aged; Parkinson Disease, Secondary; Substantia Nigra; Syndrome; Tomography, Emission-Computed | 1994 |
Enantioselective synthesis of 6-[fluorine-18]-fluoro-L-dopa from no-carrier-added fluorine-18-fluoride.
Topics: Chromatography, High Pressure Liquid; Dihydroxyphenylalanine; Fluorine Radioisotopes; Indicators and Reagents; Isotope Labeling; Molecular Structure | 1994 |
An interactive technique for three-dimensional image registration: validation for PET, SPECT, MRI and CT brain studies.
Topics: Brain; Deoxyglucose; Dihydroxyphenylalanine; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Software; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed | 1994 |
The distribution and kinetics of [18F]6-fluoro-3-O-methyl-L-dopa in the human brain.
Topics: Adult; Brain; Dihydroxyphenylalanine; Fluorine Radioisotopes; Humans; Male; Middle Aged; Models, Neurological; Time Factors; Tissue Distribution | 1994 |
Rest tremor and extrapyramidal symptoms after midbrain haemorrhage: clinical and 18F-dopa PET evaluation.
Topics: Adult; Basal Ganglia Diseases; Dihydroxyphenylalanine; Electromyography; Fluorine Radioisotopes; Humans; Intracranial Arteriovenous Malformations; Levodopa; Male; Mesencephalon; Posture; Rest; Rupture, Spontaneous; Subarachnoid Hemorrhage; Thalamus; Tomography, Emission-Computed; Tremor | 1994 |
An aging effect in striatal fluorodopa uptake? Large versus small ROIs.
Topics: Aging; Corpus Striatum; Dihydroxyphenylalanine; Humans | 1994 |
Effect of catechol-O-methyl transferase inhibition on peripheral and central metabolism of 6-[18F]fluoro-L-dopa.
Topics: Animals; Carbidopa; Catechol O-Methyltransferase Inhibitors; Catechols; Cerebellum; Chromatography, High Pressure Liquid; Corpus Striatum; Dihydroxyphenylalanine; Fluorine Radioisotopes; Male; Nitriles; Rats; Rats, Wistar | 1994 |
Evidence for a dopaminergic deficit in sporadic amyotrophic lateral sclerosis on positron emission scanning.
Topics: Adult; Aged; Amyotrophic Lateral Sclerosis; Basal Ganglia; Corpus Striatum; Dihydroxyphenylalanine; Fluorine Radioisotopes; Humans; Middle Aged; Neural Pathways; Receptors, Dopamine; Substantia Nigra; Time Factors; Tomography, Emission-Computed | 1993 |
Simultaneous demonstration of neurotransmitter and receptor systems of the rat brain using in vivo double autoradiography.
Topics: Animals; Autoradiography; Benzamides; Brain Chemistry; Corpus Striatum; Dihydroxyphenylalanine; Fluorine Radioisotopes; Male; Neurotransmitter Agents; Rats; Rats, Wistar; Receptors, Dopamine D2; Receptors, Neurotransmitter; Receptors, Presynaptic; Substantia Nigra | 1993 |
Evidence for long-term survival and function of dopaminergic grafts in progressive Parkinson's disease.
Topics: Brain Tissue Transplantation; Dihydroxyphenylalanine; Dopamine; Fetal Tissue Transplantation; Humans; Levodopa; Mesencephalon; Parkinson Disease; Putamen | 1994 |
COMT inhibitors and metabolism of fluorodopa enantiomers in aggregating cell cultures.
Topics: Amidines; Animals; Brain; Catechol O-Methyltransferase Inhibitors; Catechols; Cell Aggregation; Cells, Cultured; Chromatography, High Pressure Liquid; Dihydroxyphenylalanine; Methylation; Pyridones; Rats; Rats, Wistar; Stereoisomerism | 1993 |
Input functions for 6-[fluorine-18]fluorodopa quantitation in parkinsonism: comparative studies and clinical correlations.
Topics: Adult; Aged; Brain; Dihydroxyphenylalanine; Female; Fluorine Radioisotopes; Humans; Male; Middle Aged; Parkinson Disease; Tomography, Emission-Computed | 1994 |
The transport of L-6-fluorodopa and its metabolites from blood to cerebrospinal fluid and brain.
Topics: Amino Acids; Animals; Biological Transport; Blood-Brain Barrier; Brain; Brain Chemistry; Dihydroxyphenylalanine; Fluorine Radioisotopes; Homovanillic Acid; Macaca fascicularis; Male; Phenylalanine; Tomography, Emission-Computed | 1993 |
Positron emission tomographic studies of dopa-responsive dystonia and early-onset idiopathic parkinsonism.
Topics: Adolescent; Adult; Corpus Striatum; Diagnosis, Differential; Dihydroxyphenylalanine; Dystonia; Female; Fluorine Radioisotopes; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Prognosis; Tomography, Emission-Computed | 1993 |
6-[18F]fluoro-L-dihydroxyphenylalanine metabolism and positron emission tomography after catechol-O-methyltransferase inhibition in normal and hemiparkinsonian monkeys.
Topics: Animals; Catechol O-Methyltransferase Inhibitors; Catechols; Dihydroxyphenylalanine; Fluorine Radioisotopes; Macaca mulatta; Parkinson Disease, Secondary; Pentanones; Radioligand Assay; Reference Values; Tomography, Emission-Computed | 1993 |
Reproducibility of fluorine-18-6-fluorodopa positron emission tomography in normal human subjects.
Topics: Adult; Aged; Contrast Media; Corpus Striatum; Dihydroxyphenylalanine; Female; Fluorine Radioisotopes; Humans; Male; Middle Aged; Reference Values; Reproducibility of Results; Tomography, Emission-Computed | 1994 |
Pharmacokinetics of plasma 6-[18F]fluoro-L-3,4-dihydroxyphenylalanine ([18F]Fdopa) in humans.
Topics: Adult; Arteries; Carbidopa; Chromatography, High Pressure Liquid; Dihydroxyphenylalanine; Fluorine Radioisotopes; Humans; Parkinson Disease; Reference Values; Tomography, Emission-Computed | 1993 |
Quality assurance and quality control methods for animal and human applications of no-carrier-added 6-[18F]fluorodopa for PET investigations of dopaminergic systems.
Topics: Animals; Dihydroxyphenylalanine; Fluorine Radioisotopes; Humans; Quality Assurance, Health Care; Quality Control; Tomography, X-Ray Computed | 1993 |
Administration of the new COMT inhibitor OR-611 increases striatal uptake of fluorodopa.
Topics: Animals; Catechols; Corpus Striatum; Dihydroxyphenylalanine; Fluorine Radioisotopes; Levodopa; Macaca fascicularis; Magnetic Resonance Imaging; Male; Nitriles; Parkinson Disease; Tomography, Emission-Computed | 1993 |
Comparison of striatal 18F-dopa uptake in adult-onset dystonia-parkinsonism, Parkinson's disease, and dopa-responsive dystonia.
Topics: Adult; Age Factors; Caudate Nucleus; Dihydroxyphenylalanine; Dystonia; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Putamen; Tomography, Emission-Computed | 1993 |
Striatal 18F-dopa uptake: absence of an aging effect.
Topics: Adult; Aged; Aging; Corpus Striatum; Dihydroxyphenylalanine; Female; Fluorine Radioisotopes; Humans; Male; Middle Aged; Reference Values; Tomography, Emission-Computed | 1993 |
Human positron emission tomographic [18F]fluorodopa studies correlate with dopamine cell counts and levels.
Topics: Adult; Aged; Aged, 80 and over; Autopsy; Dihydroxyphenylalanine; Dopamine; Female; Fluorine Radioisotopes; Humans; Male; Middle Aged; Nervous System Diseases; Neurons; Reference Values; Substantia Nigra; Tomography, Emission-Computed | 1993 |
Correlation of striatal fluorodopa uptake in the MPTP monkey with dopaminergic indices.
Topics: Animals; Biological Transport; Dihydroxyphenylalanine; Dopamine; Fluorine Radioisotopes; Macaca fascicularis; Male; MPTP Poisoning; Neurons; Substantia Nigra; Tomography, Emission-Computed | 1993 |
Striatal L-dopa decarboxylase activity in Parkinson's disease in vivo: implications for the regulation of dopamine synthesis.
Topics: Corpus Striatum; Dihydroxyphenylalanine; Dopa Decarboxylase; Dopamine; Humans; Kinetics; Middle Aged; Models, Biological; Parkinson Disease; Tomography, Emission-Computed | 1993 |
Parametric imaging of the rate constant Ki using [18Fluoro]-L-dopa positron emission tomography in progressive supranuclear palsy.
Topics: Aged; Brain Mapping; Corpus Striatum; Dihydroxyphenylalanine; Dopamine; Female; Fluorine Radioisotopes; Humans; Male; Middle Aged; Substantia Nigra; Supranuclear Palsy, Progressive; Synapses; Tomography, Emission-Computed | 1993 |
Clinical heterogeneity of dopa-responsive dystonia: PET observations.
Topics: Adult; Aged; Corpus Striatum; Diagnosis, Differential; Dihydroxyphenylalanine; Dystonia; Female; Humans; Levodopa; Male; Middle Aged; Neurologic Examination; Parkinson Disease; Parkinson Disease, Secondary; Receptors, Dopamine; Tomography, Emission-Computed | 1993 |
PET scan study on the dopaminergic system in a Japanese patient with hereditary progressive dystonia (Segawa's disease). Case report.
Topics: Corpus Striatum; Dihydroxyphenylalanine; Dystonia; Female; Humans; Japan; Levodopa; Middle Aged; Neurologic Examination; Parkinson Disease; Parkinson Disease, Secondary; Tomography, Emission-Computed | 1993 |
[18F]-6-L-fluorodopa PET studies of graft and host dopaminergic function following fetal mesencephalic transplantation.
Topics: Brain Tissue Transplantation; Dihydroxyphenylalanine; Dominance, Cerebral; Dopamine; Fetal Tissue Transplantation; Follow-Up Studies; Graft Survival; Humans; Mesencephalon; Neurologic Examination; Putamen; Receptors, Dopamine; Tomography, Emission-Computed | 1993 |
Nigral dysfunction in drug-induced parkinsonism: an 18F-dopa PET study.
Topics: Adult; Aged; Animals; Caudate Nucleus; Dihydroxyphenylalanine; Dopamine; Dopamine Antagonists; Female; Fluorine Radioisotopes; Humans; Male; Middle Aged; Parkinson Disease, Secondary; Putamen; Substantia Nigra; Tomography, Emission-Computed | 1993 |
Methods for improving quantitation of putamen uptake constant of FDOPA in PET studies.
Topics: Computer Simulation; Dihydroxyphenylalanine; Fluorine Radioisotopes; Humans; Image Processing, Computer-Assisted; Models, Structural; Putamen; Tomography, Emission-Computed | 1993 |
6-[18F]fluorodopa metabolism in patients with hemiparkinsonism studied by positron emission tomography.
Topics: Adult; Aged; Aged, 80 and over; Caudate Nucleus; Dihydroxyphenylalanine; Female; Fluorine Radioisotopes; Humans; Male; Middle Aged; Parkinson Disease; Putamen; Reference Values; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1993 |
Cerebral glucose metabolism and striatal 18F-dopa uptake by PET in cases of chorea with or without dementia.
Topics: Adult; Aged; Brain; Caudate Nucleus; Chorea; Corpus Striatum; Dementia; Dihydroxyphenylalanine; Female; Fluorine Radioisotopes; Glucose; Humans; Male; Middle Aged; Putamen; Tissue Distribution; Tomography, Emission-Computed | 1993 |
Striatal glucose metabolism and [18F]fluorodopa uptake in a patient with tumor-induced hemiparkinsonism.
Topics: Blood Glucose; Corpus Striatum; Dihydroxyphenylalanine; Dominance, Cerebral; Dopamine; Electromyography; Female; Humans; Meningeal Neoplasms; Meningioma; Middle Aged; Neurologic Examination; Parkinson Disease, Secondary; Radionuclide Imaging | 1993 |
Positron emission tomography in drug evaluation: influence of three different catechol-O-methyltransferase inhibitors on metabolism of [NCA] 6-[18F]fluoro-L-dopa in rhesus monkey.
Topics: Amidines; Animals; Benzophenones; Biological Availability; Brain; Catechol O-Methyltransferase Inhibitors; Catechols; Dihydroxyphenylalanine; Drug Evaluation, Preclinical; Enzyme Inhibitors; Female; Fluorine Radioisotopes; Macaca mulatta; Nitriles; Nitrophenols; Pyridones; Tolcapone; Tomography, Emission-Computed | 1995 |
Long-term outcome of unilaterally transplanted parkinsonian patients. I. Clinical approach.
Topics: Aged; Antiparkinson Agents; Brain; Brain Tissue Transplantation; Dihydroxyphenylalanine; Female; Fetal Tissue Transplantation; Fluorine Radioisotopes; Follow-Up Studies; Humans; Male; Mesencephalon; Middle Aged; Movement Disorders; Parkinson Disease; Treatment Outcome | 1996 |
Presynaptic dopaminergic deficits in Lesch-Nyhan disease.
Topics: Adolescent; Adult; Analysis of Variance; Brain; Brain Chemistry; Caudate Nucleus; Cerebral Cortex; Child; Dihydroxyphenylalanine; Female; Fluorine Radioisotopes; Humans; Lesch-Nyhan Syndrome; Male; Presynaptic Terminals; Putamen; Receptors, Dopamine; Receptors, Presynaptic; Tomography, Emission-Computed | 1996 |
Combined FDOPA and 3OMFD PET studies in Parkinson's disease.
Topics: Adult; Blood-Brain Barrier; Brain; Case-Control Studies; Corpus Striatum; Decarboxylation; Dihydroxyphenylalanine; Female; Fluorine Radioisotopes; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Models, Biological; Parkinson Disease; Time Factors; Tomography, Emission-Computed | 1996 |
Clinical significance of striatal DOPA decarboxylase activity in Parkinson's disease.
Topics: Brain; Case-Control Studies; Corpus Striatum; Dihydroxyphenylalanine; Dopa Decarboxylase; Female; Fluorine Radioisotopes; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Models, Biological; Parkinson Disease; Tomography, Emission-Computed | 1996 |
Nigrofrontal dopaminergic function as assessed by 18F-dopa PET.
Topics: Adult; Aged; Cerebellum; Corpus Striatum; Dihydroxyphenylalanine; Dopamine; Female; Fluorine Radioisotopes; Humans; Male; Middle Aged; Neural Pathways; Parkinson Disease; Substantia Nigra; Supranuclear Palsy, Progressive; Technology, Radiologic; Tomography, Emission-Computed | 1995 |
Reproducibility and discriminating ability of fluorine-18-6-fluoro-L-Dopa PET in Parkinson's disease.
Topics: Analysis of Variance; Brain; Case-Control Studies; Dihydroxyphenylalanine; Female; Fluorine Radioisotopes; Follow-Up Studies; Humans; Male; Middle Aged; Parkinson Disease; Reproducibility of Results; Time Factors; Tomography, Emission-Computed | 1996 |
Modeling of fluorine-18-6-fluoro-L-Dopa in humans.
Topics: Adult; Biological Transport; Blood-Brain Barrier; Case-Control Studies; Corpus Striatum; Dihydroxyphenylalanine; Dopamine; Fluorine Radioisotopes; Humans; Male; Middle Aged; Models, Biological; Parkinson Disease; Time Factors; Tomography, Emission-Computed | 1996 |
Synthesis and evaluation of an 18F-labeled dopa prodrug as a PET tracer for studying brain dopamine metabolism.
Topics: Animals; Benzophenones; Biotransformation; Brain; Carbidopa; Catechol O-Methyltransferase Inhibitors; Cerebral Cortex; Corpus Striatum; Dihydroxyphenylalanine; Dopamine; Enzyme Inhibitors; Fluorine Radioisotopes; Injections, Intravenous; Mice; Nitrophenols; Prodrugs; Time Factors; Tissue Distribution; Tolcapone; Tomography, Emission-Computed | 1996 |
Fluorodopa positron emission tomography with an inhibitor of catechol-O-methyltransferase: effect of the plasma 3-O-methyldopa fraction on data analysis.
Topics: Adult; Aged; Catechol O-Methyltransferase Inhibitors; Catechols; Chromatography, High Pressure Liquid; Corpus Striatum; Dihydroxyphenylalanine; Enzyme Inhibitors; Female; Fluorine Radioisotopes; Humans; Kinetics; Male; Middle Aged; Nitriles; Occipital Lobe; Parkinson Disease; Quality Control; Sensitivity and Specificity; Tomography, Emission-Computed; Tyrosine | 1996 |
Quantification of dopamine metabolism in man: a mathematically justifiable approach.
Topics: Adult; Aged; Biophysical Phenomena; Biophysics; Brain; Corpus Striatum; Dihydroxyphenylalanine; Dopamine; Female; Fluorine Radioisotopes; Humans; Injections, Intravenous; Male; Mathematics; Middle Aged; Models, Neurological; Tomography, Emission-Computed | 1996 |
Differences in the reduced 18F-Dopa uptakes of the caudate and the putamen in Parkinson's disease: correlations with the three main symptoms.
Topics: Adult; Aged; Caudate Nucleus; Dihydroxyphenylalanine; Female; Fluorine Radioisotopes; Humans; Male; Middle Aged; Movement Disorders; Muscle Rigidity; Parkinson Disease; Putamen; Tomography, Emission-Computed; Tremor | 1996 |
6-[18F]fluoro-L-DOPA-PET studies show partial reversibility of long-term effects of chronic amphetamine in monkeys.
Topics: Amphetamine; Animals; Caudate Nucleus; Chlorocebus aethiops; Dihydroxyphenylalanine; Dopamine; Dopamine Agents; Homovanillic Acid; Image Processing, Computer-Assisted; Male; Neostriatum; Putamen; Tomography, Emission-Computed | 1996 |
Secondary parkinsonism due to focal substantia nigra lesions: a PET study with [18F]FDG and [18F]fluorodopa.
Topics: Aged; Deoxyglucose; Dihydroxyphenylalanine; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Parkinson Disease; Substantia Nigra; Tomography, Emission-Computed | 1996 |
Chemical reactivity of the 18F electrophilic reagents from the 18O(p,n) 18F gas target systems.
Topics: Aluminum; Copper; Deoxyglucose; Dihydroxyphenylalanine; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Gases; Gold; Isotope Labeling; Magnetic Resonance Spectroscopy; Metals; Nickel; Oxygen Isotopes; Silver | 1996 |
[A case of familial juvenile dystonia-parkinsonism: 18F-6-fluorodopa and 18F-fluoro-2-deoxyglucose PET study].
Topics: Adult; Age of Onset; Brain; Deoxyglucose; Dihydroxyphenylalanine; Dystonia; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glucose; Humans; Levodopa; Parkinson Disease; Tomography, Emission-Computed | 1996 |
Comparative nigrostriatal dopaminergic imaging with iodine-123-beta CIT-FP/SPECT and fluorine-18-FDOPA/PET.
Topics: Adult; Aged; Aging; Carrier Proteins; Cocaine; Corpus Striatum; Dihydroxyphenylalanine; Dopamine; Dopamine Plasma Membrane Transport Proteins; Female; Humans; Iodine Radioisotopes; Male; Membrane Glycoproteins; Membrane Transport Proteins; Middle Aged; Nerve Tissue Proteins; Parkinson Disease; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 1996 |
Bladder wall radiation dose in humans from fluorine-18-FDOPA.
Topics: Adult; Brain; Dihydroxyphenylalanine; Female; Fluorine Radioisotopes; Humans; Male; Middle Aged; Radiation Dosage; Tomography, Emission-Computed; Urinary Bladder | 1996 |
Radiofluorinated L-m-tyrosines: new in-vivo probes for central dopamine biochemistry.
Topics: Animals; Brain; Chlorocebus aethiops; Dihydroxyphenylalanine; Dopamine; Fluorine Radioisotopes; Tissue Distribution; Tyrosine | 1996 |
F-Dopa as an amino acid tracer to detect brain tumors.
Topics: Brain; Brain Neoplasms; Deoxyglucose; Dihydroxyphenylalanine; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glioma; Glucose; Humans; Magnetic Resonance Imaging; Methionine; Middle Aged; Oxygen Radioisotopes; Tomography, Emission-Computed; Water | 1996 |
Automated image registration for FDOPA PET studies.
Topics: Animals; Automation; Chlorocebus aethiops; Dihydroxyphenylalanine; Fluorine Radioisotopes; Humans; Kinetics; Reproducibility of Results; Stochastic Processes; Supine Position; Tomography, Emission-Computed | 1996 |
Brain 6-[18F]fluorodopa metabolism in early and late onset of Parkinson's disease studied by positron emission tomography.
Topics: Adult; Age of Onset; Aged; Brain; Case-Control Studies; Caudate Nucleus; Dihydroxyphenylalanine; Dopamine; Female; Fluorine Radioisotopes; Humans; Male; Middle Aged; Parkinson Disease; Presynaptic Terminals; Putamen; Radioligand Assay; Statistics, Nonparametric; Tomography, Emission-Computed | 1996 |
Co production of 2,6-[18F] difluoroDOPA during electrophilic synthesis of 6-[18F]fluoro-L-DOPA.
Topics: Animals; Brain; Chromatography, High Pressure Liquid; Dihydroxyphenylalanine; Fluorine Radioisotopes; Isotope Labeling; Magnetic Resonance Spectroscopy; Mice; Spectrophotometry, Ultraviolet; Tissue Distribution | 1996 |
Ethological and 6-[18F]fluoro-L-DOPA-PET profiles of long-term vulnerability to chronic amphetamine.
Topics: Aggression; Amphetamine; Animals; Behavior, Animal; Brain Chemistry; Central Nervous System Stimulants; Chlorocebus aethiops; Corpus Striatum; Dihydroxyphenylalanine; Dopamine; Dopamine Uptake Inhibitors; Fluorine Radioisotopes; Kinetics; Male; Motor Activity; Social Behavior; Stereotyped Behavior; Tomography, Emission-Computed | 1997 |
Evaluation of fluorinated m-tyrosine analogs as PET imaging agents of dopamine nerve terminals: comparison with 6-fluoroDOPA.
Topics: Animals; Brain; Chromatography, High Pressure Liquid; Dihydroxyphenylalanine; Dopamine; Female; Fluorine Radioisotopes; Macaca mulatta; Male; Nerve Endings; Tomography, Emission-Computed; Tyrosine | 1997 |
Increased dopamine activity associated with stuttering.
Topics: Adult; Amygdala; Brain; Cerebral Cortex; Dihydroxyphenylalanine; Dopamine; Fluorine Radioisotopes; Humans; Male; Middle Aged; Organ Specificity; Reference Values; Stuttering; Tomography, Emission-Computed | 1997 |
Presynaptic and postsynaptic striatal dopaminergic function in patients with manganese intoxication: a positron emission tomography study.
Topics: Adult; Corpus Striatum; Dihydroxyphenylalanine; Dopamine; Dopamine Antagonists; Fluorine Radioisotopes; Humans; Male; Manganese Poisoning; Middle Aged; Presynaptic Terminals; Raclopride; Salicylamides; Synapses; Tissue Distribution; Tomography, Emission-Computed | 1997 |
Determination of unchanged [18F]dopamine in human and non-human primate plasma during positron emission tomography studies: a new solid-phase extraction method comparable to radio-thin-layer chromatography analysis.
Topics: Adult; Aluminum Oxide; Animals; Chromatography, Thin Layer; Dihydroxyphenylalanine; Dopamine; Female; Fluorine Radioisotopes; Haplorhini; Humans; Male; Middle Aged; Reproducibility of Results; Tomography, Emission-Computed | 1997 |
Dopaminergic function in patients with posttraumatic parkinsonism: an 18F-dopa PET study.
Topics: Aged; Brain; Dihydroxyphenylalanine; Dopamine; Fluorine Radioisotopes; Humans; Male; Middle Aged; Parkinson Disease; Time Factors; Tomography, Emission-Computed; Wounds and Injuries | 1997 |
Short- and long-term survival and function of unilateral intrastriatal dopaminergic grafts in Parkinson's disease.
Topics: Adult; Corpus Striatum; Dihydroxyphenylalanine; Dopamine; Fetal Tissue Transplantation; Follow-Up Studies; Humans; Medical Records; Mesencephalon; Middle Aged; Parkinson Disease; Survival Analysis; Tomography, Emission-Computed; Treatment Outcome | 1997 |
Physiologic modeling of PET data: quantitative conflict and challenge.
Topics: Blood-Brain Barrier; Brain; Dihydroxyphenylalanine; Dopamine; Fluorine Radioisotopes; Humans; Models, Biological; Parkinson Disease; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 1997 |
Controversies arising from recent FDOPA articles.
Topics: Blood-Brain Barrier; Brain; Dihydroxyphenylalanine; Dopamine; Fluorine Radioisotopes; Humans; Models, Biological; Parkinson Disease; Tomography, Emission-Computed | 1997 |
Nigrostriatal dopaminergic imaging with iodine-123-beta CIT-FP/SPECT and fluorine-18-FDOPA/PET.
Topics: Aging; Carrier Proteins; Cocaine; Corpus Striatum; Dihydroxyphenylalanine; Dopamine; Dopamine Plasma Membrane Transport Proteins; Fluorine Radioisotopes; Humans; Iodine Radioisotopes; Membrane Glycoproteins; Membrane Transport Proteins; Nerve Tissue Proteins; Parkinson Disease; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 1997 |
Striatal dopamine metabolism correlated with frontotemporal glucose utilization in Alzheimer's disease: a double-tracer PET study.
Topics: Aged; Alzheimer Disease; Brain; Corpus Striatum; Dihydroxyphenylalanine; Dopamine; Female; Fluorodeoxyglucose F18; Frontal Lobe; Glucose; Humans; Male; Radiopharmaceuticals; Temporal Lobe; Tissue Distribution; Tomography, Emission-Computed | 1997 |
Fluorodopa and raclopride PET analysis of patients with Machado-Joseph disease.
Topics: Adolescent; Adult; Caudate Nucleus; Cerebellum; Dihydroxyphenylalanine; Dopamine Antagonists; Female; Humans; Machado-Joseph Disease; Male; Middle Aged; Parkinson Disease; Putamen; Raclopride; Reference Values; Salicylamides; Tissue Distribution; Tomography, Emission-Computed | 1997 |
On the accuracy of an [18F]FDOPA compartmental model: evidence for vesicular storage of [18F]fluorodopamine in vivo.
Topics: Animals; Brain; Chromatography, High Pressure Liquid; Dihydroxyphenylalanine; Fluorine Radioisotopes; Kinetics; Nonlinear Dynamics; Rats; Reproducibility of Results; Synaptic Vesicles; Tomography, Emission-Computed | 1997 |
Cerebral 6-[18F]fluoro-L-DOPA uptake in rhesus monkey: pharmacological influence of aromatic amino acid decarboxylase (AAAD) and catechol-O-methyltransferase (COMT) inhibition.
Topics: Animals; Aromatic Amino Acid Decarboxylase Inhibitors; Brain; Catechol O-Methyltransferase Inhibitors; Dihydroxyphenylalanine; Female; Fluorine Radioisotopes; Linear Models; Macaca mulatta; Tomography, Emission-Computed | 1997 |
Striatal 6-[18F]fluorodopa accumulation after combined inhibition of peripheral catechol-O-methyltransferase and monoamine oxidase type B: differing response in relation to presynaptic dopaminergic dysfunction.
Topics: Adult; Aged; Antiparkinson Agents; Case-Control Studies; Catechol O-Methyltransferase Inhibitors; Corpus Striatum; Dihydroxyphenylalanine; Dopamine; Enzyme Inhibitors; Female; Fluorine Radioisotopes; Humans; Male; Middle Aged; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Presynaptic Terminals; Radioligand Assay; Selegiline; Tomography, Emission-Computed | 1997 |
Graphical analysis of 6-fluoro-L-dopa trapping: effect of inhibition of catechol-O-methyltransferase.
Topics: Animals; Benzophenones; Brain; Catechol O-Methyltransferase; Catechol O-Methyltransferase Inhibitors; Catechols; Chromatography, High Pressure Liquid; Dihydroxyphenylalanine; Enzyme Inhibitors; Fluorine Radioisotopes; Macaca fascicularis; Male; Nitrophenols; Pentanones; Tolcapone; Tomography, Emission-Computed | 1997 |
Effects of large neutral amino acid concentrations on 6-[F-18]Fluoro-L-DOPA kinetics.
Topics: Amino Acids; Animals; Brain; Dihydroxyphenylalanine; Haplorhini; Humans; Kinetics; Tomography, Emission-Computed | 1998 |
Complementary PET studies of striatal neuronal function in the differential diagnosis between multiple system atrophy and Parkinson's disease.
Topics: Aged; Carbon Radioisotopes; Caudate Nucleus; Corpus Striatum; Diagnosis, Differential; Dihydroxyphenylalanine; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Hypotension, Orthostatic; Male; Middle Aged; Multiple System Atrophy; Neurons; Parkinson Disease; Putamen; Raclopride; Radiography; Radiopharmaceuticals; Receptors, Dopamine D2; Regression Analysis; Salicylamides; Tomography, Emission-Computed | 1997 |
[Fluorine-18 labeled 6-fluoro-L-dopa: systematization and evaluation of its usefulness].
Topics: Brain; Chromatography, High Pressure Liquid; Dihydroxyphenylalanine; Dopamine; Fluorine Radioisotopes; Humans; Radiopharmaceuticals; Tomography, Emission-Computed | 1997 |
Measuring the rate of progression and estimating the preclinical period of Parkinson's disease with [18F]dopa PET.
Topics: Aged; Case-Control Studies; Caudate Nucleus; Dihydroxyphenylalanine; Disease Progression; Humans; Linear Models; Middle Aged; Parkinson Disease; Prospective Studies; Putamen; Reproducibility of Results; Sensitivity and Specificity; Severity of Illness Index; Tomography, Emission-Computed | 1998 |
Striatal presynaptic dopamine function in type 1 alcoholics measured with positron emission tomography.
Topics: Adult; Alcoholism; Carrier Proteins; Caudate Nucleus; Corpus Striatum; Dihydroxyphenylalanine; Dominance, Cerebral; Dopamine; Dopamine Plasma Membrane Transport Proteins; Finland; Fluorine Radioisotopes; Humans; Magnetic Resonance Imaging; Male; Membrane Glycoproteins; Membrane Transport Proteins; Middle Aged; Models, Neurological; Models, Psychological; Nerve Tissue Proteins; Neuropsychological Tests; Presynaptic Terminals; Putamen; Receptors, Dopamine D2; Tomography, Emission-Computed | 1998 |
6-[18F]Fluoro-L-DOPA PET studies of the turnover of dopamine in MPTP-induced parkinsonism in monkeys.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Chromatography, High Pressure Liquid; Corpus Striatum; Dihydroxyphenylalanine; Dopamine; Macaca fascicularis; Macaca mulatta; Parkinson Disease, Secondary; Reference Values; Tomography, Emission-Computed | 1998 |
DOPA decarboxylase activity in attention deficit hyperactivity disorder adults. A [fluorine-18]fluorodopa positron emission tomographic study.
Topics: Adult; Analysis of Variance; Attention Deficit Disorder with Hyperactivity; Case-Control Studies; Dihydroxyphenylalanine; Dopa Decarboxylase; Female; Fluorine Radioisotopes; Humans; Male; Middle Aged; Presynaptic Terminals; Tomography, Emission-Computed | 1998 |
PET study and neuropsychological assessment of a long-lasting post-encephalitic parkinsonism.
Topics: Aged; Antiparkinson Agents; Brain; Dihydroxyphenylalanine; Encephalitis, Arbovirus; Female; Fluorine Radioisotopes; Follow-Up Studies; Humans; Levodopa; Memory Disorders; Neuropsychological Tests; Obsessive-Compulsive Disorder; Parkinson Disease; Phobic Disorders; Tomography, Emission-Computed | 1998 |
Statistical power analysis for PET studies in humans.
Topics: Age Factors; Aging; Brain; Dihydroxyphenylalanine; Fluorine Radioisotopes; Humans; Research Design; Sampling Studies; Tomography, Emission-Computed | 1998 |
Nervous system dysfunction in Waldenström's macroglobulinemia: response to treatment.
Topics: Antibodies, Monoclonal; Bone Marrow Transplantation; Dihydroxyphenylalanine; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Immunoglobulin M; Male; Middle Aged; Myelin-Associated Glycoprotein; Neural Conduction; Parkinson Disease, Secondary; Peripheral Nervous System Diseases; Tomography, Emission-Computed; Waldenstrom Macroglobulinemia | 1998 |
Simultaneous measurement of [18F]FDOPA metabolism and cerebral blood flow in newborn piglets.
Topics: Animals; Animals, Newborn; Cerebrovascular Circulation; Dihydroxyphenylalanine; Fluorine Radioisotopes; Microspheres; Swine; Time Factors; Tomography, Emission-Computed | 1998 |
Fluorine-18-fluoro-L-DOPA dosimetry with carbidopa pretreatment.
Topics: Aromatic Amino Acid Decarboxylase Inhibitors; Carbidopa; Dihydroxyphenylalanine; Enzyme Inhibitors; Fluorine Radioisotopes; Humans; Premedication; Radiation Dosage; Radiation Protection; Tissue Distribution; Tomography, Emission-Computed; Urinary Bladder | 1998 |
Distribution volume of radiolabeled large neutral amino acids in brain tissue.
Topics: Amino Acids; Animals; Blood-Brain Barrier; Brain; Dihydroxyphenylalanine; Models, Cardiovascular; Models, Neurological; Tissue Distribution | 1998 |
Positron emission tomographic studies in restless legs syndrome.
Topics: Aged; Brain; Dihydroxyphenylalanine; Energy Metabolism; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Receptors, Dopamine; Receptors, Presynaptic; Restless Legs Syndrome; Tomography, Emission-Computed | 1999 |
Depressive symptoms and presynaptic dopamine function in neuroleptic-naive schizophrenia.
Topics: Adolescent; Adult; Corpus Striatum; Depressive Disorder; Dihydroxyphenylalanine; Dopamine; Female; Functional Laterality; Humans; Male; Putamen; Receptors, Presynaptic; Schizophrenia; Schizophrenic Psychology; Tomography, Emission-Computed | 1999 |
Measuring the rate of progression and estimating the preclinical period of Parkinson's disease with [18F] dopa PET.
Topics: Dihydroxyphenylalanine; Fluorine Radioisotopes; Humans; Parkinson Disease; Time Factors; Tomography, Emission-Computed | 1999 |
Evaluation of dopaminergic presynaptic integrity: 6-[18F]fluoro-L-dopa versus 6-[18F]fluoro-L-m-tyrosine.
Topics: Animals; Chromatography, High Pressure Liquid; Corpus Striatum; Dihydroxyphenylalanine; Dopa Decarboxylase; Dopamine; Fluorine Radioisotopes; Macaca fascicularis; Macaca mulatta; Occipital Lobe; Synapses; Tomography, Emission-Computed; Tyrosine | 1999 |
Cocaine withdrawal and the cerebral influx of [18F]fluoro-L-DOPA (FDOPA)
Topics: Brain Chemistry; Cocaine; Dihydroxyphenylalanine; Dopamine Uptake Inhibitors; Fluorine Radioisotopes; Humans; Substance Withdrawal Syndrome | 1999 |
Striatal dopaminergic function in restless legs syndrome: 18F-dopa and 11C-raclopride PET studies.
Topics: Aged; Carbon Radioisotopes; Corpus Striatum; Dihydroxyphenylalanine; Dopamine; Female; Humans; Kinetics; Male; Middle Aged; Raclopride; Restless Legs Syndrome; Salicylamides; Syndrome; Tomography, Emission-Computed | 1999 |
Recovery rates of regional sympathetic reinnervation and myocardial blood flow after acute myocardial infarction.
Topics: Adult; Aged; Blood Flow Velocity; Coronary Vessels; Dihydroxyphenylalanine; Electrocardiography; Female; Fluorine Radioisotopes; Follow-Up Studies; Heart; Heart Rate; Humans; Male; Middle Aged; Myocardial Infarction; Prognosis; Regional Blood Flow; Reproducibility of Results; Sympathetic Nervous System; Tomography, Emission-Computed | 1999 |
The role of inheritance in sporadic Parkinson's disease: evidence from a longitudinal study of dopaminergic function in twins.
Topics: Aged; Brain; Dihydroxyphenylalanine; Diseases in Twins; Female; Humans; Longitudinal Studies; Male; Middle Aged; Parkinson Disease; Radionuclide Imaging | 1999 |
Statistical parametric mapping with 18F-dopa PET shows bilaterally reduced striatal and nigral dopaminergic function in early Parkinson's disease.
Topics: Adult; Brain; Brain Mapping; Dihydroxyphenylalanine; Female; Humans; Male; Middle Aged; Parkinson Disease; Tomography, Emission-Computed | 1999 |
Upregulation of the aromatic amino acid decarboxylase under neonatal asphyxia.
Topics: Algorithms; Animals; Animals, Newborn; Aromatic-L-Amino-Acid Decarboxylases; Asphyxia; Brain; Cerebrovascular Circulation; Chromatography, High Pressure Liquid; Dihydroxyphenylalanine; Fluorine Radioisotopes; Male; Spectrophotometry, Ultraviolet; Swine; Tomography, Emission-Computed; Up-Regulation | 1999 |
Enzymatic synthesis of no-carrier-added 6-[18F]fluoro-L-dopa with beta-tyrosinase.
Topics: Chromatography, High Pressure Liquid; Dihydroxyphenylalanine; Fluorine Radioisotopes; Indicators and Reagents; Isomerism; Kinetics; Molecular Structure; Radiopharmaceuticals; Tyrosine Phenol-Lyase | 1999 |
Imaging of a metastatic gastrointestinal carcinoid by F-18-DOPA positron emission tomography.
Topics: Carcinoid Tumor; Dihydroxyphenylalanine; Fluorine Radioisotopes; Gastrointestinal Neoplasms; Humans; Indium Radioisotopes; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Receptors, Somatostatin; Somatostatin; Tissue Distribution; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 1999 |
Cerebral 6-[(18)F]fluoro-L-DOPA (FDOPA) metabolism in pig studied by positron emission tomography.
Topics: Aging; Animals; Animals, Newborn; Aromatic Amino Acid Decarboxylase Inhibitors; Blood-Brain Barrier; Brain; Carbidopa; Dihydroxyphenylalanine; Female; Fluorine Radioisotopes; Humans; Kinetics; Macaca fascicularis; Metabolic Clearance Rate; Models, Neurological; Rats; Swine; Tomography, Emission-Computed | 1999 |
Opiate receptor avidity is reduced bilaterally in rhesus monkeys unilaterally lesioned with MPTP.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Basal Ganglia; Brain; Cerebellum; Cerebral Cortex; Dihydroxyphenylalanine; Fluorine Radioisotopes; Functional Laterality; Infusions, Parenteral; Limbic System; Macaca mulatta; Naltrexone; Narcotic Antagonists; Organ Specificity; Receptors, Opioid; Receptors, Opioid, kappa; Receptors, Opioid, mu; Tomography, Emission-Computed | 1999 |
Dopaminergic dysfunction in midbrain dystonia: anatomoclinical study using 3-dimensional magnetic resonance imaging and fluorodopa F 18 positron emission tomography.
Topics: Adolescent; Aged; Cerebellum; Cerebrovascular Disorders; Corpus Striatum; Dihydroxyphenylalanine; Dopamine; Dystonia; Female; Fluorine Radioisotopes; Follow-Up Studies; Humans; Magnetic Resonance Imaging; Male; Mesencephalon; Middle Aged; Stereotaxic Techniques; Substantia Nigra; Tomography, Emission-Computed | 1999 |
High midbrain [18F]DOPA accumulation in children with attention deficit hyperactivity disorder.
Topics: Adolescent; Attention Deficit Disorder with Hyperactivity; Caudate Nucleus; Child; Dihydroxyphenylalanine; Dopa Decarboxylase; Dopamine; Female; Fluorine Radioisotopes; Frontal Lobe; Functional Laterality; Humans; Male; Mesencephalon; Presynaptic Terminals; Putamen; Severity of Illness Index; Tomography, Emission-Computed | 1999 |
Frontal, midbrain and striatal dopaminergic function in early and advanced Parkinson's disease A 3D [(18)F]dopa-PET study.
Topics: Biological Transport; Brain Mapping; Corpus Striatum; Dihydroxyphenylalanine; Fluorine Radioisotopes; Frontal Lobe; Functional Laterality; Humans; Mesencephalon; Middle Aged; Parkinson Disease; Reference Values; Software; Tissue Distribution; Tomography, Emission-Computed | 1999 |
Localization of trapping of 6-[(18)F]fluoro-L-m-tyrosine, an aromatic L-amino acid decarboxylase tracer for PET.
Topics: Animals; Brain; Dihydroxyphenylalanine; Fluorine Radioisotopes; Macaca mulatta; Organ Specificity; Time Factors; Tomography, Emission-Computed; Tyrosine | 1999 |
Pharmacokinetics of radiotracers in human plasma during positron emission tomography.
Topics: Benzazepines; Carbon Radioisotopes; Chromatography, High Pressure Liquid; Cocaine; Dihydroxyphenylalanine; Dopamine Antagonists; Drug Interactions; Fluorine Radioisotopes; Humans; Nicotine; Raclopride; Radiopharmaceuticals; Selegiline; Tomography, Emission-Computed | 1999 |
FluoroDOPA PET shows the nondopaminergic as well as dopaminergic destinations of levodopa.
Topics: Aged; Brain; Dihydroxyphenylalanine; Dopamine; Female; Humans; Kinetics; Levodopa; Male; Middle Aged; Tomography, Emission-Computed | 1999 |
A comparison of 11C-labeled L-DOPA and L-fluorodopa as positron emission tomography tracers for the presynaptic dopaminergic system.
Topics: Animals; Antiparkinson Agents; Benzophenones; Carbon Radioisotopes; Corpus Striatum; Dihydroxyphenylalanine; Dopamine; Female; Fluorine Radioisotopes; Levodopa; Macaca mulatta; Nitrophenols; Presynaptic Terminals; Tolcapone; Tomography, Emission-Computed | 1999 |
[Diagnostic utility of positron emission tomography for parkinsonism after chronic manganese exposure].
Topics: Diagnosis, Differential; Dihydroxyphenylalanine; Fluorine Radioisotopes; Humans; Male; Manganese Poisoning; Middle Aged; Occupational Exposure; Parkinsonian Disorders; Radiopharmaceuticals; Tomography, Emission-Computed | 1999 |
Spatial memory improvement by levodopa in parkinsonian MPTP-treated monkeys.
Topics: Animals; Antiparkinson Agents; Dihydroxyphenylalanine; Dopamine Agents; Fluorine Radioisotopes; Levodopa; Macaca mulatta; Male; Memory; Motor Activity; MPTP Poisoning; Parkinson Disease, Secondary; Psychomotor Performance; Space Perception | 1999 |
Fluorodopa uptake and glucose metabolism in early stages of corticobasal degeneration.
Topics: Aged; Basal Ganglia; Brain Diseases; Cerebral Cortex; Dihydroxyphenylalanine; Female; Fluorodeoxyglucose F18; Glucose; Humans; Male; Middle Aged; Nerve Degeneration; Parkinson Disease; Radiopharmaceuticals; Reference Values; Tissue Distribution; Tomography, Emission-Computed | 1999 |
An FDOPA PET study in patients with periodic limb movement disorder and restless legs syndrome.
Topics: Adult; Dihydroxyphenylalanine; Dopamine; Female; Fluorine Radioisotopes; Humans; Male; Middle Aged; Movement Disorders; Neostriatum; Restless Legs Syndrome; Substantia Nigra; Tomography, Emission-Computed | 2000 |
Nigrostriatal reduction of aromatic L-amino acid decarboxylase activity in MPTP-treated squirrel monkeys: in vivo and in vitro investigations.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Aromatic Amino Acid Decarboxylase Inhibitors; Aromatic-L-Amino-Acid Decarboxylases; Corpus Striatum; Dihydroxyphenylalanine; Dopamine Agents; Female; Male; Saimiri; Substantia Nigra; Tomography, Emission-Computed | 2000 |
Putaminal necrosis presenting with hemidystonia.
Topics: Antiparkinson Agents; Brain Diseases; Child; Dihydroxyphenylalanine; Dose-Response Relationship, Drug; Dystonia; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Levodopa; Magnetic Resonance Imaging; Necrosis; Putamen; Tomography, Emission-Computed; Treatment Outcome | 2000 |
High levels of dopamine activity in the basal ganglia of cigarette smokers.
Topics: Adult; Basal Ganglia; Caudate Nucleus; Corpus Striatum; Dihydroxyphenylalanine; Dopamine; Female; Fluorine Radioisotopes; Functional Laterality; Humans; Male; Putamen; Smoking; Tobacco Use Disorder; Tomography, Emission-Computed | 2000 |
Parkinson's disease in twins.
Topics: Dihydroxyphenylalanine; Diseases in Twins; False Negative Reactions; False Positive Reactions; Humans; Parkinson Disease; Predictive Value of Tests; Reproducibility of Results; Sensitivity and Specificity; Tomography, Emission-Computed | 2000 |
Enhancement of survival of stored dopaminergic cells and promotion of graft survival by exposure of human fetal nigral tissue to glial cell line--derived neurotrophic factor in patients with Parkinson's disease. Report of two cases and technical considera
Topics: Aged; Brain Tissue Transplantation; Cell Count; Cell Line; Cell Survival; Dihydroxyphenylalanine; Dopamine; Feasibility Studies; Fetal Tissue Transplantation; Fluorine Radioisotopes; Follow-Up Studies; Graft Survival; Humans; Male; Mesencephalon; Middle Aged; Nerve Growth Factor; Neuroglia; Parkinson Disease; Putamen; Radiopharmaceuticals; Substantia Nigra; Tissue Preservation; Tomography, Emission-Computed; Treatment Outcome; Tyrosine 3-Monooxygenase | 2000 |
Evidence for impaired presynaptic dopamine function in parkinsonian patients with motor fluctuations.
Topics: Antiparkinson Agents; Dihydroxyphenylalanine; Dopamine; Female; Fluorine Radioisotopes; Humans; Levodopa; Male; Middle Aged; Motor Neurons; Movement Disorders; Parkinson Disease; Presynaptic Terminals; Substantia Nigra; Tomography, Emission-Computed | 2000 |
Extrastriatal mean regional uptake of fluorine-18-FDOPA in the normal aged brain--an approach using MRI-aided spatial normalization.
Topics: Aged; Aging; Brain; Dihydroxyphenylalanine; Female; Fluorine Radioisotopes; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Reference Values; Tissue Distribution; Visual Cortex | 2000 |
Effect of partial volume correction on estimates of the influx and cerebral metabolism of 6-[(18)F]fluoro-L-dopa studied with PET in normal control and Parkinson's disease subjects.
Topics: Adult; Aged; Algorithms; Brain; Dihydroxyphenylalanine; Humans; Magnetic Resonance Imaging; Middle Aged; Models, Neurological; Parkinson Disease; Reference Values; Time Factors; Tissue Distribution; Tomography, Emission-Computed | 2000 |
Striatal kinetic modeling of FDOPA with a cerebellar-derived constraint on the distribution of volume of 30MFD: a PET investigation using non-human primates.
Topics: Animals; Cercopithecus; Cerebellum; Corpus Striatum; Dihydroxyphenylalanine; Kinetics; Models, Biological; Saimiri; Tomography, Emission-Computed | 2000 |
6-fluoroDOPA metabolism in rat striatum: time course of extracellular metabolites.
Topics: Animals; Cerebellum; Corpus Striatum; Dihydroxyphenylalanine; Fluorine Radioisotopes; Rats; Rats, Sprague-Dawley | 2000 |
Risk for Parkinson's disease: twin studies for the detection of asymptomatic subjects using [18F]6-fluorodopa PET.
Topics: Analysis of Variance; Dihydroxyphenylalanine; Female; Humans; Male; Parkinson Disease; Risk Factors; Tomography, Emission-Computed | 2000 |
Neurodegeneration prevented by lentiviral vector delivery of GDNF in primate models of Parkinson's disease.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Aging; Animals; Antigens, CD; Dihydroxyphenylalanine; Disease Models, Animal; Dopamine; Female; Gene Expression; Genetic Therapy; Genetic Vectors; Glial Cell Line-Derived Neurotrophic Factor; Lentivirus; Macaca mulatta; Neostriatum; Nerve Degeneration; Nerve Growth Factors; Nerve Tissue Proteins; Neurons; Parkinson Disease; Parkinsonian Disorders; Psychomotor Performance; Substantia Nigra; Tyrosine 3-Monooxygenase | 2000 |
Robotic synthesis of 6-[18F]fluoro-L-dopa.
Topics: Dihydroxyphenylalanine; Fluorine Radioisotopes | 2000 |
Noninvasive assessment of aromatic L-amino acid decarboxylase activity in aging rhesus monkey brain in vivo.
Topics: Aging; Animals; Aromatic-L-Amino-Acid Decarboxylases; Brain; Dihydroxyphenylalanine; Macaca mulatta; Male; Neurons; Tomography, Emission-Computed; Tyrosine | 2001 |
6-(18)F-DOPA PET study in patients with schizophrenia. Positron emission tomography.
Topics: Adult; Antipsychotic Agents; Aromatic-L-Amino-Acid Decarboxylases; Brain; Case-Control Studies; Chronic Disease; Dihydroxyphenylalanine; Dopamine; Female; Fluorine Radioisotopes; Frontal Lobe; Gyrus Cinguli; Humans; Male; Multivariate Analysis; Neostriatum; Neurologic Examination; Schizophrenia; Tomography, Emission-Computed | 2000 |
18F-fluorodopa PET study of striatal dopamine uptake in the diagnosis of dementia with Lewy bodies.
Topics: Aged; Aged, 80 and over; Corpus Striatum; Dihydroxyphenylalanine; Dopamine; Humans; Kinetics; Lewy Body Disease; Middle Aged; Tomography, Emission-Computed | 2000 |
Disturbed functional brain interactions underlying deficient tactile object discrimination in Parkinson's disease.
Topics: Adult; Aged; Brain; Brain Mapping; Caudate Nucleus; Cerebrovascular Circulation; Dihydroxyphenylalanine; Discrimination, Psychological; Female; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Oxygen Radioisotopes; Parkinson Disease; Radiopharmaceuticals; Reference Values; Regional Blood Flow; Tomography, Emission-Computed; Touch | 2000 |
FDG- and Dopa-PET in postencephalitic parkinsonism.
Topics: Aged; Diagnosis, Differential; Dihydroxyphenylalanine; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Parkinson Disease; Parkinson Disease, Postencephalitic; Radiopharmaceuticals; Reference Values; Tomography, Emission-Computed | 2000 |
Welding-related parkinsonism: clinical features, treatment, and pathophysiology.
Topics: Adult; Age of Onset; Aged; Case-Control Studies; Dihydroxyphenylalanine; Female; Humans; Male; Manganese; Middle Aged; Neostriatum; Occupational Diseases; Occupational Exposure; Parkinson Disease; Risk Factors; Tomography, Emission-Computed; Welding | 2001 |
Decreased presynaptic dopamine function in the left caudate of depressed patients with affective flattening and psychomotor retardation.
Topics: Adult; Caudate Nucleus; Depressive Disorder; Dihydroxyphenylalanine; Dopamine; Female; Functional Laterality; Humans; Male; Middle Aged; Presynaptic Terminals; Psychiatric Status Rating Scales; Radionuclide Imaging; Severity of Illness Index | 2001 |
Detection of response to COMT inhibition in FDOPA PET in advanced Parkinson's disease requires prolonged imaging.
Topics: Aged; Antiparkinson Agents; Brain; Catechol O-Methyltransferase; Catechols; Dihydroxyphenylalanine; Female; Humans; Levodopa; Male; Middle Aged; Movement; Nitriles; Parkinson Disease; Time Factors; Tomography, Emission-Computed | 2001 |
Role of the dopaminergic system in chronic pain -- a fluorodopa-PET study.
Topics: Adult; Aged; Burning Mouth Syndrome; Chronic Disease; Dihydroxyphenylalanine; Female; Humans; Middle Aged; Neostriatum; Pain; Tomography, Emission-Computed | 2001 |
Quantitative PET studies in pretreated melanoma patients: a comparison of 6-[18F]fluoro-L-dopa with 18F-FDG and (15)O-water using compartment and noncompartment analysis.
Topics: Dihydroxyphenylalanine; Fluorodeoxyglucose F18; Humans; Melanoma; Models, Theoretical; Oxygen Radioisotopes; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 2001 |
Combined 18F-FDG-FDOPA tumor imaging for assessing response to therapy.
Topics: Dihydroxyphenylalanine; Fluorodeoxyglucose F18; Humans; Melanoma; Neoplasms; Radiopharmaceuticals; Tomography, Emission-Computed | 2001 |
Intrauterine growth restriction induces up-regulation of cerebral aromatic amino acid decarboxylase activity in newborn piglets: [18F]fluorodopa positron emission tomographis study.
Topics: Animals; Animals, Newborn; Aromatic-L-Amino-Acid Decarboxylases; Body Weight; Brain; Dihydroxyphenylalanine; Dopamine; Fetal Growth Retardation; Organ Size; Swine; Tomography, Emission-Computed; Up-Regulation | 2001 |
[(18)F]FDOPA and [(18)F]CFT are both sensitive PET markers to detect presynaptic dopaminergic hypofunction in early Parkinson's disease.
Topics: Aged; Brain; Caudate Nucleus; Cocaine; Dihydroxyphenylalanine; Dopamine; Down-Regulation; Female; Fluorine Radioisotopes; Functional Laterality; Humans; Male; Middle Aged; Parkinson Disease; Positron-Emission Tomography; Predictive Value of Tests; Presynaptic Terminals; Putamen; Synaptic Transmission | 2001 |
A reversible tracer analysis approach to the study of effective dopamine turnover.
Topics: Animals; Brain; Dihydroxyphenylalanine; Dopamine; Fluorine Radioisotopes; Macaca fascicularis; Models, Biological | 2001 |
Normalization of markers for dopamine innervation in striatum of MPTP-lesioned miniature pigs with intrastriatal grafts.
Topics: Animals; Antineoplastic Agents; Dihydroxyphenylalanine; Dopamine; Graft Survival; Isoquinolines; Parkinsonian Disorders; Receptors, Dopamine; Regional Blood Flow; Swine; Tomography, Emission-Computed; Visual Cortex | 2001 |
Increased pineal Fdopa uptake is related to severity of Parkinson's disease--a PET study.
Topics: Adult; Aromatic-L-Amino-Acid Decarboxylases; Biological Transport, Active; Case-Control Studies; Dihydroxyphenylalanine; Female; Fluorine Radioisotopes; Humans; Magnetic Resonance Imaging; Male; Melatonin; Middle Aged; Parkinson Disease; Pineal Gland; Tomography, Emission-Computed | 2001 |
A comparison of (18)F-dopa PET and inversion recovery MRI in the diagnosis of Parkinson's disease.
Topics: Brain; Dihydroxyphenylalanine; Humans; Magnetic Resonance Imaging; Middle Aged; Parkinson Disease; Tomography, Emission-Computed | 2001 |
Increased frontal [(18)F]fluorodopa uptake in early Parkinson's disease: sex differences in the prefrontal cortex.
Topics: Aged; Dihydroxyphenylalanine; Disease Progression; Dopamine; Female; Functional Laterality; Humans; Male; Middle Aged; Neostriatum; Neurons; Parkinson Disease; Prefrontal Cortex; Sex Characteristics | 2001 |
Loss of metabolites from monkey striatum during PET with FDOPA.
Topics: Animals; Blood-Brain Barrier; Denervation; Dihydroxyphenylalanine; Dopa Decarboxylase; Dopamine; Fluorine Radioisotopes; Macaca mulatta; Neostriatum; Parkinsonian Disorders; Tomography, Emission-Computed | 2001 |
Acute neuroleptic stimulates DOPA decarboxylase in porcine brain in vivo.
Topics: Animals; Antipsychotic Agents; Dihydroxyphenylalanine; Dopa Decarboxylase; Dopamine; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Drug Administration Schedule; Female; Haloperidol; Neostriatum; Neurons; Parkinson Disease; Pharmacokinetics; Receptors, Dopamine D2; Swine; Tomography, Emission-Computed | 2001 |
Anatomic and biochemical correlates of the dopamine transporter ligand 11C-PE2I in normal and parkinsonian primates: comparison with 6-[18F]fluoro-L-dopa.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Brain; Brain Chemistry; Carbon Radioisotopes; Carrier Proteins; Caudate Nucleus; Cerebellum; Corpus Striatum; Dihydroxyphenylalanine; Dopamine Plasma Membrane Transport Proteins; Fluorine Radioisotopes; Kinetics; Ligands; Membrane Glycoproteins; Membrane Transport Proteins; Nerve Tissue Proteins; Nortropanes; Papio; Parkinson Disease, Secondary; Putamen; Reserpine; Substantia Nigra; Tomography, Emission-Computed; Tyrosine 3-Monooxygenase | 2001 |
Disturbed neural circuits in a subtype of chronic catatonic schizophrenia demonstrated by F-18-FDG-PET and F-18-DOPA-PET.
Topics: Adult; Brain; Chronic Disease; Dihydroxyphenylalanine; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glucose; Humans; Neural Pathways; Radiopharmaceuticals; Schizophrenia, Catatonic; Speech; Tomography, Emission-Computed | 2001 |
Rate of progression in Parkinson's disease: a 6-[18F]fluoro-L-dopa PET study.
Topics: Adult; Aged; Caudate Nucleus; Dihydroxyphenylalanine; Disease Progression; Female; Follow-Up Studies; Humans; Male; Middle Aged; Parkinson Disease; Putamen; Tomography, Emission-Computed | 2001 |
Positron emission tomography shows that impaired frontal lobe functioning in Parkinson's disease is related to dopaminergic hypofunction in the caudate nucleus.
Topics: Adult; Caudate Nucleus; Cognition; Dihydroxyphenylalanine; Dopamine; Female; Fluorine Radioisotopes; Frontal Lobe; Humans; Male; Middle Aged; Parkinson Disease; Tomography, Emission-Computed | 2001 |
Functional decline in Parkinson disease.
Topics: Adolescent; Adult; Age of Onset; Aged; Aged, 80 and over; Autonomic Nervous System Diseases; Demography; Dihydroxyphenylalanine; Disease Progression; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Middle Aged; Multiple System Atrophy; Multivariate Analysis; Neurologic Examination; Parkinson Disease; Radiopharmaceuticals; Time Factors | 2001 |
FDOPA metabolism in the adult porcine brain: influence of tracer circulation time and VOI selection on estimates of striatal DOPA decarboxylation.
Topics: Animals; Blood-Brain Barrier; Brain; Corpus Striatum; Decarboxylation; Dihydroxyphenylalanine; Female; Fluorine Radioisotopes; Homeostasis; Models, Biological; Models, Neurological; Swine; Swine, Miniature; Time Factors | 2001 |
Fluoro-DOPA and FDG positron emission tomography in a case of pathologically verified pure diffuse Lewy body disease.
Topics: Dihydroxyphenylalanine; Female; Fluorodeoxyglucose F18; Humans; Lewy Body Disease; Magnetic Resonance Imaging; Middle Aged; Radiopharmaceuticals; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2001 |
Blood-brain barrier and neuronal membrane transport of 6-[18F]fluoro-L-DOPA.
Topics: Animals; Biological Transport; Blood-Brain Barrier; Cell Membrane; Dihydroxyphenylalanine; Fluorine Radioisotopes; Levodopa; Male; Models, Animal; Neurons; Rats; Rats, Sprague-Dawley | 2001 |
Novel observations with FDOPA-PET imaging after early nigrostriatal damage.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Corpus Striatum; Dihydroxyphenylalanine; Disease Models, Animal; Dopamine; Female; Fluorine Radioisotopes; Male; Neural Pathways; Neurotoxins; Parkinsonian Disorders; Saimiri; Substantia Nigra; Tomography, Emission-Computed | 2001 |
Pheochromocytomas: detection with 18F DOPA whole body PET--initial results..
Topics: Adolescent; Adrenal Gland Neoplasms; Adult; Aged; Dihydroxyphenylalanine; Female; Fluorine Radioisotopes; Humans; Male; Middle Aged; Pheochromocytoma; Sensitivity and Specificity; Tomography, Emission-Computed; Whole-Body Counting | 2002 |
Increase in dopamine turnover occurs early in Parkinson's disease: evidence from a new modeling approach to PET 18 F-fluorodopa data.
Topics: Aged; Brain; Dihydroxyphenylalanine; Discriminant Analysis; Dopamine; Female; Fluorine Radioisotopes; Humans; Male; Middle Aged; Models, Biological; Parkinson Disease; Tomography, Emission-Computed | 2002 |
Reduced prefrontal activity predicts exaggerated striatal dopaminergic function in schizophrenia.
Topics: Cerebrovascular Circulation; Corpus Striatum; Dihydroxyphenylalanine; Dopamine; Fluorine Radioisotopes; Humans; Neuropsychological Tests; Prefrontal Cortex; Schizophrenia; Statistics as Topic; Synapses; Tomography, Emission-Computed | 2002 |
Simultaneous intrastriatal and intranigral fetal dopaminergic grafts in patients with Parkinson disease: a pilot study. Report of three cases.
Topics: Cells, Cultured; Dihydroxyphenylalanine; Dominance, Cerebral; Dopamine; Feasibility Studies; Female; Fetal Tissue Transplantation; Follow-Up Studies; Humans; Male; Mesencephalon; Middle Aged; Neurologic Examination; Neurons; Parkinson Disease; Pilot Projects; Putamen; Stereotaxic Techniques; Substantia Nigra; Tomography, Emission-Computed | 2002 |
The striatal dopaminergic deficit is dependent on the number of mutant alleles in a family with mutations in the parkin gene: evidence for enzymatic parkin function in humans.
Topics: Adult; Alleles; Corpus Striatum; Dihydroxyphenylalanine; Dopamine; Humans; Ligases; Middle Aged; Mutation; Parkinson Disease; Pedigree; Tomography, Emission-Computed; Ubiquitin-Protein Ligases | 2002 |
Effect of hypoxia/hypercapnia on metabolism of 6-[(18)F]fluoro-L-DOPA in newborn piglets.
Topics: Animals; Animals, Newborn; Aromatic-L-Amino-Acid Decarboxylases; Asphyxia Neonatorum; Brain; Cardiovascular Physiological Phenomena; Cerebrovascular Circulation; Dihydroxyphenylalanine; Dopamine; Energy Metabolism; Humans; Hypercapnia; Hypoxia-Ischemia, Brain; Infant, Newborn; Lactic Acid; Male; Metabolic Clearance Rate; Oxygen; Oxygen Consumption; Swine; Tomography, Emission-Computed | 2002 |
Effect of tetrabenazine on the striatal uptake of exogenous L-DOPA in vivo: a PET study in young and aged rhesus monkeys.
Topics: Adrenergic Uptake Inhibitors; Aging; Animals; Aromatic-L-Amino-Acid Decarboxylases; Dihydroxyphenylalanine; Dopamine Agents; Image Processing, Computer-Assisted; Levodopa; Macaca mulatta; Magnetic Resonance Imaging; Male; Membrane Glycoproteins; Membrane Transport Proteins; Neostriatum; Neuropeptides; Tetrabenazine; Tomography, Emission-Computed; Vesicular Biogenic Amine Transport Proteins; Vesicular Monoamine Transport Proteins | 2002 |
PET study of [(18)F]6-fluoro-L-dopa uptake in neuroleptic- and mood-stabilizer-naive first-episode nonpsychotic mania: effects of treatment with divalproex sodium.
Topics: Adult; Age Factors; Anticonvulsants; Antipsychotic Agents; Bipolar Disorder; Corpus Striatum; Dihydroxyphenylalanine; Dopamine; Female; Fluorine Radioisotopes; Humans; Male; Middle Aged; Tomography, Emission-Computed; Valproic Acid | 2002 |
Aspects of 6-[18F]fluoro-L-DOPA preparation: precursor synthesis, preparative HPLC purification and determination of radiochemical purity.
Topics: Chromatography, High Pressure Liquid; Dihydroxyphenylalanine; Models, Chemical; Quality Control; Radiopharmaceuticals; Sensitivity and Specificity | 2002 |
Monosymptomatic resting tremor and Parkinson's disease: a multitracer positron emission tomographic study.
Topics: Adult; Aged; Brain; Cerebellum; Dihydroxyphenylalanine; Dominance, Cerebral; Energy Metabolism; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neurologic Examination; Parkinson Disease; Putamen; Raclopride; Receptors, Dopamine D2; Reference Values; Tomography, Emission-Computed; Tremor; Up-Regulation | 2002 |
[18F]-Dopa positron emission tomography imaging in early-stage, non-parkin juvenile parkinsonism.
Topics: Adolescent; Caudate Nucleus; Corpus Striatum; Dihydroxyphenylalanine; DNA Mutational Analysis; Dominance, Cerebral; Gene Expression; Humans; Image Processing, Computer-Assisted; Imaging, Three-Dimensional; Ligases; Male; Neurologic Examination; Parkinsonian Disorders; Putamen; Tomography, Emission-Computed; Ubiquitin-Protein Ligases | 2002 |
Sex differences in striatal presynaptic dopamine synthesis capacity in healthy subjects.
Topics: Adult; Age Factors; Corpus Striatum; Dihydroxyphenylalanine; Dopamine; Female; Humans; Male; Middle Aged; Presynaptic Terminals; Sex Factors; Tomography, Emission-Computed | 2002 |
99mTc-TRODAT-1 SPECT in healthy and 6-OHDA lesioned parkinsonian monkeys: comparison with 18F-FDOPA PET.
Topics: Animals; Corpus Striatum; Dihydroxyphenylalanine; Macaca; Metabolic Clearance Rate; Models, Animal; Organotechnetium Compounds; Oxidopamine; Parkinsonian Disorders; Radiopharmaceuticals; Reference Values; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon; Tropanes | 2003 |
[Synthesis and determination for enantiomeric purity of 6-fluoro-L-DOPA].
Topics: Dihydroxyphenylalanine; Fluorine Radioisotopes; Stereoisomerism | 2001 |
Quantitative [18F]fluorodopa/PET and histology of fetal mesencephalic dopaminergic grafts to the striatum of MPTP-poisoned minipigs.
Topics: Animals; Behavior, Animal; Brain Tissue Transplantation; Cell Line; Corpus Striatum; Dihydroxyphenylalanine; Dopamine; Fluorine Radioisotopes; Glial Cell Line-Derived Neurotrophic Factor; Graft Survival; Male; Mesencephalon; MPTP Poisoning; Nerve Growth Factors; Neurons; Rats; Swine, Miniature; Tomography, Emission-Computed; Transplantation, Heterologous | 2002 |
Effect of dopamine loss and the metabolite 3-O-methyl-[18F]fluoro-dopa on the relation between the 18F-fluorodopa tissue input uptake rate constant Kocc and the [18F]fluorodopa plasma input uptake rate constant Ki.
Topics: Adult; Aged; Dihydroxyphenylalanine; Dopamine; Female; Fluorine Radioisotopes; Humans; Male; Middle Aged; Parkinson Disease; Reference Values; Severity of Illness Index | 2003 |
Neurotransmitter specificity of sympathetic denervation in Parkinson's disease.
Topics: Acetylcholine; Autonomic Fibers, Postganglionic; Cholinergic Fibers; Dihydroxyphenylalanine; Fluorine Radioisotopes; Heart Ventricles; Hemodynamics; Humans; Hypohidrosis; Hypotension, Orthostatic; Norepinephrine; Parkinson Disease; Radiopharmaceuticals; Sympathectomy; Tomography, Emission-Computed; Valsalva Maneuver | 2003 |
Young-onset Parkinson disease with and without parkin gene mutations: a fluorodopa F 18 positron emission tomography study.
Topics: Adolescent; Adult; Age of Onset; Aged; Corpus Striatum; Dihydroxyphenylalanine; Female; Fluorine Radioisotopes; Humans; Ligases; Male; Middle Aged; Parkinson Disease; Severity of Illness Index; Substantia Nigra; Tomography, Emission-Computed; Ubiquitin-Protein Ligases | 2003 |
Correlation of dopamine transporter imaging with parkinsonian motor handicap: how close is it?
Topics: Activities of Daily Living; Aged; Brain; Cocaine; Corpus Striatum; Diagnosis, Differential; Dihydroxyphenylalanine; Dominance, Cerebral; Dopamine Plasma Membrane Transport Proteins; Female; Fluorine Radioisotopes; Humans; Iodine Radioisotopes; Male; Membrane Glycoproteins; Membrane Transport Proteins; Middle Aged; Nerve Tissue Proteins; Neural Pathways; Neurologic Examination; Parkinson Disease; Sensitivity and Specificity; Substantia Nigra; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 2003 |
Dopamine transporter imaging and SPECT in diagnostic work-up of Parkinson's disease: a decision-analytic approach.
Topics: Ambulatory Care Facilities; Brain; Cost-Benefit Analysis; Decision Trees; Dihydroxyphenylalanine; Dopamine Plasma Membrane Transport Proteins; Germany; Health Care Costs; Humans; Membrane Glycoproteins; Membrane Transport Proteins; National Health Programs; Nerve Tissue Proteins; Neurologic Examination; Parkinson Disease; Prospective Payment System; Referral and Consultation; Tomography, Emission-Computed, Single-Photon | 2003 |
TCH346 prevents motor symptoms and loss of striatal FDOPA uptake in bilaterally MPTP-treated primates.
Topics: Animals; Corpus Striatum; Dihydroxyphenylalanine; Macaca mulatta; Male; Motor Skills Disorders; MPTP Poisoning; Pargyline; Propylamines | 2003 |
Altered dopamine D2 receptor binding in atypical facial pain.
Topics: Aged; Benzazepines; Benzofurans; Carbon Radioisotopes; Dihydroxyphenylalanine; Dopamine Antagonists; Facial Pain; Humans; Middle Aged; Putamen; Raclopride; Receptors, Dopamine D1; Receptors, Dopamine D2; Tomography, Emission-Computed | 2003 |
Uptake of 6-[18F]fluoro-L-dopa and [18F]CFT reflect nigral neuronal loss in a rat model of Parkinson's disease.
Topics: Amphetamine; Animals; Apomorphine; Autoradiography; Behavior, Animal; Brain; Brain Mapping; Central Nervous System Stimulants; Dihydroxyphenylalanine; Disease Models, Animal; Dopamine Agonists; Functional Laterality; Immunohistochemistry; Levodopa; Male; Oxidopamine; Parkinson Disease; Propionates; Radioligand Assay; Rats; Rats, Sprague-Dawley; Stereotyped Behavior; Substantia Nigra; Sympatholytics; Tyrosine 3-Monooxygenase | 2004 |
Complete dopamine D2 receptor occupancy without extrapyramidal side effects under benperidol.
Topics: Adult; Basal Ganglia; Benperidol; Carbon Radioisotopes; Clozapine; Dihydroxyphenylalanine; Dyskinesia, Drug-Induced; Fluorine Radioisotopes; Humans; Male; Raclopride; Receptors, Dopamine D2; Schizophrenia; Tomography, Emission-Computed; Treatment Outcome; Ultrasonography | 2004 |
Presynaptic dopaminergic dysfunction in schizophrenia: a positron emission tomographic [18F]fluorodopa study.
Topics: Adult; Case-Control Studies; Cognition; Corpus Striatum; Dihydroxyphenylalanine; Dopamine; Humans; Male; Middle Aged; Receptors, Dopamine; Schizophrenia; Tomography, Emission-Computed; Visual Perception | 2004 |
Time profile of cerebral [18F]6-fluoro-L-DOPA metabolites in nonhuman primate: implications for the kinetics of therapeutic L-DOPA.
Topics: Animals; Dihydroxyphenylalanine; Dopamine Agents; Fluorine Radioisotopes; Levodopa; Macaca nemestrina; Models, Biological; Time Factors | 2004 |
The surgical management of congenital hyperinsulinemic hypoglycemia in infancy.
Topics: ATP-Binding Cassette Transporters; Calcium Channels; Chromosomes, Human, Pair 11; Congenital Hyperinsulinism; Diagnosis, Differential; Dihydroxyphenylalanine; Genes, Recessive; Humans; Hyperplasia; Infant; Infant, Newborn; Islets of Langerhans; Mutation; Pancreatectomy; Potassium Channels; Potassium Channels, Inwardly Rectifying; Radiopharmaceuticals; Receptors, Drug; Sulfonylurea Receptors; Tomography, Emission-Computed | 2004 |
Pharmacological and PET studies in patient's with Parkinson's disease and a short duration-motor response: implications in the pathophysiology of motor complications.
Topics: Adult; Age of Onset; Aged; Apomorphine; Biological Transport; Corpus Striatum; Dihydroxyphenylalanine; Female; Fluorine Radioisotopes; Humans; Male; Middle Aged; Parkinson Disease; Raclopride; Reaction Time; Tomography, Emission-Computed; Tritium | 2004 |
Cardiac uptake-1 inhibition by high circulating norepinephrine levels in patients with pheochromocytoma.
Topics: Adrenal Gland Neoplasms; Adult; Aged; Aged, 80 and over; Binding, Competitive; Dihydroxyphenylalanine; False Negative Reactions; Female; Heart; Humans; Imaging, Three-Dimensional; Liver; Male; Middle Aged; Myocardium; Norepinephrine; Norepinephrine Plasma Membrane Transport Proteins; Pheochromocytoma; Radiopharmaceuticals; Symporters; Tomography, Emission-Computed | 2004 |
Striatal and cortical pre- and postsynaptic dopaminergic dysfunction in sporadic parkin-linked parkinsonism.
Topics: Adult; Age of Onset; Aged; Cerebral Cortex; Corpus Striatum; Dihydroxyphenylalanine; Dopamine; Female; Fluorine Radioisotopes; Humans; Male; Middle Aged; Mutation; Parkinson Disease; Presynaptic Terminals; Receptors, Dopamine D2; Tomography, Emission-Computed; Ubiquitin-Protein Ligases | 2004 |
Effects of fibroblast growth factor and glial-derived neurotrophic factor on akinesia, F-DOPA uptake and dopamine cells in parkinsonian primates.
Topics: Animals; Cell Count; Dihydroxyphenylalanine; Dopamine; Fibroblast Growth Factor 2; Fluorine Radioisotopes; Glial Cell Line-Derived Neurotrophic Factor; Macaca fascicularis; Nerve Growth Factors; Neurons; Neuroprotective Agents; Parkinsonian Disorders; Severity of Illness Index; Tyrosine 3-Monooxygenase | 2002 |
Encapsulated GDNF-producing C2C12 cells for Parkinson's disease: a pre-clinical study in chronic MPTP-treated baboons.
Topics: Animals; Capsules; Dihydroxyphenylalanine; Fluorine Radioisotopes; Genetic Therapy; Glial Cell Line-Derived Neurotrophic Factor; Lateral Ventricles; Magnetic Resonance Imaging; Male; Motor Activity; Nerve Growth Factors; Neuroglia; Neurons; Papio; Parkinsonian Disorders; Recovery of Function; Substantia Nigra; Tomography, Emission-Computed; Tyrosine 3-Monooxygenase | 2004 |
Cognitive- and motor-related regions in Parkinson's disease: FDOPA and FDG PET studies.
Topics: Biological Transport; Brain; Brain Mapping; Cognition; Dihydroxyphenylalanine; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Functional Laterality; Humans; Male; Middle Aged; Motor Activity; Parkinson Disease; Radiopharmaceuticals; Regression Analysis; Tomography, Emission-Computed | 2004 |
Developmental changes in the activities of aromatic amino acid decarboxylase and catechol-O-methyl transferase in the porcine brain: a positron emission tomography study.
Topics: Age Factors; Animals; Animals, Newborn; Aromatic-L-Amino-Acid Decarboxylases; Brain; Catechol O-Methyltransferase; Dihydroxyphenylalanine; Swine; Tomography, Emission-Computed | 2004 |
Catalytic enantioselective synthesis of 18F-fluorinated alpha-amino acids under phase-transfer conditions using (S)-NOBIN.
Topics: 2-Naphthylamine; Animals; Catalysis; Dihydroxyphenylalanine; Fluorine Radioisotopes; Glioma; Isomerism; Isotope Labeling; Metabolic Clearance Rate; Naphthols; Organ Specificity; Phase Transition; Radionuclide Imaging; Radiopharmaceuticals; Rats; Rats, Wistar; Tissue Distribution; Tyrosine | 2004 |
PET evidence for a role of the basal ganglia in patients with ring chromosome 20 epilepsy.
Topics: Adolescent; Adult; Anticonvulsants; Caudate Nucleus; Chromosome Disorders; Chromosomes, Human, Pair 20; Dihydroxyphenylalanine; Dopamine; Drug Resistance; Electroencephalography; Epilepsies, Partial; Epilepsy; Epilepsy, Generalized; Epilepsy, Tonic-Clonic; Fear; Female; Humans; Intellectual Disability; Magnetic Resonance Imaging; Male; Positron-Emission Tomography; Putamen; Radiopharmaceuticals; Ring Chromosomes; Status Epilepticus; Synaptic Transmission | 2004 |
Age-dependent effects of severe traumatic brain injury on cerebral dopaminergic activity in newborn and juvenile pigs.
Topics: Age Factors; Aging; Animals; Animals, Newborn; Aromatic-L-Amino-Acid Decarboxylases; Brain Injuries; Cerebral Cortex; Cerebrovascular Circulation; Dihydroxyphenylalanine; Disease Models, Animal; Dopamine; Energy Metabolism; Female; Glucose; Oxygen Consumption; Positron-Emission Tomography; Sus scrofa; Up-Regulation | 2004 |
The influx of neutral amino acids into the porcine brain during development: a positron emission tomography study.
Topics: Aging; Amino Acids, Neutral; Animals; Animals, Newborn; Blood-Brain Barrier; Brain; Brain Chemistry; Dihydroxyphenylalanine; Down-Regulation; Enzyme Inhibitors; Kinetics; Large Neutral Amino Acid-Transporter 1; Metabolic Clearance Rate; Models, Biological; Nerve Tissue Proteins; Positron-Emission Tomography; Sus scrofa | 2004 |
Changes of dopamine turnover in the progression of Parkinson's disease as measured by positron emission tomography: their relation to disease-compensatory mechanisms.
Topics: Brain; Dihydroxyphenylalanine; Disease Progression; Dopamine; Female; Fluorine Radioisotopes; Humans; Male; Middle Aged; Parkinson Disease; Tomography, Emission-Computed | 2004 |
PET imaging of implanted human retinal pigment epithelial cells in the MPTP-induced primate model of Parkinson's disease.
Topics: Animals; Binding, Competitive; Dihydroxyphenylalanine; Disease Models, Animal; Dopamine; Female; Humans; Macaca fascicularis; Macaca mulatta; Male; Parkinsonian Disorders; Pigment Epithelium of Eye; Putamen; Raclopride; Radioligand Assay; Recovery of Function; Tomography, Emission-Computed; Treatment Outcome; Up-Regulation | 2004 |
Visualization of the gall bladder on F-18 FDOPA PET imaging: a potential pitfall.
Topics: Artifacts; Diagnosis, Differential; Diagnostic Errors; Dihydroxyphenylalanine; Gallbladder; Humans; Liver Neoplasms; Male; Middle Aged; Pheochromocytoma; Positron-Emission Tomography; Radiopharmaceuticals; Tissue Distribution | 2005 |
Prevalence of parkinsonism and relationship to exposure in a large sample of Alabama welders.
Topics: Adult; Age of Onset; Aged; Alabama; Dihydroxyphenylalanine; Female; Humans; Male; Middle Aged; Occupational Diseases; Occupational Exposure; Parkinson Disease; Positron-Emission Tomography; Prevalence; Psychomotor Performance; Radiopharmaceuticals; Severity of Illness Index; Videotape Recording; Welding | 2005 |
Dopamine overload visualized in the basal ganglia of rabbit brain during heatstroke can be suppressed by hypothermia.
Topics: Animals; Basal Ganglia; Blood Pressure; Body Temperature; Cerebellum; Dihydroxyphenylalanine; Disease Models, Animal; Dopamine; Heat Stroke; Hypotension; Hypothermia, Induced; Male; Positron-Emission Tomography; Rabbits | 2005 |
PET studies of net blood-brain clearance of FDOPA to human brain: age-dependent decline of [18F]fluorodopamine storage capacity.
Topics: Adult; Aging; Brain; Diffusion; Dihydroxyphenylalanine; Fluorine Radioisotopes; Humans; Middle Aged; Positron-Emission Tomography | 2005 |
Clinical and positron emission tomography of Parkinson's disease caused by LRRK2.
Topics: Aged; Amino Acid Sequence; Animals; Dihydroxyphenylalanine; DNA Mutational Analysis; Family Health; Female; Genetic Predisposition to Disease; Genotype; Glycine; Humans; Leucine-Rich Repeat Serine-Threonine Protein Kinase-2; Male; Mutation; Parkinson Disease; Pedigree; Positron-Emission Tomography; Protein Serine-Threonine Kinases; Serine | 2005 |
Nonlinear progression of Parkinson disease as determined by serial positron emission tomographic imaging of striatal fluorodopa F 18 activity.
Topics: Adult; Aged; Cohort Studies; Corpus Striatum; Dihydroxyphenylalanine; Disease Progression; Female; Fluorine Radioisotopes; Follow-Up Studies; Humans; Longitudinal Studies; Male; Middle Aged; Nonlinear Dynamics; Parkinson Disease; Positron-Emission Tomography; Severity of Illness Index; Statistics, Nonparametric | 2005 |
Visualisation of impaired dopamine biosynthesis in a case of aromatic L-amino acid decarboxylase deficiency by co-registered 18F-FDOPA PET and magnetic resonance imaging.
Topics: Aromatic-L-Amino-Acid Decarboxylases; Brain; Brain Diseases, Metabolic, Inborn; Dihydroxyphenylalanine; Dopamine; Female; Humans; Infant; Magnetic Resonance Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Subtraction Technique | 2005 |
Genetic linkage of autosomal dominant progressive supranuclear palsy to 1q31.1.
Topics: Aged; Brain Chemistry; Caudate Nucleus; Chromosomes, Human, Pair 1; Dihydroxyphenylalanine; DNA; Female; Genetic Linkage; Glucose; Humans; Lod Score; Male; Middle Aged; Pedigree; Phenotype; Positron-Emission Tomography; Putamen; Radiopharmaceuticals; Supranuclear Palsy, Progressive | 2005 |
F-18 FDG and F-18 FDOPA PET brain imaging in subacute sclerosing panencephalitis.
Topics: Adult; Brain; Dihydroxyphenylalanine; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Positron-Emission Tomography; Radiopharmaceuticals; Severity of Illness Index; Subacute Sclerosing Panencephalitis | 2005 |
Carcinoid crisis after injection of 6-18F-fluorodihydroxyphenylalanine in a patient with metastatic carcinoid.
Topics: Dihydroxyphenylalanine; Female; Gastrointestinal Neoplasms; Humans; Injections, Intravenous; Liver Neoplasms; Malignant Carcinoid Syndrome; Middle Aged; Octreotide; Radionuclide Imaging; Radiopharmaceuticals | 2005 |
Alteration of striatal [11C]raclopride and 6-[18F]fluoro-L-3,4-dihydroxyphenylalanine uptake precedes development of methamphetamine-induced rotation following unilateral 6-hydroxydopamine lesions of medial forebrain bundle in rats.
Topics: Animals; Biological Transport; Carbon Radioisotopes; Dihydroxyphenylalanine; Fluorine Radioisotopes; Functional Laterality; Methamphetamine; Motor Activity; Oxidopamine; Prosencephalon; Raclopride; Radionuclide Imaging; Rats; Rotation; Tissue Distribution | 2005 |
Lateralisation of striatal function: evidence from 18F-dopa PET in Parkinson's disease.
Topics: Aged; Dihydroxyphenylalanine; Female; Functional Laterality; Glucose; Humans; Male; Middle Aged; Parkinson Disease; Positron-Emission Tomography; Receptors, Dopamine; Task Performance and Analysis; Visual Cortex | 2005 |
A new mutation of the tau gene, G303V, in early-onset familial progressive supranuclear palsy.
Topics: Amino Acid Substitution; Blotting, Northern; Blotting, Western; Brain; Dihydroxyphenylalanine; DNA Mutational Analysis; Family Health; Female; Genetic Predisposition to Disease; Glycine; Humans; Immunohistochemistry; Middle Aged; Mutation; Neurologic Examination; Positron-Emission Tomography; Protein Isoforms; Raclopride; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Supranuclear Palsy, Progressive; tau Proteins; Valine | 2005 |
Fluorodopa F 18 positron emission tomography and the progression of Parkinson disease.
Topics: Corpus Striatum; Dihydroxyphenylalanine; Disease Progression; Humans; Linear Models; Parkinson Disease; Positron-Emission Tomography; Tomography, Emission-Computed | 2005 |
The role of radiotracer imaging in Parkinson disease.
Topics: Brain; Dihydroxyphenylalanine; Disease Progression; Dopamine; Parkinson Disease; Patient Selection; Positron-Emission Tomography; Predictive Value of Tests; Tomography, Emission-Computed, Single-Photon | 2005 |
Corticostriatal covariance patterns of 6-[18F]fluoro-L-dopa and [18F]fluorodeoxyglucose PET in Parkinson's disease.
Topics: Aged; Cerebral Cortex; Corpus Striatum; Diagnosis, Differential; Dihydroxyphenylalanine; Female; Fluorodeoxyglucose F18; Functional Laterality; Humans; Male; Middle Aged; Parkinson Disease; Positron-Emission Tomography; Sex Factors | 2006 |
Fluorine-18 DOPA PET imaging of paraganglioma syndrome.
Topics: Abdominal Neoplasms; Child; Dihydroxyphenylalanine; Head and Neck Neoplasms; Humans; Male; Paraganglioma; Positron-Emission Tomography; Radiopharmaceuticals; Succinate Dehydrogenase; Syndrome | 2006 |
Modulation of [18F]fluorodopa (FDOPA) kinetics in the brain of healthy volunteers after acute haloperidol challenge.
Topics: Adult; Attention; Blood-Brain Barrier; Brain; Corpus Striatum; Dihydroxyphenylalanine; Dominance, Cerebral; Fluorine Radioisotopes; Haloperidol; Humans; Image Processing, Computer-Assisted; Male; Mesencephalon; Middle Aged; Neuropsychological Tests; Pattern Recognition, Visual; Positron-Emission Tomography; Prefrontal Cortex; Psychomotor Performance | 2006 |
Age-related differences in levodopa dynamics in Parkinson's: implications for motor complications.
Topics: Adult; Age Factors; Age of Onset; Aged; Antiparkinson Agents; Dihydroxyphenylalanine; Dopamine Agents; Dyskinesia, Drug-Induced; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Tomography, Emission-Computed | 2006 |
[18F]FDOPA PET as an endophenotype for Parkinson's Disease linkage studies.
Topics: Adult; Aged; Aged, 80 and over; Consanguinity; Dihydroxyphenylalanine; Ethnicity; Family Health; Female; Fluorine Radioisotopes; Genetic Linkage; Genetic Predisposition to Disease; Genotype; Humans; Lod Score; Male; Middle Aged; Parkinson Disease; Pedigree; Phenotype; Positron-Emission Tomography | 2006 |
Striatal subregional 6-[18F]fluoro-L-dopa uptake in early Parkinson's disease: a two-year follow-up study.
Topics: Aged; Corpus Striatum; Dihydroxyphenylalanine; Disease Progression; Dominance, Cerebral; Female; Fluorine Radioisotopes; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Parkinson Disease; Positron-Emission Tomography; Putamen; Reference Values | 2006 |
Bilateral adrenal metastases from malignant melanoma: concordant findings on (18)F-FDG and (18)F-FDOPA PET.
Topics: Adrenal Gland Neoplasms; Dihydroxyphenylalanine; Fluorodeoxyglucose F18; Humans; Male; Melanoma; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Skin Neoplasms | 2006 |
Striatal dopa and glucose metabolism in PD patients with freezing of gait.
Topics: Blood Glucose; Brain Mapping; Corpus Striatum; Dihydroxyphenylalanine; Dominance, Cerebral; Female; Fluorodeoxyglucose F18; Gait Apraxia; Humans; Male; Neurologic Examination; Occipital Lobe; Parietal Lobe; Parkinson Disease; Positron-Emission Tomography; Putamen | 2006 |
Long-term 24-hour duodenal infusion of levodopa: outcome and dose requirements.
Topics: Animals; Antiparkinson Agents; Cocaine; Dihydroxyphenylalanine; Dopamine Agents; Dose-Response Relationship, Drug; Drug Administration Routes; Drug Administration Schedule; Duodenum; Humans; Indoles; Infusion Pumps; Levodopa; Parkinson Disease; Positron-Emission Tomography; Radiopharmaceuticals; Treatment Outcome | 2006 |
Attenuation of cocaine and methamphetamine neurotoxicity by coenzyme Q10.
Topics: alpha-Synuclein; Animals; Central Nervous System Stimulants; Cocaine; Coenzymes; Corpus Striatum; Dihydroxyphenylalanine; Dopamine; Electron Transport Complex I; Immunoblotting; Lipid Peroxidation; Male; Methamphetamine; Mice; Mice, Inbred C57BL; Microdialysis; Reactive Oxygen Species; Tyrosine 3-Monooxygenase; Ubiquinone | 2006 |
More to movement disorders than motion.
Topics: Basal Ganglia; Deep Brain Stimulation; Dihydroxyphenylalanine; Humans; Mental Disorders; Movement Disorders; Parkinson Disease; Positron-Emission Tomography | 2006 |
Comparative assessment of statistical brain MR image segmentation algorithms and their impact on partial volume correction in PET.
Topics: Algorithms; Brain; Brain Mapping; Data Interpretation, Statistical; Dihydroxyphenylalanine; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Phantoms, Imaging; Positron-Emission Tomography; Radiopharmaceuticals | 2006 |
Comparison of [18F]FDOPA, [18F]FMT and [18F]FECNT for imaging dopaminergic neurotransmission in mice.
Topics: Animals; Corpus Striatum; Dihydroxyphenylalanine; Dopamine; Male; Mice; Mice, Inbred C57BL; Neurotransmitter Agents; Nortropanes; Parkinson Disease; Parkinsonian Disorders; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Substantia Nigra; Synaptic Transmission; Tyrosine | 2006 |
Net influx of plasma 6-[18F]fluoro-L-DOPA (FDOPA) to the ventral striatum correlates with prefrontal processing of affective stimuli.
Topics: Adult; Affect; Caudate Nucleus; Corpus Striatum; Dihydroxyphenylalanine; Dopamine; Fluorine Radioisotopes; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Photic Stimulation; Positron-Emission Tomography; Prefrontal Cortex; Putamen; Radiopharmaceuticals; Synaptic Transmission | 2006 |
Characterization of dopaminergic dysfunction in familial progressive supranuclear palsy: an 18F-dopa PET study.
Topics: Aged; Amygdala; Cerebral Cortex; Corpus Striatum; Dihydroxyphenylalanine; Disease Progression; Dopamine; Down-Regulation; Female; Genetic Predisposition to Disease; Humans; Limbic System; Male; Neurocognitive Disorders; Pedigree; Positron-Emission Tomography; Predictive Value of Tests; Reference Values; Supranuclear Palsy, Progressive | 2007 |
Changes in dopamine D2 receptors and 6-[18F]fluoro-L-3,4-dihydroxyphenylalanine uptake in the brain of 6-hydroxydopamine-lesioned rats.
Topics: Animals; Benzazepines; Brain; Cerebellum; Cerebral Cortex; Dihydroxyphenylalanine; Dopamine Antagonists; Ligands; Male; Neostriatum; Oxidopamine; Raclopride; Rats; Rats, Wistar; Receptors, Dopamine D1; Receptors, Dopamine D2; Sympathectomy, Chemical; Sympatholytics; Tissue Distribution | 2004 |
18F-DOPA PET/CT and neuroendocrine tumours.
Topics: Dihydroxyphenylalanine; Fluorodeoxyglucose F18; Humans; Neuroendocrine Tumors; Positron-Emission Tomography; Practice Guidelines as Topic; Practice Patterns, Physicians'; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Tomography, X-Ray Computed | 2006 |
Staging of carcinoid tumours with 18F-DOPA PET: a prospective, diagnostic accuracy study.
Topics: Adult; Aged; Carcinoid Tumor; Dihydroxyphenylalanine; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasms; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Receptors, Somatostatin; Reproducibility of Results; Somatostatin; Tomography, X-Ray Computed | 2006 |
Can fluorodihydroxyphenylalanine PET replace somatostatin receptor scintigraphy in patients with digestive endocrine tumors?
Topics: Adult; Aged; Carcinoid Tumor; Digestive System Neoplasms; Dihydroxyphenylalanine; Endocrine Gland Neoplasms; Female; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Receptors, Somatostatin; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Somatostatin | 2006 |
Safety of 18F-DOPA injection for PET of carcinoid tumor.
Topics: Carcinoid Tumor; Dihydroxyphenylalanine; Fluorine Radioisotopes; Humans; Injections, Intravenous; Malignant Carcinoid Syndrome; Positron-Emission Tomography; Radiopharmaceuticals | 2006 |
PET with 18F-DOPA in the imaging of parathyroid adenoma in patients with primary hyperparathyroidism. A pilot study.
Topics: Adenoma; Aged; Dihydroxyphenylalanine; Fluorine Radioisotopes; Humans; Hyperparathyroidism; Middle Aged; Parathyroid Neoplasms; Positron-Emission Tomography; Reproducibility of Results; Ultrasonography | 2006 |
'Prefrontal' cognitive performance of healthy subjects positively correlates with cerebral FDOPA influx: an exploratory [18F]-fluoro-L-DOPA-PET investigation.
Topics: Adult; Basal Ganglia; Blood-Brain Barrier; Brain Mapping; Caudate Nucleus; Cognition; Dihydroxyphenylalanine; Dopamine; Functional Laterality; Humans; Male; Mesencephalon; Metabolic Clearance Rate; Middle Aged; Neural Pathways; Neuropsychological Tests; Positron-Emission Tomography; Prefrontal Cortex; Putamen; Reaction Time; Receptors, Dopamine D2; Reference Values; Synaptic Transmission | 2007 |
Regional metabolic changes in parkinsonian patients with normal dopaminergic imaging.
Topics: Brain; Corpus Striatum; Dihydroxyphenylalanine; Dopamine; Female; Ganglia; Humans; Male; Middle Aged; Multiple System Atrophy; Occipital Lobe; Parkinson Disease; Positron-Emission Tomography; Putamen; Retrospective Studies; Spinocerebellar Degenerations; Supranuclear Palsy, Progressive | 2007 |
Imaging the role of dopamine in health and disease Parkinson's disease as a lesion model.
Topics: Antiparkinson Agents; Arousal; Brain; Brain Mapping; Diagnostic Imaging; Dihydroxyphenylalanine; Dopamine; Humans; Levodopa; Movement; Neuropsychological Tests; Parkinson Disease; Positron-Emission Tomography; Regional Blood Flow; Tomography, Emission-Computed, Single-Photon | 2006 |
PET scanning for infants with HHI: a small step for affected infants, a giant leap for the field.
Topics: Congenital Hyperinsulinism; Dihydroxyphenylalanine; Female; Humans; Infant; Infant, Newborn; Male; Positron-Emission Tomography; Prospective Studies; Risk Assessment; Sensitivity and Specificity | 2007 |
Diagnosis and localization of focal congenital hyperinsulinism by 18F-fluorodopa PET scan.
Topics: Confidence Intervals; Congenital Hyperinsulinism; Dihydroxyphenylalanine; Female; Humans; Infant; Infant, Newborn; Injections, Intravenous; Male; Pancreas; Positron-Emission Tomography; Prospective Studies; Risk Assessment; Sensitivity and Specificity; Severity of Illness Index | 2007 |
Diagnostic impact of PET with 18F-FDG, 18F-DOPA and 3-O-methyl-6-[18F]fluoro-DOPA in recurrent or metastatic medullary thyroid carcinoma.
Topics: Adult; Aged; Carcinoma, Medullary; Dihydroxyphenylalanine; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Thyroid Neoplasms | 2007 |
Striatal dopaminergic activity (FDOPA-PET) associated with cognitive items of a depression scale (MADRS) in Parkinson's disease.
Topics: Aged; Brain Chemistry; Caudate Nucleus; Cognition Disorders; Corpus Striatum; Depressive Disorder; Dihydroxyphenylalanine; Disability Evaluation; Dopamine; Female; Humans; Male; Middle Aged; Neuropsychological Tests; Parkinson Disease; Positron-Emission Tomography; Predictive Value of Tests; Putamen; Synaptic Transmission | 2007 |
Neurocirculatory and nigrostriatal abnormalities in Parkinson disease from LRRK2 mutation.
Topics: Arrhythmias, Cardiac; Autonomic Nervous System Diseases; Baroreflex; Dihydroxyphenylalanine; DNA Mutational Analysis; Genetic Predisposition to Disease; Genotype; Heart; Humans; Leucine-Rich Repeat Serine-Threonine Protein Kinase-2; Male; Middle Aged; Myocardium; Neostriatum; Neural Pathways; Parkinson Disease; Positron-Emission Tomography; Protein Serine-Threonine Kinases; Reflex, Abnormal; Substantia Nigra; Valsalva Maneuver | 2007 |
Elevated [18F]fluorodopamine turnover in brain of patients with schizophrenia: an [18F]fluorodopa/positron emission tomography study.
Topics: Adult; Brain; Dihydroxyphenylalanine; Fluorine Radioisotopes; Humans; Male; Positron-Emission Tomography; Schizophrenia | 2007 |
The added value of [18F]fluoro-L-DOPA PET in the diagnosis of hyperinsulinism of infancy: a retrospective study involving 49 children.
Topics: Congenital Hyperinsulinism; Dihydroxyphenylalanine; Female; Humans; Infant; Infant, Newborn; Male; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity | 2007 |
Morphometric fingerprint of asymptomatic Parkin and PINK1 mutation carriers in the basal ganglia.
Topics: Adult; Basal Ganglia Diseases; Corpus Striatum; Dihydroxyphenylalanine; DNA Mutational Analysis; Dopamine; Female; Genetic Predisposition to Disease; Genetic Testing; Genotype; Globus Pallidus; Heterozygote; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Mutation; Positron-Emission Tomography; Protein Kinases; Putamen; Ubiquitin-Protein Ligases | 2007 |
18F-FDOPA kinetics in brain tumors.
Topics: Adult; Aged; Brain; Brain Neoplasms; Computer Simulation; Dihydroxyphenylalanine; Female; Humans; Image Interpretation, Computer-Assisted; Kinetics; Male; Metabolic Clearance Rate; Middle Aged; Models, Biological; Radionuclide Imaging; Radiopharmaceuticals | 2007 |
The use of 18-fluoro-dihydroxyphenylalanine and 18-fluorodeoxyglucose positron emission tomography scanning in the assessment of metaiodobenzylguanidine-negative phaeochromocytoma.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Adult; Dihydroxyphenylalanine; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Pheochromocytoma; Positron-Emission Tomography; Radiopharmaceuticals; Whole Body Imaging | 2007 |
Accuracy of [18F]fluorodopa positron emission tomography for diagnosing and localizing focal congenital hyperinsulinism.
Topics: Biopsy; Dihydroxyphenylalanine; Humans; Hyperinsulinism; Image Interpretation, Computer-Assisted; Infant; Infant, Newborn; Islets of Langerhans; Kidney; Multiple Endocrine Neoplasia; Pancreatectomy; Pancreatic Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Sample Size | 2007 |
18F-DOPA PET and PET/CT.
Topics: Brain; Carcinoma, Neuroendocrine; Dihydroxyphenylalanine; Humans; Image Enhancement; Parkinson Disease; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2007 |
Functional imaging of the pancreas: the role of [18F]fluoro-L-DOPA PET in the diagnosis of hyperinsulinism of infancy.
Topics: Child, Preschool; Dihydroxyphenylalanine; Female; Fluorine Radioisotopes; Humans; Hyperinsulinism; Infant; Magnetic Resonance Imaging; Male; Pancreas; Positron-Emission Tomography | 2007 |
A Pulmonary adrenocorticotropin-secreting carcinoid tumor localized by 6-Fluoro-[18F]L-dihydroxyphenylalanine positron emission/computed tomography imaging in a patient with Cushing's syndrome.
Topics: Adolescent; Adrenocorticotropic Hormone; Carcinoid Tumor; Cushing Syndrome; Dihydroxyphenylalanine; Humans; Lung Neoplasms; Male; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2007 |
Evaluation of [18F]fluoro-L-DOPA positron emission tomography-computed tomography for surgery in focal congenital hyperinsulinism.
Topics: Child, Preschool; Congenital Hyperinsulinism; Dihydroxyphenylalanine; Female; Fluorine Radioisotopes; Humans; Infant; Male; Positron-Emission Tomography; Tomography, X-Ray Computed | 2008 |
[Evaluation of dopaminergic presynaptic function by [F-18] DOPA PET].
Topics: Dementia; Dihydroxyphenylalanine; Humans; Parkinson Disease; Positron-Emission Tomography; Presynaptic Terminals | 2007 |
Autosomal dominant dopa-responsive parkinsonism in a multigenerational Swiss family.
Topics: Adult; Aged; Antiparkinson Agents; Brain; Chromosome Disorders; Dihydroxyphenylalanine; DNA Mutational Analysis; Female; Genes, Dominant; Humans; Levodopa; Male; Middle Aged; Mutation; Parkinson Disease; Pedigree; Phenotype; Positron-Emission Tomography; Radiopharmaceuticals | 2008 |
68Ga-DOTA-peptides versus 18F-DOPA PET for the assessment of NET patients.
Topics: Dihydroxyphenylalanine; Humans; Neuroendocrine Tumors; Organometallic Compounds; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2008 |
The role of 18F-FDOPA and 18F-FDG-PET in the management of malignant and multifocal phaeochromocytomas.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Adult; Aged; Dihydroxyphenylalanine; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasms, Multiple Primary; Pheochromocytoma; Positron-Emission Tomography; Retrospective Studies; Tomography, Emission-Computed, Single-Photon | 2008 |
Comparison between 68Ga-DOTA-NOC and 18F-DOPA PET for the detection of gastro-entero-pancreatic and lung neuro-endocrine tumours.
Topics: Aged; Aged, 80 and over; Dihydroxyphenylalanine; Female; Gastrointestinal Neoplasms; Humans; Lung Neoplasms; Male; Middle Aged; Neuroendocrine Tumors; Organometallic Compounds; Pancreatic Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2008 |
Pre- and post-synaptic dopamine imaging and its relation with frontostriatal cognitive function in Parkinson disease: PET studies with [11C]NNC 112 and [18F]FDOPA.
Topics: Attention; Benzazepines; Benzofurans; Brain Mapping; Carbon Radioisotopes; Cognition Disorders; Color Perception; Corpus Striatum; Dihydroxyphenylalanine; Discrimination Learning; Dopamine; Fluorine Radioisotopes; Frontal Lobe; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Mental Status Schedule; Nerve Net; Neuropsychological Tests; Parkinson Disease; Pattern Recognition, Visual; Positron-Emission Tomography; Presynaptic Terminals; Problem Solving; Psychomotor Performance; Receptors, Dopamine D1; Synaptic Membranes | 2008 |
18F-FDOPA PET/MRI fusion in patients with primary/recurrent gliomas: initial experience.
Topics: Adult; Aged; Brain Neoplasms; Dihydroxyphenylalanine; Female; Glioma; Humans; Image Enhancement; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Recurrence, Local; Pilot Projects; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique | 2009 |
Whole body 18fluoro-L-dopa PET-CT: a useful tool for location and surgical guidance in primary carcinoid tumours.
Topics: Adolescent; Dihydroxyphenylalanine; Female; Humans; Neuroendocrine Tumors; Positron-Emission Tomography; Radiopharmaceuticals; Subtraction Technique; Surgery, Computer-Assisted; Tomography, X-Ray Computed | 2008 |
Improvements in small bowel carcinoid diagnosis and staging: 18F-DOPA PET, capsule endoscopy and double balloon enteroscopy.
Topics: Capsule Endoscopy; Carcinoid Tumor; Cone-Beam Computed Tomography; Dihydroxyphenylalanine; Fluorine Radioisotopes; Humans; Image Interpretation, Computer-Assisted; Jejunal Neoplasms; Laparotomy; Liver Neoplasms; Male; Middle Aged; Positron-Emission Tomography | 2009 |
[Sedation of infants with congenital hyperinsulinism during PET CAT scanning. A case collection].
Topics: Blood Glucose; Conscious Sedation; Dihydroxyphenylalanine; Female; Glucose; Homeostasis; Humans; Hyperinsulinism; Hypnotics and Sedatives; Infant; Infusions, Intravenous; Male; Positron-Emission Tomography; Preanesthetic Medication; Propofol; Radiopharmaceuticals; Tomography, X-Ray Computed | 2008 |
Age-related changes in midbrain dopaminergic regulation of the human reward system.
Topics: Adult; Age Factors; Aged; Aging; Dihydroxyphenylalanine; Dopamine; Female; Humans; Magnetic Resonance Imaging; Male; Mesencephalon; Middle Aged; Positron-Emission Tomography; Prefrontal Cortex; Reward | 2008 |
Classification of schizophrenic patients and healthy controls using [18F] fluorodopa PET imaging.
Topics: Adult; Aged; Brain; Control Groups; Corpus Striatum; Dihydroxyphenylalanine; Female; Fluorine Radioisotopes; Humans; Image Interpretation, Computer-Assisted; Male; Middle Aged; Neural Networks, Computer; Positron-Emission Tomography; Schizophrenia, Paranoid; Sensitivity and Specificity | 2008 |
Multimodal functional imaging investigation before and after the onset of psychosis.
Topics: Brain; Diagnostic Imaging; Dihydroxyphenylalanine; Humans; Magnetic Resonance Imaging; Male; Positron-Emission Tomography; Psychiatric Status Rating Scales; Psychotic Disorders; Radiopharmaceuticals; Schizophrenia, Paranoid; Young Adult | 2009 |
Dopamine in amygdala gates limbic processing of aversive stimuli in humans.
Topics: Adult; Affect; Amygdala; Brain Mapping; Dihydroxyphenylalanine; Dopamine; Fluorine Radioisotopes; Gyrus Cinguli; Humans; Image Processing, Computer-Assisted; Limbic System; Magnetic Resonance Imaging; Male; Middle Aged; Oxygen; Positron-Emission Tomography; Psychophysics | 2008 |
Neuroradiologic evidence of pre-synaptic and post-synaptic nigrostriatal dopaminergic dysfunction in idiopathic Basal Ganglia calcification: a case report.
Topics: Adult; Basal Ganglia Diseases; Corpus Striatum; Dihydroxyphenylalanine; Dopamine; Female; Humans; Radionuclide Imaging; Radiopharmaceuticals | 2010 |
Basal ganglia involvement in temporal lobe epilepsy: a functional and morphologic study.
Topics: Basal Ganglia; Basal Ganglia Diseases; Dihydroxyphenylalanine; Epilepsy, Temporal Lobe; Fluorine Radioisotopes; Humans; Radionuclide Imaging; Substantia Nigra | 2008 |
Direct comparison of FP-CIT SPECT and F-DOPA PET in patients with Parkinson's disease and healthy controls.
Topics: Adult; Aged; Brain; Case-Control Studies; Dihydroxyphenylalanine; Dopamine Plasma Membrane Transport Proteins; Female; Humans; Iodine Radioisotopes; Male; Middle Aged; Parkinson Disease; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Sex Characteristics; Tomography, Emission-Computed, Single-Photon; Tropanes | 2009 |
Elevated striatal dopamine function linked to prodromal signs of schizophrenia.
Topics: Adult; Brain Mapping; Cognition Disorders; Corpus Striatum; Diagnostic and Statistical Manual of Mental Disorders; Dihydroxyphenylalanine; Dominance, Cerebral; Dopamine; Female; Humans; Image Processing, Computer-Assisted; Male; Neuropsychological Tests; Positron-Emission Tomography; Psychiatric Status Rating Scales; Reference Values; Risk Factors; Schizophrenia; Schizotypal Personality Disorder; Young Adult | 2009 |
Intraindividual comparison of 68Ga-DOTA-TATE and 18F-DOPA PET in patients with well-differentiated metastatic neuroendocrine tumours.
Topics: Adult; Aged; Dihydroxyphenylalanine; Female; Gallium Radioisotopes; Humans; Male; Middle Aged; Neoplasm Metastasis; Neuroendocrine Tumors; Positron-Emission Tomography; Radiopharmaceuticals; Receptors, Somatostatin; Sensitivity and Specificity; Serotonin | 2009 |
The value of 18F-DOPA PET-CT in patients with medullary thyroid carcinoma: comparison with 18F-FDG PET-CT.
Topics: Dihydroxyphenylalanine; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Thyroid Neoplasms; Tomography, X-Ray Computed | 2009 |
Image in endocrinology. Localization of an adrenocorticotropin-producing pheochromocytoma using 18F-dihydroxyphenylalanine positron emission tomography.
Topics: Adrenal Gland Neoplasms; Adrenocorticotropic Hormone; Aged; Dihydroxyphenylalanine; Humans; Male; Pheochromocytoma; Positron-Emission Tomography | 2009 |
18F-FDOPA PET and PET/CT accurately localize pheochromocytomas.
Topics: Adrenal Gland Neoplasms; Adult; Aged; Dihydroxyphenylalanine; Female; Humans; Image Enhancement; Male; Middle Aged; Pheochromocytoma; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Tomography, X-Ray Computed | 2009 |
New MRI, 18F-DOPA and 11C-(+)-alpha-dihydrotetrabenazine templates for Macaca fascicularis neuroimaging: advantages to improve PET quantification.
Topics: Animals; Brain; Carbon Radioisotopes; Dihydroxyphenylalanine; Image Enhancement; Macaca fascicularis; Magnetic Resonance Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Reference Values; Subtraction Technique; Tetrabenazine | 2009 |
Simple ratio analysis of 18F-fluorodopa uptake in striatal subregions separates patients with early Parkinson disease from healthy controls.
Topics: Aged; Corpus Striatum; Diagnosis, Differential; Dihydroxyphenylalanine; Female; Fluorine Radioisotopes; Humans; Male; Middle Aged; Parkinson Disease; Radionuclide Imaging; ROC Curve | 2009 |
Combining 6-fluoro-[18F]l-dihydroxyphenylalanine and [18F]fluoro-2-deoxy-d-glucose positron emission tomography for distinction of non-carcinoid malignancies in carcinoid patients.
Topics: Adenocarcinoma; Aged; Carcinoid Tumor; Diagnosis, Differential; Dihydroxyphenylalanine; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Rectal Neoplasms; Tomography, X-Ray Computed | 2009 |
6-[F-18]Fluoro-L-dihydroxyphenylalanine positron emission tomography is superior to conventional imaging with (123)I-metaiodobenzylguanidine scintigraphy, computer tomography, and magnetic resonance imaging in localizing tumors causing catecholamine exces
Topics: 3-Iodobenzylguanidine; Adolescent; Adrenal Gland Neoplasms; Adrenal Glands; Adult; Aged; Biomarkers; Catecholamines; Child; Child, Preschool; Dihydroxyphenylalanine; Female; Humans; Hyperplasia; Magnetic Resonance Imaging; Male; Middle Aged; Paraganglioma; Pheochromocytoma; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed; Young Adult | 2009 |
PET imaging of medullary thyroid carcinoma in MEN2A transgenic mice using 6-[(18)F]F-L-DOPA.
Topics: Animals; Carcinoma, Medullary; Dihydroxyphenylalanine; Mice; Mice, Transgenic; Multiple Endocrine Neoplasia Type 2a; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Thyroid Neoplasms | 2010 |
Hypertension increases cerebral 6-18F-fluorodopa-derived radioactivity.
Topics: Aged; Brain; Dihydroxyphenylalanine; Female; Humans; Hypertension; Male; Metabolic Clearance Rate; Middle Aged; Parkinson Disease; Radionuclide Imaging; Radiopharmaceuticals; Tissue Distribution | 2009 |
(68)Ga-somatostatin analogues PET and (18)F-DOPA PET in medullary thyroid carcinoma.
Topics: Carcinoma, Medullary; Dihydroxyphenylalanine; Humans; Neoplasm Recurrence, Local; Organometallic Compounds; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Somatostatin; Thyroid Gland; Thyroid Neoplasms | 2010 |
Value of 18F-fluoro-L-dopa PET in the preoperative localization of focal lesions in congenital hyperinsulinism.
Topics: Congenital Hyperinsulinism; Diagnostic Errors; Dihydroxyphenylalanine; Female; Humans; Image Interpretation, Computer-Assisted; Infant; Infant, Newborn; Male; Positron-Emission Tomography; Radiopharmaceuticals; Recurrence; Retrospective Studies; Sensitivity and Specificity; Statistics, Nonparametric | 2009 |
Three-step, "one-pot" radiosynthesis of 6-fluoro-3,4-dihydroxy-L-phenylalanine by isotopic exchange.
Topics: Amino Acids; Dihydroxyphenylalanine; Fluorine Radioisotopes; Halogenation; Kinetics; Radiochemistry; Stereoisomerism | 2009 |
Nigrostriatal dysfunction in homozygous and heterozygous parkin gene carriers: an 18F-dopa PET progression study.
Topics: Aged; Corpus Striatum; Dihydroxyphenylalanine; Female; Heterozygote; Humans; Longitudinal Studies; Male; Middle Aged; Parkinson Disease; Positron-Emission Tomography; Substantia Nigra; Ubiquitin-Protein Ligases | 2009 |
Animal model of metastatic pheochromocytoma: evaluation by MRI and PET.
Topics: Adrenal Gland Neoplasms; Animals; Dihydroxyphenylalanine; Disease Models, Animal; Dopamine; Female; Fluorine Radioisotopes; Liver Neoplasms, Experimental; Magnetic Resonance Imaging; Mice; Mice, Nude; Ovarian Neoplasms; Pheochromocytoma; Positron-Emission Tomography; Radiopharmaceuticals | 2009 |
Clinical value of 18F-fluorodihydroxyphenylalanine positron emission tomography/computed tomography (18F-DOPA PET/CT) for detecting pheochromocytoma.
Topics: Adolescent; Adult; Aged; Biological Transport; Child; Dihydroxyphenylalanine; Endocrine Gland Neoplasms; Female; Follow-Up Studies; Humans; Male; Middle Aged; Neoplasm Staging; Pheochromocytoma; Positron-Emission Tomography; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed; Young Adult | 2010 |
[Recurrent carcinoid tumor and 18F-DOPA PET].
Topics: Biomarkers, Tumor; Carcinoid Tumor; Colonic Neoplasms; Dihydroxyphenylalanine; Fluorine Radioisotopes; Humans; Liver Neoplasms; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Peritoneal Neoplasms; Positron-Emission Tomography; Predictive Value of Tests; Sensitivity and Specificity | 2010 |
Comparison of 18F-fluoro-L-DOPA, 18F-fluoro-deoxyglucose, and 18F-fluorodopamine PET and 123I-MIBG scintigraphy in the localization of pheochromocytoma and paraganglioma.
Topics: 3-Iodobenzylguanidine; Adolescent; Adrenal Gland Neoplasms; Adult; Aged; Dihydroxyphenylalanine; Dopamine; Female; Fluorodeoxyglucose F18; Genotype; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Paraganglioma; Pheochromocytoma; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Young Adult | 2009 |
Supplement neuroimaging movement disorders.
Topics: Diagnostic Imaging; Dihydroxyphenylalanine; Humans; Magnetic Resonance Imaging; Movement Disorders; Parkinson Disease; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, Emission-Computed, Single-Photon | 2009 |
Striatal "function-metabolism" mismatch on F-18 FDG/F-18 FDOPA PET/CT.
Topics: Corpus Striatum; Dihydroxyphenylalanine; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Injections, Intravenous; Male; Middle Aged; Oligodendroglioma; Positron-Emission Tomography; Tomography, X-Ray Computed | 2009 |
18F-FDOPA: a multiple-target molecule.
Topics: Adult; Biological Transport; Dihydroxyphenylalanine; Humans; Hyperinsulinism; Infant, Newborn; Neuroendocrine Cells; Neuroendocrine Tumors; Positron-Emission Tomography; Tomography, X-Ray Computed | 2009 |
Limited value of 18F-F-DOPA PET to localize pancreatic insulin-secreting tumors in adults with hyperinsulinemic hypoglycemia.
Topics: Adolescent; Adult; Aged; Child; Dihydroxyphenylalanine; Female; Humans; Hyperinsulinism; Hypoglycemia; Insulin-Secreting Cells; Insulinoma; Male; Middle Aged; Pancreatic Neoplasms; Positron-Emission Tomography; Predictive Value of Tests; Retrospective Studies; Young Adult | 2010 |
Elevated [(18)F]FDOPA utilization in the periaqueductal gray and medial nucleus accumbens of patients with early Parkinson's disease.
Topics: Adult; Aged; Dihydroxyphenylalanine; Female; Humans; Male; Metabolic Clearance Rate; Middle Aged; Nucleus Accumbens; Parkinson Disease; Periaqueductal Gray; Positron-Emission Tomography; Radiopharmaceuticals | 2010 |
Utility of various functional and anatomic imaging modalities for detection of ectopic adrenocorticotropin-secreting tumors.
Topics: ACTH Syndrome, Ectopic; Adult; Aged; Dihydroxyphenylalanine; Female; Fluorine Radioisotopes; Humans; Indium Radioisotopes; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Staging; Sensitivity and Specificity; Somatostatin; Thoracic Neoplasms | 2010 |
Dual PET/CT with (18)F-DOPA and (18)F-FDG in metastatic medullary thyroid carcinoma and rapidly increasing calcitonin levels: Comparison with conventional imaging.
Topics: Adult; Aged; Biomarkers, Tumor; Calcitonin; Carcinoma, Medullary; Chi-Square Distribution; Dihydroxyphenylalanine; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiography; Radiopharmaceuticals; Sensitivity and Specificity; Statistics, Nonparametric; Thyroid Neoplasms; Thyroidectomy | 2010 |
The use of functional imaging in a patient with head and neck paragangliomas.
Topics: Adult; Dihydroxyphenylalanine; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Paraganglioma, Extra-Adrenal; Positron-Emission Tomography; Tomography, X-Ray Computed | 2010 |
Comparative evaluation of F-18 FDOPA, F-18 FDG, and F-18 FLT-PET/CT for metabolic imaging of low grade gliomas.
Topics: Adolescent; Adult; Brain Neoplasms; Child; Child, Preschool; Dideoxynucleosides; Dihydroxyphenylalanine; Female; Fluorodeoxyglucose F18; Glioma; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Tomography, X-Ray Computed; Young Adult | 2009 |
Comparison of (68)Ga-DOTA-Tyr(3)-octreotide and (18)F-fluoro-L-dihydroxyphenylalanine positron emission tomography in neuroendocrine tumor patients.
Topics: Adolescent; Adult; Aged; Dihydroxyphenylalanine; Female; Gallium Radioisotopes; Humans; Male; Middle Aged; Neoplasm Staging; Neuroendocrine Tumors; Octreotide; Positron-Emission Tomography; Young Adult | 2010 |
Neurotransmitter changes in dementia with Lewy bodies and Parkinson disease dementia in vivo.
Topics: Acetylcholine; Aged; Brain; Brain Mapping; Dihydroxyphenylalanine; Dopamine; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Imaging, Three-Dimensional; Lewy Bodies; Lewy Body Disease; Middle Aged; Neuropsychological Tests; Parkinson Disease; Positron-Emission Tomography | 2010 |
Value of combined 6-[18F]fluorodihydroxyphenylalanine PET/CT for imaging of neuroendocrine tumours.
Topics: Adult; Aged; Aged, 80 and over; Dihydroxyphenylalanine; Female; Humans; Male; Middle Aged; Neuroendocrine Tumors; Octreotide; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Spiral Computed | 2010 |
Visualization of cardiac metastasis from medullary thyroid carcinoma on F-18 DOPA PET/CT scan.
Topics: Carcinoma; Dihydroxyphenylalanine; Female; Heart Neoplasms; Humans; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Subtraction Technique; Thyroid Neoplasms; Tomography, X-Ray Computed | 2010 |
Diagnosis: imaging of pheochromocytomas and paragangliomas.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Contrast Media; Diagnostic Imaging; Dihydroxyphenylalanine; Evaluation Studies as Topic; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Paraganglioma; Pheochromocytoma; Positron-Emission Tomography; Tomography, X-Ray Computed | 2010 |
Carbon monoxide poisoning-induced nigrostriatal dopaminergic dysfunction detected using positron emission tomography (PET).
Topics: Adult; Basal Ganglia Diseases; Carbon Monoxide Poisoning; Corpus Striatum; Dihydroxyphenylalanine; Dopamine; Functional Laterality; Globus Pallidus; Humans; Magnetic Resonance Imaging; Necrosis; Nerve Fibers, Myelinated; Positron-Emission Tomography; Putamen; Raclopride; Radioligand Assay; Receptors, Dopamine D2; Substantia Nigra | 2010 |
6-18F-fluoro-L-dihydroxyphenylalanine positron emission tomography is superior to 123I-metaiodobenzyl-guanidine scintigraphy in the detection of extraadrenal and hereditary pheochromocytomas and paragangliomas: correlation with vesicular monoamine transpo
Topics: 3-Iodobenzylguanidine; Adolescent; Adrenal Gland Neoplasms; Adult; Aged; Biomarkers; Data Interpretation, Statistical; Dihydroxyphenylalanine; Female; Genetic Markers; Humans; Immunohistochemistry; Magnetic Resonance Imaging; Male; Middle Aged; Paraganglioma; Pheochromocytoma; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Vesicular Monoamine Transport Proteins; Young Adult | 2010 |
Clinical value of 18-fluorine-fluorodihydroxyphenylalanine positron emission tomography/computed tomography in the follow-up of medullary thyroid carcinoma.
Topics: Adolescent; Adult; Aged; Calcitonin; Carcinoma, Medullary; Child; Dihydroxyphenylalanine; Disease Progression; False Negative Reactions; False Positive Reactions; Female; Follow-Up Studies; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Thyroid Neoplasms; Young Adult | 2010 |
Solitary hepatic metastasis from medullary thyroid carcinoma mimicking atypical hemangioma: insights from multimodality diagnostic approach by MRI, F-18 FDG and F-18 FDOPA PET/CT.
Topics: Diagnosis, Differential; Diagnostic Imaging; Dihydroxyphenylalanine; Female; Fluorodeoxyglucose F18; Hemangioma; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Middle Aged; Positron-Emission Tomography; Thyroid Neoplasms; Tomography, X-Ray Computed | 2010 |
Abnormal frontostriatal interactions in people with prodromal signs of psychosis: a multimodal imaging study.
Topics: Adult; Corpus Striatum; Dihydroxyphenylalanine; Dopamine; Frontal Lobe; Functional Laterality; Humans; Magnetic Resonance Imaging; Memory Disorders; Neural Pathways; Oxygen; Positron-Emission Tomography; Prefrontal Cortex; Psychomotor Performance; Psychotic Disorders; Reaction Time; Schizophrenia; Synaptic Transmission | 2010 |
Gaucher disease ascertained through a Parkinson's center: imaging and clinical characterization.
Topics: Adult; Aged; Dihydroxyphenylalanine; Female; Fluorodeoxyglucose F18; Gaucher Disease; Glucosylceramidase; Humans; Male; Middle Aged; Mutation; Neuropsychological Tests; Olfaction Disorders; Parkinson Disease; Phenotype; Positron-Emission Tomography; Ultrasonography, Doppler, Transcranial | 2010 |
Clinical value of a combined multi-phase contrast enhanced DOPA-PET/CT in neuroendocrine tumours with emphasis on the diagnostic CT component.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Contrast Media; Dihydroxyphenylalanine; Female; Humans; Iohexol; Male; Middle Aged; Neuroendocrine Tumors; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Tomography, X-Ray Computed; Young Adult | 2011 |
Radiosynthesis and evaluation of [18F]Selectfluor bis(triflate).
Topics: Diazonium Compounds; Dihydroxyphenylalanine; Fluorine Radioisotopes; Halogenation; Isotope Labeling; Positron-Emission Tomography; Temperature | 2010 |
Joint factor and kinetic analysis of dynamic FDOPA PET scans of brain cancer patients.
Topics: Algorithms; Brain Neoplasms; Computer Simulation; Dihydroxyphenylalanine; Factor Analysis, Statistical; Glioblastoma; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Kinetics; Metabolic Clearance Rate; Models, Biological; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2010 |
Seasonal effects on human striatal presynaptic dopamine synthesis.
Topics: Adult; Brain Chemistry; Circadian Rhythm; Corpus Striatum; Dihydroxyphenylalanine; Dopamine; Female; Humans; Male; Middle Aged; Neurocognitive Disorders; Positron-Emission Tomography; Presynaptic Terminals; Putamen; Seasonal Affective Disorder; Seasons; Synaptic Transmission; Young Adult | 2010 |
Dyskinesias do not develop after chronic intermittent levodopa therapy in clinically hemiparkinsonian rhesus monkeys.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Antiparkinson Agents; Behavior, Animal; Carotid Arteries; Conditioning, Operant; Corpus Striatum; Dihydroxyphenylalanine; Dopamine Agents; Dyskinesia, Drug-Induced; Dystonia; Female; Injections, Intravenous; Levodopa; Macaca mulatta; MPTP Poisoning; Parkinson Disease, Secondary; Psychomotor Performance; Radionuclide Imaging; Radiopharmaceuticals; Substantia Nigra | 2011 |
Persistent nigrostriatal dopaminergic abnormalities in ex-users of MDMA ('Ecstasy'): an 18F-dopa PET study.
Topics: Adult; Corpus Striatum; Dihydroxyphenylalanine; Dopamine; Humans; Male; Middle Aged; N-Methyl-3,4-methylenedioxyamphetamine; Positron-Emission Tomography; Substance-Related Disorders; Substantia Nigra; Time Factors | 2011 |
Enhanced GDNF expression in dopaminergic cells of monkeys grafted with carotid body cell aggregates.
Topics: Animals; Carotid Body; Cell Count; Cell Transplantation; Dihydroxyphenylalanine; Dopamine; Glial Cell Line-Derived Neurotrophic Factor; Graft Survival; Immunohistochemistry; Macaca fascicularis; Male; Neurons; Phenotype; Positron-Emission Tomography; Radiopharmaceuticals; Substantia Nigra; Tyrosine 3-Monooxygenase | 2011 |
Sensitivity of kinetic macro parameters to changes in dopamine synthesis, storage, and metabolism: a simulation study for [¹⁸F]FDOPA PET by a model with detailed dopamine pathway.
Topics: Animals; Brain; Dihydroxyphenylalanine; Dopamine; Levodopa; Linear Models; Macaca fascicularis; Models, Neurological; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2011 |
I-123 MIBG scintigraphy and 68Ga-DOTANOC PET/CT negative but F-18 DOPA PET/CT positive pheochromocytoma: a case report.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Adult; Dihydroxyphenylalanine; False Negative Reactions; Humans; Male; Organometallic Compounds; Pheochromocytoma; Positron-Emission Tomography; Tomography, X-Ray Computed | 2011 |
The predictive value of preoperative fluorine-18-L-3,4-dihydroxyphenylalanine positron emission tomography-computed tomography scans in children with congenital hyperinsulinism of infancy.
Topics: Child, Preschool; Congenital Hyperinsulinism; Diagnostic Errors; Dihydroxyphenylalanine; Female; Fluorine Radioisotopes; Humans; Infant; Laparoscopy; Male; Pancreas; Positron-Emission Tomography; Predictive Value of Tests; Preoperative Care; Tomography, X-Ray Computed | 2011 |
Pancreatic and hepatobiliary cancers.
Topics: Biliary Tract Neoplasms; Carcinoma, Hepatocellular; Dihydroxyphenylalanine; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Middle Aged; Octreotide; Organometallic Compounds; Pancreas; Pancreatic Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals | 2011 |
GMP production of [18F]FDOPA and issues concerning its quality analyses as in USP "Fluorodopa F 18 Injection".
Topics: Dihydroxyphenylalanine; Equipment Contamination; Injections; Manufactured Materials; Microbiology; Organizations, Nonprofit; Positron-Emission Tomography; Quality Control; United States | 2011 |
Progressive increase in striatal dopamine synthesis capacity as patients develop psychosis: a PET study.
Topics: Adult; Corpus Striatum; Dihydroxyphenylalanine; Dopamine; Female; Fluorine Radioisotopes; Functional Neuroimaging; Humans; Male; Positron-Emission Tomography; Psychotic Disorders | 2011 |
Positron emission tomography in congenital hyperinsulinism.
Topics: Blood Glucose; Breast Feeding; Congenital Hyperinsulinism; Dihydroxyphenylalanine; Female; Humans; Infant; Infant, Newborn; Pancreatectomy; Positron-Emission Tomography; Radiopharmaceuticals | 2011 |
Progression of monoaminergic dysfunction in Parkinson's disease: a longitudinal 18F-dopa PET study.
Topics: Amino Acid Transport Systems, Neutral; Antiparkinson Agents; Biogenic Monoamines; Decarboxylation; Dihydroxyphenylalanine; Dopamine; Female; Follow-Up Studies; Humans; Image Processing, Computer-Assisted; Levodopa; Longitudinal Studies; Male; Middle Aged; Norepinephrine; Parkinson Disease; Positron-Emission Tomography; Radiopharmaceuticals; Serotonin | 2011 |
Rate of 6-[18F]fluorodopa uptake decline in striatal subregions in Parkinson's disease.
Topics: Adult; Aged; Brain Mapping; Corpus Striatum; Dihydroxyphenylalanine; Dopamine Agents; Female; Fluorine Radioisotopes; Humans; Linear Models; Longitudinal Studies; Magnetic Resonance Imaging; Male; Middle Aged; Parkinson Disease; Time Factors; Tomography, Emission-Computed | 2011 |
Fuming over Parkinson disease: are welders at risk?
Topics: Corpus Striatum; Dihydroxyphenylalanine; Fluorine Radioisotopes; Globus Pallidus; Humans; Magnetic Resonance Imaging; Manganese Poisoning; Nervous System; Occupational Diseases; Parkinson Disease; Risk Assessment; Welding | 2011 |
Reduced uptake of [¹⁸F]FDOPA PET in asymptomatic welders with occupational manganese exposure.
Topics: Adult; Aged; Corpus Striatum; Dihydroxyphenylalanine; Female; Fluorine Radioisotopes; Humans; Linear Models; Male; Manganese Poisoning; Middle Aged; Occupational Exposure; Parkinson Disease; Positron-Emission Tomography; Putamen; Substantia Nigra; Welding | 2011 |
Comparison of 123I-MIBG SPECT-CT and 18F-DOPA PET-CT in the evaluation of patients with known or suspected recurrent paraganglioma.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Adult; Aged; Dihydroxyphenylalanine; Female; Humans; Male; Middle Aged; Neoplasm Staging; Paraganglioma; Paraganglioma, Extra-Adrenal; Pheochromocytoma; Positron-Emission Tomography; Recurrence; Retrospective Studies; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; Young Adult | 2011 |
Neuropsychiatric symptoms in Lewy body diffuse disease: a case report.
Topics: Aged; Antidepressive Agents; Cognition Disorders; Depressive Disorder, Major; Dihydroxyphenylalanine; Hallucinations; Humans; Lewy Body Disease; Male; Neuropsychological Tests | 2011 |
Diagnostic accuracy of [¹⁸F]-fluoro-L-dihydroxyphenylalanine positron emission tomography scan for persistent congenital hyperinsulinism in Japan.
Topics: Asian People; Child, Preschool; Congenital Hyperinsulinism; Dihydroxyphenylalanine; Fluorine Radioisotopes; Humans; Infant; Japan; Pancreas; Pancreatectomy; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2011 |
Novel use of F-DOPA PET/CT imaging in a child with paraganglioma/pheochromocytoma syndrome.
Topics: Adolescent; Adrenal Gland Neoplasms; Dihydroxyphenylalanine; Female; Humans; Kidney Neoplasms; Multimodal Imaging; Paraganglioma; Pheochromocytoma; Positron-Emission Tomography; Radiopharmaceuticals; Syndrome; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; Ultrasonography, Interventional; Whole Body Imaging | 2011 |
Graft-induced dyskinesias in Parkinson's disease: High striatal serotonin/dopamine transporter ratio.
Topics: Brain Mapping; Brain Tissue Transplantation; Corpus Striatum; Dihydroxyphenylalanine; Dopamine Plasma Membrane Transport Proteins; Dyskinesias; Functional Laterality; Humans; Longitudinal Studies; Male; Middle Aged; Parkinson Disease; Positron-Emission Tomography; Serotonin Plasma Membrane Transport Proteins; Time Factors; Tomography, Emission-Computed, Single-Photon; Tropanes | 2011 |
A within-subject comparison of 6-[18F]fluoro-m-tyrosine and 6-[18F]fluoro-L-dopa in Parkinson's disease.
Topics: Aged; Brain; Dihydroxyphenylalanine; Female; Fluorine Radioisotopes; Humans; Male; Middle Aged; Parkinson Disease; Severity of Illness Index; Tomography, Emission-Computed; Tyrosine | 2011 |
Total 18F-dopa PET tumour uptake reflects metabolic endocrine tumour activity in patients with a carcinoid tumour.
Topics: Adolescent; Adult; Aged; Biological Transport; Carcinoid Tumor; Dihydroxyphenylalanine; Endocrine Gland Neoplasms; Female; Humans; Image Interpretation, Computer-Assisted; Male; Middle Aged; Positron-Emission Tomography; Retrospective Studies; Young Adult | 2011 |
Sympathetic noradrenergic before striatal dopaminergic denervation: relevance to Braak staging of synucleinopathy.
Topics: Aged; alpha-Synuclein; Autonomic Denervation; Dementia; Dihydroxyphenylalanine; Disease Progression; Dopamine; Dopaminergic Neurons; Gait Disorders, Neurologic; Hallucinations; Humans; Lewy Body Disease; Male; Neostriatum; Norepinephrine; Parkinson Disease; Radiopharmaceuticals; Shy-Drager Syndrome; Sympathetic Nervous System | 2012 |
Automated striatal uptake analysis of ¹⁸F-FDOPA PET images applied to Parkinson's disease patients.
Topics: Automation; Biological Transport; Dihydroxyphenylalanine; Female; Humans; Image Processing, Computer-Assisted; Male; Neostriatum; Occipital Lobe; Parkinson Disease; Positron-Emission Tomography; Retrospective Studies | 2011 |
Lasting 18F-DOPA PET uptake after clinical remission of the focal form of congenital hyperinsulinism.
Topics: ATP-Binding Cassette Transporters; Congenital Hyperinsulinism; Dihydroxyphenylalanine; Follow-Up Studies; Humans; Infant; Infant, Newborn; Insulin-Secreting Cells; Male; Pancreas; Positron-Emission Tomography; Potassium Channels, Inwardly Rectifying; Receptors, Drug; Sulfonylurea Receptors | 2011 |
Comparison of 18F-dopa PET/CT and 123I-MIBG scintigraphy in stage 3 and 4 neuroblastoma: a pilot study.
Topics: 3-Iodobenzylguanidine; Adult; Child; Child, Preschool; Dihydroxyphenylalanine; Female; Humans; Infant; Male; Multimodal Imaging; Neoplasm Staging; Neuroblastoma; Pilot Projects; Positron-Emission Tomography; Tomography, X-Ray Computed | 2012 |
Usefulness of [18F]-DA and [18F]-DOPA for PET imaging in a mouse model of pheochromocytoma.
Topics: Adrenal Gland Neoplasms; Animals; Contrast Media; Dihydroxyphenylalanine; Dopamine; Female; Liver Neoplasms; Lung Neoplasms; Magnetic Resonance Imaging; Mice; Neoplasm Recurrence, Local; Neoplasms, Experimental; Norepinephrine Plasma Membrane Transport Proteins; Ovarian Neoplasms; Pheochromocytoma; Positron-Emission Tomography; Sensitivity and Specificity; Tomography, X-Ray Computed; Vesicular Monoamine Transport Proteins | 2012 |
[¹⁸F]FDOPA uptake in the raphe nuclei complex reflects serotonin transporter availability. A combined [¹⁸F]FDOPA and [¹¹C]DASB PET study in Parkinson's disease.
Topics: Aged; Aniline Compounds; Biological Availability; Dihydroxyphenylalanine; Female; Humans; Male; Parkinson Disease; Positron-Emission Tomography; Radiopharmaceuticals; Raphe Nuclei; Serotonin Plasma Membrane Transport Proteins; Sulfides; Tissue Distribution | 2012 |
18F-DOPA PET/CT biodistribution consideration in 107 consecutive patients with neuroendocrine tumours.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Child; Dihydroxyphenylalanine; Female; Humans; Image Enhancement; Male; Middle Aged; Multimodal Imaging; Neuroendocrine Tumors; Positron-Emission Tomography; Tissue Distribution; Tomography, X-Ray Computed; Young Adult | 2012 |
PET/CT using ¹⁸F-FDOPA provides improved staging of carcinoid tumor patients in a Canadian setting.
Topics: Adult; Aged; Aged, 80 and over; Canada; Carcinoid Tumor; Dihydroxyphenylalanine; Female; Fluorine Radioisotopes; Humans; Intestinal Neoplasms; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prospective Studies; Reproducibility of Results; Sensitivity and Specificity; Somatostatin; Tomography, X-Ray Computed | 2012 |
Comparison of 18F-DOPA, 18F-FDG and 68Ga-somatostatin analogue PET/CT in patients with recurrent medullary thyroid carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Calcitonin; Carcinoma, Neuroendocrine; Dihydroxyphenylalanine; Female; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Precision Medicine; Recurrence; Retrospective Studies; Somatostatin; Thyroid Neoplasms; Tomography, X-Ray Computed | 2012 |
Is there an optimal scan time for 6-[F-18]fluoro-L-DOPA PET in pheochromocytomas and paragangliomas?
Topics: Adolescent; Adrenal Gland Neoplasms; Adult; Aged; Aged, 80 and over; Dihydroxyphenylalanine; Female; Humans; Male; Middle Aged; Paraganglioma; Pheochromocytoma; Positron-Emission Tomography; Time Factors; Young Adult | 2012 |
Clinical utility of functional imaging with ¹⁸F-FDOPA in Von Hippel-Lindau syndrome.
Topics: Adult; Central Nervous System Neoplasms; Cohort Studies; Contrast Media; Dihydroxyphenylalanine; Female; Fluorine Radioisotopes; Humans; Kidney Neoplasms; Male; Middle Aged; Neuroendocrine Tumors; Pancreatic Neoplasms; Positron-Emission Tomography; Prospective Studies; von Hippel-Lindau Disease | 2012 |
Brain monoamine systems in multiple system atrophy: a positron emission tomography study.
Topics: Aged; Biogenic Monoamines; Brain; Dihydroxyphenylalanine; Dopamine; Female; Fluorine Radioisotopes; Humans; Male; Middle Aged; Multiple System Atrophy; Norepinephrine; Parkinson Disease; Positron-Emission Tomography; Serotonin | 2012 |
Transition to psychosis associated with prefrontal and subcortical dysfunction in ultra high-risk individuals.
Topics: Adult; Brain; Brain Mapping; Case-Control Studies; Dihydroxyphenylalanine; Disease Progression; Female; Fluorine Radioisotopes; Functional Neuroimaging; Hippocampus; Humans; Longitudinal Studies; Magnetic Resonance Imaging; Male; Mesencephalon; Pons; Positron-Emission Tomography; Prefrontal Cortex; Prodromal Symptoms; Psychotic Disorders; Radiopharmaceuticals; Risk; Speech Production Measurement | 2012 |
Impact of 3,4-dihydroxy-6-18F-fluoro-L-phenylalanine PET/CT on managing patients with brain tumors: the referring physician's perspective.
Topics: Adult; Aged; Aged, 80 and over; Astrocytoma; Brain Neoplasms; Dihydroxyphenylalanine; Female; Follow-Up Studies; Humans; Image Processing, Computer-Assisted; Logistic Models; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Oligodendroglioma; Patient Care Management; Physicians; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Surveys and Questionnaires; Tomography, X-Ray Computed; Young Adult | 2012 |
5-(2-18F-fluoroethoxy)-L-tryptophan as a substrate of system L transport for tumor imaging by PET.
Topics: Amino Acid Transport System L; Animals; Aromatic Amino Acid Decarboxylase Inhibitors; Aromatic-L-Amino-Acid Decarboxylases; Cell Line, Tumor; Cells, Cultured; Dihydroxyphenylalanine; Enzyme Inhibitors; Female; Image Processing, Computer-Assisted; Isotope Labeling; Mice; Mice, Inbred BALB C; Neoplasm Transplantation; Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Serum Albumin; Tissue Distribution; Tryptophan | 2012 |
Reduced uptake of FDOPA PET in end-stage liver disease with elevated manganese levels.
Topics: Caudate Nucleus; Ceruloplasmin; Dihydroxyphenylalanine; End Stage Liver Disease; Hepatitis B; Humans; Image Processing, Computer-Assisted; Imaging, Three-Dimensional; Liver Cirrhosis, Alcoholic; Magnetic Resonance Imaging; Male; Manganese; Middle Aged; Parkinson Disease; Putamen; Radionuclide Imaging; Radiopharmaceuticals | 2012 |
Partial trisomy 4q associated with young-onset dopa-responsive parkinsonism.
Topics: Adult; Age of Onset; alpha-Synuclein; Antiparkinson Agents; Chromosomes, Human, Pair 4; Dihydroxyphenylalanine; Dopamine Agonists; Female; Gene Duplication; Humans; Intellectual Disability; Karyotyping; Levodopa; Magnetic Resonance Imaging; Parkinson Disease; Positron-Emission Tomography; Radiopharmaceuticals; Trisomy | 2012 |
Midbrain presynaptic dopamine tone predicts sustained and transient neural response to emotional salience in humans: fMRI, MEG and FDOPA PET.
Topics: Adult; Brain Mapping; Dihydroxyphenylalanine; Dopamine; Emotions; Female; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Magnetoencephalography; Male; Mesencephalon; Oxygen; Photic Stimulation; Positron-Emission Tomography; Predictive Value of Tests; Presynaptic Terminals | 2013 |
Functional imaging in hyperinsulinemic hypoglycemia after gastric bypass surgery for morbid obesity.
Topics: Adult; Carbon Radioisotopes; Dihydroxyphenylalanine; Female; Fluorodeoxyglucose F18; Gastric Bypass; Humans; Hyperinsulinism; Hypoglycemia; Nesidioblastosis; Obesity, Morbid; Positron-Emission Tomography; Postoperative Complications | 2012 |
Added value of early 18F-FDOPA PET/CT acquisition time in medullary thyroid cancer.
Topics: Adult; Aged; Carcinoma, Medullary; Dihydroxyphenylalanine; Female; Humans; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Retrospective Studies; Thyroid Neoplasms; Time Factors; Tomography, X-Ray Computed | 2012 |
Increased medial orbitofrontal [18F]fluorodopa uptake in Parkinsonian impulse control disorders.
Topics: Aged; Compulsive Behavior; Dihydroxyphenylalanine; Disruptive, Impulse Control, and Conduct Disorders; Frontal Lobe; Humans; Male; Middle Aged; Parkinsonian Disorders | 2012 |
Terminal ileum neuroendocrine incidentaloma in a patient with sporadic medullary thyroid carcinoma: findings from 18F-FDOPA PET/CT investigation.
Topics: Carcinoma, Neuroendocrine; Dihydroxyphenylalanine; Female; Humans; Ileal Neoplasms; Incidental Findings; Middle Aged; Multimodal Imaging; Neuroendocrine Tumors; Positron-Emission Tomography; Thyroid Neoplasms; Tomography, X-Ray Computed; Whole Body Imaging | 2012 |
Correlation of the genotype of paragangliomas and pheochromocytomas with their metabolic phenotype on 3,4-dihydroxy-6-18F-fluoro-L-phenylalanin PET.
Topics: Adolescent; Adrenal Gland Neoplasms; Adult; Aged; Aged, 80 and over; Biological Transport; Child; Dihydroxyphenylalanine; Female; Genotype; Humans; Male; Middle Aged; Mutation; Paraganglioma; Phenotype; Pheochromocytoma; Positron-Emission Tomography; Retrospective Studies; Tumor Burden; Young Adult | 2012 |
Head-to-head comparison between SRS, (18)F-FDG and (18)F-FDOPA PET/CT in a patient with recurrent SDHC-related jugular paraganglioma.
Topics: Dihydroxyphenylalanine; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Membrane Proteins; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Paraganglioma; Positron-Emission Tomography; Tomography, X-Ray Computed | 2012 |
Recurrent glioma and crossed cerebellar diaschisis in a patient examined with 18F-DOPA and 18F-FDG PET/CT.
Topics: Cerebellar Diseases; Dihydroxyphenylalanine; Female; Fluorodeoxyglucose F18; Glioma; Humans; Middle Aged; Radionuclide Imaging; Recurrence | 2012 |
18F-DOPA PET/CT but not 68Ga-DOTA-TOC PET/CT revealed the underlying cause of ectopic Cushing syndrome.
Topics: Cushing Syndrome; Dihydroxyphenylalanine; Humans; Male; Middle Aged; Multimodal Imaging; Octreotide; Organometallic Compounds; Positron-Emission Tomography; Tomography, X-Ray Computed | 2012 |
In-vivo measurement of LDOPA uptake, dopamine reserve and turnover in the rat brain using [18F]FDOPA PET.
Topics: Animals; Corpus Striatum; Dihydroxyphenylalanine; Disease Models, Animal; Dopamine; Fluorine Radioisotopes; Male; Oxidopamine; Parkinsonian Disorders; Rats; Rats, Sprague-Dawley; Tomography, Emission-Computed | 2013 |
Dopaminergic mechanisms of reduced basal ganglia responses to hedonic reward during interferon alfa administration.
Topics: Adult; Corpus Striatum; Dihydroxyphenylalanine; Dopamine; Female; Hepatitis C, Chronic; Humans; Interferon-alpha; Magnetic Resonance Imaging; Male; Mental Disorders; Middle Aged; Neuropsychological Tests; Positron-Emission Tomography; Reward | 2012 |
Dopamine synthesis capacity in patients with treatment-resistant schizophrenia.
Topics: Adult; Antipsychotic Agents; Corpus Striatum; Dihydroxyphenylalanine; Dopamine; Drug Resistance; Female; Humans; Image Interpretation, Computer-Assisted; Limbic System; Male; Middle Aged; Positron-Emission Tomography; Psychiatric Status Rating Scales; Receptors, Presynaptic; Reference Values; Schizophrenia; Schizophrenic Psychology | 2012 |
Seasonality of striatal dopamine synthesis capacity in Parkinson's disease.
Topics: Adult; Aged; Aged, 80 and over; Corpus Striatum; Dihydroxyphenylalanine; Dopamine; Dopamine Agents; Female; Fluorine Radioisotopes; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Positron-Emission Tomography; Putamen; Seasons | 2012 |
Clinical relevance of 18F-FDG PET and 18F-DOPA PET in recurrent medullary thyroid carcinoma.
Topics: Adult; Aged; Carcinoembryonic Antigen; Carcinoma, Neuroendocrine; Dihydroxyphenylalanine; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Recurrence; Retrospective Studies; Survival Analysis; Thyroid Neoplasms; Young Adult | 2012 |
The role of LAT1 in (18)F-DOPA uptake in malignant gliomas.
Topics: Animals; Biological Transport; Blotting, Western; Brain Neoplasms; Dihydroxyphenylalanine; Fluorescent Antibody Technique; Fluorine Radioisotopes; Glioma; Humans; Immunoenzyme Techniques; Large Neutral Amino Acid-Transporter 1; Mice; Neoplasm Grading; Positron-Emission Tomography; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; RNA, Small Interfering; Tumor Cells, Cultured | 2013 |
Hypofractionated stereotactic radiotherapy and continuous low-dose temozolomide in patients with recurrent or progressive malignant gliomas.
Topics: Adult; Aged; Antineoplastic Agents, Alkylating; Brain Neoplasms; Dacarbazine; Dihydroxyphenylalanine; Disease-Free Survival; Female; Follow-Up Studies; Glioma; Humans; Karnofsky Performance Status; Male; Middle Aged; Radiosurgery; Retrospective Studies; Temozolomide | 2013 |
Characterization of neuroblastic tumors using 18F-FDOPA PET.
Topics: 3-Iodobenzylguanidine; Biological Transport; Carboxy-Lyases; Catecholamines; Dihydroxyphenylalanine; Female; Fluorodeoxyglucose F18; Gene Expression Regulation, Neoplastic; Humans; Infant; Male; Neuroblastoma; Positron-Emission Tomography; Retrospective Studies; Sensitivity and Specificity; Vanilmandelic Acid | 2013 |
Functional characterization of nonmetastatic paraganglioma and pheochromocytoma by (18) F-FDOPA PET: focus on missed lesions.
Topics: Abdominal Neoplasms; Adrenal Gland Neoplasms; Dihydroxyphenylalanine; False Negative Reactions; Head and Neck Neoplasms; Humans; Paraganglioma; Pheochromocytoma; Positron-Emission Tomography; Retrospective Studies; Succinate Dehydrogenase | 2013 |
Neural and behavioral correlates of aberrant salience in individuals at risk for psychosis.
Topics: Adult; Basal Ganglia; Cerebrum; Delusions; Dihydroxyphenylalanine; Dopamine; Female; Functional Neuroimaging; Hippocampus; Humans; Magnetic Resonance Imaging; Male; Positron-Emission Tomography; Prodromal Symptoms; Psychotic Disorders; Risk; Severity of Illness Index; Young Adult | 2013 |
Presynaptic striatal dopamine dysfunction in people at ultra-high risk for psychosis: findings in a second cohort.
Topics: Adult; Basal Ganglia; Cohort Studies; Corpus Striatum; Dihydroxyphenylalanine; Dopamine; Female; Humans; Male; Presynaptic Terminals; Prodromal Symptoms; Psychotic Disorders; Radionuclide Imaging; Risk Factors; Young Adult | 2013 |
Evaluation of quantitative criteria for glioma grading with static and dynamic 18F-FDopa PET/CT.
Topics: Adult; Aged; Aged, 80 and over; Brain Neoplasms; Dihydroxyphenylalanine; Female; Glioma; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Multimodal Imaging; Neoplasm Grading; Neoplasm Invasiveness; Positron-Emission Tomography; Time Factors; Tomography, X-Ray Computed; Young Adult | 2013 |
High incidence of extraadrenal paraganglioma in families with SDHx syndromes detected by functional imaging with [18F]fluorodihydroxyphenylalanine PET.
Topics: Adolescent; Adult; Child; Dihydroxyphenylalanine; False Negative Reactions; Female; Germ-Line Mutation; Humans; Incidence; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Mutation; Paraganglioma, Extra-Adrenal; Positron-Emission Tomography; Sensitivity and Specificity; Succinate Dehydrogenase; Syndrome; Young Adult | 2013 |
Utility of intrastriatal ratios of FDOPA to differentiate idiopathic Parkinson's disease from atypical parkinsonian disorders.
Topics: Diagnosis, Differential; Dihydroxyphenylalanine; Female; Humans; Male; Middle Aged; Neostriatum; Occipital Lobe; Parkinson Disease; Positron-Emission Tomography | 2013 |
Biopsy validation of 18F-DOPA PET and biodistribution in gliomas for neurosurgical planning and radiotherapy target delineation: results of a prospective pilot study.
Topics: Adult; Aged; Brain Neoplasms; Dihydroxyphenylalanine; Female; Follow-Up Studies; Glioma; Humans; Immunoenzyme Techniques; Male; Middle Aged; Neoplasm Grading; Neurosurgical Procedures; Pilot Projects; Positron-Emission Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Image-Guided; Surgery, Computer-Assisted; Tissue Distribution; Young Adult | 2013 |
Partial volume correction using structural-functional synergistic resolution recovery: comparison with geometric transfer matrix method.
Topics: Adult; Algorithms; Brain; Dihydroxyphenylalanine; Dopamine; Female; Humans; Kinetics; Male; Positron-Emission Tomography; Young Adult | 2013 |
Multifocal extra-adrenal paraganglioma evaluated with different PET tracers: comparison between 18F-FDG, 18F-DOPA and 68Ga DOTANOC PET/CT.
Topics: Adult; Dihydroxyphenylalanine; Female; Fluorodeoxyglucose F18; Humans; Multimodal Imaging; Organometallic Compounds; Paraganglioma, Extra-Adrenal; Positron-Emission Tomography; Radioactive Tracers; Tomography, X-Ray Computed | 2013 |
Cognitive slowing in Parkinson's disease is related to frontostriatal dopaminergic dysfunction.
Topics: Aged; Choice Behavior; Cognition Disorders; Corpus Striatum; Dihydroxyphenylalanine; Dopamine; Female; Frontal Lobe; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neuropsychological Tests; Parkinson Disease; Positron-Emission Tomography; Reaction Time; Statistics, Nonparametric | 2013 |
Substantia nigra hyperechogenicity in healthy controls: a [¹⁸Fluoro] Dopa-PET follow-up study.
Topics: Adult; Aged; Dihydroxyphenylalanine; Female; Follow-Up Studies; Humans; Male; Middle Aged; Neurologic Examination; Positron-Emission Tomography; Radiopharmaceuticals; Substantia Nigra | 2013 |
18F-DOPA PET and enhanced CT imaging for congenital hyperinsulinism: initial UK experience from a technologist's perspective.
Topics: Child; Child, Preschool; Congenital Hyperinsulinism; Dihydroxyphenylalanine; Female; Humans; Infant; Infant, Newborn; Male; Medical Laboratory Personnel; Multimodal Imaging; Positron-Emission Tomography; Retrospective Studies; Tomography, X-Ray Computed; United Kingdom | 2013 |
Bone and lymph node metastases from neuroblastoma detected by 18F-DOPA-PET/CT and confirmed by posttherapy 131I-MIBG but negative on diagnostic 123I-MIBG scan.
Topics: 3-Iodobenzylguanidine; Bone Neoplasms; Child; Dihydroxyphenylalanine; Humans; Lymphatic Metastasis; Male; Multimodal Imaging; Neuroblastoma; Positron-Emission Tomography; Tomography, X-Ray Computed | 2014 |
Acute effects of three club drugs on the striatum of rats: evaluation by quantitative autoradiography with [18F]FDOPA.
Topics: Animals; Autoradiography; Corpus Striatum; Dihydroxyphenylalanine; Illicit Drugs; Male; Metabolic Clearance Rate; Radionuclide Imaging; Radiopharmaceuticals; Rats; Tissue Distribution | 2013 |
Comparative diagnostic accuracy of contrast-enhanced MRI and (18)F-FDOPA PET-CT in recurrent glioma.
Topics: Adult; Brain Neoplasms; Contrast Media; Dihydroxyphenylalanine; Female; Glioma; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Recurrence; Reference Standards; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed; Treatment Outcome | 2013 |
Production at the Curie level of no-carrier-added 6-18F-fluoro-L-dopa.
Topics: Dihydroxyphenylalanine; Isotope Labeling; Radiopharmaceuticals | 2013 |
Solid pseudopapillary pancreatic tumor mimicking a neuroendocrine neoplasm on ¹⁸F-FDOPA PET/CT.
Topics: Adult; Carbidopa; Diagnosis, Differential; Dihydroxyphenylalanine; Dopamine Agents; Fluorine Radioisotopes; Humans; Male; Multimodal Imaging; Neuroendocrine Tumors; Pancreas; Pancreatic Neoplasms; Positron-Emission Tomography; Premedication; Radiopharmaceuticals; Tomography, X-Ray Computed | 2013 |
Dopaminergic function in cannabis users and its relationship to cannabis-induced psychotic symptoms.
Topics: Cannabis; Case-Control Studies; Corpus Striatum; Dihydroxyphenylalanine; Dopamine; Dopaminergic Neurons; Female; Functional Neuroimaging; Humans; Male; Marijuana Abuse; Positron-Emission Tomography; Psychoses, Substance-Induced; Young Adult | 2014 |
18F-DOPA PET/CT in the evaluation of hereditary SDH-deficiency paraganglioma-pheochromocytoma syndromes.
Topics: Adolescent; Adrenal Gland Neoplasms; Adult; Dihydroxyphenylalanine; Female; Humans; Male; Middle Aged; Multimodal Imaging; Mutation; Pheochromocytoma; Positron-Emission Tomography; Retrospective Studies; Succinate Dehydrogenase; Tomography, X-Ray Computed; Young Adult | 2014 |
Multitracer PET imaging of bone metastases from paraganglioma: peripheral halo of uptake on 18F-FLT PET mismatching with central uptake of 18F-FDOPA, 18F-fluorodopamine, and 18F-FDG.
Topics: Adrenal Gland Neoplasms; Aged; Biological Transport; Bone Neoplasms; Dideoxynucleosides; Dihydroxyphenylalanine; Dopamine; Fluorodeoxyglucose F18; Humans; Male; Paraganglioma; Positron-Emission Tomography; Radioactive Tracers | 2013 |
Antipsychotic treatment resistance in schizophrenia associated with elevated glutamate levels but normal dopamine function.
Topics: Analysis of Variance; Antipsychotic Agents; Aspartic Acid; Dihydroxyphenylalanine; Dopamine; Female; Glutamic Acid; Humans; Magnetic Resonance Spectroscopy; Male; Positron-Emission Tomography; Protons; Schizophrenia | 2014 |
A retrospective comparison between 68Ga-DOTA-TOC PET/CT and 18F-DOPA PET/CT in patients with extra-adrenal paraganglioma.
Topics: Adult; Aged; Dihydroxyphenylalanine; Female; Humans; Male; Middle Aged; Multimodal Imaging; Octreotide; Organometallic Compounds; Paraganglioma, Extra-Adrenal; Positron-Emission Tomography; Retrospective Studies; Tomography, X-Ray Computed; Young Adult | 2013 |
Could 68Ga-somatostatin analogues replace other PET tracers in evaluating extra-adrenal paragangliomas?
Topics: Dihydroxyphenylalanine; Female; Humans; Male; Multimodal Imaging; Octreotide; Organometallic Compounds; Paraganglioma, Extra-Adrenal; Positron-Emission Tomography; Tomography, X-Ray Computed | 2013 |
Levodopa induces long-lasting modification in the functional activity of the nigrostriatal pathway.
Topics: Animals; Antiparkinson Agents; Aromatic-L-Amino-Acid Decarboxylases; Corpus Striatum; Dihydroxyphenylalanine; Dopamine Plasma Membrane Transport Proteins; Dopaminergic Neurons; Levodopa; Macaca fascicularis; Magnetic Resonance Imaging; Male; Neural Pathways; Parkinsonian Disorders; Positron-Emission Tomography; Substantia Nigra | 2014 |
Midbrain dopamine function in schizophrenia and depression: a post-mortem and positron emission tomographic imaging study.
Topics: Adult; Depressive Disorder, Major; Dihydroxyphenylalanine; Dopamine; Dopamine Agents; Female; Humans; Male; Middle Aged; Neostriatum; Positron-Emission Tomography; Schizophrenia; Substantia Nigra; Tissue Banks; Tyrosine 3-Monooxygenase | 2013 |
The impact of dopamine on aggression: an [18F]-FDOPA PET Study in healthy males.
Topics: Adult; Aggression; Corpus Striatum; Dihydroxyphenylalanine; Dopamine; Humans; Male; Mesencephalon; Positron-Emission Tomography; Radiopharmaceuticals; Reward | 2013 |
High-grade glioma radiation therapy target volumes and patterns of failure obtained from magnetic resonance imaging and 18F-FDOPA positron emission tomography delineations from multiple observers.
Topics: Adult; Aged; Astrocytoma; Brain Neoplasms; Contrast Media; Dihydroxyphenylalanine; Female; Fluorine Radioisotopes; Gadolinium; Glioblastoma; Glioma; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Observer Variation; Oligodendroglioma; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Sensitivity and Specificity; Tumor Burden; Young Adult | 2013 |
On the use of [18F]DOPA as an imaging biomarker for transplanted islet mass.
Topics: Animals; Biological Transport; Carboxylic Acids; Cattle; Cell Line; Dihydroxyphenylalanine; Dopa Decarboxylase; Gene Expression Regulation, Enzymologic; Humans; Insulin-Secreting Cells; Islets of Langerhans; Islets of Langerhans Transplantation; Mice; Organ Size; Positron-Emission Tomography | 2014 |
(18)F-FDOPA PET for differentiating recurrent or progressive brain metastatic tumors from late or delayed radiation injury after radiation treatment.
Topics: Adult; Aged; Brain Neoplasms; Diagnosis, Differential; Dihydroxyphenylalanine; Disease Progression; Female; Fluorine Radioisotopes; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Neoplasm Metastasis; Positron-Emission Tomography; Predictive Value of Tests; Proportional Hazards Models; Radiation Injuries; Radiotherapy; Recurrence; Sensitivity and Specificity; Young Adult | 2014 |
Can (18)F-FDOPA PET/CT predict survival in patients with suspected recurrent glioma? A prospective study.
Topics: Adolescent; Adult; Brain Neoplasms; Child; Dihydroxyphenylalanine; Female; Glioma; Humans; India; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prevalence; Prospective Studies; Radiopharmaceuticals; Reproducibility of Results; Risk Assessment; Sensitivity and Specificity; Survival Rate; Tomography, X-Ray Computed; Young Adult | 2014 |
(18)F-DOPA PET/CT for assessment of response to induction chemotherapy in a child with high-risk neuroblastoma.
Topics: Bone Marrow Neoplasms; Child, Preschool; Dihydroxyphenylalanine; Female; Humans; Induction Chemotherapy; Multimodal Imaging; Neuroblastoma; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Risk Factors; Tomography, X-Ray Computed; Treatment Outcome | 2014 |
Role of 18F-DOPA PET/CT in diagnosis and follow-up of adrenal and extra-adrenal paragangliomas.
Topics: Adolescent; Adrenal Gland Neoplasms; Adult; Aged; Dihydroxyphenylalanine; Female; Follow-Up Studies; Humans; Male; Middle Aged; Multimodal Imaging; Paraganglioma, Extra-Adrenal; Positron-Emission Tomography; Tomography, X-Ray Computed; Young Adult | 2014 |
Intra-individual comparison of ¹⁸F-FET and ¹⁸F-DOPA in PET imaging of recurrent brain tumors.
Topics: Astrocytoma; Brain Neoplasms; Dihydroxyphenylalanine; Glioblastoma; Humans; Neoplasm Recurrence, Local; Positron-Emission Tomography; Tyrosine | 2014 |
Comparison of visual and semiquantitative analysis of 18F-FDOPA-PET/CT for recurrence detection in glioblastoma patients.
Topics: Adult; Aged; Aged, 80 and over; Dihydroxyphenylalanine; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Glioblastoma; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Survival Rate; Tomography, X-Ray Computed; Young Adult | 2014 |
18F-fluorodihydroxyphenylalanine PET/CT in patients with neuroendocrine tumors of unknown origin: relation to tumor origin and differentiation.
Topics: Adult; Aged; Cohort Studies; Dihydroxyphenylalanine; Female; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Neuroendocrine Tumors; Positron-Emission Tomography; Receptors, Somatostatin; Retrospective Studies; Tomography, X-Ray Computed | 2014 |
18F-DOPA and other radiopharmaceuticals for imaging unknown primary neuroendocrine tumors.
Topics: Dihydroxyphenylalanine; Female; Humans; Male; Multimodal Imaging; Neuroendocrine Tumors; Positron-Emission Tomography; Tomography, X-Ray Computed | 2014 |
(18)F-DOPA PET/CT and MRI: description of 12 histologically-verified pheochromocytomas.
Topics: Adrenal Gland Neoplasms; Adult; Aged; Dihydroxyphenylalanine; Female; Fluorine Radioisotopes; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Pheochromocytoma; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2014 |
Prognostic value of ¹⁸F-DOPA PET/CT at the time of recurrence in patients affected by neuroblastoma.
Topics: 3-Iodobenzylguanidine; Abdominal Neoplasms; Adolescent; Adult; Child; Child, Preschool; Dihydroxyphenylalanine; Female; Head and Neck Neoplasms; Humans; Male; Multimodal Imaging; Neuroblastoma; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Recurrence; Thoracic Neoplasms; Tomography, X-Ray Computed; Treatment Outcome | 2014 |
18F-DOPA, a clinically available PET tracer to study brain inflammation?
Topics: Adult; Dihydroxyphenylalanine; Encephalitis; Female; Humans; Male; Middle Aged; Positron-Emission Tomography; Radioactive Tracers | 2014 |
¹⁸F-FLT and ¹⁸F-FDOPA PET kinetics in recurrent brain tumors.
Topics: Adult; Aged; Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Bevacizumab; Brain Neoplasms; Camptothecin; Data Interpretation, Statistical; Dideoxynucleosides; Dihydroxyphenylalanine; Female; Glioma; Humans; Irinotecan; Kinetics; Male; Middle Aged; Models, Biological; Positron-Emission Tomography; Radiopharmaceuticals; Recurrence; Tissue Distribution | 2014 |
Value of 18F-3,4-dihydroxyphenylalanine PET/MR image fusion in pediatric supratentorial infiltrative astrocytomas: a prospective pilot study.
Topics: Adolescent; Astrocytoma; Biomarkers; Brain; Brain Neoplasms; Child; Dihydroxyphenylalanine; Disease Progression; Disease-Free Survival; Female; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Pilot Projects; Positron-Emission Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Treatment Outcome | 2014 |
Treatment response evaluation using 18F-FDOPA PET in patients with recurrent malignant glioma on bevacizumab therapy.
Topics: Adult; Aged; Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Brain Neoplasms; Dihydroxyphenylalanine; Female; Glioma; Humans; Male; Middle Aged; Neoplasm Grading; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Treatment Outcome; Tumor Burden | 2014 |
A dual-tracer study of extrastriatal 6-[18F]fluoro-m-tyrosine and 6-[18F]-fluoro-L-dopa uptake in Parkinson's disease.
Topics: Brain; Dihydroxyphenylalanine; Disease Progression; Female; Fluorine Radioisotopes; Humans; Image Processing, Computer-Assisted; Levodopa; Magnetic Resonance Imaging; Male; Middle Aged; Parkinson Disease; Positron-Emission Tomography; Radiopharmaceuticals; Time Factors; Tyrosine | 2014 |
Dopamine function in cigarette smokers: an [¹⁸F]-DOPA PET study.
Topics: Adult; Case-Control Studies; Corpus Striatum; Dihydroxyphenylalanine; Dopamine; Female; Humans; Male; Positron-Emission Tomography; Radiopharmaceuticals; Smoking; Surveys and Questionnaires; Tobacco Use Disorder | 2014 |
Occurrence of giant focal forms of congenital hyperinsulinism with incorrect visualization by (18) F DOPA-PET/CT scanning.
Topics: Child; Child, Preschool; Congenital Hyperinsulinism; Diagnostic Errors; Dihydroxyphenylalanine; Female; Humans; Infant; Infant, Newborn; Insulin-Secreting Cells; Male; Multimodal Imaging; Pancreatectomy; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2014 |
Parkinson's disease subtypes show a specific link between dopaminergic and glucose metabolism in the striatum.
Topics: Aged; Dihydroxyphenylalanine; Dopamine; Dopaminergic Neurons; Female; Fluorodeoxyglucose F18; Glucose; Humans; Male; Middle Aged; Parkinson Disease; Radionuclide Imaging; Radiopharmaceuticals; Retrospective Studies; Ventral Striatum | 2014 |
¹⁸F-fluorodopa positron-emission tomography: an emerging imaging modality for patients with brain metastases.
Topics: Biopsy; Brain Neoplasms; Dihydroxyphenylalanine; Disease Progression; Humans; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiation Injuries | 2014 |
Dual acquisition of (18)F-FMISO and (18)F-FDOPA.
Topics: Dihydroxyphenylalanine; Humans; Image Processing, Computer-Assisted; Kinetics; Misonidazole; Models, Biological; Positron-Emission Tomography; Radiation Dosage | 2014 |
Fetal and maternal absorbed dose estimates for positron-emitting molecular imaging probes.
Topics: Dihydroxyphenylalanine; Female; Fetus; Fluorodeoxyglucose F18; Humans; Molecular Imaging; Pheochromocytoma; Positron-Emission Tomography; Pregnancy; Radiation Dosage | 2014 |
A novel adaptive discrete cosine transform-domain filter for gap-inpainting of high resolution PET scanners.
Topics: Computer Simulation; Corpus Striatum; Dihydroxyphenylalanine; Dopamine; Head; Humans; Models, Biological; Phantoms, Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Signal Processing, Computer-Assisted | 2014 |
Comparison of the amino acid tracers 18F-FET and 18F-DOPA in high-grade glioma patients.
Topics: Adult; Aged; Aged, 80 and over; Amino Acids; Basal Ganglia; Biopsy; Brain; Brain Neoplasms; Dihydroxyphenylalanine; Female; Glioma; Humans; Logistic Models; Male; Middle Aged; Prospective Studies; Radionuclide Imaging; Recurrence; Tyrosine | 2014 |
Simulation-based partial volume correction for dopaminergic PET imaging: Impact of segmentation accuracy.
Topics: Artifacts; Brain; Computer Simulation; Dihydroxyphenylalanine; Dopamine; Image Enhancement; Image Interpretation, Computer-Assisted; Imaging, Three-Dimensional; Models, Biological; Molecular Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tissue Distribution | 2015 |
Accuracy of F-DOPA PET and perfusion-MRI for differentiating radionecrotic from progressive brain metastases after radiosurgery.
Topics: Adult; Aged; Aged, 80 and over; Brain Neoplasms; Diagnosis, Differential; Dihydroxyphenylalanine; Female; Humans; Magnetic Resonance Angiography; Male; Middle Aged; Multimodal Imaging; Necrosis; Positron-Emission Tomography; Postoperative Period; Radiation Injuries; Radiopharmaceuticals; Radiosurgery; Sensitivity and Specificity; Tomography, X-Ray Computed | 2015 |
18F-FDOPA PET/CT imaging of insulinoma revisited.
Topics: Adult; Aged; Aged, 80 and over; Carbidopa; Dihydroxyphenylalanine; Female; Humans; Hyperinsulinism; Insulinoma; Male; Middle Aged; Multimodal Imaging; Pancreatic Neoplasms; Positron-Emission Tomography; Premedication; Radiopharmaceuticals; Tomography, X-Ray Computed | 2015 |
Relevance of calcitonin cut-off in the follow-up of medullary thyroid carcinoma for conventional imaging and 18-fluorine-fluorodihydroxyphenylalanine PET.
Topics: Adult; Aged; Aged, 80 and over; Calcitonin; Carcinoma, Medullary; Dihydroxyphenylalanine; Female; Follow-Up Studies; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Staging; Prognosis; Radionuclide Imaging; Radiopharmaceuticals; Retrospective Studies; Thyroid Neoplasms; Tomography, X-Ray Computed; Ultrasonography | 2014 |
Myocardial metastases on 6-[18F] fluoro-L-DOPA PET/CT: a retrospective analysis of 116 serotonin producing neuroendocrine tumour patients.
Topics: Carcinoid Heart Disease; Dihydroxyphenylalanine; Female; Heart Neoplasms; Humans; Male; Middle Aged; Multimodal Imaging; Myocardium; Neuroendocrine Tumors; Positron-Emission Tomography; Retrospective Studies; Serotonin; Tomography, X-Ray Computed; Ultrasonography | 2014 |
Combined PET/CT by 18F-FDOPA, 18F-FDA, 18F-FDG, and MRI correlation on a patient with Carney triad.
Topics: Adult; Chondroma; Dihydroxyphenylalanine; Female; Fluorodeoxyglucose F18; Humans; Leiomyosarcoma; Liver Neoplasms; Lung Neoplasms; Magnetic Resonance Imaging; Multimodal Imaging; Paraganglioma, Extra-Adrenal; Positron-Emission Tomography; Radiopharmaceuticals; Stomach Neoplasms; Tomography, X-Ray Computed | 2015 |
Relationship Between [18F]FDOPA PET Uptake, Apparent Diffusion Coefficient (ADC), and Proliferation Rate in Recurrent Malignant Gliomas.
Topics: Adult; Aged; Brain Neoplasms; Cell Proliferation; Contrast Media; Diffusion; Dihydroxyphenylalanine; Female; Glioma; Humans; Image Processing, Computer-Assisted; Immunohistochemistry; Inflammation; Ki-67 Antigen; Magnetic Resonance Imaging; Male; Middle Aged; Mitosis; Mitotic Index; Neoplasm Recurrence, Local; Positron-Emission Tomography; Retrospective Studies; Young Adult | 2015 |
In vivo biodistribution of no-carrier-added 6-18F-fluoro-3,4-dihydroxy-L-phenylalanine (18F-DOPA), produced by a new nucleophilic substitution approach, compared with carrier-added 18F-DOPA, prepared by conventional electrophilic substitution.
Topics: Animals; Cell Line, Tumor; Dihydroxyphenylalanine; Drug Stability; Humans; Male; Mice; Neuroendocrine Tumors; Positron-Emission Tomography; Radiochemistry; Tissue Distribution | 2015 |
Dynamic 18F-FDOPA PET Findings After Carbidopa Premedication in 2 Adult Patients With Insulinoma-Related Hyperinsulinemic Hypoglycemia.
Topics: Adult; Carbidopa; Dihydroxyphenylalanine; Female; Humans; Hyperinsulinism; Hypoglycemia; Insulinoma; Male; Middle Aged; Multimodal Imaging; Pancreatic Neoplasms; Positron-Emission Tomography; Premedication; Radiopharmaceuticals; Tomography, X-Ray Computed | 2015 |
Dopaminergic function and intertemporal choice.
Topics: Adult; Aged; Antiparkinson Agents; Behavior, Addictive; Brain; Case-Control Studies; Caudate Nucleus; Delay Discounting; Dihydroxyphenylalanine; Dopamine; Dopamine Antagonists; Gambling; Humans; Male; Middle Aged; Parkinson Disease; Positron-Emission Tomography; Raclopride; Radiopharmaceuticals; Receptors, Dopamine; Synaptic Transmission; Ventral Striatum; Young Adult | 2015 |
Simultaneous (18)F-FDOPA PET/CT-guided biopsy and radiofrequency ablation of recurrent neuroendocrine hepatic metastasis: further step toward a theranostic approach.
Topics: Ablation Techniques; Dihydroxyphenylalanine; Humans; Ileal Neoplasms; Image-Guided Biopsy; Liver; Liver Neoplasms; Male; Middle Aged; Multimodal Imaging; Neuroendocrine Tumors; Positron-Emission Tomography; Radiofrequency Therapy; Radiopharmaceuticals; Tomography, X-Ray Computed | 2015 |
18F-DOPA vs. 18F-FDG PET/CT in the ectopic ACTH syndrome due to pulmonary carcinoid tumor.
Topics: ACTH Syndrome, Ectopic; Adult; Carcinoid Tumor; Dihydroxyphenylalanine; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Pituitary ACTH Hypersecretion; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2015 |
(18)F-FDOPA accumulation in traumatic rib fractures: a potential pitfall.
Topics: Diagnostic Errors; Dihydroxyphenylalanine; Female; Humans; Male; Middle Aged; Multimodal Imaging; Neuroendocrine Tumors; Positron-Emission Tomography; Radiopharmaceuticals; Rib Fractures; Tomography, X-Ray Computed | 2015 |
Volumetric assessment of recurrent or progressive gliomas: comparison between F-DOPA PET and perfusion-weighted MRI.
Topics: Adult; Aged; Brain Neoplasms; Cone-Beam Computed Tomography; Dihydroxyphenylalanine; Female; Glioma; Humans; Magnetic Resonance Angiography; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals | 2015 |
Brain (18)F-DOPA PET and cognition in de novo Parkinson's disease.
Topics: Aged; Case-Control Studies; Cerebral Cortex; Cognition; Dihydroxyphenylalanine; Dopaminergic Neurons; Executive Function; Female; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Parkinson Disease; Positron-Emission Tomography; Radiopharmaceuticals; Verbal Behavior | 2015 |
Impact of residual (18)F-fluoride in (18)F-FDOPA for the diagnosis of neuroblastoma.
Topics: Bone Neoplasms; Child; Child, Preschool; Chromatography; Dihydroxyphenylalanine; Female; Fluorine Radioisotopes; Follow-Up Studies; Humans; Infant; Male; Multimodal Imaging; N-Myc Proto-Oncogene Protein; Neuroblastoma; Nuclear Proteins; Oncogene Proteins; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Whole Body Imaging | 2015 |
Trimodal (18)F-DOPA PET/CT/MR fusion imaging for optimal restaging of head and neck paragangliomas in a SDHD mutation carrier.
Topics: Adult; Dihydroxyphenylalanine; Female; Head and Neck Neoplasms; Humans; Magnetic Resonance Imaging; Neoplasm Staging; Paraganglioma; Positron Emission Tomography Computed Tomography; Succinate Dehydrogenase | 2016 |
Late Persistent Increased Putaminal 18F-DOPA Uptake Following Ipsilateral Frontal Resection: Evidence for Corticostriatal Synaptic Plasticity?
Topics: Adolescent; Brain Neoplasms; Dihydroxyphenylalanine; Glioma; Humans; Male; Neuronal Plasticity; Putamen; Radionuclide Imaging; Radiopharmaceuticals | 2015 |
The role of 18FDG, 18FDOPA PET/CT and 99mTc bone scintigraphy imaging in Erdheim-Chester disease.
Topics: Adult; Aged; Bone and Bones; Dihydroxyphenylalanine; Erdheim-Chester Disease; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Radionuclide Imaging; Radiopharmaceuticals; Retrospective Studies; Technetium; Tomography, X-Ray Computed | 2015 |
Automated production at the curie level of no-carrier-added 6-[(18)F]fluoro-L-dopa and 2-[(18)F]fluoro-L-tyrosine on a FASTlab synthesizer.
Topics: Automation, Laboratory; Chemistry Techniques, Synthetic; Dihydroxyphenylalanine; Radiopharmaceuticals; Tyrosine | 2015 |
Epiglottic Squamous Cell Carcinoma Showing Unexpected 18F-FDOPA Uptake on PET/CT Investigation.
Topics: Carcinoma, Squamous Cell; Dihydroxyphenylalanine; Epiglottis; Head and Neck Neoplasms; Humans; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Squamous Cell Carcinoma of Head and Neck; Tomography, X-Ray Computed | 2015 |
A compound heterozygous mutation of ABCC8 gene causing a diazoxide-unresponsive congenital hyperinsulinism with an atypical form: Not a focal lesion in the pancreas reported by ¹⁸F-DOPA-PET/CT scan.
Topics: Congenital Hyperinsulinism; Diagnosis, Differential; Dihydroxyphenylalanine; Heterozygote; Humans; Male; Mutation; Pancreas; Positron-Emission Tomography; Sulfonylurea Receptors | 2015 |
Correlation of SUV-Derived Indices With Tumoral Aggressiveness of Gliomas in Static 18F-FDOPA PET: Use in Clinical Practice.
Topics: Adult; Aged; Brain Neoplasms; Dihydroxyphenylalanine; Female; Glioma; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals | 2015 |
Multimodality imaging of bilateral pheochromocytoma. A case report.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Adrenalectomy; Aged; Dihydroxyphenylalanine; False Negative Reactions; Female; Fluorine Radioisotopes; Humans; Iodine Radioisotopes; Magnetic Resonance Imaging; Multimodal Imaging; Neoplasms, Multiple Primary; Pheochromocytoma; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2015 |
(18)F-DOPA PET/CT in the diagnosis and localization of persistent medullary thyroid carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Calcitonin; Carcinoma, Neuroendocrine; Dihydroxyphenylalanine; Female; Humans; Middle Aged; Positron Emission Tomography Computed Tomography; Prognosis; Retrospective Studies; Thyroid Neoplasms; Young Adult | 2016 |
Weak uptake of 123I-MIBG and 18F-FDOPA contrasting with high 18F-FDG uptake in stage I neuroblastoma.
Topics: 3-Iodobenzylguanidine; Brain Neoplasms; Child; Dihydroxyphenylalanine; Female; Fluorodeoxyglucose F18; Humans; Neuroblastoma; Positron-Emission Tomography; Radiopharmaceuticals | 2015 |
Evaluation of 6-11C-Methyl-m-Tyrosine as a PET Probe for Presynaptic Dopaminergic Activity: A Comparison PET Study with β-11C-l-DOPA and 18F-FDOPA in Parkinson Disease Monkeys.
Topics: Animals; Brain; Carbidopa; Dihydroxyphenylalanine; Dopamine Plasma Membrane Transport Proteins; Dopaminergic Neurons; Enzyme Inhibitors; Levodopa; Macaca fascicularis; MPTP Poisoning; Parkinson Disease, Secondary; Positron-Emission Tomography; Radiopharmaceuticals; Receptors, Presynaptic; Tyrosine | 2016 |
68Ga-DOTATATE PET/CT in the Localization of Head and Neck Paragangliomas Compared with Other Functional Imaging Modalities and CT/MRI.
Topics: Adult; Aged; Dihydroxyphenylalanine; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Organometallic Compounds; Paraganglioma; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Succinate Dehydrogenase; Tomography, X-Ray Computed | 2016 |
A family with pheochromocytoma-paraganglioma inherited tumour syndrome. Serial 18F-DOPA PET/CT investigations.
Topics: Adult; Dihydroxyphenylalanine; Female; Humans; Male; Middle Aged; Neoplastic Syndromes, Hereditary; Paraganglioma; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2016 |
Effects of Smoking Cessation on Presynaptic Dopamine Function of Addicted Male Smokers.
Topics: Adult; Case-Control Studies; Caudate Nucleus; Dihydroxyphenylalanine; Dopamine; Female; Functional Neuroimaging; Humans; Kinetics; Longitudinal Studies; Male; Middle Aged; Positron-Emission Tomography; Presynaptic Terminals; Putamen; Smoking Cessation; Substance Withdrawal Syndrome; Young Adult | 2016 |
Relation of 18-F-Dopa PET with hypokinesia-rigidity, tremor and freezing in Parkinson's disease.
Topics: Corpus Striatum; Dihydroxyphenylalanine; Dopamine; Female; Humans; Hypokinesia; Male; Parkinson Disease; Positron-Emission Tomography; Retrospective Studies; Tremor | 2016 |
Ability of (18)F-DOPA PET/CT and fused (18)F-DOPA PET/MRI to assess striatal involvement in paediatric glioma.
Topics: Adolescent; Brain Neoplasms; Child; Child, Preschool; Dihydroxyphenylalanine; False Negative Reactions; False Positive Reactions; Female; Glioma; Humans; Infant; Magnetic Resonance Imaging; Male; Multimodal Imaging; Neostriatum; Positron Emission Tomography Computed Tomography; Retrospective Studies | 2016 |
Diagnostic FDG and FDOPA positron emission tomography scans distinguish the genomic type and treatment outcome of neuroblastoma.
Topics: Cohort Studies; Dihydroxyphenylalanine; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Genomics; Humans; Infant; Male; Neuroblastoma; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Treatment Outcome | 2016 |
(18)F-DOPA: the versatile radiopharmaceutical.
Topics: Biological Transport; Dihydroxyphenylalanine; Humans; Neuroendocrine Tumors; Nuclear Medicine; Radiopharmaceuticals | 2016 |
18F-FDOPA PET/CT-Guided Radiofrequency Ablation of Liver Metastases from Neuroendocrine Tumours: Technical Note on a Preliminary Experience.
Topics: Adult; Catheter Ablation; Dihydroxyphenylalanine; Female; Humans; Liver; Liver Neoplasms; Male; Middle Aged; Neuroendocrine Tumors; Positron Emission Tomography Computed Tomography; Prospective Studies; Radiography, Interventional; Treatment Outcome | 2016 |
18F-DOPA PET/CT and MRI Findings in a Patient With Multiple Meningiomas.
Topics: Dihydroxyphenylalanine; Humans; Magnetic Resonance Imaging; Male; Meningeal Neoplasms; Meningioma; Middle Aged; Neoplasms, Multiple Primary; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2016 |
(18)F-DOPA Positron Emission Tomography in Medulloblastoma: 2 Case Reports.
Topics: Adult; Cerebellar Neoplasms; Dihydroxyphenylalanine; Humans; Image Enhancement; Male; Medulloblastoma; Neuroimaging; Positron-Emission Tomography; Radiopharmaceuticals; Young Adult | 2016 |
Adrenal Metastasis of a Poorly Differentiated Adenocarcinoma Mimicking a Pheochromocytoma on 18F-FDOPA PET/CT.
Topics: Adenocarcinoma; Adrenal Gland Neoplasms; Adult; Diagnosis, Differential; Dihydroxyphenylalanine; Fatal Outcome; Fluorine Radioisotopes; Humans; Male; Pheochromocytoma; Positron Emission Tomography Computed Tomography | 2016 |
Clinical Value of 18F-fluorodihydroxyphenylalanine Positron Emission Tomography/Contrast-enhanced Computed Tomography (18F-DOPA PET/CT) in Patients with Suspected Paraganglioma.
Topics: Adrenal Gland Neoplasms; Adult; Aged; Dihydroxyphenylalanine; False Negative Reactions; Female; Humans; Male; Middle Aged; Paraganglioma; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Young Adult | 2016 |
Multiparametric evaluation of low grade gliomas at follow-up: comparison between diffusion and perfusion MR with (18)F-FDOPA PET.
Topics: Adult; Aged; Brain Neoplasms; Diffusion Magnetic Resonance Imaging; Dihydroxyphenylalanine; Female; Follow-Up Studies; Glioma; Humans; Image Interpretation, Computer-Assisted; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity | 2016 |
Effect of Carbidopa on 18F-FDOPA Uptake in Insulinoma: From Cell Culture to Small-Animal PET Imaging.
Topics: Animals; Carbidopa; Cell Line, Tumor; Dihydroxyphenylalanine; Female; Image Enhancement; Insulinoma; Metabolic Clearance Rate; Mice, Nude; Organ Specificity; Pancreatic Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tissue Distribution | 2017 |
Salience attribution and its relationship to cannabis-induced psychotic symptoms.
Topics: Adult; Brain; Cannabis; Case-Control Studies; Dihydroxyphenylalanine; Dopamine; Female; Humans; Male; Marijuana Abuse; Neostriatum; Positron-Emission Tomography; Psychoses, Substance-Induced; Radiopharmaceuticals; Reward; Young Adult | 2016 |
Small Bowel Carcinoid: The "Dancing Bowel Sign" on 18F-FDOPA PET/CT.
Topics: Adult; Carcinoid Tumor; Dihydroxyphenylalanine; Female; Fluorine Radioisotopes; Humans; Intestinal Neoplasms; Male; Middle Aged; Neuroendocrine Tumors; Positron Emission Tomography Computed Tomography | 2016 |
Fluorodopa is a Promising Fluorine-19 MRI Probe for Evaluating Striatal Dopaminergic Function in a Rat Model of Parkinson's Disease.
Topics: Animals; Corpus Striatum; Dihydroxyphenylalanine; Disease Models, Animal; Dopamine; Dopaminergic Neurons; Fluorine; Fluorine Radioisotopes; Fluorine-19 Magnetic Resonance Imaging; Male; Parkinson Disease; PC12 Cells; Rats; Rats, Wistar | 2017 |
Multiple Neoplasms Simultaneously Diagnosed by Complementary Triple-Tracer PET/CT and 123I-MIBG Scintigraphy.
Topics: 3-Iodobenzylguanidine; Dihydroxyphenylalanine; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasms, Multiple Primary; Octreotide; Organometallic Compounds; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2017 |
Presynaptic Dopamine Capacity in Patients with Treatment-Resistant Schizophrenia Taking Clozapine: An [
Topics: Antipsychotic Agents; Biomarkers; Clozapine; Dihydroxyphenylalanine; Dopamine; Female; Humans; Male; Positron-Emission Tomography; Schizophrenia; Young Adult | 2017 |
Dopamine and Opioid Neurotransmission in Behavioral Addictions: A Comparative PET Study in Pathological Gambling and Binge Eating.
Topics: Adult; Analgesics, Opioid; Behavior, Addictive; Brain; Bulimia; Carbon Radioisotopes; Dihydroxyphenylalanine; Dopamine; Female; Fentanyl; Gambling; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals | 2017 |
Evaluation of two nucleophilic syntheses routes for the automated synthesis of 6-[
Topics: Automation; Chemistry Techniques, Synthetic; Dihydroxyphenylalanine; Radiochemistry; Stereoisomerism | 2017 |
Pancreatic Uptake by 18F-FDOPA PET/CT in Patients With Hypoglycemia After Gastric Bypass Surgery Compared With Controls With or Without Carbidopa Pretreatment.
Topics: Adult; Aged; Carbidopa; Case-Control Studies; Dihydroxyphenylalanine; Dopamine Agents; Female; Fluorine Radioisotopes; Gastric Bypass; Humans; Hypoglycemia; Male; Middle Aged; Pancreas; Pancreatic Diseases; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Premedication; Radiopharmaceuticals; Retrospective Studies | 2017 |
Risk Stratification of Pediatric Patients With Neuroblastoma Using Volumetric Parameters of 18F-FDG and 18F-DOPA PET/CT.
Topics: Adolescent; Child; Child, Preschool; Cone-Beam Computed Tomography; Dihydroxyphenylalanine; Female; Fluorodeoxyglucose F18; Humans; Infant; Lymphatic Metastasis; Male; Neuroblastoma; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2017 |
FDOPA PET-CT of Nonenhancing Brain Tumors.
Topics: Adult; Brain Neoplasms; Dihydroxyphenylalanine; Female; Glioma; Humans; Magnetic Resonance Imaging; Male; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Radiopharmaceuticals | 2017 |
A novel injectable formulation of 6-fluoro-l-DOPA imaging agent for diagnosis of neuroendocrine tumors and Parkinson's disease.
Topics: Animals; beta-Cyclodextrins; Cell Line, Tumor; Chemistry, Pharmaceutical; Cysteine; Dihydroxyphenylalanine; Humans; Magnetic Resonance Imaging; Male; Mice; Mice, Inbred C57BL; Muscle Fibers, Skeletal; Neuroblastoma; Neuroendocrine Tumors; Parkinson Disease; Positron-Emission Tomography; Radiopharmaceuticals; Rats; Rats, Wistar | 2017 |
Dual time point method for the quantification of irreversible tracer kinetics: A reference tissue approach applied to [
Topics: Brain; Case-Control Studies; Caudate Nucleus; Dihydroxyphenylalanine; Discriminant Analysis; Fluorine Radioisotopes; Humans; Image Processing, Computer-Assisted; Linear Models; Models, Theoretical; Parkinson Disease; Positron-Emission Tomography; Putamen; Reference Values; Time Factors | 2017 |
Regulation of dopaminergic function: an [
Topics: Adult; Apomorphine; Brain; Dihydroxyphenylalanine; Dopamine; Dopamine Agonists; Humans; Male; Positron-Emission Tomography; Radiopharmaceuticals; Young Adult | 2017 |
IDH mutation is paradoxically associated with higher
Topics: Adult; Biological Transport; Brain Neoplasms; Dihydroxyphenylalanine; Female; Glioma; Humans; Isocitrate Dehydrogenase; Male; Middle Aged; Mutation; Neoplasm Grading; Positron-Emission Tomography; Retrospective Studies | 2017 |
Comparative assessment of 6-[
Topics: Animals; Apomorphine; Aromatic-L-Amino-Acid Decarboxylases; Dihydroxyphenylalanine; Disease Models, Animal; Dopamine; Fluorine Radioisotopes; Image Processing, Computer-Assisted; Male; Neostriatum; Oxidopamine; Parkinson Disease; Parkinson Disease, Secondary; Positron-Emission Tomography; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Receptors, Presynaptic; Stereotyped Behavior; Tyrosine | 2017 |
Serotonin and dopamine transporter PET changes in the premotor phase of LRRK2 parkinsonism: cross-sectional studies.
Topics: Adult; Aged; Brain; Cross-Sectional Studies; Dihydroxyphenylalanine; Dopamine Plasma Membrane Transport Proteins; Female; Heterozygote; Humans; Leucine-Rich Repeat Serine-Threonine Protein Kinase-2; Male; Middle Aged; Mutation; Parkinson Disease; Positron-Emission Tomography; Radiopharmaceuticals; Serotonin Plasma Membrane Transport Proteins | 2017 |
Presynaptic Dopamine Synthesis Capacity in Schizophrenia and Striatal Blood Flow Change During Antipsychotic Treatment and Medication-Free Conditions.
Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Corpus Striatum; Dihydroxyphenylalanine; Dopamine; Dose-Response Relationship, Drug; Female; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Middle Aged; Oxygen Radioisotopes; Positron-Emission Tomography; Regional Blood Flow; Schizophrenia; Statistics, Nonparametric; Water; Young Adult | 2017 |
Guideline for PET/CT imaging of neuroendocrine neoplasms with
Topics: Dihydroxyphenylalanine; Gallium Radioisotopes; Heterocyclic Compounds, 1-Ring; Humans; Image Interpretation, Computer-Assisted; Neuroendocrine Tumors; Peptides; Positron Emission Tomography Computed Tomography; Practice Guidelines as Topic; Quality Control; Receptors, Somatostatin; Tissue Distribution | 2017 |
The value of 18F-DOPA PET/CT in patients with medullary thyroid carcinoma and increased calcitonin values.
Topics: Adolescent; Adult; Aged; Calcitonin; Carcinoembryonic Antigen; Carcinoma, Neuroendocrine; Dihydroxyphenylalanine; Female; Humans; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Thyroid Neoplasms; Young Adult | 2017 |
18F-FDOPA PET Imaging in Prolactinoma.
Topics: Dihydroxyphenylalanine; Humans; Male; Middle Aged; Pituitary Neoplasms; Positron-Emission Tomography; Prolactinoma; Sensitivity and Specificity | 2017 |
Assessment of neuroinflammation in patients with idiopathic rapid-eye-movement sleep behaviour disorder: a case-control study.
Topics: Aged; Amides; Axons; Case-Control Studies; Caudate Nucleus; Denmark; Dihydroxyphenylalanine; Dopaminergic Neurons; Female; Humans; Inflammation; Isoquinolines; Male; Microglia; Middle Aged; Positron-Emission Tomography; Prospective Studies; Putamen; REM Sleep Behavior Disorder; Spain; Substantia Nigra | 2017 |
[
Topics: Adult; Corpus Striatum; Cross-Sectional Studies; Dihydroxyphenylalanine; Female; Humans; Magnetic Resonance Imaging; Male; Manganese Poisoning; Middle Aged; Occupational Diseases; Occupational Exposure; Parkinsonian Disorders; Positron-Emission Tomography; Welding | 2018 |
Quantitative analysis of normal and pathologic adrenal glands with 18F-FDOPA PET/CT: focus on pheochromocytomas.
Topics: Adrenal Gland Neoplasms; Adrenal Glands; Adrenalectomy; Diagnosis, Differential; Dihydroxyphenylalanine; Female; Humans; Image Interpretation, Computer-Assisted; Male; Metabolic Clearance Rate; Middle Aged; Pheochromocytoma; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Tissue Distribution; Treatment Outcome | 2017 |
Recurrent Scapular Metastasis From Hepatoblastoma Shown on FDG PET/CT and F-DOPA PET/CT.
Topics: Bone Neoplasms; Child; Dihydroxyphenylalanine; Female; Fluorodeoxyglucose F18; Hepatoblastoma; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Positron Emission Tomography Computed Tomography; Recurrence; Scapula | 2017 |
Cardiac sympathetic denervation predicts PD in at-risk individuals.
Topics: Aged; Biomarkers; Dihydroxyphenylalanine; Female; Heart Septum; Heart Ventricles; Humans; Male; Middle Aged; Parkinson Disease; Positron-Emission Tomography; Prodromal Symptoms; Prospective Studies; Risk Factors; Sympathetic Nervous System | 2018 |
18F-DOPA PET/CT and 68Ga-DOTANOC PET/CT scans as diagnostic tools in focal congenital hyperinsulinism: a blinded evaluation.
Topics: Child; Child, Preschool; Congenital Hyperinsulinism; Dihydroxyphenylalanine; Female; Humans; Infant; Male; Organometallic Compounds; Positron Emission Tomography Computed Tomography; Retrospective Studies | 2018 |
Focal 18F-DOPA Uptake in Brain Parenchyma Surrounding Developmental Venous Anomalies.
Topics: Biological Transport; Brain; Brain Neoplasms; Dihydroxyphenylalanine; Female; Humans; Middle Aged; Parenchymal Tissue; Positron-Emission Tomography; Veins | 2018 |
Topics: Antineoplastic Agents, Alkylating; Brain Neoplasms; Dacarbazine; Dihydroxyphenylalanine; Female; Glioma; Humans; Male; Middle Aged; Neoplasm Grading; Positron Emission Tomography Computed Tomography; Radiographic Image Interpretation, Computer-Assisted; Radiopharmaceuticals; Retrospective Studies; Temozolomide; Tumor Burden | 2018 |
Clinical Value of
Topics: Adult; Aged; Aged, 80 and over; Aromatic Amino Acid Decarboxylase Inhibitors; Carbidopa; Dihydroxyphenylalanine; Female; Humans; Insulinoma; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Premedication; Radiopharmaceuticals; Retrospective Studies | 2018 |
Seizure-Induced Increased 18F-DOPA Uptake in a Child With Diffuse Astrocytoma and Transient Brain MRI Abnormalities Related to Status Epilepticus.
Topics: Astrocytoma; Brain; Brain Neoplasms; Child, Preschool; Dihydroxyphenylalanine; Humans; Magnetic Resonance Imaging; Male; Positron-Emission Tomography; Radiopharmaceuticals; Status Epilepticus | 2018 |
18F-FDOPA PET/CT Imaging of MAX-Related Pheochromocytoma.
Topics: Adrenal Gland Neoplasms; Adult; Basic Helix-Loop-Helix Leucine Zipper Transcription Factors; Dihydroxyphenylalanine; Female; Humans; Male; Middle Aged; Mutation; Pheochromocytoma; Positron Emission Tomography Computed Tomography; Young Adult | 2018 |
Determinants of treatment response in first-episode psychosis: an
Topics: Adult; Antipsychotic Agents; Case-Control Studies; Cohort Studies; Corpus Striatum; Dihydroxyphenylalanine; Dopamine; Female; Humans; Male; Positron-Emission Tomography; Prospective Studies; Psychiatric Status Rating Scales; Psychotic Disorders; Treatment Outcome | 2019 |
[
Topics: Adult; Aged; Carcinoma, Neuroendocrine; Dihydroxyphenylalanine; Female; Humans; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Thyroid Neoplasms | 2018 |
Synthesis and evaluation of
Topics: Animals; Celecoxib; Cholangiocarcinoma; Cyclooxygenase 2; Dihydroxyphenylalanine; Disease Models, Animal; Dose-Response Relationship, Drug; Male; Mice; Molecular Structure; Positron-Emission Tomography; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley | 2018 |
False-positive findings on 6-[18F]fluor-l-3,4-dihydroxyphenylalanine PET (
Topics: Adrenal Gland Neoplasms; Adult; Aged; Dihydroxyphenylalanine; False Positive Reactions; Female; Humans; Immunohistochemistry; Intestinal Neoplasms; Male; Middle Aged; Neuroendocrine Tumors; Pancreatic Neoplasms; Paraganglioma; Pheochromocytoma; Positron-Emission Tomography; Radionuclide Imaging; Retrospective Studies; Stomach Neoplasms; Tissue Distribution | 2018 |
The effect of the DISC1 Ser704Cys polymorphism on striatal dopamine synthesis capacity: an [18F]-DOPA PET study.
Topics: Adult; Corpus Striatum; Dihydroxyphenylalanine; Dopamine; Female; Genetic Predisposition to Disease; Humans; Male; MAP Kinase Signaling System; Nerve Tissue Proteins; Polymorphism, Single Nucleotide; Positron-Emission Tomography; Psychotic Disorders; Schizophrenia; Young Adult | 2018 |
18F-FDOPA PET/CT Uptake Parameters Correlate with Catecholamine Secretion in Human Pheochromocytomas.
Topics: Adrenal Gland Neoplasms; Adult; Aged; Catecholamines; Dihydroxyphenylalanine; Female; Humans; Male; Middle Aged; Pheochromocytoma; Positron Emission Tomography Computed Tomography; Retrospective Studies | 2018 |
18F-FDOPA PET/CT of Nonfunctioning Paraganglioma of the Gastroepiploic Pedicle.
Topics: Diagnosis, Differential; Dihydroxyphenylalanine; Female; Gastrointestinal Neoplasms; Humans; Mesentery; Middle Aged; Paraganglioma; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2018 |
18F-FDOPA Uptake Reflects the Efficacy of Dopamine Agonists Treatment in Pituitary Prolactinoma.
Topics: Adult; Bone Neoplasms; Dihydroxyphenylalanine; Dopamine Agonists; Female; Humans; Magnetic Resonance Imaging; Pituitary Neoplasms; Positron-Emission Tomography; Prolactinoma; Radiopharmaceuticals | 2018 |
Physiological Whole-Brain Distribution of [
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Brain; Corpus Striatum; Dihydroxyphenylalanine; Female; Humans; Linear Models; Male; Middle Aged; Positron-Emission Tomography; Tissue Distribution; Young Adult | 2019 |
Discovery of a neuroendocrine tumor of the caecum by mammary metastasis using 18F-DOPA-PET.
Topics: Adult; Breast Neoplasms; Cecal Neoplasms; Dihydroxyphenylalanine; Female; Humans; Neoplasm Metastasis; Neuroendocrine Tumors; Positron-Emission Tomography | 2018 |
The relationship between cortical glutamate and striatal dopamine in first-episode psychosis: a cross-sectional multimodal PET and magnetic resonance spectroscopy imaging study.
Topics: Adult; Corpus Striatum; Cross-Sectional Studies; Dihydroxyphenylalanine; Dopamine; Female; Glutamic Acid; Humans; London; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Psychiatric Status Rating Scales; Psychotic Disorders | 2018 |
Medullary Thyroid Carcinoma: Do Ultrasonography and F-DOPA-PET-CT Influence the Initial Surgical Strategy?
Topics: Adolescent; Adult; Aged; Calcitonin; Carcinoma, Neuroendocrine; Child; Clinical Decision-Making; Dihydroxyphenylalanine; False Negative Reactions; False Positive Reactions; Female; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Mediastinum; Middle Aged; Neck; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Prospective Studies; Sensitivity and Specificity; Thyroid Neoplasms; Tumor Burden; Ultrasonography; Young Adult | 2018 |
Mesolimbic Dopamine Function Is Related to Salience Network Connectivity: An Integrative Positron Emission Tomography and Magnetic Resonance Study.
Topics: Adult; Cerebral Cortex; Dihydroxyphenylalanine; Dopamine; Female; Functional Neuroimaging; Humans; Magnetic Resonance Imaging; Male; Neural Pathways; Oxazines; Positron-Emission Tomography; Ventral Striatum; Young Adult | 2019 |
The role of exposure to pesticides in the etiology of Parkinson's disease: a
Topics: Aged; Austria; Cohort Studies; Dihydroxyphenylalanine; Environmental Exposure; Female; Humans; Israel; Male; Middle Aged; Neostriatum; Parkinson Disease; Parkinson Disease, Secondary; Pesticides; Positron-Emission Tomography | 2019 |
Topics: Biological Transport; Brain Neoplasms; Chromosome Deletion; Chromosomes, Human, Pair 1; Chromosomes, Human, Pair 19; Dihydroxyphenylalanine; Female; Glioma; Humans; Isocitrate Dehydrogenase; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Survival Analysis | 2019 |
The mean striatal
Topics: Amino Acids; Dihydroxyphenylalanine; Fluorodeoxyglucose F18; Glioma; Humans; Positron-Emission Tomography; Tumor Burden | 2019 |
Cardiac Metastases of Small-Bowel Carcinoid
Topics: Adult; Carcinoid Heart Disease; Carcinoid Tumor; Dihydroxyphenylalanine; Humans; Intestinal Neoplasms; Magnetic Resonance Imaging; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals | 2019 |
Covariance statistics and network analysis of brain PET imaging studies.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Brain; Case-Control Studies; Cross-Sectional Studies; Dihydroxyphenylalanine; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Male; Neuroimaging; Positron-Emission Tomography; Radiographic Image Interpretation, Computer-Assisted; Radiopharmaceuticals | 2019 |
Extended Treatment with Glial Cell Line-Derived Neurotrophic Factor in Parkinson's Disease.
Topics: Antiparkinson Agents; Dihydroxyphenylalanine; Female; Fluorine Radioisotopes; Glial Cell Line-Derived Neurotrophic Factor; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Positron-Emission Tomography; Putamen; Randomized Controlled Trials as Topic | 2019 |
Topics: Abdominal Neoplasms; Dihydroxyphenylalanine; Head and Neck Neoplasms; Humans; Hypertension; Image Processing, Computer-Assisted; Mutation; Organometallic Compounds; Paraganglioma; Peptides; Positron Emission Tomography Computed Tomography; Succinate Dehydrogenase | 2019 |
Overall survival and progression-free survival in patients with primary brain tumors after treatment: is the outcome of [
Topics: Adult; Brain Neoplasms; Cohort Studies; Dihydroxyphenylalanine; Female; Humans; Male; Positron Emission Tomography Computed Tomography; Progression-Free Survival; Retrospective Studies; ROC Curve | 2019 |
68Ga-DOTA-Exendin PET-MRI Fusion Imaging in a Case of Insulinoma.
Topics: Adult; Dihydroxyphenylalanine; Female; Humans; Insulinoma; Magnetic Resonance Imaging; Multimodal Imaging; Organometallic Compounds; Pancreatic Neoplasms; Peptides; Positron-Emission Tomography; Radiopharmaceuticals | 2019 |
18F-FDOPA PET Compared With 123I-Metaiodobenzylguanidine Scintigraphy and 18F-FDG PET in Secreting Sporadic Pheochromocytoma.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Dihydroxyphenylalanine; Fluorodeoxyglucose F18; Humans; Male; Pheochromocytoma; Positron Emission Tomography Computed Tomography; Sensitivity and Specificity; Young Adult | 2019 |
Diagnosis of Huntington's disease via sequential 18F-DOPA and 18F-FDG PET/MRI.
Topics: Dihydroxyphenylalanine; Female; Fluorodeoxyglucose F18; Humans; Huntington Disease; Magnetic Resonance Imaging; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Time Factors | 2019 |
Uptake of Pineal Gland Visible on 18F-DOPA PET/CT With Last Generation of SiPM PET/CT.
Topics: Adolescent; Astrocytoma; Biological Transport; Dihydroxyphenylalanine; Female; Humans; Pineal Gland; Positron Emission Tomography Computed Tomography | 2020 |
The effect of a genetic variant at the schizophrenia associated AS3MT/BORCS7 locus on striatal dopamine function: A PET imaging study.
Topics: Adult; Chromosomes, Human, Pair 10; Corpus Striatum; Cytoskeletal Proteins; Dihydroxyphenylalanine; Dopamine; Female; Genetic Predisposition to Disease; Healthy Volunteers; Humans; Male; Methyltransferases; Polymorphism, Single Nucleotide; Positron-Emission Tomography; Schizophrenia | 2019 |
Synchronous bilateral pheochromocytomas and bilobar medullary thyroid carcinoma revealed by
Topics: Adrenal Gland Neoplasms; Adult; Carcinoma, Neuroendocrine; Dihydroxyphenylalanine; Female; Humans; Multiple Endocrine Neoplasia Type 2a; Pheochromocytoma; Positron Emission Tomography Computed Tomography; Thyroid Neoplasms | 2019 |
Diagnostic value of fusion of metabolic and structural images for stereotactic biopsy of brain tumors without enhancement after contrast medium injection.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Biopsy; Brain Neoplasms; Child; Contrast Media; Dihydroxyphenylalanine; Female; Glioma; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Robotics; Sensitivity and Specificity; Stereotaxic Techniques; Young Adult | 2019 |
The relationship between grey matter volume and striatal dopamine function in psychosis: a multimodal
Topics: Dihydroxyphenylalanine; Dopamine; Gray Matter; Humans; Magnetic Resonance Imaging; Positron-Emission Tomography; Psychotic Disorders | 2021 |
Cholinergic denervation in patients with idiopathic rapid eye movement sleep behaviour disorder.
Topics: Aged; Brain; Cholinesterases; Denervation; Dihydroxyphenylalanine; Female; Humans; Male; Middle Aged; Polysomnography; Positron-Emission Tomography; REM Sleep Behavior Disorder | 2020 |
Olfactory dysfunction correlates with putaminal dopamine turnover in early de novo Parkinson's disease.
Topics: Aged; Cohort Studies; Dihydroxyphenylalanine; Dopamine; Dopamine Agents; Female; Humans; Male; Middle Aged; Olfaction Disorders; Parkinson Disease; Positron-Emission Tomography; Putamen | 2020 |
The Role of the Striatum in Learning to Orthogonalize Action and Valence: A Combined PET and 7 T MRI Aging Study.
Topics: Adult; Aged; Aging; Caudate Nucleus; Conditioning, Operant; Dihydroxyphenylalanine; Dopamine; Female; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neostriatum; Organ Size; Positron-Emission Tomography; Punishment; Reward; Young Adult | 2020 |
Which Is the Optimal Scan Time of 18F-DOPA PET/CT in Patients With Recurrent Medullary Thyroid Carcinoma?: Results From a Dynamic Acquisition Study.
Topics: Carcinoma, Neuroendocrine; Dihydroxyphenylalanine; Female; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Recurrence; Retrospective Studies; Thyroid Neoplasms; Time Factors; Whole Body Imaging | 2020 |
Intrastriatal gradient analyses of 18F-FDOPA PET scans for differentiation of Parkinsonian disorders.
Topics: Aged; Caudate Nucleus; Corpus Striatum; Diagnosis, Differential; Dihydroxyphenylalanine; Female; Humans; Male; Middle Aged; Neuroimaging; Parkinson Disease; Parkinsonian Disorders; Positron-Emission Tomography; Putamen; Retrospective Studies | 2020 |
Comparison of 68Ga-Dotatate PET/CT and 18F-FDOPA PET/CT for the diagnosis of pancreatic neuroendocrine tumors in a MEN1 patient.
Topics: Dihydroxyphenylalanine; Female; Humans; Middle Aged; Multiple Endocrine Neoplasia Type 1; Neuroendocrine Tumors; Organometallic Compounds; Pancreatic Neoplasms; Positron Emission Tomography Computed Tomography | 2020 |
Longitudinal Positron Emission Tomography of Dopamine Synthesis in Subjects with GBA1 Mutations.
Topics: Adult; Aged; Case-Control Studies; Dihydroxyphenylalanine; Dopamine; Female; Gaucher Disease; Genetic Predisposition to Disease; Glucosylceramidase; Heterozygote; Homozygote; Humans; Longitudinal Studies; Male; Middle Aged; Mutation; Neostriatum; Parkinson Disease; Positron-Emission Tomography | 2020 |
18F-FDOPA PET/CT Findings in a Patient With Primary Cerebral Amyloidoma.
Topics: Aged; Amyloidosis; Brain Neoplasms; Diagnosis, Differential; Dihydroxyphenylalanine; Female; Glioma; Humans; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2020 |
Network degeneration in Parkinson's disease: multimodal imaging of nigro-striato-cortical dysfunction.
Topics: Aged; Case-Control Studies; Cerebral Cortex; Corpus Striatum; Dihydroxyphenylalanine; Dopamine; Female; Fluorodeoxyglucose F18; Functional Neuroimaging; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Neural Pathways; Parkinson Disease; Positron-Emission Tomography; Putamen; Substantia Nigra | 2020 |
The impact of 18F-FDOPA-PET/MRI image fusion in detecting liver metastasis in patients with neuroendocrine tumors of the gastrointestinal tract.
Topics: Adult; Aged; Aged, 80 and over; Diffusion Tensor Imaging; Dihydroxyphenylalanine; Female; Gastrointestinal Neoplasms; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Neuroendocrine Tumors; Positron-Emission Tomography; Radiographic Image Interpretation, Computer-Assisted; Sensitivity and Specificity; Whole Body Imaging; Young Adult | 2020 |
Metabolic Evolution of Brain Metastasis After Stereotactic Radiosurgery: Mismatch Between F-DOPA and FDG PET.
Topics: Brain Neoplasms; Diagnosis, Differential; Dihydroxyphenylalanine; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Neoplasms, Radiation-Induced; Positron-Emission Tomography; Radiosurgery | 2020 |
Deep learning-guided joint attenuation and scatter correction in multitracer neuroimaging studies.
Topics: Adult; Aged; Aged, 80 and over; Aniline Compounds; Benzothiazoles; Carbolines; Cognitive Dysfunction; Deep Learning; Dihydroxyphenylalanine; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neuroimaging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Young Adult | 2020 |
Altered sensorimotor cortex noradrenergic function in idiopathic REM sleep behaviour disorder - A PET study.
Topics: Aged; Dihydroxyphenylalanine; Female; Humans; Male; Middle Aged; Morpholines; Norepinephrine; Parkinson Disease; Positron-Emission Tomography; Putamen; REM Sleep Behavior Disorder; Sensorimotor Cortex; Thalamus | 2020 |
Prediction of MGMT Status for Glioblastoma Patients Using Radiomics Feature Extraction From
Topics: Adult; Aged; Aged, 80 and over; Algorithms; Brain Neoplasms; Dihydroxyphenylalanine; DNA Modification Methylases; DNA Repair Enzymes; Female; Glioblastoma; Humans; Machine Learning; Male; Methylation; Middle Aged; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Tomography, X-Ray Computed; Tumor Suppressor Proteins; Young Adult | 2020 |
PET Imaging of L-Type Amino Acid Transporter (LAT1) and Cystine-Glutamate Antiporter (x
Topics: Amino Acid Transport System y+; Animals; Breast Neoplasms; Cell Hypoxia; Cell Line, Tumor; Dihydroxyphenylalanine; Female; Gene Expression Regulation, Neoplastic; Glutamates; Humans; Large Neutral Amino Acid-Transporter 1; Mice, Nude; Positron-Emission Tomography; Radiopharmaceuticals; RNA, Messenger | 2020 |
Incidental Metastatic Melanoma Identified on 18F-FDOPA PET/CT With Confirmation by Histology.
Topics: Dihydroxyphenylalanine; Female; Humans; Incidental Findings; Melanoma; Middle Aged; Neoplasm Staging; Paraganglioma; Positron Emission Tomography Computed Tomography; Recurrence | 2020 |
Photopenic Defects in Gliomas With Amino-Acid PET and Relative Prognostic Value: A Multicentric 11C-Methionine and 18F-FDOPA PET Experience.
Topics: Adult; Aged; Brain Neoplasms; Dihydroxyphenylalanine; Female; Glioma; Humans; Male; Methionine; Middle Aged; Positron-Emission Tomography; Progression-Free Survival | 2021 |
Hemispheric Network Expression in Parkinson's Disease: Relationship to Dopaminergic Asymmetries.
Topics: Aged; Corpus Striatum; Dihydroxyphenylalanine; Dopamine; Dopamine Agents; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Nerve Net; Parkinson Disease; Positron-Emission Tomography | 2020 |
High 18F-FDOPA PET Uptake in Primary Central Nervous System Lymphoma.
Topics: Adult; Biological Transport; Central Nervous System Neoplasms; Diagnosis, Differential; Dihydroxyphenylalanine; Humans; Lymphoma, Non-Hodgkin; Male; Positron-Emission Tomography | 2021 |
Maximum Uptake and Hypermetabolic Volume of 18F-FDOPA PET Estimate Molecular Status and Overall Survival in Low-Grade Gliomas: A PET and MRI Study.
Topics: Adult; Biological Transport; Brain Neoplasms; Diffusion Magnetic Resonance Imaging; Dihydroxyphenylalanine; Female; Glioma; Humans; Isocitrate Dehydrogenase; Male; Middle Aged; Mutation; Positron-Emission Tomography; Retrospective Studies; ROC Curve | 2020 |
[18F] FDOPA PET may confirm the clinical diagnosis of Parkinson's disease by imaging the nigro-striatal pathway and the sympathetic cardiac innervation: Proof-of-concept study.
Topics: Aged; Corpus Striatum; Dihydroxyphenylalanine; Female; Heart Ventricles; Humans; Male; Middle Aged; Parkinson Disease; Positron-Emission Tomography; Substantia Nigra; Sympathetic Nervous System; Ventricular Function, Left | 2020 |
Visual interpretation, not SUV ratios, is the ideal method to interpret 18F-DOPA PET scans to aid in the cure of patients with focal congenital hyperinsulinism.
Topics: Child; Child, Preschool; Congenital Hyperinsulinism; Dihydroxyphenylalanine; Female; Humans; Infant; Infant, Newborn; Male; Positron-Emission Tomography | 2020 |
Comparative Performance of 99mTc-TRODAT-1 SPECT/CT and 18F-FDOPA PET/CT Imaging in Patients With Parkinson's Disease, Parkinson-Plus Syndrome, and Essential Tremor.
Topics: Dihydroxyphenylalanine; Essential Tremor; Female; Humans; Male; Middle Aged; Organotechnetium Compounds; Parkinson Disease; Parkinsonian Disorders; Positron Emission Tomography Computed Tomography; Single Photon Emission Computed Tomography Computed Tomography; Tropanes | 2021 |
Prognostic impact of bone metastases detected by
Topics: Aged; Dihydroxyphenylalanine; Humans; Neuroendocrine Tumors; Positron-Emission Tomography; Prognosis | 2021 |
Head-to-Head Comparison of 18F-DOPA PET/CT and 68Ga-DOTANOC PET/CT in Patients With Midgut Neuroendocrine Tumors.
Topics: Adult; Aged; Aged, 80 and over; Dihydroxyphenylalanine; Female; Humans; Intestinal Neoplasms; Male; Middle Aged; Neuroendocrine Tumors; Organometallic Compounds; Pancreatic Neoplasms; Positron Emission Tomography Computed Tomography; Retrospective Studies; Stomach Neoplasms | 2021 |
Comparison of 18F-DOPA Versus 68Ga-DOTATOC as Preferred PET Imaging Tracer in Well-Differentiated Neuroendocrine Neoplasms.
Topics: Adult; Dihydroxyphenylalanine; Female; Humans; Male; Middle Aged; Neuroendocrine Tumors; Octreotide; Organometallic Compounds; Positron-Emission Tomography; Retrospective Studies; Sensitivity and Specificity | 2021 |
Assessment of myocardial sympathetic innervation with 18F-FDOPA-PET/CT in patients with autonomic dysfunction: feasibility study in IPD patients.
Topics: Aged; Dihydroxyphenylalanine; Feasibility Studies; Female; Heart Diseases; Humans; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Primary Dysautonomias | 2022 |
Illustration of the Added Value of 18F-DOPA PET to Multimodal MRI to Distinguish Low- and High-Grade Gliomas.
Topics: Adult; Brain Neoplasms; Dihydroxyphenylalanine; Glioma; Humans; Magnetic Resonance Imaging; Male; Multimodal Imaging; Neoplasm Grading; Positron-Emission Tomography | 2021 |
Striatal dopaminergic alterations in individuals with copy number variants at the 22q11.2 genetic locus and their implications for psychosis risk: a [18F]-DOPA PET study.
Topics: DiGeorge Syndrome; Dihydroxyphenylalanine; DNA Copy Number Variations; Dopamine; Humans; Positron-Emission Tomography; Psychotic Disorders | 2023 |
Letter to the Editor Regarding "
Topics: Cerebellar Neoplasms; Dihydroxyphenylalanine; Humans; Medulloblastoma; Positron-Emission Tomography | 2021 |
In Reply to the Letter to the Editor Regarding "
Topics: Cerebellar Neoplasms; Dihydroxyphenylalanine; Humans; Medulloblastoma; Positron-Emission Tomography | 2021 |
Differential Morphological Diagnosis of Various Forms of Congenital Hyperinsulinism in Children.
Topics: Adenoma; Adenoma, Islet Cell; Congenital Hyperinsulinism; Diagnosis, Differential; Dihydroxyphenylalanine; Fluorescent Antibody Technique; Humans; Hyperplasia; Immunohistochemistry; Infant; Infant, Newborn; Intraoperative Period; Microscopy, Confocal; Pancreas; Pancreatectomy; Pancreatic Neoplasms; Positron Emission Tomography Computed Tomography | 2021 |
Recurrence of a Pheochromocytoma With TNEM127 Mutation Negative on 18F-FDOPA and 18F-FDG but Positive on 123I-MIBG and 68Ga-DOTATOC Imaging.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Aged; Dihydroxyphenylalanine; Female; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Mutation; Octreotide; Organometallic Compounds; Pheochromocytoma; Positron Emission Tomography Computed Tomography | 2022 |
Hybrid PET-MRI for early detection of dopaminergic dysfunction and microstructural degradation involved in Parkinson's disease.
Topics: Aged; Aged, 80 and over; Dihydroxyphenylalanine; Dopamine; Dopaminergic Neurons; Female; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Middle Aged; Parkinson Disease; Positron-Emission Tomography; Putamen; Substantia Nigra | 2021 |
Comparison of Transcranial Sonography and [
Topics: Dihydroxyphenylalanine; Dopamine; Glucosylceramidase; Humans; Mutation; Parkinsonian Disorders; Positron-Emission Tomography; Ultrasonography | 2022 |
Contralateral Posterior Putaminal
Topics: Corpus Striatum; Dihydroxyphenylalanine; Humans; Parkinson Disease; Positron Emission Tomography Computed Tomography; Putamen | 2021 |
Performances of 18F-FDOPA PET/CT in the Preoperative Evaluation of the Peritoneal Cancer Index in Small Intestine Neuroendocrine Tumors.
Topics: Dihydroxyphenylalanine; Humans; Intestine, Small; Neuroendocrine Tumors; Positron Emission Tomography Computed Tomography; Retrospective Studies | 2022 |
Frontostriatothalamic effective connectivity and dopaminergic function in the psychosis continuum.
Topics: Dihydroxyphenylalanine; Dopamine; Humans; Magnetic Resonance Imaging; Neural Pathways; Psychotic Disorders; Schizophrenia | 2023 |
Orbital Metastasis: A Rare but Typical Location of Small Intestine Neuroendocrine Tumor on 18F-FDOPA PET/CT.
Topics: Dihydroxyphenylalanine; Humans; Intestinal Neoplasms; Intestine, Small; Neuroendocrine Tumors; Positron Emission Tomography Computed Tomography | 2022 |
Comparison of 18 F-DOPA and 18 F-DTBZ for PET/CT Imaging of Idiopathic Parkinson Disease.
Topics: Dihydroxyphenylalanine; Humans; Parkinson Disease; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography | 2022 |
Bone metastases in midgut neuroendocrine tumors: imaging characteristics, distribution, and risk factors.
Topics: Bone Neoplasms; Dihydroxyphenylalanine; Fluorodeoxyglucose F18; Humans; Neuroendocrine Tumors; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; Risk Factors | 2022 |
Effect of striatal dopamine on Pavlovian bias. A large [¹⁸F]-DOPA PET study.
Topics: Corpus Striatum; Dihydroxyphenylalanine; Dopamine; Humans; Positron-Emission Tomography | 2023 |
Dose evaluation of the one-year-old child in PET imaging by
Topics: Child; Dihydroxyphenylalanine; Edetic Acid; Fluorodeoxyglucose F18; Humans; Infant; Positron-Emission Tomography | 2023 |